Document and Entity Information
Document and Entity Information - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Mar. 07, 2024 | Jun. 30, 2023 | |
Document Information [Line Items] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Dec. 31, 2023 | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Current Fiscal Year End Date | --12-31 | ||
Entity File Number | 814-01180 | ||
Entity Central Index Key | 0001653384 | ||
Entity Registrant Name | Runway Growth Finance Corp. | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | true | ||
Entity Ex Transition Period | false | ||
ICFR Auditor Attestation Flag | false | ||
Document Financial Statement Error Correction | false | ||
Entity Common Stock, Shares Outstanding | 40,509,269 | ||
Entity Current Reporting Status | Yes | ||
Entity Shell Company | false | ||
Entity Tax Identification Number | 47-5049745 | ||
Entity Address, Address Line One | 205 N. Michigan Ave | ||
Entity Address, Address Line Two | Suite 4200 | ||
Entity Address, City or Town | Chicago | ||
Entity Address, State or Province | IL | ||
Entity Address, Postal Zip Code | 60601 | ||
City Area Code | 312 | ||
Local Phone Number | 698‑6902 | ||
Entity Incorporation, State or Country Code | MD | ||
Entity Interactive Data Current | Yes | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Public Float | $ 293 | ||
Auditor Name | RSM US LLP | ||
Auditor Location | Chicago, Illinois | ||
Auditor Firm ID | 49 | ||
Common Stock, par value $0.01 per share | |||
Document Information [Line Items] | |||
Title of 12(b) Security | Common Stock, par value $0.01 per share | ||
Trading Symbol | RWAY | ||
Security Exchange Name | NASDAQ | ||
7.50% Notes due 2027 | |||
Document Information [Line Items] | |||
Title of 12(b) Security | 7.50% Notes due 2027 | ||
Trading Symbol | RWAYL | ||
Security Exchange Name | NASDAQ | ||
8.00% Notes due 2027 | |||
Document Information [Line Items] | |||
Title of 12(b) Security | 8.00% Notes due 2027 | ||
Trading Symbol | RWAYZ | ||
Security Exchange Name | NASDAQ |
Statements of Assets and Liabil
Statements of Assets and Liabilities - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | |
Assets | |||
Total investments at fair value | $ 1,067,009 | $ 1,126,309 | |
Cash and cash equivalents | 2,970 | 5,761 | |
Interest and fees receivable | 8,269 | 8,766 | |
Other assets | 905 | 930 | |
Total assets | 1,079,153 | 1,141,766 | |
Liabilities | |||
Credit facility | 272,000 | 337,000 | |
Unamortized deferred debt costs | (9,172) | (10,293) | |
Total debt, less unamortized deferred debt costs | 510,078 | 548,957 | |
Incentive fees payable | 12,500 | 8,808 | |
Interest payable | 6,764 | 6,221 | |
Accrued expenses and other liabilities | 2,740 | 1,728 | |
Total liabilities | 532,082 | 565,714 | |
Commitments and contingencies (Note 3) | |||
Net assets | |||
Common stock, par value | 414 | 414 | |
Additional paid-in capital | 605,110 | 605,774 | |
Distributable earnings (losses) | (47,637) | (19,320) | |
Treasury stock | (10,816) | (10,816) | |
Total net assets | $ 547,071 | $ 576,052 | |
Shares of common stock outstanding ($0.01 par value, 100,000,000 shares authorized) | 40,509,269 | 40,509,269 | |
Net asset value per share | [1] | $ 13.5 | $ 14.22 |
2026 Notes | |||
Liabilities | |||
Notes | $ 95,000 | $ 70,000 | |
2027 Notes | |||
Liabilities | |||
Notes | 152,250 | 152,250 | |
Non-Control/Non-Affiliate Investments | |||
Assets | |||
Total investments at fair value | 972,604 | 1,114,935 | |
Affiliate Investments | |||
Assets | |||
Total investments at fair value | 51,456 | 2,084 | |
Control Investments | |||
Assets | |||
Total investments at fair value | 950 | $ 9,290 | |
U.S. Treasury Bills | |||
Assets | |||
Total investments at fair value | $ 41,999 | ||
[1] All per share activity, excluding dividends, is calculated based on the weighted-average shares outstanding for the relevant period. |
Statements of Assets and Liab_2
Statements of Assets and Liabilities (Parenthetical) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Investment cost | $ 1,106,849 | $ 1,150,602 |
Common stock, par value | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Non-Control/Non-Affiliate Investments | ||
Investment cost | $ 1,005,024 | $ 1,126,879 |
Affiliate Investments | ||
Investment cost | 58,861 | 4,551 |
Control Investments | ||
Investment cost | 950 | 19,172 |
U.S. Treasury Bills | ||
Investment cost | $ 42,014 | $ 0 |
Statements of Operations
Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | ||
Investment income | ||||
Other income | $ 488 | $ 2 | $ 1 | |
Total investment income | 164,209 | 107,751 | 71,095 | |
Operating expenses | ||||
Management fees | 16,711 | 11,882 | 8,989 | |
Incentive fees | 19,046 | 13,183 | 9,232 | |
Interest and other debt financing expenses | 43,143 | 16,761 | 4,192 | |
Professional fees | 2,350 | 2,133 | 1,601 | |
Administration agreement expenses | 2,125 | 1,838 | 1,566 | |
Insurance expense | 1,028 | 1,016 | 339 | |
Tax expense | 664 | 291 | 1 | |
Other expenses | 867 | 851 | 683 | |
Total operating expenses | 85,934 | 47,955 | 26,603 | |
Net investment income | 78,275 | 59,796 | 44,492 | |
Net realized and net change in unrealized gain (loss) on investments | ||||
Net realized gain (loss) on investments, including U.S. Treasury Bills | (18,387) | (1,061) | 4,172 | |
Net change in unrealized gain (loss) on investments, including U.S. Treasury Bills | (15,547) | (26,485) | (3,045) | |
Net realized and unrealized gain (loss) on investments | (33,934) | (27,546) | 1,127 | |
Net increase in net assets resulting from operations | $ 44,341 | $ 32,250 | $ 45,619 | |
Net investment income per common share (basic and diluted) | [1] | $ 1.93 | $ 1.46 | $ 1.3 |
Net increase (decrease) in net assets resulting from operations per common share, Basic | 1.09 | 0.79 | 1.33 | |
Net increase (decrease) in net assets resulting from operations per common share, Diluted | $ 1.09 | $ 0.79 | $ 1.33 | |
Weighted average shares outstanding, Basic | 40,509,269 | 40,971,242 | 34,183,358 | |
Weighted average shares outstanding, Diluted | 40,509,269 | 40,971,242 | 34,183,358 | |
From Non-controlled/ Non-affiliated Investments | ||||
Investment income | ||||
Interest income | $ 136,912 | $ 95,264 | $ 63,226 | |
Payment in-kind interest income | 20,083 | 5,558 | 2,992 | |
Dividend income | 1,279 | 1,338 | 1,395 | |
Fee income | 3,342 | 1,383 | 3,364 | |
Net realized and net change in unrealized gain (loss) on investments | ||||
Net realized gain (loss) on investments, including U.S. Treasury Bills | (1,374) | 939 | 4,172 | |
Net change in unrealized gain (loss) on investments, including U.S. Treasury Bills | (20,491) | (18,870) | (16,231) | |
From affiliated investments | ||||
Investment income | ||||
Interest income | 2,090 | 5 | 0 | |
Payment in-kind interest income | 0 | 96 | 0 | |
Fee income | 15 | 8 | 0 | |
Net realized and net change in unrealized gain (loss) on investments | ||||
Net change in unrealized gain (loss) on investments, including U.S. Treasury Bills | (4,938) | (3,476) | 0 | |
From controlled Investments | ||||
Investment income | ||||
Interest income | 0 | 1,112 | 113 | |
Payment in-kind interest income | 0 | 2,985 | 4 | |
Net realized and net change in unrealized gain (loss) on investments | ||||
Net realized gain (loss) on investments, including U.S. Treasury Bills | (17,013) | (2,000) | 0 | |
Net change in unrealized gain (loss) on investments, including U.S. Treasury Bills | $ 9,882 | $ (4,139) | $ 13,186 | |
[1] All per share activity, excluding dividends, is calculated based on the weighted-average shares outstanding for the relevant period. |
Statements of Changes in Net As
Statements of Changes in Net Assets - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Beginning balance | $ 576,052 | $ 606,195 | $ 466,244 |
Beginning balance, Shares | 40,509,269 | ||
Net investment income | $ 78,275 | 59,796 | 44,492 |
Net realized gain (loss) on investments | (18,387) | (1,061) | 4,172 |
Net change in unrealized gain (loss) on investments | (15,547) | (26,485) | (3,045) |
Issuance of common stock, value | 119,294 | ||
Reinvestment of dividends, value | $ 2,500 | $ 10,900 | $ 26,995 |
Reinvestment of dividends, Shares | 204,658 | 781,498 | 1,830,974 |
Acquisition of treasury shares, value | $ (10,816) | ||
Refunds (payments) of offering costs | 16 | $ (7,014) | |
Dividends paid to stockholders | $ (73,322) | (51,593) | (44,943) |
Ending balance | $ 547,071 | $ 576,052 | 606,195 |
Ending balance, Shares | 40,509,269 | 40,509,269 | |
Common Stock | |||
Beginning balance | $ 414 | $ 414 | $ 314 |
Beginning balance, Shares | 40,509,269 | 41,380,614 | 31,414,051 |
Issuance of common stock, value | $ 82 | ||
Issuance of common stock, Shares | 8,135,589 | ||
Reinvestment of dividends, value | $ 18 | ||
Reinvestment of dividends, Shares | 1,830,974 | ||
Acquisition of treasury shares | (871,345) | ||
Ending balance | $ 414 | $ 414 | $ 414 |
Ending balance, Shares | 40,509,269 | 40,509,269 | 41,380,614 |
Treasury Stock | |||
Beginning balance | $ (10,816) | ||
Acquisition of treasury shares, value | $ (10,816) | ||
Ending balance | (10,816) | (10,816) | |
Additional Paid-in Capital | |||
Beginning balance | 605,774 | 606,048 | $ 466,873 |
Issuance of common stock, value | 119,212 | ||
Reinvestment of dividends, value | 26,977 | ||
Refunds (payments) of offering costs | 16 | (7,014) | |
Tax reclassification | (664) | (290) | |
Ending balance | 605,110 | 605,774 | 606,048 |
Distributable Earnings (Losses) | |||
Beginning balance | (19,320) | (267) | (943) |
Net investment income | 78,275 | 59,796 | 44,492 |
Net realized gain (loss) on investments | (18,387) | (1,061) | 4,172 |
Net change in unrealized gain (loss) on investments | (15,547) | (26,485) | (3,045) |
Dividends paid to stockholders | (73,322) | (51,593) | (44,943) |
Tax reclassification | 664 | 290 | |
Ending balance | $ (47,637) | $ (19,320) | $ (267) |
Statements of Changes in Net _2
Statements of Changes in Net Assets (Parenthetical) - shares | Dec. 31, 2023 | Dec. 31, 2022 |
Common Stock | ||
Treasury stock repurchases | 871,345 | 871,345 |
Statements of Cash Flows
Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Cash flows from operating activities | |||
Net increase in net assets resulting from operations | $ 44,341 | $ 32,250 | $ 45,619 |
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities: | |||
Payment-in-kind interest | (19,924) | (8,655) | (2,996) |
Sales or repayments of investments | 296,409 | 168,898 | 303,602 |
Net realized (gain) loss on investments | 18,387 | 1,061 | (4,172) |
Net change in unrealized (gain) loss on investments | 15,547 | 26,485 | 3,045 |
Amortization of fixed income premiums or accretion of discounts | (8,682) | (6,863) | (7,742) |
Amortization of deferred debt costs | 3,027 | 1,390 | 472 |
Changes in operating assets and liabilities: | |||
(Increase) decrease in interest and fees receivable | 497 | (5,782) | (301) |
(Increase) decrease in other assets | 25 | 227 | (599) |
Increase (decrease) in incentive fees payable | 3,692 | 2,798 | 1,003 |
Increase (decrease) in interest payable | 543 | 5,972 | (219) |
Increase (decrease) in accrued expenses and other liabilities | 1,012 | 92 | 486 |
Net cash provided by (used in) operating activities | 112,437 | (359,846) | (61,246) |
Cash flows from financing activities | |||
Payments of deferred debt costs | (1,906) | (10,172) | (400) |
Borrowings under credit facilities | 210,000 | 484,000 | 161,000 |
Repayments under credit facilities | (275,000) | (208,000) | (199,000) |
Proceeds from reverse repurchase agreements | 149,249 | ||
Repayments of reverse repurchase agreements | (44,775) | (174,124) | |
Acquisition of treasury shares | (10,816) | ||
Dividends paid to stockholders | (73,322) | (51,593) | (17,948) |
Refunds (payments) of offering costs | 16 | (7,014) | |
Cash received from common stock issued | 119,294 | ||
Net cash (used in) provided by financing activities | (115,228) | 360,910 | 51,057 |
Net increase (decrease) in cash and cash equivalents | (2,791) | 1,064 | (10,189) |
Cash and cash equivalents at beginning of period | 5,761 | 4,697 | 14,886 |
Cash and cash equivalents at end of period | 2,970 | 5,761 | 4,697 |
Supplemental and non-cash financing cash flow information: | |||
Taxes paid | 340 | 1 | |
Interest paid | 38,099 | 7,784 | 2,773 |
Non-cash dividend reinvestments | 26,995 | ||
U.S. Treasury Bill | |||
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities: | |||
Purchases of investments | (76,973) | (210,002) | |
Sales or maturities of U.S. Treasury Bills | 35,000 | 45,000 | 234,999 |
Purchases of Investments | |||
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities: | |||
Purchases of investments | (200,464) | (622,719) | (424,441) |
2026 Notes | |||
Cash flows from financing activities | |||
Proceeds from Notes | $ 25,000 | 50,000 | $ 20,000 |
2027 Notes | |||
Cash flows from financing activities | |||
Proceeds from Notes | $ 152,250 |
Consolidated Schedule of Invest
Consolidated Schedule of Investments - USD ($) | 12 Months Ended | |||||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | ||||
Investment cost | $ 1,106,849,000 | $ 1,150,602,000 | ||||
Investment Owned, at Fair Value | $ 1,067,009,000 | $ 1,126,309,000 | ||||
Percentage of Net Assets | 195.04% | 195.52% | ||||
Investment, Identifier [Axis]: Affiliate Investments | ||||||
Investment cost | $ 58,861,000 | $ 4,551,000 | ||||
Investment Owned, at Fair Value | $ 51,456,000 | [1] | $ 2,084,000 | [2] | ||
Percentage of Net Assets | 9.41% | 0.36% | ||||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments | ||||||
Investment Owned, at Fair Value | [1] | $ 23,586,000 | ||||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments Coginiti Corp | ||||||
Investment Floor Rate | 10.81% | |||||
Investment Interest PIK | 9.50% | |||||
Maturity Date | Dec. 15, 2022 | |||||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments Health Care Technology | ||||||
Investment cost | 25,897,000 | |||||
Investment Owned, at Fair Value | $ 23,586,000 | |||||
Percentage of Net Assets | 4.31% | |||||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments Health Care Technology Gynesonics, Inc. Investment Type Senior Secured SOFR+8.75%, 8.00% ceiling, 5.00% ETP Initial Acquisition Date 3/1/2023 Maturity Date 11/30/2026 | ||||||
Investment, Spread | 8.75% | |||||
Investment Ceiling Rate | 8% | |||||
Investment Interest ETP | 5% | |||||
Initial Acquisition Date | Mar. 01, 2023 | |||||
Maturity Date | Nov. 30, 2026 | |||||
Principal Amount | $ 25,595 | |||||
Investment cost | 25,897,000 | |||||
Investment Owned, at Fair Value | $ 23,586,000 | |||||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments Senior Secured Gynesonics, Inc. | ||||||
Investment, Spread | 8.75% | |||||
Investment Ceiling Rate | 8% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Nov. 30, 2026 | |||||
Investment Owned, at Fair Value | [1] | $ 23,586,000 | ||||
Investment, Identifier [Axis]: Affiliate Investments Debt investments | ||||||
Investment cost | 25,897,000 | |||||
Investment Owned, at Fair Value | $ 23,586,000 | |||||
Percentage of Net Assets | 4.31% | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments | ||||||
Investment cost | $ 4,551,000 | |||||
Investment Owned, at Fair Value | $ 26,894,000 | [1] | $ 1,174,000 | [2] | ||
Percentage of Net Assets | 0.20% | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Application Software | ||||||
Investment cost | 4,551,000 | $ 4,551,000 | ||||
Investment Owned, at Fair Value | $ 856,000 | $ 1,174,000 | ||||
Percentage of Net Assets | 0.16% | 0.20% | ||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Application Software Coginiti Corp Common Stock Initial Acquisition Date 3/9/2020 | ||||||
Initial Acquisition Date | Mar. 09, 2020 | |||||
Principal/ Shares | 1,040,160 | |||||
Investment cost | $ 4,551,000 | |||||
Investment Owned, at Fair Value | 1,174,000 | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Coginiti Corp | ||||||
Investment Owned, at Fair Value | [2] | 1,174,000 | ||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Coginiti Corp Common Stock | ||||||
Investment Owned, at Fair Value | $ 856,000 | [1] | 1,174,000 | |||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Gynesonics, Inc. Series A-1 Preferred Stock | ||||||
Investment Owned, at Fair Value | [1] | 4,577,000 | ||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Gynesonics, Inc. Series A-2 Preferred Stock | ||||||
Investment Owned, at Fair Value | [1] | 21,461,000 | ||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments | ||||||
Investment cost | 32,651,000 | |||||
Investment Owned, at Fair Value | $ 26,894,000 | |||||
Percentage of Net Assets | 4.92% | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments Application Software Coginiti Corp, Investment Type Equity Common Stock Initial Acquisition Date 3/9/2020 | ||||||
Initial Acquisition Date | Mar. 09, 2020 | |||||
Principal/ Shares | 1,040,160 | |||||
Investment cost | $ 4,551,000 | |||||
Investment Owned, at Fair Value | 856,000 | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments Health Care Technology | ||||||
Investment cost | 28,100,000 | |||||
Investment Owned, at Fair Value | $ 26,038,000 | |||||
Percentage of Net Assets | 4.76% | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments Health Care Technology Gynesonics, Inc. Investment Type Equity Series A-1 Preferred Stock Initial Acquisition Date 10/24/2023 | ||||||
Initial Acquisition Date | Oct. 24, 2023 | |||||
Principal/ Shares | 3,100,000 | |||||
Investment cost | $ 3,100,000 | |||||
Investment Owned, at Fair Value | $ 4,577,000 | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments Health Care Technology Gynesonics, Inc. Investment Type Equity Series A-2 Preferred Stock Initial Acquisition Date 3/1/2023 | ||||||
Initial Acquisition Date | Mar. 01, 2023 | |||||
Principal/ Shares | 3,266,668 | |||||
Investment cost | $ 25,000,000 | |||||
Investment Owned, at Fair Value | 21,461,000 | |||||
Investment, Identifier [Axis]: Affiliate Investments Warrants | ||||||
Investment cost | 313,000 | |||||
Investment Owned, at Fair Value | $ 976,000 | [1] | $ 910,000 | [2] | ||
Percentage of Net Assets | 0.18% | 0.16% | ||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Application Software | ||||||
Investment Owned, at Fair Value | $ 663,000 | $ 910,000 | ||||
Percentage of Net Assets | 0.12% | 0.16% | ||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Application Software Coginiti Corp Common Stock Initial Acquisition Date 3/9/2020 Maturity Date 3/9/2030 | ||||||
Initial Acquisition Date | Mar. 09, 2020 | |||||
Maturity Date | Mar. 09, 2030 | |||||
Principal/ Shares | 811,770 | |||||
Investment Owned, at Fair Value | $ 910,000 | |||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Application Software Coginiti Corp Investment Type Warrants Common Stock Initial Acquisition Date 3/9/2020 Maturity Date 3/9/2030 | ||||||
Initial Acquisition Date | Mar. 09, 2020 | |||||
Maturity Date | Mar. 09, 2030 | |||||
Principal/ Shares | 811,770 | |||||
Investment Owned, at Fair Value | $ 663,000 | |||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Coginiti Corp | ||||||
Investment Owned, at Fair Value | 663,000 | [1] | 910,000 | [2] | ||
Investment, Identifier [Axis]: Affiliate Investments Warrants Gynesonics, Inc. | ||||||
Investment Owned, at Fair Value | [1] | 313,000 | ||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Health Care Technology | ||||||
Investment cost | 313,000 | |||||
Investment Owned, at Fair Value | $ 313,000 | |||||
Percentage of Net Assets | 0.06% | |||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Health Care Technology Gynesonics, Inc. Investment Type Warrants Success Fee Initial Acquisition Date 3/1/2023 Maturity Date 3/1/2030 | ||||||
Initial Acquisition Date | Mar. 01, 2023 | |||||
Maturity Date | Mar. 01, 2030 | |||||
Investment cost | $ 313,000 | |||||
Investment Owned, at Fair Value | 313,000 | |||||
Investment, Identifier [Axis]: Control Investments | ||||||
Investment cost | 950,000 | 19,172,000 | ||||
Investment Owned, at Fair Value | $ 950,000 | [1] | $ 9,290,000 | [2] | $ 29,131,000 | |
Percentage of Net Assets | 0.17% | 1.61% | ||||
Investment, Identifier [Axis]: Control Investments Debt Investments | ||||||
Investment cost | $ 19,172,000 | |||||
Investment Owned, at Fair Value | $ 9,290,000 | [2] | 28,261,000 | |||
Percentage of Net Assets | 1.61% | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Data Processing & Outsourced Services | ||||||
Investment cost | $ 19,172,000 | |||||
Investment Owned, at Fair Value | $ 9,290,000 | |||||
Percentage of Net Assets | 1.61% | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Data Processing & Outsourced Services Pivot3, Inc. LIBOR+8.50% PIK, 11.00% floor, 4.00% ETP Initial Acquisition Date 5/13/2019 Maturity Date 1/15/2023 | ||||||
Investment Floor Rate | 11% | |||||
Investment Interest PIK | 8.50% | |||||
Investment Interest ETP | 4% | |||||
Initial Acquisition Date | May 13, 2019 | |||||
Maturity Date | Jan. 15, 2023 | |||||
Principal Amount | $ 18,598,000 | |||||
Investment cost | 19,172,000 | |||||
Investment Owned, at Fair Value | $ 9,290,000 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Five | ||||||
Investment, Spread | 12% | |||||
Investment Interest Cash Cap | 12% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Jan. 15, 2025 | |||||
Investment Owned, at Fair Value | 1,253,000 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Four | ||||||
Investment, Spread | 12% | |||||
Investment Interest Cash Cap | 12% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Jan. 15, 2025 | |||||
Investment Owned, at Fair Value | 629,000 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc One | ||||||
Investment, Spread | 12% | |||||
Investment Interest Cash Cap | 12% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Jan. 15, 2025 | |||||
Investment Owned, at Fair Value | 7,568,000 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Six | ||||||
Investment, Spread | 12% | |||||
Investment Interest Cash Cap | 12% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Jan. 15, 2025 | |||||
Investment Owned, at Fair Value | 1,008,000 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Three | ||||||
Investment, Spread | 12% | |||||
Investment Interest Cash Cap | 12% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Jan. 15, 2025 | |||||
Investment Owned, at Fair Value | 630,000 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Two | ||||||
Investment, Spread | 12% | |||||
Investment Interest Cash Cap | 12% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Jan. 15, 2025 | |||||
Investment Owned, at Fair Value | 2,523,000 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Pivot3, Inc | ||||||
Investment Floor Rate | 11% | |||||
Investment Interest PIK | 8.50% | |||||
Maturity Date | Nov. 15, 2022 | |||||
Investment Owned, at Fair Value | $ 9,290,000 | [2] | 14,650,000 | |||
Investment, Identifier [Axis]: Control Investments Debt Investments Pivot3, Inc. | ||||||
Investment Floor Rate | 11% | |||||
Investment Interest PIK | 8.50% | |||||
Investment Interest ETP | 4% | |||||
Maturity Date | Oct. 15, 2023 | |||||
Investment Owned, at Fair Value | 9,290,000 | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments | ||||||
Investment cost | $ 950,000 | |||||
Investment Owned, at Fair Value | $ 950,000 | [1] | 870,000 | |||
Percentage of Net Assets | 0.17% | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments Data Processing & Outsourced Services | ||||||
Investment cost | $ 950,000 | |||||
Investment Owned, at Fair Value | $ 950,000 | |||||
Percentage of Net Assets | 0.17% | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments Data Processing & Outsourced Services Pivot3, Inc. Investment Type Equity Equity Interest Initial Acquisition Date 12/31/2023 | ||||||
Initial Acquisition Date | Dec. 31, 2023 | |||||
Investment cost | $ 950,000 | |||||
Investment Owned, at Fair Value | 950,000 | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments Mojix, Inc. Series A-1 Preferred Stock | ||||||
Investment Owned, at Fair Value | $ 870,000 | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments Pivot3, Inc. | ||||||
Investment Owned, at Fair Value | [1] | $ 950,000 | ||||
Investment, Identifier [Axis]: Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software Blueshift Labs, Inc. Investment Type Senior Secured Interest Rate SOFR+6.25%, 11.25% floor, 2.00% PIK, 1.50% ETP Initial Acquisition Date 12/19/2023 Maturity Date 12/15/2028 | ||||||
Investment, Spread | 6.25% | |||||
Investment Floor Rate | 11.25% | |||||
Investment Interest PIK | 2% | |||||
Investment Interest ETP | 1.50% | |||||
Initial Acquisition Date | Dec. 19, 2023 | |||||
Maturity Date | Dec. 15, 2028 | |||||
Principal Amount | $ 25,500,000 | |||||
Investment cost | 25,083,000 | |||||
Investment Owned, at Fair Value | $ 25,083,000 | |||||
Investment, Identifier [Axis]: Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services Interactions Corporation Investment Type Senior Secured Interest Rate SOFR+9.26%, 9.76% floor, 3.4375% ETP Initial Acquisition Date 6/24/2022 Maturity Date 6/15/2027 | ||||||
Investment, Spread | 9.26% | |||||
Investment Floor Rate | 9.76% | |||||
Investment Interest ETP | 3.4375% | |||||
Initial Acquisition Date | Jun. 24, 2022 | |||||
Maturity Date | Jun. 15, 2027 | |||||
Principal Amount | $ 40,000,000 | |||||
Investment cost | 39,907,000 | |||||
Investment Owned, at Fair Value | 39,945,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments | ||||||
Investment cost | 1,005,024,000 | 1,126,879,000 | ||||
Investment Owned, at Fair Value | $ 972,604,000 | $ 1,114,935,000 | ||||
Percentage of Net Assets | 177.78% | 193.55% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments | ||||||
Investment cost | $ 1,091,206,000 | |||||
Investment Owned, at Fair Value | $ 1,084,485,000 | |||||
Percentage of Net Assets | 188.26% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments | ||||||
Investment cost | $ 966,328,000 | |||||
Investment Owned, at Fair Value | $ 954,912,000 | |||||
Percentage of Net Assets | 174.54% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software | ||||||
Investment cost | $ 203,979,000 | $ 180,759,000 | ||||
Investment Owned, at Fair Value | $ 196,540,000 | $ 176,582,000 | ||||
Percentage of Net Assets | 35.92% | 30.66% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software Circadence Corporation Investment Type Senior Secured Interest Rate SOFR+9.50% PIK, 12.26% floor, 7.50% ETP Initial Acquisition Date 12/20/2018 Maturity Date 12/15/2023 | ||||||
Investment Floor Rate | 12.26% | |||||
Investment Interest PIK | 9.50% | |||||
Investment Interest ETP | 7.50% | |||||
Initial Acquisition Date | Dec. 20, 2018 | |||||
Maturity Date | Dec. 15, 2023 | |||||
Principal Amount | $ 19,928,000 | |||||
Investment cost | 21,260,000 | |||||
Investment Owned, at Fair Value | $ 17,083,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software Circadence Corporation Investment Type Senior Secured Interest Rate SOFR+9.50%, 12.26% floor, 10.00% cash cap, 7.50% ETP Initial Acquisition Date 12/20/2018 Maturity Date 3/15/2024 | ||||||
Investment, Spread | 9.50% | |||||
Investment Floor Rate | 12.26% | |||||
Investment Interest Cash Cap | 10% | |||||
Investment Interest ETP | 7.50% | |||||
Initial Acquisition Date | Dec. 20, 2018 | |||||
Maturity Date | Mar. 15, 2024 | |||||
Principal Amount | $ 23,147,000 | |||||
Investment cost | 24,281,000 | |||||
Investment Owned, at Fair Value | $ 19,028,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software Dtex Systems, Inc. Investment Type Senior Secured Interest Rate SOFR+9.25%, 9.75% floor, 1.75% ETP Initial Acquisition Date 6/1/2021 Maturity Date 6/1/2025 | ||||||
Investment, Spread | 9.25% | |||||
Investment Floor Rate | 9.75% | |||||
Investment Interest ETP | 1.75% | |||||
Initial Acquisition Date | Jun. 01, 2021 | |||||
Maturity Date | Jun. 01, 2025 | |||||
Principal Amount | $ 10,000,000 | |||||
Investment cost | 10,033,000 | |||||
Investment Owned, at Fair Value | $ 10,033,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software FiscalNote, Inc. Investment Type Senior Secured Interest Rate PRIME+5.00%, 9.00% floor, 1.00% PIK, 4.25% ETP Initial Acquisition Date 10/19/2020 Maturity Date 7/15/2027 | ||||||
Investment, Spread | 5% | |||||
Investment Floor Rate | 9% | |||||
Investment Interest PIK | 1% | |||||
Investment Interest ETP | 4.25% | |||||
Initial Acquisition Date | Oct. 19, 2020 | |||||
Maturity Date | Jul. 15, 2027 | |||||
Principal Amount | $ 65,251,000 | |||||
Investment cost | 64,466,000 | |||||
Investment Owned, at Fair Value | $ 64,466,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software FiscalNote, Inc. Investment Type Senior Secured Interest Rate PRIME+5.00%, 9.00% floor, 1.00% PIK, 5.75% ETP Initial Acquisition Date 10/19/2020 Maturity Date 7/15/2027 | ||||||
Investment, Spread | 5% | |||||
Investment Floor Rate | 9% | |||||
Investment Interest PIK | 1% | |||||
Investment Interest ETP | 5.75% | |||||
Initial Acquisition Date | Oct. 19, 2020 | |||||
Maturity Date | Jul. 15, 2027 | |||||
Principal Amount | $ 65,916,000 | |||||
Investment cost | 65,868,000 | |||||
Investment Owned, at Fair Value | $ 64,615,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software VTX Intermediate Holdings, Inc. (dba VertexOne) Investment Type Senior Secured Interest Rate SOFR+9.00%, 9.50% floor, 10.00% cash cap, 4.50% ETP Initial Acquisition Date 12/28/2021 Maturity Date 12/28/2026 | ||||||
Investment, Spread | 9% | |||||
Investment Floor Rate | 9.50% | |||||
Investment Interest Cash Cap | 10% | |||||
Investment Interest ETP | 4.50% | |||||
Initial Acquisition Date | Dec. 28, 2021 | |||||
Maturity Date | Dec. 28, 2026 | |||||
Principal Amount | $ 87,971,000 | |||||
Investment cost | 88,747,000 | |||||
Investment Owned, at Fair Value | 87,814,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software VTX Intermediate Holdings, Inc. (dba VertexOne) Investment Type Senior Secured Interest Rate SOFR+9.00%, 9.50% floor, 4.50% ETP Initial Acquisition Date 12/28/2021 Maturity Date 12/28/2026 | ||||||
Investment, Spread | 9% | |||||
Investment Floor Rate | 9.50% | |||||
Investment Interest ETP | 4.50% | |||||
Initial Acquisition Date | Dec. 28, 2021 | |||||
Maturity Date | Dec. 28, 2026 | |||||
Principal Amount | $ 85,000,000 | |||||
Investment cost | 85,000,000 | |||||
Investment Owned, at Fair Value | 85,000,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Asset Management & Custody Banks | ||||||
Investment cost | 7,888,000 | |||||
Investment Owned, at Fair Value | $ 7,860,000 | |||||
Percentage of Net Assets | 1.44% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Asset Management & Custody Banks Betterment Holdings, Inc. Investment Type Senior Secured Interest Rate PRIME+4.50%, 8.50% floor Initial Acquisition Date 10/6/2023 Maturity Date 10/6/2027 | ||||||
Investment, Spread | 4.50% | |||||
Investment Floor Rate | 8.50% | |||||
Initial Acquisition Date | Oct. 06, 2023 | |||||
Maturity Date | Oct. 06, 2027 | |||||
Principal Amount | $ 8,000,000 | |||||
Investment cost | 7,888,000 | |||||
Investment Owned, at Fair Value | 7,860,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Biotechnology | ||||||
Investment cost | 39,504,000 | |||||
Investment Owned, at Fair Value | $ 39,709,000 | |||||
Percentage of Net Assets | 6.89% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Biotechnology Mustang Bio, Inc. Investment Type Senior Secured Interest Rate SOFR+8.75%, 9.25% floor, 3.50% ETP Initial Acquisition Date 3/4/2022 Maturity Date 4/15/2027 | ||||||
Investment, Spread | 8.75% | |||||
Investment Floor Rate | 9.25% | |||||
Investment Interest ETP | 3.50% | |||||
Initial Acquisition Date | Mar. 04, 2022 | |||||
Maturity Date | Apr. 15, 2027 | |||||
Principal Amount | $ 30,000,000 | |||||
Investment cost | 29,709,000 | |||||
Investment Owned, at Fair Value | $ 29,709,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Biotechnology TRACON Pharmaceuticals, Inc. Investment Type Senior Secured Interest Rate PRIME+5.00%, 8.50% floor, 4.25% ETP Initial Acquisition Date 9/2/2022 Maturity Date 9/1/2026 | ||||||
Investment, Spread | 5% | |||||
Investment Floor Rate | 8.50% | |||||
Investment Interest ETP | 4.25% | |||||
Initial Acquisition Date | Sep. 02, 2022 | |||||
Maturity Date | Sep. 01, 2026 | |||||
Principal Amount | $ 10,000,000 | |||||
Investment cost | 9,795,000 | |||||
Investment Owned, at Fair Value | 10,000,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services | ||||||
Investment cost | 105,581,000 | 86,551,000 | ||||
Investment Owned, at Fair Value | $ 104,581,000 | $ 86,182,000 | ||||
Percentage of Net Assets | 19.12% | 14.96% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services Elevate Services, Inc. Investment Type Senior Secured Interest Rate SOFR+7.50%, 12.78% floor Initial Acquisition Date 7/10/2023 Maturity Date 7/10/2027 | ||||||
Investment, Spread | 7.50% | |||||
Investment Floor Rate | 12.78% | |||||
Initial Acquisition Date | Jul. 10, 2023 | |||||
Maturity Date | Jul. 10, 2027 | |||||
Principal Amount | $ 20,000,000 | |||||
Investment cost | 19,424,000 | |||||
Investment Owned, at Fair Value | $ 19,424,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services Interactions Corporation Investment Type Senior Secured Interest Rate SOFR+9.26%, 9.76% floor, 3.4375% ETP Initial Acquisition Date 6/24/2022 Maturity Date 6/15/2027 | ||||||
Investment, Spread | 9.26% | |||||
Investment Floor Rate | 9.76% | |||||
Investment Interest ETP | 3.4375% | |||||
Initial Acquisition Date | Jun. 24, 2022 | |||||
Maturity Date | Jun. 15, 2027 | |||||
Principal Amount | $ 40,000,000 | |||||
Investment cost | 39,504,000 | |||||
Investment Owned, at Fair Value | $ 39,504,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services ShareThis, Inc. Investment Type Senior Secured Interest Rate SOFR+8.25%, 10.86% floor, 3.00% ETP Initial Acquisition Date 8/18/2020 Maturity Date 7/15/2025 | ||||||
Investment, Spread | 8.25% | |||||
Investment Floor Rate | 10.86% | |||||
Investment Interest ETP | 3% | |||||
Initial Acquisition Date | Aug. 18, 2020 | |||||
Maturity Date | Jul. 15, 2025 | |||||
Principal Amount | $ 1,000,000 | |||||
Investment cost | 1,026,000 | |||||
Investment Owned, at Fair Value | $ 1,007,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services ShareThis, Inc. Investment Type Senior Secured Interest Rate SOFR+8.25%, 10.86% floor, 3.00% ETP Initial Acquisition Date 8/18/2020 Maturity Date 9/30/2024 | ||||||
Investment, Spread | 8.25% | |||||
Investment Floor Rate | 10.86% | |||||
Investment Interest ETP | 3% | |||||
Initial Acquisition Date | Aug. 18, 2020 | |||||
Maturity Date | Sep. 30, 2024 | |||||
Principal Amount | $ 950,000 | |||||
Investment cost | 978,000 | |||||
Investment Owned, at Fair Value | $ 947,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services ShareThis, Inc. Investment Type Senior Secured Interest Rate SOFR+9.25%, 11.86% floor, 3.00% ETP Initial Acquisition Date 12/3/2018 Maturity Date 7/15/2025 | ||||||
Investment, Spread | 9.25% | |||||
Investment Floor Rate | 11.86% | |||||
Investment Interest ETP | 3% | |||||
Initial Acquisition Date | Dec. 03, 2018 | |||||
Maturity Date | Jul. 15, 2025 | |||||
Principal Amount | $ 21,000,000 | |||||
Investment cost | 21,500,000 | |||||
Investment Owned, at Fair Value | $ 21,150,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services ShareThis, Inc. Investment Type Senior Secured Interest Rate SOFR+9.25%, 11.86% floor, 3.00% ETP Initial Acquisition Date 12/3/2018 Maturity Date 9/30/2024 | ||||||
Investment, Spread | 9.25% | |||||
Investment Floor Rate | 11.86% | |||||
Investment Interest ETP | 3% | |||||
Initial Acquisition Date | Dec. 03, 2018 | |||||
Maturity Date | Sep. 30, 2024 | |||||
Principal Amount | $ 19,950,000 | |||||
Investment cost | 20,503,000 | |||||
Investment Owned, at Fair Value | $ 19,895,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services Vesta Payment Solutions, Inc. Investment Type Senior Secured Interest Rate SOFR+7.00%, 9.00% floor, 3.00% ETP Initial Acquisition Date 11/29/2022 Maturity Date 11/15/2026 | ||||||
Investment, Spread | 7% | 7% | ||||
Investment Floor Rate | 9% | 9% | ||||
Investment Interest ETP | 3% | 3% | ||||
Initial Acquisition Date | Nov. 29, 2022 | Nov. 29, 2022 | ||||
Maturity Date | Nov. 15, 2026 | Nov. 15, 2026 | ||||
Principal Amount | $ 25,000,000 | $ 25,000,000 | ||||
Investment cost | 24,769,000 | 24,521,000 | ||||
Investment Owned, at Fair Value | 24,370,000 | 24,521,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Education Services | ||||||
Investment cost | 25,702,000 | 25,305,000 | ||||
Investment Owned, at Fair Value | $ 25,796,000 | $ 25,305,000 | ||||
Percentage of Net Assets | 4.72% | 4.39% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Education Services Turning Tech Intermediate, Inc. (dba Echo 360, Inc.) Investment Type Senior Secured Interest Rate SOFR+8.50%, 9.00% floor, 13.00% cash cap, 3.00% ETP Initial Acquisition Date 6/22/2021 Maturity Date 12/14/2025 | ||||||
Investment, Spread | 8.50% | 8.50% | ||||
Investment Floor Rate | 9% | 9% | ||||
Investment Interest Cash Cap | 13% | 13% | ||||
Investment Interest ETP | 3% | 3% | ||||
Initial Acquisition Date | Jun. 22, 2021 | Jun. 22, 2021 | ||||
Maturity Date | Dec. 14, 2025 | Dec. 14, 2025 | ||||
Principal Amount | $ 25,218,000 | $ 25,000,000 | ||||
Investment cost | 25,702,000 | 25,305,000 | ||||
Investment Owned, at Fair Value | 25,796,000 | 25,305,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Electronic Equipment & Instruments | ||||||
Investment cost | 26,323,000 | 77,551,000 | ||||
Investment Owned, at Fair Value | $ 26,790,000 | $ 77,551,000 | ||||
Percentage of Net Assets | 4.90% | 13.46% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Electronic Equipment & Instruments Brivo, Inc. Investment Type Senior Secured Interest Rate SOFR+6.85%, 10.89% floor, 3.00% ETP Initial Acquisition Date 10/20/2022 Maturity Date 10/20/2027 | ||||||
Investment, Spread | 6.85% | |||||
Investment Floor Rate | 10.89% | |||||
Investment Interest ETP | 3% | |||||
Initial Acquisition Date | Oct. 20, 2022 | |||||
Maturity Date | Oct. 20, 2027 | |||||
Principal Amount | $ 26,293,000 | |||||
Investment cost | 26,323,000 | |||||
Investment Owned, at Fair Value | 26,790,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Electronic Equipment & Instruments Brivo,Inc. Investment Type Senior Secured Interest Rate SOFR+6.85%, 10.89% floor, 50% of interest PIK, 3.00% ETP Initial Acquisition Date 10/20/2022 Maturity Date 10/20/2027 | ||||||
Investment, Spread | 6.85% | |||||
Investment Floor Rate | 10.89% | |||||
Investment Interest PIK | 50% | |||||
Investment Interest ETP | 3% | |||||
Initial Acquisition Date | Oct. 20, 2022 | |||||
Maturity Date | Oct. 20, 2027 | |||||
Principal Amount | $ 44,378,000 | |||||
Investment cost | 43,912,000 | |||||
Investment Owned, at Fair Value | $ 43,912,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Electronic Equipment & Instruments Intellisite Holdings, Inc. (dba Epic IO Technologies, Inc.) Investment Type Senior Secured Interest Rate SOFR+9.75%, 10.25% floor, 2.00% ETP Initial Acquisition Date 12/17/2021 Maturity Date 12/17/2025 | ||||||
Investment, Spread | 9.75% | |||||
Investment Floor Rate | 10.25% | |||||
Investment Interest ETP | 2% | |||||
Initial Acquisition Date | Dec. 17, 2021 | |||||
Maturity Date | Dec. 17, 2025 | |||||
Principal Amount | $ 34,000,000 | |||||
Investment cost | 33,639,000 | |||||
Investment Owned, at Fair Value | 33,639,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Equipment | ||||||
Investment cost | 14,919,000 | 27,149,000 | ||||
Investment Owned, at Fair Value | $ 15,284,000 | $ 27,149,000 | ||||
Percentage of Net Assets | 2.79% | 4.71% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Equipment Moximed, Inc. Investment Type Senior Secured Interest Rate PRIME+5.25%, 8.75% floor, 3.50% ETP Initial Acquisition Date 6/24/2022 Maturity Date 7/1/2027 | ||||||
Investment, Spread | 5.25% | 5.25% | ||||
Investment Floor Rate | 8.75% | 8.75% | ||||
Investment Interest ETP | 3.50% | 3.50% | ||||
Initial Acquisition Date | Jun. 24, 2022 | Jun. 24, 2022 | ||||
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027 | ||||
Principal Amount | $ 15,000,000 | $ 15,000,000 | ||||
Investment cost | 14,919,000 | 14,772,000 | ||||
Investment Owned, at Fair Value | 15,284,000 | $ 14,772,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Equipment Revelle Aesthetics, Inc. Investment Type Senior Secured Interest Rate PRIME+5.50%, 8.75% floor, 4.00% ETP Initial Acquisition Date 3/30/2022 Maturity Date 4/1/2027 | ||||||
Investment, Spread | 5.50% | |||||
Investment Floor Rate | 8.75% | |||||
Investment Interest ETP | 4% | |||||
Initial Acquisition Date | Mar. 30, 2022 | |||||
Maturity Date | Apr. 01, 2027 | |||||
Principal Amount | $ 12,500,000 | |||||
Investment cost | 12,377,000 | |||||
Investment Owned, at Fair Value | 12,377,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology | ||||||
Investment cost | 124,096,000 | 226,709,000 | ||||
Investment Owned, at Fair Value | $ 126,204,000 | $ 225,915,000 | ||||
Percentage of Net Assets | 23.06% | 39.22% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Allurion Technologies, Inc. Investment Type Senior Secured Interest Rate PRIME+6.44%, 9.50% floor, 3.00% ETP Initial Acquisition Date 12/30/2021 Maturity Date 12/30/2026 | ||||||
Investment, Spread | 6.44% | |||||
Investment Floor Rate | 9.50% | |||||
Investment Interest ETP | 3% | |||||
Initial Acquisition Date | Dec. 30, 2021 | |||||
Maturity Date | Dec. 30, 2026 | |||||
Principal Amount | $ 55,000,000 | |||||
Investment cost | 54,715,000 | |||||
Investment Owned, at Fair Value | $ 54,715,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology EBR Systems, Inc. Investment Type Senior Secured Interest Rate PRIME+4.90%, 8.90% floor, 4.50% ETP Initial Acquisition Date 6/30/2022 Maturity Date 6/15/2027 | ||||||
Investment, Spread | 4.90% | 4.90% | ||||
Investment Floor Rate | 8.90% | 8.90% | ||||
Investment Interest ETP | 4.50% | 4.50% | ||||
Initial Acquisition Date | Jun. 30, 2022 | Jun. 30, 2022 | ||||
Maturity Date | Jun. 15, 2027 | Jun. 15, 2027 | ||||
Principal Amount | $ 40,000,000 | $ 20,000,000 | ||||
Investment cost | 39,496,000 | 19,648,000 | ||||
Investment Owned, at Fair Value | $ 40,337,000 | $ 19,648,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Gynesonics, Inc. Investment Type Senior Secured Interest Rate SOFR+8.75%, 9.25% floor, 3.50% ETP Initial Acquisition Date 12/1/2020 Maturity Date 12/1/2025 | ||||||
Investment, Spread | 8.75% | |||||
Investment Floor Rate | 9.25% | |||||
Investment Interest ETP | 3.50% | |||||
Initial Acquisition Date | Dec. 01, 2020 | |||||
Maturity Date | Dec. 01, 2025 | |||||
Principal Amount | $ 50,000,000 | |||||
Investment cost | 50,022,000 | |||||
Investment Owned, at Fair Value | $ 50,022,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Mingle Healthcare Solutions, Inc. Investment Type Senior Secured Interest Rate SOFR+9.50%, 12.01% floor, .25% PIK, 10.50% ETP Initial Acquisition Date 8/15/2018 Maturity Date 12/15/2023 | ||||||
Investment, Spread | 9.50% | |||||
Investment Floor Rate | 12.01% | |||||
Investment Interest PIK | 0.25% | |||||
Investment Interest ETP | 10.50% | |||||
Initial Acquisition Date | Aug. 15, 2018 | |||||
Maturity Date | Dec. 15, 2023 | |||||
Principal Amount | $ 4,015,000 | |||||
Investment cost | 4,615,000 | |||||
Investment Owned, at Fair Value | $ 3,821,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Mingle Healthcare Solutions, Inc. Investment Type Senior Secured Interest Rate SOFR+9.75%, 12.26% floor, 10.50% ETP Initial Acquisition Date 8/15/2018 Maturity Date 12/15/2026 | ||||||
Investment, Spread | 9.75% | |||||
Investment Floor Rate | 12.26% | |||||
Investment Interest ETP | 10.50% | |||||
Initial Acquisition Date | Aug. 15, 2018 | |||||
Maturity Date | Dec. 15, 2026 | |||||
Principal Amount | $ 4,322,000 | |||||
Investment cost | 4,952,000 | |||||
Investment Owned, at Fair Value | $ 3,791,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Nalu Medical, Inc. Investment Type Senior Secured Interest Rate PRIME+2.70%, 6.70% floor, 2.00% PIK, 4.50% ETP Initial Acquisition Date 10/12/2022 Maturity Date 10/12/2027 | ||||||
Investment, Spread | 2.70% | 2.70% | ||||
Investment Floor Rate | 6.70% | 6.70% | ||||
Investment Interest PIK | 2% | 2% | ||||
Investment Interest ETP | 4.50% | 4.50% | ||||
Initial Acquisition Date | Oct. 12, 2022 | Oct. 12, 2022 | ||||
Maturity Date | Oct. 12, 2027 | Oct. 12, 2027 | ||||
Principal Amount | $ 20,482,000 | $ 20,071,000 | ||||
Investment cost | 20,395,000 | 19,756,000 | ||||
Investment Owned, at Fair Value | $ 21,191,000 | $ 19,756,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Route 92 Medical, Inc. Investment Type Senior Secured Interest Rate SOFR+8.48%, 8.98% floor, 3.95% ETP Initial Acquisition Date 8/17/2021 Maturity Date 7/1/2026 | ||||||
Investment, Spread | 8.48% | 8.48% | ||||
Investment Floor Rate | 8.98% | 8.98% | ||||
Investment Interest ETP | 3.95% | 3.95% | ||||
Initial Acquisition Date | Aug. 17, 2021 | Aug. 17, 2021 | ||||
Maturity Date | Jul. 01, 2026 | Jul. 01, 2026 | ||||
Principal Amount | $ 35,000,000 | $ 13,000,000 | ||||
Investment cost | 34,239,000 | 12,843,000 | ||||
Investment Owned, at Fair Value | $ 35,435,000 | $ 12,843,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology SetPoint Medical Corporation Investment Type Senior Secured Interest Rate SOFR+5.75%, 9.00% floor, 4.00% ETP Initial Acquisition Date 12/29/2022 Maturity Date 12/1/2027 | ||||||
Investment, Spread | 5.75% | 5.75% | ||||
Investment Floor Rate | 9% | 9% | ||||
Investment Interest ETP | 4% | 4% | ||||
Initial Acquisition Date | Dec. 29, 2022 | Dec. 29, 2022 | ||||
Maturity Date | Dec. 01, 2027 | Dec. 01, 2027 | ||||
Principal Amount | $ 25,000,000 | $ 25,000,000 | ||||
Investment cost | 25,014,000 | 24,802,000 | ||||
Investment Owned, at Fair Value | 25,450,000 | $ 24,802,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology VERO Biotech LLC Investment Type Senior Secured Interest Rate SOFR+9.05%, 9.55% floor, 3.00% ETP Initial Acquisition Date 12/29/2020 Maturity Date 12/1/2024 | ||||||
Investment, Spread | 9.05% | |||||
Investment Floor Rate | 9.55% | |||||
Investment Interest ETP | 3% | |||||
Initial Acquisition Date | Dec. 29, 2020 | |||||
Maturity Date | Dec. 01, 2024 | |||||
Principal Amount | $ 40,000,000 | |||||
Investment cost | 40,308,000 | |||||
Investment Owned, at Fair Value | 40,308,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Human Resource & Employment Services | ||||||
Investment cost | 116,109,000 | 97,267,000 | ||||
Investment Owned, at Fair Value | $ 112,006,000 | $ 96,478,000 | ||||
Percentage of Net Assets | 20.47% | 16.75% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Human Resource & Employment Services CloudPay, Inc. Investment Type Senior Secured Interest Rate PRIME+6.25%, 10.25% floor, 2.00% ETP Initial Acquisition Date 9/26/2022 Maturity Date 8/17/2027 | ||||||
Investment, Spread | 6.25% | 6.25% | ||||
Investment Floor Rate | 10.25% | 10.25% | ||||
Investment Interest ETP | 2% | 2% | ||||
Initial Acquisition Date | Sep. 26, 2022 | Sep. 26, 2022 | ||||
Maturity Date | Aug. 17, 2027 | Aug. 17, 2027 | ||||
Principal Amount | $ 75,000,000 | $ 60,000,000 | ||||
Investment cost | 74,939,000 | 59,693,000 | ||||
Investment Owned, at Fair Value | $ 75,465,000 | $ 59,693,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Human Resource & Employment Services Snagajob.com, Inc. Investment Type Senior Secured Interest Rate SOFR+8.50% PIK, 9.00% floor, 2.75% ETP Initial Acquisition Date 9/29/2021 Maturity Date 9/1/2025 | ||||||
Investment Floor Rate | 9% | |||||
Investment Interest PIK | 8.50% | |||||
Investment Interest ETP | 2.75% | |||||
Initial Acquisition Date | Sep. 29, 2021 | |||||
Maturity Date | Sep. 01, 2025 | |||||
Principal Amount | $ 40,825,000 | |||||
Investment cost | 41,170,000 | |||||
Investment Owned, at Fair Value | 36,541,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Human Resource & Employment Services Snagajob.com, Inc. Investment Type Senior Secured Interest Rate SOFR+8.50%, 9.00% floor, 9.00% cash cap, 2.75% ETP Initial Acquisition Date 9/29/2021 Maturity Date 9/1/2025 | ||||||
Investment, Spread | 8.50% | |||||
Investment Floor Rate | 9% | |||||
Investment Interest Cash Cap | 9% | |||||
Investment Interest ETP | 2.75% | |||||
Initial Acquisition Date | Sep. 29, 2021 | |||||
Maturity Date | Sep. 01, 2025 | |||||
Principal Amount | $ 37,609,000 | |||||
Investment cost | 37,574,000 | |||||
Investment Owned, at Fair Value | 36,785,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail | ||||||
Investment cost | 55,620,000 | 55,853,000 | ||||
Investment Owned, at Fair Value | $ 55,309,000 | $ 55,853,000 | ||||
Percentage of Net Assets | 10.11% | 9.70% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail Madison Reed, Inc. Investment Type Senior Secured Interest Rate PRIME+4.75%, 11.00% floor, 11.00% cash cap, 3.00% ETP Initial Acquisition Date 12/16/2022 Maturity Date 12/16/2026 | ||||||
Investment, Spread | 4.75% | |||||
Investment Floor Rate | 11% | |||||
Investment Interest Cash Cap | 11% | |||||
Investment Interest ETP | 3% | |||||
Initial Acquisition Date | Dec. 16, 2022 | |||||
Maturity Date | Dec. 16, 2026 | |||||
Principal Amount | $ 10,913,000 | |||||
Investment cost | 10,784,000 | |||||
Investment Owned, at Fair Value | $ 10,847,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail Madison Reed, Inc. Investment Type Senior Secured Interest Rate PRIME+4.75%, 11.00% floor, 3.00% ETP Initial Acquisition Date 12/16/2022 Maturity Date 12/16/2026 | ||||||
Investment, Spread | 4.75% | |||||
Investment Floor Rate | 11% | |||||
Investment Interest ETP | 3% | |||||
Initial Acquisition Date | Dec. 16, 2022 | |||||
Maturity Date | Dec. 16, 2026 | |||||
Principal Amount | $ 9,600,000 | |||||
Investment cost | 9,353,000 | |||||
Investment Owned, at Fair Value | $ 9,353,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail Marley Spoon AG Investment Type Senior Secured Interest Rate SOFR+8.50%, 1.25% PIK, 9.26% floor Initial Acquisition Date 6/30/2021 Maturity Date 6/15/2025 | ||||||
Investment, Spread | 8.50% | |||||
Investment Floor Rate | 9.26% | |||||
Investment Interest PIK | 1.25% | |||||
Initial Acquisition Date | Jun. 30, 2021 | |||||
Maturity Date | Jun. 15, 2025 | |||||
Principal Amount | $ 46,754,000 | |||||
Investment cost | 46,500,000 | |||||
Investment Owned, at Fair Value | 46,500,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail Marley Spoon SE Investment Type Senior Secured Interest Rate SOFR+7.50%, 8.26% floor, 1.25% PIK Initial Acquisition Date 6/30/2021 Maturity Date 6/15/2026 | ||||||
Investment, Spread | 7.50% | |||||
Investment Floor Rate | 8.26% | |||||
Investment Interest PIK | 1.25% | |||||
Initial Acquisition Date | Jun. 30, 2021 | |||||
Maturity Date | Jun. 15, 2026 | |||||
Principal Amount | $ 44,983,000 | |||||
Investment cost | 44,836,000 | |||||
Investment Owned, at Fair Value | 44,462,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services | ||||||
Investment cost | 97,402,000 | 147,332,000 | ||||
Investment Owned, at Fair Value | $ 96,820,000 | $ 146,535,000 | ||||
Percentage of Net Assets | 17.70% | 25.44% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Bombora, Inc. Investment Type Senior Secured Interest Rate SOFR+4.75%, 6.75% floor, 3.25% PIK, 0.96% ETP Initial Acquisition Date 12/26/2023 Maturity Date 1/15/2028 | ||||||
Investment, Spread | 4.75% | |||||
Investment Floor Rate | 6.75% | |||||
Investment Interest PIK | 3.25% | |||||
Investment Interest ETP | 0.96% | |||||
Initial Acquisition Date | Dec. 26, 2023 | |||||
Maturity Date | Jan. 15, 2028 | |||||
Principal Amount | $ 28,000,000 | |||||
Investment cost | 27,879,000 | |||||
Investment Owned, at Fair Value | $ 27,879,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Bombora, Inc. Investment Type Senior Secured Interest Rate SOFR+5.00%, 5.76% floor, 3.75% PIK, 2.00% ETP Initial Acquisition Date 3/31/2021 Maturity Date 3/31/2025 | ||||||
Investment, Spread | 5% | |||||
Investment Floor Rate | 5.76% | |||||
Investment Interest PIK | 3.75% | |||||
Investment Interest ETP | 2% | |||||
Initial Acquisition Date | Mar. 31, 2021 | |||||
Maturity Date | Mar. 31, 2025 | |||||
Principal Amount | $ 21,341,000 | |||||
Investment cost | 21,337,000 | |||||
Investment Owned, at Fair Value | $ 21,337,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Fidelis Cybersecurity, Inc. Investment Type Senior Secured Interest Rate SOFR+11.00%, 12.00% floor, 2.39% ETP Initial Acquisition Date 3/25/2022 Maturity Date 5/13/2024 | ||||||
Investment, Spread | 11% | |||||
Investment Floor Rate | 12% | |||||
Investment Interest ETP | 2% | |||||
Initial Acquisition Date | Mar. 25, 2022 | |||||
Maturity Date | May 13, 2024 | |||||
Principal Amount | $ 8,947,000 | |||||
Investment cost | 8,986,000 | |||||
Investment Owned, at Fair Value | $ 8,692,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Fidelis Cybersecurity, Inc. Investment Type Senior Secured Interest Rate SOFR+11.00%, 12.00% floor, 2.39% ETP Initial Acquisition Date 5/13/2021 Maturity Date 5/13/2024 | ||||||
Investment, Spread | 11% | |||||
Investment Floor Rate | 12% | |||||
Investment Interest ETP | 2.39% | |||||
Initial Acquisition Date | May 13, 2021 | |||||
Maturity Date | May 13, 2024 | |||||
Principal Amount | $ 12,205,000 | |||||
Investment cost | 12,360,000 | |||||
Investment Owned, at Fair Value | $ 11,857,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services INRIX, Inc. Investment Type Senior Secured Interest Rate SOFR+9.00%, 9.76% floor, 2.50% ETP Initial Acquisition Date 11/15/2021 Maturity Date 11/15/2025 | ||||||
Investment, Spread | 9% | |||||
Investment Floor Rate | 9.76% | |||||
Investment Interest ETP | 2.50% | |||||
Initial Acquisition Date | Nov. 15, 2021 | |||||
Maturity Date | Nov. 15, 2025 | |||||
Principal Amount | $ 45,000,000 | |||||
Investment cost | 45,329,000 | |||||
Investment Owned, at Fair Value | $ 45,329,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Skillshare, Inc. Investment Type Senior Secured Interest Rate SOFR+6.50%, 10.72% floor, 3.00% ETP Initial Acquisition Date 11/8/2022 Maturity Date 11/8/2026 | ||||||
Investment, Spread | 6.50% | 6.50% | ||||
Investment Floor Rate | 10.72% | 10.72% | ||||
Investment Interest ETP | 3% | 3% | ||||
Initial Acquisition Date | Nov. 08, 2022 | Nov. 08, 2022 | ||||
Maturity Date | Nov. 08, 2026 | Nov. 08, 2026 | ||||
Principal Amount | $ 30,000,000 | $ 25,000,000 | ||||
Investment cost | 29,765,000 | 24,414,000 | ||||
Investment Owned, at Fair Value | $ 29,183,000 | $ 24,414,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Synack, Inc. Investment Type Senior Secured Interest Rate PRIME+4.25%, 8.25% floor Initial Acquisition Date 6/30/2022 Maturity Date 6/30/2027 | ||||||
Investment, Spread | 4.25% | |||||
Investment Floor Rate | 8.25% | |||||
Initial Acquisition Date | Jun. 30, 2022 | |||||
Maturity Date | Jun. 30, 2027 | |||||
Principal Amount | $ 35,000,000 | |||||
Investment cost | 34,906,000 | |||||
Investment Owned, at Fair Value | 34,906,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Synack, Inc. Investment Type Senior Secured Interest Rate SOFR+7.00%, 11.07% floor, 1.00% ETP Initial Acquisition Date 12/29/2023 Maturity Date 12/29/2028 | ||||||
Investment, Spread | 7% | |||||
Investment Floor Rate | 11.07% | |||||
Investment Interest ETP | 1% | |||||
Initial Acquisition Date | Dec. 29, 2023 | |||||
Maturity Date | Dec. 29, 2028 | |||||
Principal Amount | $ 40,000,000 | |||||
Investment cost | 39,758,000 | |||||
Investment Owned, at Fair Value | 39,758,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Property & Casualty Insurance | ||||||
Investment cost | 74,877,000 | 49,143,000 | ||||
Investment Owned, at Fair Value | $ 74,767,000 | $ 49,143,000 | ||||
Percentage of Net Assets | 13.67% | 8.53% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Property & Casualty Insurance Kin Insurance, Inc. Investment Type Senior Secured Interest Rate PRIME+6.25%, 12.50% floor, 3.00% ETP Initial Acquisition Date 9/26/2022 Maturity Date 9/15/2026 | ||||||
Investment, Spread | 6.25% | 6.25% | ||||
Investment Floor Rate | 12.50% | 12.50% | ||||
Investment Interest ETP | 3% | 3% | ||||
Initial Acquisition Date | Sep. 26, 2022 | Sep. 26, 2022 | ||||
Maturity Date | Sep. 15, 2026 | Sep. 15, 2026 | ||||
Principal Amount | $ 75,000,000 | $ 50,000,000 | ||||
Investment cost | 74,877,000 | 49,143,000 | ||||
Investment Owned, at Fair Value | 74,767,000 | 49,143,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software | ||||||
Investment cost | 113,832,000 | 78,083,000 | ||||
Investment Owned, at Fair Value | $ 112,955,000 | $ 78,083,000 | ||||
Percentage of Net Assets | 20.64% | 13.55% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software 3PL Central LLC Investment Type Senior Secured Interest Rate SOFR+4.50%, 6.50 floor, 2.50% PIK, 2.00% ETP Initial Acquisition Date 11/9/2022 Maturity Date 11/9/2027 | ||||||
Investment, Spread | 4.50% | 4.50% | ||||
Investment Floor Rate | 6.50% | 6.50% | ||||
Investment Interest PIK | 2.50% | 2.50% | ||||
Investment Interest ETP | 2% | 2% | ||||
Initial Acquisition Date | Nov. 09, 2022 | Nov. 09, 2022 | ||||
Maturity Date | Nov. 09, 2027 | Nov. 09, 2027 | ||||
Principal Amount | $ 70,395,000 | $ 65,163,000 | ||||
Investment cost | 70,064,000 | 64,429,000 | ||||
Investment Owned, at Fair Value | $ 69,066,000 | $ 64,429,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software Dejero Labs Inc. Investment Type Second Lien Interest Rate SOFR+8.00%, 8.50% floor, 2.00% PIK, 3.00% ETP Initial Acquisition Date 12/22/2021 Maturity Date 12/22/2025 | ||||||
Investment, Spread | 8% | |||||
Investment Floor Rate | 8.50% | |||||
Investment Interest PIK | 2% | |||||
Investment Interest ETP | 3% | |||||
Initial Acquisition Date | Dec. 22, 2021 | |||||
Maturity Date | Dec. 22, 2025 | |||||
Principal Amount | $ 14,172,000 | |||||
Investment cost | 14,278,000 | |||||
Investment Owned, at Fair Value | $ 14,399,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software Dejero Labs Inc. Investment Type Senior Lien Interest Rate SOFR+5.00%, 5.50 floor, 5.00% PIK, 3.00% ETP Initial Acquisition Date 12/22/2021 Maturity Date 12/22/2025 | ||||||
Investment, Spread | 5% | |||||
Investment Floor Rate | 5.50% | |||||
Investment Interest PIK | 5% | |||||
Investment Interest ETP | 3% | |||||
Initial Acquisition Date | Dec. 22, 2021 | |||||
Maturity Date | Dec. 22, 2025 | |||||
Principal Amount | $ 13,661,000 | |||||
Investment cost | 13,654,000 | |||||
Investment Owned, at Fair Value | 13,654,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software Linxup, LLC Investment Type Senior Secured Interest Rate PRIME+3.25%, 11.75% floor, 2.25% ETP Initial Acquisition Date 11/03/2023 Maturity Date 11/15/2027 | ||||||
Investment, Spread | 3.25% | |||||
Investment Floor Rate | 11.75% | |||||
Investment Interest ETP | 2.25% | |||||
Initial Acquisition Date | Nov. 03, 2023 | |||||
Maturity Date | Nov. 15, 2027 | |||||
Principal Amount | $ 30,000,000 | |||||
Investment cost | 29,490,000 | |||||
Investment Owned, at Fair Value | 29,490,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments | ||||||
Investment cost | 18,449,000 | 16,546,000 | ||||
Investment Owned, at Fair Value | $ 5,721,000 | $ 14,605,000 | ||||
Percentage of Net Assets | 1.05% | 2.54% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Advertising | ||||||
Investment cost | $ 136,000 | |||||
Investment Owned, at Fair Value | $ 136,000 | |||||
Percentage of Net Assets | 0.03% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Advertising Minute Media Inc. Investment Type Equity Common Stock Initial Acquisition Date 12/13/2023 | ||||||
Initial Acquisition Date | Dec. 13, 2023 | |||||
Principal/ Shares | 134 | |||||
Investment cost | $ 16,000 | |||||
Investment Owned, at Fair Value | $ 16,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Advertising Minute Media Inc. Investment Type Equity Preferred Stock Initial Acquisition Date 12/13/2023 | ||||||
Initial Acquisition Date | Dec. 13, 2023 | |||||
Principal/ Shares | 1,030 | |||||
Investment cost | $ 120,000 | |||||
Investment Owned, at Fair Value | 120,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Application Software | ||||||
Investment cost | 688,000 | $ 688,000 | ||||
Investment Owned, at Fair Value | $ 390,000 | $ 1,769,000 | ||||
Percentage of Net Assets | 0.07% | 0.31% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Application Software Aria Systems, Inc. Investment Type Equity Series G Preferred Stock Initial Acquisition Date 7/10/2018 | ||||||
Initial Acquisition Date | Jul. 10, 2018 | Jul. 10, 2018 | ||||
Principal/ Shares | 289,419 | 289,419 | ||||
Investment cost | $ 250,000 | $ 250,000 | ||||
Investment Owned, at Fair Value | $ 127,000 | $ 347,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Application Software FiscalNote, Inc. Investment Type Equity Common Stock Initial Acquisition Date 10/19/2020 | ||||||
Initial Acquisition Date | Oct. 19, 2020 | Oct. 19, 2020 | ||||
Principal/ Shares | 230,881 | 230,881 | ||||
Investment cost | $ 438,000 | $ 438,000 | ||||
Investment Owned, at Fair Value | 263,000 | 1,422,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Health Care Technology | ||||||
Investment cost | 12,132,000 | 12,132,000 | ||||
Investment Owned, at Fair Value | $ 3,553,000 | $ 12,335,000 | ||||
Percentage of Net Assets | 0.65% | 2.14% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Health Care Technology CareCloud, Inc. Investment Type Equity 11% Series A Cumulative Redeemable Perpetual Initial Acquisition Date 1/8/2020 | ||||||
Initial Acquisition Date | Jan. 08, 2020 | |||||
Principal/ Shares | 462,064 | |||||
Investment cost | $ 12,132,000 | |||||
Investment Owned, at Fair Value | $ 12,335,000 | |||||
Temporary equity, dividend rate percentage | 11% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Health Care Technology CareCloud, Inc. Investment Type Equity 11% Series A Cumulative Redeemable Perpetual Preferred Stock Initial Acquisition Date 1/8/2020 | ||||||
Initial Acquisition Date | Jan. 08, 2020 | |||||
Principal/ Shares | 462,064 | |||||
Investment cost | $ 12,132,000 | |||||
Investment Owned, at Fair Value | $ 3,553,000 | |||||
Temporary equity, dividend rate percentage | 11% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Human Resource & Employment Services | ||||||
Investment cost | $ 1,357,000 | |||||
Investment Owned, at Fair Value | $ 1,357,000 | |||||
Percentage of Net Assets | 0.25% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Human Resource & Employment Services Snagajob.com, Inc. Investment Type Equity Convertible Note Initial Acquisition Date 10/26/2023 Maturity Date 12/31/2026 | ||||||
Initial Acquisition Date | Oct. 26, 2023 | |||||
Maturity Date | Dec. 31, 2026 | |||||
Principal/ Shares | 1,357 | |||||
Investment cost | $ 1,357,000 | |||||
Investment Owned, at Fair Value | 1,357,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Internet & Direct Marketing Retail | ||||||
Investment cost | 410,000 | |||||
Investment Owned, at Fair Value | $ 125,000 | |||||
Percentage of Net Assets | 0.02% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Internet & Direct Marketing Retail Marley Spoon SE Investment Type Equity Common Stock Initial Acquisition Date 7/7/2023 | ||||||
Initial Acquisition Date | Jul. 07, 2023 | |||||
Principal/ Shares | 46,004 | |||||
Investment cost | $ 410,000 | |||||
Investment Owned, at Fair Value | 125,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Technology Hardware, Storage & Peripherals | ||||||
Investment cost | 3,726,000 | $ 3,726,000 | ||||
Investment Owned, at Fair Value | $ 160,000 | $ 501,000 | ||||
Percentage of Net Assets | 0.03% | 0.09% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Technology Hardware, Storage & Peripherals Quantum Corporation Investment Type Equity Common Stock Initial Acquisition Date 8/13/2021 | ||||||
Initial Acquisition Date | Aug. 13, 2021 | Aug. 13, 2021 | ||||
Principal/ Shares | 459,720 | 459,720 | ||||
Investment cost | $ 2,607,000 | $ 2,607,000 | ||||
Investment Owned, at Fair Value | $ 160,000 | $ 501,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Technology Hardware, Storage & Peripherals zSpace, Inc. Investment Type Equity Common Stock Initial Acquisition Date 12/31/2020 | ||||||
Initial Acquisition Date | Dec. 31, 2020 | Dec. 31, 2020 | ||||
Principal/ Shares | 6,078,499 | 6,078,499 | ||||
Investment cost | $ 1,119,000 | $ 1,119,000 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants | ||||||
Investment cost | 20,247,000 | 19,127,000 | ||||
Investment Owned, at Fair Value | $ 11,971,000 | $ 15,845,000 | ||||
Percentage of Net Assets | 2.19% | 2.75% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Advertising | ||||||
Investment cost | $ 246,000 | |||||
Percentage of Net Assets | 0% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Advertising STN Video Inc. Class B Non-Voting Stock Initial Acquisition Date 6/30/2017 Maturity Date 6/30/2027 | ||||||
Initial Acquisition Date | Jun. 30, 2017 | |||||
Maturity Date | Jun. 30, 2027 | |||||
Principal/ Shares | 191,500 | |||||
Investment cost | $ 246,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software | ||||||
Investment cost | $ 6,400,000 | 5,928,000 | ||||
Investment Owned, at Fair Value | $ 2,196,000 | $ 3,649,000 | ||||
Percentage of Net Assets | 0.40% | 0.63% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software 3DNA Corp. (dba NationBuilder) Investment Type Warrants Series C-1 Preferred Stock Initial Acquisition Date 12/28/2018 Maturity Date 12/28/2028 | ||||||
Initial Acquisition Date | Dec. 28, 2018 | |||||
Maturity Date | Dec. 28, 2028 | |||||
Principal/ Shares | 273,164 | |||||
Investment cost | $ 104,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software 3DNA Corp. (dba NationBuilder) Series C-1 Preferred Stock Initial Acquisition Date 12/28/2018 Maturity Date 12/28/2028 | ||||||
Initial Acquisition Date | Dec. 28, 2018 | |||||
Maturity Date | Dec. 28, 2028 | |||||
Principal/ Shares | 273,164 | |||||
Investment cost | $ 104,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Aria Systems, Inc. Investment Type Warrants Series G Preferred Stock Initial Acquisition Date 6/29/2018 Maturity Date 6/29/2028 | ||||||
Initial Acquisition Date | Jun. 29, 2018 | |||||
Maturity Date | Jun. 29, 2028 | |||||
Principal/ Shares | 2,387,705 | |||||
Investment cost | $ 1,048,000 | |||||
Investment Owned, at Fair Value | $ 1,048,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Aria Systems, Inc. Series G Preferred Stock Initial Acquisition Date 6/29/2018 Maturity Date 6/29/2028 | ||||||
Initial Acquisition Date | Jun. 29, 2018 | |||||
Maturity Date | Jun. 29, 2028 | |||||
Principal/ Shares | 2,387,705 | |||||
Investment cost | $ 1,048,000 | |||||
Investment Owned, at Fair Value | $ 2,865,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Blueshift Labs, Inc. Investment Type Warrants Success fee Initial Acquisition Date 12/19/2023 | ||||||
Initial Acquisition Date | Dec. 19, 2023 | |||||
Investment cost | $ 167,000 | |||||
Investment Owned, at Fair Value | $ 167,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Investment Type Warrants Series A-6 Preferred Stock Initial Acquisition Date 10/31/2019 Maturity Date 10/31/2029 | ||||||
Initial Acquisition Date | Oct. 31, 2019 | |||||
Maturity Date | Oct. 31, 2029 | |||||
Principal/ Shares | 384,615 | |||||
Investment cost | $ 846,000 | |||||
Investment Owned, at Fair Value | $ 12,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Investment Type Warrants Series A-6 Preferred Stock Initial Acquisition Date 12/20/2018 Maturity Date 12/20/2028 | ||||||
Initial Acquisition Date | Dec. 20, 2018 | |||||
Maturity Date | Dec. 20, 2028 | |||||
Principal/ Shares | 1,538,462 | |||||
Investment cost | $ 3,630,000 | |||||
Investment Owned, at Fair Value | $ 48,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Investment Type Warrants Success fee Initial Acquisition Date 12/21/2023 | ||||||
Initial Acquisition Date | Dec. 21, 2023 | |||||
Investment cost | $ 304,000 | |||||
Investment Owned, at Fair Value | $ 283,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Series A-6 Preferred Stock Initial Acquisition Date 10/31/2019 Maturity Date 10/31/2029 | ||||||
Initial Acquisition Date | Oct. 31, 2019 | |||||
Maturity Date | Oct. 31, 2029 | |||||
Principal/ Shares | 384,615 | |||||
Investment cost | $ 845,000 | |||||
Investment Owned, at Fair Value | $ 22,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Series A-6 Preferred Stock Initial Acquisition Date 12/20/2018 Maturity Date 12/20/2028 | ||||||
Initial Acquisition Date | Dec. 20, 2018 | |||||
Maturity Date | Dec. 20, 2028 | |||||
Principal/ Shares | 1,538,462 | |||||
Investment cost | $ 3,630,000 | |||||
Investment Owned, at Fair Value | $ 87,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Dtex Systems, Inc. Investment Type Warrants Series C-Prime Preferred Stock Initial Acquisition Date 6/1/2018 Maturity Date 6/1/2025 | ||||||
Initial Acquisition Date | Jun. 01, 2018 | |||||
Maturity Date | Jun. 01, 2025 | |||||
Principal/ Shares | 500,000 | |||||
Investment cost | $ 59,000 | |||||
Investment Owned, at Fair Value | $ 233,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Dtex Systems, Inc. Series C-Prime Preferred Stock Initial Acquisition Date 6/1/2018 Maturity Date 6/1/2025 | ||||||
Initial Acquisition Date | Jun. 01, 2018 | |||||
Maturity Date | Jun. 01, 2025 | |||||
Principal/ Shares | 500,000 | |||||
Investment cost | $ 59,000 | |||||
Investment Owned, at Fair Value | $ 214,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Dtex Systems, Inc. Series C-Prime Preferred Stock Initial Acquisition Date 7/11/2019 Maturity Date 7/11/2026 | ||||||
Initial Acquisition Date | Jul. 11, 2019 | |||||
Maturity Date | Jul. 11, 2026 | |||||
Principal/ Shares | 833,333 | |||||
Investment cost | $ 115,000 | |||||
Investment Owned, at Fair Value | $ 356,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Dtex Systems, Inc.Investment Type Warrants Series C-Prime Preferred Stock Initial Acquisition Date 7/11/2019 Maturity Date 7/11/2026 | ||||||
Initial Acquisition Date | Jul. 11, 2019 | |||||
Maturity Date | Jul. 11, 2026 | |||||
Principal/ Shares | 833,333 | |||||
Investment cost | $ 115,000 | |||||
Investment Owned, at Fair Value | $ 389,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software FiscalNote, Inc. Earnout Initial Acquisition Date 7/29/2022 Maturity Date 7/29/2027 | ||||||
Initial Acquisition Date | Jul. 29, 2022 | |||||
Maturity Date | Jul. 29, 2027 | |||||
Investment cost | $ 127,000 | |||||
Investment Owned, at Fair Value | $ 105,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software FiscalNote, Inc. Investment Type Warrants Earnout Initial Acquisition Date 7/29/2022 Maturity Date 7/29/2027 | ||||||
Initial Acquisition Date | Jul. 29, 2022 | |||||
Maturity Date | Jul. 29, 2027 | |||||
Investment cost | $ 127,000 | |||||
Investment Owned, at Fair Value | 16,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Porch Group, Inc. Earnout Initial Acquisition Date 12/23/2020 Maturity Date 12/23/2023 | ||||||
Initial Acquisition Date | Dec. 23, 2020 | |||||
Maturity Date | Dec. 23, 2023 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Asset Management & Custody Banks | ||||||
Investment cost | 75,000 | |||||
Investment Owned, at Fair Value | $ 161,000 | |||||
Percentage of Net Assets | 0.03% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Asset Management & Custody Banks Betterment Holdings, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 10/6/2023 Maturity Date 10/6/2033 | ||||||
Initial Acquisition Date | Oct. 06, 2023 | |||||
Maturity Date | Oct. 06, 2033 | |||||
Principal/ Shares | 7,680 | |||||
Investment cost | $ 35,000 | |||||
Investment Owned, at Fair Value | $ 146,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Asset Management & Custody Banks Betterment Holdings, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 10/6/2023 Maturity Date 10/6/2033 one | ||||||
Initial Acquisition Date | Oct. 06, 2023 | |||||
Maturity Date | Oct. 06, 2033 | |||||
Principal/ Shares | 9,818 | |||||
Investment cost | $ 40,000 | |||||
Investment Owned, at Fair Value | 15,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology | ||||||
Investment cost | 541,000 | $ 541,000 | ||||
Investment Owned, at Fair Value | $ 51,000 | $ 216,000 | ||||
Percentage of Net Assets | 0.01% | 0.04% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology Mustang Bio, Inc. Common Stock Initial Acquisition Date 3/4/2022 Maturity Date 3/4/2032 | ||||||
Initial Acquisition Date | Mar. 04, 2022 | |||||
Maturity Date | Mar. 04, 2032 | |||||
Principal/ Shares | 748,036 | |||||
Investment cost | $ 315,000 | |||||
Investment Owned, at Fair Value | $ 59,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology Mustang Bio, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 3/4/2022 Maturity Date 3/4/2032 | ||||||
Initial Acquisition Date | Mar. 04, 2022 | |||||
Maturity Date | Mar. 04, 2032 | |||||
Principal/ Shares | 748,036 | |||||
Investment cost | $ 315,000 | |||||
Investment Owned, at Fair Value | $ 39,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology TRACON Pharmaceuticals, Inc. Common Stock Initial Acquisition Date 9/2/2022 Maturity Date 9/2/2032 | ||||||
Initial Acquisition Date | Sep. 02, 2022 | |||||
Maturity Date | Sep. 02, 2032 | |||||
Principal/ Shares | 150,753 | |||||
Investment cost | $ 226,000 | |||||
Investment Owned, at Fair Value | 157,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology TRACON Pharmaceuticals, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 9/2/2022 Maturity Date 9/2/2032 | ||||||
Initial Acquisition Date | Sep. 02, 2022 | |||||
Maturity Date | Sep. 02, 2032 | |||||
Principal/ Shares | 150,753 | |||||
Investment cost | $ 226,000 | |||||
Investment Owned, at Fair Value | 12,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Computer & Electronics Retail | ||||||
Investment cost | $ 183,000 | 183,000 | ||||
Investment Owned, at Fair Value | $ 68,000 | |||||
Percentage of Net Assets | 0% | 0.01% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Computer & Electronics Retail Massdrop, Inc. Investment Type Warrants Series B Preferred Stock Initial Acquisition Date 7/22/2019 Maturity Date 7/22/2029 | ||||||
Initial Acquisition Date | Jul. 22, 2019 | |||||
Maturity Date | Jul. 22, 2029 | |||||
Principal/ Shares | 848,093 | |||||
Investment cost | $ 183,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Computer & Electronics Retail Massdrop, Inc. Series B Preferred Stock Initial Acquisition Date 7/22/2019 Maturity Date 7/22/2029 | ||||||
Initial Acquisition Date | Jul. 22, 2019 | |||||
Maturity Date | Jul. 22, 2029 | |||||
Principal/ Shares | 848,093 | |||||
Investment cost | $ 183,000 | |||||
Investment Owned, at Fair Value | 68,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services | ||||||
Investment cost | 2,828,000 | 2,381,000 | ||||
Investment Owned, at Fair Value | $ 1,254,000 | $ 1,932,000 | ||||
Percentage of Net Assets | 0.23% | 0.34% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services Elevate Services, Inc. Investment Type Warrants Series C Preferred Stock Initial Acquisition Date 7/10/2023 Maturity Date 7/10/2033 | ||||||
Initial Acquisition Date | Jul. 10, 2023 | |||||
Maturity Date | Jul. 10, 2033 | |||||
Principal/ Shares | 248,997 | |||||
Investment cost | $ 447,000 | |||||
Investment Owned, at Fair Value | $ 384,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services Interactions Corporation Common Stock Initial Acquisition Date 6/24/2022 Maturity Date 6/24/2032 | ||||||
Initial Acquisition Date | Jun. 24, 2022 | |||||
Maturity Date | Jun. 24, 2032 | |||||
Principal/ Shares | 189,408 | |||||
Investment cost | $ 219,000 | |||||
Investment Owned, at Fair Value | $ 204,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services Interactions Corporation Investment Type Warrants Common Stock Initial Acquisition Date 6/24/2022 Maturity Date 6/24/2032 | ||||||
Initial Acquisition Date | Jun. 24, 2022 | |||||
Maturity Date | Jun. 24, 2032 | |||||
Principal/ Shares | 189,408 | |||||
Investment cost | $ 219,000 | |||||
Investment Owned, at Fair Value | $ 67,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services ShareThis, Inc. Investment Type Warrants Series D-3 Preferred Stock Initial Acquisition Date 12/3/2018 Maturity Date 12/3/2028 | ||||||
Initial Acquisition Date | Dec. 03, 2018 | |||||
Maturity Date | Dec. 03, 2028 | |||||
Principal/ Shares | 647,615 | |||||
Investment cost | $ 2,162,000 | |||||
Investment Owned, at Fair Value | 803,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services ShareThis, Inc. Series D-3 Preferred Stock Initial Acquisition Date 12/3/2018 Maturity Date 12/3/2028 | ||||||
Initial Acquisition Date | Dec. 03, 2018 | |||||
Maturity Date | Dec. 03, 2028 | |||||
Principal/ Shares | 647,615 | |||||
Investment cost | $ 2,162,000 | |||||
Investment Owned, at Fair Value | 1,728,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments | ||||||
Investment cost | 603,000 | 528,000 | ||||
Investment Owned, at Fair Value | $ 745,000 | $ 563,000 | ||||
Percentage of Net Assets | 0.14% | 0.10% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments Brivo, Inc. Investment Type Warrants Series A-2 Preferred Stock Initial Acquisition Date 10/20/2022 Maturity Date 10/20/2032 | ||||||
Initial Acquisition Date | Oct. 20, 2022 | |||||
Maturity Date | Oct. 20, 2032 | |||||
Principal/ Shares | 201,000 | |||||
Investment cost | $ 98,000 | |||||
Investment Owned, at Fair Value | $ 322,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments Brivo, Inc. Series A-2 Preferred Stock Initial Acquisition Date 10/20/2022 Maturity Date 10/20/2032 | ||||||
Initial Acquisition Date | Oct. 20, 2022 | |||||
Maturity Date | Oct. 20, 2032 | |||||
Principal/ Shares | 201,000 | |||||
Investment cost | $ 98,000 | |||||
Investment Owned, at Fair Value | $ 107,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments Epic IO Technologies, Inc. Investment Type Warrants Success fee Initial Acquisition Date 12/17/2021 Maturity Date 12/17/2028 | ||||||
Initial Acquisition Date | Dec. 17, 2021 | |||||
Maturity Date | Dec. 17, 2028 | |||||
Investment cost | $ 505,000 | |||||
Investment Owned, at Fair Value | 423,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments Epic IO Technologies, Inc. Success fee Initial Acquisition Date 12/17/2021 Maturity Date 12/17/2024 | ||||||
Initial Acquisition Date | Dec. 17, 2021 | |||||
Maturity Date | Dec. 17, 2024 | |||||
Investment cost | $ 430,000 | |||||
Investment Owned, at Fair Value | 456,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment | ||||||
Investment cost | 301,000 | 302,000 | ||||
Investment Owned, at Fair Value | $ 240,000 | $ 284,000 | ||||
Percentage of Net Assets | 0.04% | 0.05% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment Moximed, Inc. Investment Type Warrants Series C Preferred Stock Initial Acquisition Date 6/24/2022 Maturity Date 6/24/2032 | ||||||
Initial Acquisition Date | Jun. 24, 2022 | |||||
Maturity Date | Jun. 24, 2032 | |||||
Principal/ Shares | 214,285 | |||||
Investment cost | $ 175,000 | |||||
Investment Owned, at Fair Value | $ 138,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment Moximed, Inc. Series C Preferred Stock Initial Acquisition Date 6/24/2022 Maturity Date 6/24/2032 | ||||||
Initial Acquisition Date | Jun. 24, 2022 | |||||
Maturity Date | Jun. 24, 2032 | |||||
Principal/ Shares | 214,285 | |||||
Investment cost | $ 175,000 | |||||
Investment Owned, at Fair Value | $ 163,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment Revelle Aesthetics, Inc. Investment Type Warrants Series A-2 Preferred Stock Initial Acquisition Date 3/30/2022 Maturity Date 3/30/2032 | ||||||
Initial Acquisition Date | Mar. 30, 2022 | |||||
Maturity Date | Mar. 30, 2032 | |||||
Principal/ Shares | 115,591 | |||||
Investment cost | $ 126,000 | |||||
Investment Owned, at Fair Value | 102,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment Revelle Aesthetics, Inc. Series A-2 Preferred Stock Initial Acquisition Date 3/30/2022 Maturity Date 3/30/2032 | ||||||
Initial Acquisition Date | Mar. 30, 2022 | |||||
Maturity Date | Mar. 30, 2032 | |||||
Principal/ Shares | 115,591 | |||||
Investment cost | $ 127,000 | |||||
Investment Owned, at Fair Value | 121,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology | ||||||
Investment cost | 3,137,000 | 3,415,000 | ||||
Investment Owned, at Fair Value | $ 2,506,000 | $ 2,594,000 | ||||
Percentage of Net Assets | 0.46% | 0.45% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 09/15/2022 Maturity Date 1/22/2025 | ||||||
Initial Acquisition Date | Sep. 15, 2022 | |||||
Maturity Date | Jan. 22, 2025 | |||||
Principal/ Shares | 46,256 | |||||
Investment cost | $ 144,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 3/30/2021 Maturity Date 1/22/2025 | ||||||
Initial Acquisition Date | Mar. 30, 2021 | |||||
Maturity Date | Jan. 22, 2025 | |||||
Principal/ Shares | 132,979 | |||||
Investment cost | $ 282,000 | |||||
Investment Owned, at Fair Value | $ 15,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 6/14/2022 Maturity Date 1/22/2025 | ||||||
Initial Acquisition Date | Jun. 14, 2022 | |||||
Maturity Date | Jan. 22, 2025 | |||||
Principal/ Shares | 46,256 | |||||
Investment cost | $ 141,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Investment Type Warrants Earnout Initial Acquisition Date 8/2/2023 Maturity Date 8/1/2028 | ||||||
Initial Acquisition Date | Aug. 02, 2023 | |||||
Maturity Date | Aug. 01, 2028 | |||||
Investment Owned, at Fair Value | $ 77,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Series C Preferred Stock Initial Acquisition Date 3/30/2021 Maturity Date 3/30/2031 | ||||||
Initial Acquisition Date | Mar. 30, 2021 | |||||
Maturity Date | Mar. 30, 2031 | |||||
Principal/ Shares | 132,979 | |||||
Investment cost | $ 283,000 | |||||
Investment Owned, at Fair Value | $ 632,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Series D-1 Preferred Stock Initial Acquisition Date 6/14/2022 Maturity Date 3/30/2031 | ||||||
Initial Acquisition Date | Jun. 14, 2022 | |||||
Maturity Date | Mar. 30, 2031 | |||||
Principal/ Shares | 88,440 | |||||
Investment cost | $ 284,000 | |||||
Investment Owned, at Fair Value | $ 259,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology CareCloud, Inc. Common Stock Initial Acquisition Date 1/8/2020 Maturity Date 1/8/2023 | ||||||
Initial Acquisition Date | Jan. 08, 2020 | |||||
Maturity Date | Jan. 08, 2023 | |||||
Principal/ Shares | 1,000,000 | |||||
Investment cost | $ 837,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology EBR Systems, Inc. Investment Type Warrants Success fee Initial Acquisition Date 6/30/2022 Maturity Date 6/30/2032 | ||||||
Initial Acquisition Date | Jun. 30, 2022 | |||||
Maturity Date | Jun. 30, 2032 | |||||
Investment cost | $ 605,000 | |||||
Investment Owned, at Fair Value | $ 690,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology EBR Systems, Inc. Success fee Initial Acquisition Date 6/30/2022 Maturity Date 6/30/2032 | ||||||
Initial Acquisition Date | Jun. 30, 2022 | |||||
Maturity Date | Jun. 30, 2032 | |||||
Investment cost | $ 292,000 | |||||
Investment Owned, at Fair Value | $ 305,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Gynesonics, Inc. Series G Convertible Preferred Stock Initial Acquisition Date 11/19/2021 Maturity Date 11/19/2031 | ||||||
Initial Acquisition Date | Nov. 19, 2021 | |||||
Maturity Date | Nov. 19, 2031 | |||||
Principal/ Shares | 27,978,115 | |||||
Investment cost | $ 341,000 | |||||
Investment Owned, at Fair Value | $ 446,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Mingle Healthcare Solutions, Inc. Investment Type Warrants Series CC Preferred Stock Initial Acquisition Date 8/15/2018 Maturity Date 8/15/2028 | ||||||
Initial Acquisition Date | Aug. 15, 2018 | |||||
Maturity Date | Aug. 15, 2028 | |||||
Principal/ Shares | 1,770,973 | |||||
Investment cost | $ 492,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Mingle Healthcare Solutions, Inc. Series CC Preferred Stock Initial Acquisition Date 8/15/2018 Maturity Date 8/15/2028 | ||||||
Initial Acquisition Date | Aug. 15, 2018 | |||||
Maturity Date | Aug. 15, 2028 | |||||
Principal/ Shares | 1,770,973 | |||||
Investment cost | $ 492,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Nalu Medical, Inc. Investment Type Warrants Series D-2 Preferred Stock Initial Acquisition Date 10/12/2022 Maturity Date 10/12/2032 | ||||||
Initial Acquisition Date | Oct. 12, 2022 | |||||
Maturity Date | Oct. 12, 2032 | |||||
Principal/ Shares | 91,717 | |||||
Investment cost | $ 173,000 | |||||
Investment Owned, at Fair Value | $ 99,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Nalu Medical, Inc. Series D-2 Preferred Stock Initial Acquisition Date 10/12/2022 Maturity Date 10/12/2032 | ||||||
Initial Acquisition Date | Oct. 12, 2022 | |||||
Maturity Date | Oct. 12, 2032 | |||||
Principal/ Shares | 91,717 | |||||
Investment cost | $ 173,000 | |||||
Investment Owned, at Fair Value | $ 137,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Route 92 Medical, Inc. Investment Type Warrants Success Fee Initial Acquisition Date 8/17/2021 Maturity Date 8/17/2031 | ||||||
Initial Acquisition Date | Aug. 17, 2021 | |||||
Maturity Date | Aug. 17, 2031 | |||||
Investment cost | $ 835,000 | |||||
Investment Owned, at Fair Value | $ 897,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Route 92 Medical, Inc. Success fee Initial Acquisition Date 8/17/2021 Maturity Date 8/17/2031 | ||||||
Initial Acquisition Date | Aug. 17, 2021 | |||||
Maturity Date | Aug. 17, 2031 | |||||
Investment cost | $ 248,000 | |||||
Investment Owned, at Fair Value | $ 297,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology SetPoint Medical Corporation Investment Type Warrants Series B Preferred Stock Initial Acquisition Date 12/29/2022 Maturity Date 12/29/2032 | ||||||
Initial Acquisition Date | Dec. 29, 2022 | |||||
Maturity Date | Dec. 29, 2032 | |||||
Principal/ Shares | 600,000 | |||||
Investment cost | $ 74,000 | |||||
Investment Owned, at Fair Value | $ 199,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology SetPoint Medical Corporation Investment Type Warrants Series B Preferred Stock Initial Acquisition Date 6/29/2021 Maturity Date 6/29/2031 | ||||||
Initial Acquisition Date | Jun. 29, 2021 | |||||
Maturity Date | Jun. 29, 2031 | |||||
Principal/ Shares | 400,000 | |||||
Investment cost | $ 14,000 | |||||
Investment Owned, at Fair Value | $ 133,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology SetPoint Medical Corporation Series B Preferred Stock Initial Acquisition Date 12/29/2022 Maturity Date 12/29/2032 | ||||||
Initial Acquisition Date | Dec. 29, 2022 | |||||
Maturity Date | Dec. 29, 2032 | |||||
Principal/ Shares | 600,000 | |||||
Investment cost | $ 74,000 | |||||
Investment Owned, at Fair Value | $ 74,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology SetPoint Medical Corporation Series B Preferred Stock Initial Acquisition Date 6/29/2021 Maturity Date 6/29/2031 | ||||||
Initial Acquisition Date | Jun. 29, 2021 | |||||
Maturity Date | Jun. 29, 2031 | |||||
Principal/ Shares | 400,000 | |||||
Investment cost | $ 14,000 | |||||
Investment Owned, at Fair Value | $ 50,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology VERO Biotech LLC Investment Type Warrants Success Fee Initial Acquisition Date 12/29/2020 Maturity Date 12/29/2025 | ||||||
Initial Acquisition Date | Dec. 29, 2020 | |||||
Maturity Date | Dec. 29, 2025 | |||||
Investment cost | $ 377,000 | |||||
Investment Owned, at Fair Value | 396,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology VERO Biotech LLC Success fee Initial Acquisition Date 12/29/2020 Maturity Date 12/29/2025 | ||||||
Initial Acquisition Date | Dec. 29, 2020 | |||||
Maturity Date | Dec. 29, 2025 | |||||
Investment cost | $ 377,000 | |||||
Investment Owned, at Fair Value | 394,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services | ||||||
Investment cost | 789,000 | 721,000 | ||||
Investment Owned, at Fair Value | $ 1,239,000 | $ 1,310,000 | ||||
Percentage of Net Assets | 0.23% | 0.23% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Investment Type Warrants Series B Preferred Stock Initial Acquisition Date 6/30/2020 Maturity Date 6/30/2030 | ||||||
Initial Acquisition Date | Jun. 30, 2020 | |||||
Maturity Date | Jun. 30, 2030 | |||||
Principal/ Shares | 11,273 | |||||
Investment cost | $ 218,000 | |||||
Investment Owned, at Fair Value | $ 1,001,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Investment Type Warrants Series D Preferred Stock Initial Acquisition Date 8/17/2021 Maturity Date 8/17/2031 | ||||||
Initial Acquisition Date | Aug. 17, 2021 | |||||
Maturity Date | Aug. 17, 2031 | |||||
Principal/ Shares | 3,502 | |||||
Investment cost | $ 52,000 | |||||
Investment Owned, at Fair Value | $ 95,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Investment Type Warrants Series D Preferred Stock Initial Acquisition Date 9/26/2022 Maturity Date 9/26/2032 | ||||||
Initial Acquisition Date | Sep. 26, 2022 | |||||
Maturity Date | Sep. 26, 2032 | |||||
Principal/ Shares | 5,252 | |||||
Investment cost | $ 176,000 | |||||
Investment Owned, at Fair Value | $ 143,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Series B Preferred Stock Initial Acquisition Date 6/30/2020 Maturity Date 6/30/2030 | ||||||
Initial Acquisition Date | Jun. 30, 2020 | |||||
Maturity Date | Jun. 30, 2030 | |||||
Principal/ Shares | 11,273 | |||||
Investment cost | $ 218,000 | |||||
Investment Owned, at Fair Value | $ 920,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Series D Preferred Stock Initial Acquisition Date 8/17/2021 Maturity Date 8/17/2031 | ||||||
Initial Acquisition Date | Aug. 17, 2021 | |||||
Maturity Date | Aug. 17, 2031 | |||||
Principal/ Shares | 6,129 | |||||
Investment cost | $ 160,000 | |||||
Investment Owned, at Fair Value | $ 170,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services Snagajob.com, Inc. Investment Type Warrants Warrant for Series B-1 Preferred Stock Initial Acquisition Date 9/29/2021 Maturity Date 9/29/2031 | ||||||
Initial Acquisition Date | Sep. 29, 2021 | |||||
Maturity Date | Sep. 29, 2031 | |||||
Principal/ Shares | 763,269 | |||||
Investment cost | $ 343,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services Snagajob.com, Inc. Series B-1 Preferred Stock Initial Acquisition Date 9/29/2021 Maturity Date 9/29/2031 | ||||||
Initial Acquisition Date | Sep. 29, 2021 | |||||
Maturity Date | Sep. 29, 2031 | |||||
Principal/ Shares | 763,269 | |||||
Investment cost | $ 343,000 | |||||
Investment Owned, at Fair Value | 220,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet & Direct Marketing Retail | ||||||
Investment cost | 143,000 | 132,000 | ||||
Investment Owned, at Fair Value | $ 154,000 | $ 133,000 | ||||
Percentage of Net Assets | 0.03% | 0.02% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet & Direct Marketing Retail Madison Reed, Inc. Investment Type Warrants Success fee Initial Acquisition Date 12/16/2022 | ||||||
Initial Acquisition Date | Dec. 16, 2022 | |||||
Investment cost | $ 143,000 | |||||
Investment Owned, at Fair Value | 154,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet & Direct Marketing Retail Madison Reed, Inc. Success fee Initial Acquisition Date 12/16/2022 | ||||||
Initial Acquisition Date | Dec. 16, 2022 | |||||
Investment cost | $ 132,000 | |||||
Investment Owned, at Fair Value | 133,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services | ||||||
Investment cost | 1,313,000 | 1,193,000 | ||||
Investment Owned, at Fair Value | $ 1,642,000 | $ 3,245,000 | ||||
Percentage of Net Assets | 0.30% | 0.56% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Bombora, Inc. Common Stock Initial Acquisition Date 3/31/2021 Maturity Date 3/31/2031 | ||||||
Initial Acquisition Date | Mar. 31, 2021 | |||||
Maturity Date | Mar. 31, 2031 | |||||
Principal/ Shares | 121,581 | |||||
Investment cost | $ 175,000 | |||||
Investment Owned, at Fair Value | $ 248,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Bombora, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 12/26/2023 Maturity Date 12/26/2033 | ||||||
Initial Acquisition Date | Dec. 26, 2023 | |||||
Maturity Date | Dec. 26, 2033 | |||||
Principal/ Shares | 48,632 | |||||
Investment cost | $ 43,000 | |||||
Investment Owned, at Fair Value | $ 41,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Bombora, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 3/31/2021 Maturity Date 3/31/2031 | ||||||
Initial Acquisition Date | Mar. 31, 2021 | |||||
Maturity Date | Mar. 31, 2031 | |||||
Principal/ Shares | 121,581 | |||||
Investment cost | $ 174,000 | |||||
Investment Owned, at Fair Value | $ 104,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Fidelis Cybersecurity, Inc. Common Stock Initial Acquisition Date 3/25/2022 Maturity Date 3/25/2032 | ||||||
Initial Acquisition Date | Mar. 25, 2022 | |||||
Maturity Date | Mar. 25, 2032 | |||||
Investment cost | $ 79,000 | |||||
Investment Owned, at Fair Value | $ 100,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Fidelis Cybersecurity, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 3/25/2022 Maturity Date 3/25/2032 | ||||||
Initial Acquisition Date | Mar. 25, 2022 | |||||
Maturity Date | Mar. 25, 2032 | |||||
Investment cost | $ 79,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services INRIX, Inc. Common Stock Initial Acquisition Date 7/26/2019 Maturity Date 7/26/2029 | ||||||
Initial Acquisition Date | Jul. 26, 2019 | |||||
Maturity Date | Jul. 26, 2029 | |||||
Principal/ Shares | 150,804 | |||||
Investment cost | $ 522,000 | |||||
Investment Owned, at Fair Value | $ 2,198,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services INRIX, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 7/26/2019 Maturity Date 7/26/2029 | ||||||
Initial Acquisition Date | Jul. 26, 2019 | |||||
Maturity Date | Jul. 26, 2029 | |||||
Principal/ Shares | 150,804 | |||||
Investment cost | $ 522,000 | |||||
Investment Owned, at Fair Value | $ 735,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Longtail Ad Solutions, Inc. (dba JW Player) Common Stock Initial Acquisition Date 12/12/2019 Maturity Date 12/12/2029 | ||||||
Initial Acquisition Date | Dec. 12, 2019 | |||||
Maturity Date | Dec. 12, 2029 | |||||
Principal/ Shares | 387,596 | |||||
Investment cost | $ 47,000 | |||||
Investment Owned, at Fair Value | $ 345,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Longtail Ad Solutions, Inc. (dba JW Player) Investment Type Warrants Common Stock Initial Acquisition Date 12/12/2019 Maturity Date 12/12/2029 | ||||||
Initial Acquisition Date | Dec. 12, 2019 | |||||
Maturity Date | Dec. 12, 2029 | |||||
Principal/ Shares | 387,596 | |||||
Investment cost | $ 47,000 | |||||
Investment Owned, at Fair Value | $ 321,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Skillshare, Inc. Investment Type Warrants Success Fee Initial Acquisition Date 11/8/2022 Maturity Date 11/8/2026 | ||||||
Initial Acquisition Date | Nov. 08, 2022 | |||||
Maturity Date | Nov. 08, 2026 | |||||
Investment cost | $ 301,000 | |||||
Investment Owned, at Fair Value | $ 294,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Skillshare, Inc. Success fee Initial Acquisition Date 11/8/2022 Maturity Date 11/8/2026 | ||||||
Initial Acquisition Date | Nov. 08, 2022 | |||||
Maturity Date | Nov. 08, 2026 | |||||
Investment cost | $ 243,000 | |||||
Investment Owned, at Fair Value | $ 225,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Synack, Inc. Common Stock Initial Acquisition Date 6/30/2022 Maturity Date 6/30/2032 | ||||||
Initial Acquisition Date | Jun. 30, 2022 | |||||
Maturity Date | Jun. 30, 2032 | |||||
Principal/ Shares | 100,645 | |||||
Investment cost | $ 127,000 | |||||
Investment Owned, at Fair Value | 129,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Synack, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 12/29/2023 Maturity Date 6/30/2032 | ||||||
Initial Acquisition Date | Dec. 29, 2023 | |||||
Maturity Date | Jun. 30, 2032 | |||||
Principal/ Shares | 116,908 | |||||
Investment cost | $ 147,000 | |||||
Investment Owned, at Fair Value | 147,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance | ||||||
Investment cost | 426,000 | 302,000 | ||||
Investment Owned, at Fair Value | $ 438,000 | $ 297,000 | ||||
Percentage of Net Assets | 0.08% | 0.05% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance Kin Insurance, Inc. Investment Type Warrants Series D-3 Preferred Stock Initial Acquisition Date 5/5/2023 Maturity Date 9/26/2032 | ||||||
Initial Acquisition Date | May 05, 2023 | |||||
Maturity Date | Sep. 26, 2032 | |||||
Principal/ Shares | 11,549 | |||||
Investment cost | $ 69,000 | |||||
Investment Owned, at Fair Value | $ 81,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance Kin Insurance, Inc. Investment Type Warrants Series D-3 Preferred Stock Initial Acquisition Date 8/25/2023 Maturity Date 9/26/2032 | ||||||
Initial Acquisition Date | Aug. 25, 2023 | |||||
Maturity Date | Sep. 26, 2032 | |||||
Principal/ Shares | 9,239 | |||||
Investment cost | $ 55,000 | |||||
Investment Owned, at Fair Value | $ 65,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance Kin Insurance, Inc. Investment Type Warrants Series D-3 Preferred Stock Initial Acquisition Date 9/26/2022 Maturity Date 9/26/2032 | ||||||
Initial Acquisition Date | Sep. 26, 2022 | |||||
Maturity Date | Sep. 26, 2032 | |||||
Principal/ Shares | 41,576 | |||||
Investment cost | $ 302,000 | |||||
Investment Owned, at Fair Value | 292,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance Kin Insurance, Inc. Series D-3 Preferred Stock Initial Acquisition Date 9/26/2022 Maturity Date 9/26/2032 | ||||||
Initial Acquisition Date | Sep. 26, 2022 | |||||
Maturity Date | Sep. 26, 2032 | |||||
Principal/ Shares | 41,576 | |||||
Investment cost | $ 302,000 | |||||
Investment Owned, at Fair Value | 297,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services | ||||||
Investment cost | 2,175,000 | 2,175,000 | ||||
Investment Owned, at Fair Value | $ 373,000 | $ 796,000 | ||||
Percentage of Net Assets | 0.07% | 0.14% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services AllClear ID, Inc. Common Stock Initial Acquisition Date 9/1/2017 Maturity Date 9/1/2027 | ||||||
Initial Acquisition Date | Sep. 01, 2017 | |||||
Maturity Date | Sep. 01, 2027 | |||||
Principal/ Shares | 870,514 | |||||
Investment cost | $ 1,750,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services AllClear ID, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 10/17/2018 Maturity Date 8/31/2027 | ||||||
Initial Acquisition Date | Oct. 17, 2018 | |||||
Maturity Date | Aug. 31, 2027 | |||||
Principal/ Shares | 346,621 | |||||
Investment cost | $ 697,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services AllClear ID, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 8/31/2017 Maturity Date 8/31/2027 | ||||||
Initial Acquisition Date | Aug. 31, 2017 | |||||
Maturity Date | Aug. 31, 2027 | |||||
Principal/ Shares | 523,893 | |||||
Investment cost | $ 1,053,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services Credit Sesame, Inc. Common Stock Initial Acquisition Date 1/7/2020 Maturity Date 1/7/2030 | ||||||
Initial Acquisition Date | Jan. 07, 2020 | |||||
Maturity Date | Jan. 07, 2030 | |||||
Principal/ Shares | 191,601 | |||||
Investment cost | $ 425,000 | |||||
Investment Owned, at Fair Value | 796,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services Credit Sesame, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 1/7/2020 Maturity Date 1/7/2030 | ||||||
Initial Acquisition Date | Jan. 07, 2020 | |||||
Maturity Date | Jan. 07, 2030 | |||||
Principal/ Shares | 191,601 | |||||
Investment cost | $ 425,000 | |||||
Investment Owned, at Fair Value | 373,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software | ||||||
Investment cost | 791,000 | 538,000 | ||||
Investment Owned, at Fair Value | $ 562,000 | $ 191,000 | ||||
Percentage of Net Assets | 0.10% | 0.03% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software Dejero Labs Inc. Common Stock Initial Acquisition Date 5/31/2019 Maturity Date 5/31/2029 | ||||||
Initial Acquisition Date | May 31, 2019 | |||||
Maturity Date | May 31, 2029 | |||||
Principal/ Shares | 333,621 | |||||
Investment cost | $ 192,000 | |||||
Investment Owned, at Fair Value | $ 191,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software Dejero Labs Inc. Investment Type Warrants Common Stock Initial Acquisition Date 5/31/2019 Maturity Date 5/31/2029 | ||||||
Initial Acquisition Date | May 31, 2019 | |||||
Maturity Date | May 31, 2029 | |||||
Principal/ Shares | 333,621 | |||||
Investment cost | $ 192,000 | |||||
Investment Owned, at Fair Value | $ 268,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software Linxup, LLC Investment Type Warrants Success Fee Initial Acquisition Date 11/3/2023 Maturity Date 11/3/2033 | ||||||
Initial Acquisition Date | Nov. 03, 2023 | |||||
Maturity Date | Nov. 03, 2033 | |||||
Investment cost | $ 253,000 | |||||
Investment Owned, at Fair Value | $ 294,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software Scale Computing, Inc. Common Stock Initial Acquisition Date 3/29/2019 Maturity Date 3/29/2029 | ||||||
Initial Acquisition Date | Mar. 29, 2019 | |||||
Maturity Date | Mar. 29, 2029 | |||||
Principal/ Shares | 9,665,667 | |||||
Investment cost | $ 346,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software Scale Computing, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 3/29/2019 Maturity Date 3/29/2029 | ||||||
Initial Acquisition Date | Mar. 29, 2019 | |||||
Maturity Date | Mar. 29, 2029 | |||||
Principal/ Shares | 9,665,667 | |||||
Investment cost | $ 346,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals | ||||||
Investment cost | 542,000 | 542,000 | ||||
Investment Owned, at Fair Value | $ 410,000 | $ 567,000 | ||||
Percentage of Net Assets | 0.07% | 0.10% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Investment Type Warrants Series A Preferred Stock Initial Acquisition Date 10/5/2018 Maturity Date 10/5/2028 | ||||||
Initial Acquisition Date | Oct. 05, 2018 | |||||
Maturity Date | Oct. 05, 2028 | |||||
Principal/ Shares | 112,451 | |||||
Investment cost | $ 136,000 | |||||
Investment Owned, at Fair Value | $ 178,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Investment Type Warrants Series A Preferred Stock Initial Acquisition Date 12/28/2018 Maturity Date 10/5/2028 | ||||||
Initial Acquisition Date | Dec. 28, 2018 | |||||
Maturity Date | Oct. 05, 2028 | |||||
Principal/ Shares | 22,491 | |||||
Investment cost | $ 25,000 | |||||
Investment Owned, at Fair Value | $ 36,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Investment Type Warrants Series A Preferred Stock Initial Acquisition Date 6/27/2019 Maturity Date 6/27/2029 | ||||||
Initial Acquisition Date | Jun. 27, 2019 | |||||
Maturity Date | Jun. 27, 2029 | |||||
Principal/ Shares | 123,894 | |||||
Investment cost | $ 381,000 | |||||
Investment Owned, at Fair Value | 196,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Series A Preferred Stock Initial Acquisition Date 10/5/2018 Maturity Date 10/5/2028 | ||||||
Initial Acquisition Date | Oct. 05, 2018 | |||||
Maturity Date | Oct. 05, 2028 | |||||
Principal/ Shares | 112,451 | |||||
Investment cost | $ 136,000 | |||||
Investment Owned, at Fair Value | $ 246,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Series A Preferred Stock Initial Acquisition Date 12/28/2018 Maturity Date 12/28/2028 | ||||||
Initial Acquisition Date | Dec. 28, 2018 | |||||
Maturity Date | Dec. 28, 2028 | |||||
Principal/ Shares | 22,491 | |||||
Investment cost | $ 25,000 | |||||
Investment Owned, at Fair Value | $ 49,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Series A Preferred Stock Initial Acquisition Date 6/27/2019 Maturity Date 6/27/2029 | ||||||
Initial Acquisition Date | Jun. 27, 2019 | |||||
Maturity Date | Jun. 27, 2029 | |||||
Principal/ Shares | 123,894 | |||||
Investment cost | $ 381,000 | |||||
Investment Owned, at Fair Value | $ 272,000 | |||||
Investment, Identifier [Axis]: Total Investments, Excluding U.S. Treasury Bills | ||||||
Investment cost | 1,064,835,000 | |||||
Investment Owned, at Fair Value | $ 1,025,010,000 | |||||
Percentage of Net Assets | 187.36% | |||||
Investment, Identifier [Axis]: Total U.S. Treasury | ||||||
Investment cost | $ 42,014,000 | |||||
Investment Owned, at Fair Value | $ 41,999,000 | |||||
Percentage of Net Assets | 7.68% | |||||
Investment, Identifier [Axis]: U.S. Treasury U.S. Treasury Bill, 4.324% Initial Acquisition Date 12/29/2023 Maturity Date 1/4/2024 | ||||||
Initial Acquisition Date | Dec. 29, 2023 | |||||
Maturity Date | Jan. 04, 2024 | |||||
Principal Amount | $ 42,029 | |||||
Investment cost | 42,014,000 | |||||
Investment Owned, at Fair Value | $ 41,999,000 | |||||
Investment interest percentage | 4.324% | |||||
[1] All investments in the portfolio companies, which as of December 31, 2023 represented 9.58 % of the Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors. All investments in the portfolio company, which as of December 31, 2022 represented 1.97 % of the Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors. |
Consolidated Schedule of Inve_2
Consolidated Schedule of Investments (Parenthetical) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Percentage of Net Assets | 195.04% | 195.52% |
Minimum | Affiliate Investments | ||
Investment owned from voting securities | 5% | 5% |
Minimum | Control Investments | ||
Investment owned from voting securities | 25% | 25% |
Investment owned from voting securities | 50% | 50% |
Maximum | Affiliate Investments | ||
Investment owned from voting securities | 25% | 25% |
Investment owned from voting securities | 50% | 50% |
Non Qualifying Assets at Fair Value | ||
Percentage of Net Assets | 12.63% | 10.65% |
Qualifying Assets | Minimum | ||
Percentage of Net Assets | 70% | 70% |
Percentage of assets represent of total assets | 70% | |
United Kingdom | ||
Percentage of Net Assets | 14.05% | 10.55% |
Germany | ||
Percentage of Net Assets | 8.15% | 8.07% |
Canada | ||
Percentage of Net Assets | 2.68% | 2.40% |
3-Month LIBOR | ||
Investment Interest Rate | 4.77% | |
US Prime Rate | ||
Investment Interest Rate | 8.50% | 7.50% |
3-Month SOFR | ||
Investment Interest Rate | 5.33% | 4.79% |
1-Month SOFR | ||
Investment Interest Rate | 5.35% |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Pay vs Performance Disclosure | |||
Net Income (Loss) | $ 44,341 | $ 32,250 | $ 45,619 |
Insider Trading Arrangements
Insider Trading Arrangements | 12 Months Ended |
Dec. 31, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Insider Trading Policies and Pr
Insider Trading Policies and Procedures | 12 Months Ended |
Dec. 31, 2023 | |
Insider Trading Policies and Procedures [Line Items] | |
Insider Trading Policies and Procedures Adopted | true |
N-2
N-2 - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | 12 Months Ended | |||||||||||||||||||||||||
Mar. 06, 2024 | Dec. 31, 2023 | Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2022 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2023 | Dec. 31, 2020 | [1] | Dec. 31, 2019 | [1] | Dec. 31, 2018 | [1] | Dec. 31, 2017 | [1] | Dec. 31, 2016 | [1] | Dec. 31, 2015 | [1] | |||||
Cover [Abstract] | |||||||||||||||||||||||||||
Entity Central Index Key | 0001653384 | ||||||||||||||||||||||||||
Amendment Flag | false | ||||||||||||||||||||||||||
Securities Act File Number | 814-01180 | ||||||||||||||||||||||||||
Document Type | 10-K | ||||||||||||||||||||||||||
Entity Registrant Name | Runway Growth Finance Corp. | ||||||||||||||||||||||||||
Entity Address, Address Line One | 205 N. Michigan Ave | ||||||||||||||||||||||||||
Entity Address, Address Line Two | Suite 4200 | ||||||||||||||||||||||||||
Entity Address, City or Town | Chicago | ||||||||||||||||||||||||||
Entity Address, State or Province | IL | ||||||||||||||||||||||||||
Entity Address, Postal Zip Code | 60601 | ||||||||||||||||||||||||||
City Area Code | 312 | ||||||||||||||||||||||||||
Local Phone Number | 698‑6902 | ||||||||||||||||||||||||||
Entity Well-known Seasoned Issuer | No | ||||||||||||||||||||||||||
Entity Emerging Growth Company | true | ||||||||||||||||||||||||||
Entity Ex Transition Period | false | ||||||||||||||||||||||||||
Fee Table [Abstract] | |||||||||||||||||||||||||||
Shareholder Transaction Expenses [Table Text Block] | Stockholder transaction expenses: Sales load (as a percentage of offering price) — % (1) Offering expenses (as a percentage of offering price) — % (2) Dividend reinvestment plan expenses — % (3) Total stockholder transaction expenses (as a percentage of offering price) — % Annual expenses (as a percentage of net assets attributable to common stock): Management Fee payable under the Advisory Agreement 3.02 % (4) (8) Incentive Fee payable under the Advisory Agreement 3.24 % (5) (8) Interest payments and fees paid on borrowed funds 9.09 % (6) (8) Other expenses 1.51 % (7) (8) Total annual expenses 16.86 % | ||||||||||||||||||||||||||
Sales Load [Percent] | 0% | ||||||||||||||||||||||||||
Dividend Reinvestment and Cash Purchase Fees | $ 0 | ||||||||||||||||||||||||||
Other Transaction Expenses [Abstract] | |||||||||||||||||||||||||||
Other Transaction Expense 1 [Percent] | 0% | ||||||||||||||||||||||||||
Other Transaction Expenses [Percent] | 0% | ||||||||||||||||||||||||||
Annual Expenses [Table Text Block] | Fees and Expenses The following information is intended to assist you in understanding the costs and expenses that an investor in our common stock will bear directly or indirectly. We caution you that some of the percentages indicated in the table below are estimates and may vary. Except where the context suggests otherwise, whenever this Annual Report on Form 10-K contains a reference to fees or expenses paid by "you," "us," or "the Company," or that "we" will pay for expenses, stockholders will indirectly bear such fees or expenses as investors in us. Stockholder transaction expenses: Sales load (as a percentage of offering price) — % (1) Offering expenses (as a percentage of offering price) — % (2) Dividend reinvestment plan expenses — % (3) Total stockholder transaction expenses (as a percentage of offering price) — % Annual expenses (as a percentage of net assets attributable to common stock): Management Fee payable under the Advisory Agreement 3.02 % (4) (8) Incentive Fee payable under the Advisory Agreement 3.24 % (5) (8) Interest payments and fees paid on borrowed funds 9.09 % (6) (8) Other expenses 1.51 % (7) (8) Total annual expenses 16.86 % (1) In the event that the securities are sold to or through underwriters, a related prospectus will disclose the applicable sales load (underwriting discount or commission). (2) A related prospectus will disclose the estimated amount of offering expenses, the offering price and the estimated amount of offering expenses borne by the Company as a percentage of the offering price. (3) The expenses of the Dividend Reinvestment Plan are included in "other expenses" in the table above. For additional information, refer to "Note 9 – Net Assets." (4) Assumes the base management fee will be an amount equal to 0.375% (1.50% annualized) of our average daily Gross Assets during the most recently completed calendar quarter. For additional information, refer to "Note 3 – Related Party Agreements and Transactions." (5) The incentive fee, which provides RGC with a share of the income that RGC generates for us, consists of an Investment Income Fee and a Capital Gains Fee. For additional information, refer to "Note 3 – Related Party Agreements and Transactions." (6) Interest payments on borrowed funds represents an estimate of our annualized interest expense based on borrowings under the Credit Agreement. The assumed weighted average interest rate on our total debt outstanding was 7.86%. We may borrow additional funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. We may also issue debt securities or preferred stock, subject to our compliance with applicable requirements under the 1940 Act. For additional information, refer to "Note 7 – Borrowings." (7) Includes our overhead and other expenses, such as payments under the Investment Management Agreement for certain expenses incurred by the Adviser and Administration Agreement for certain expenses incurred by the Administrator. For additional information, refer to "Note 3 – Related Party Agreements and Transaction." We based these expenses on estimated amounts for the current fiscal year. (8) Estimated. Under the Income Incentive Fee, we pay RGC each quarter an incentive fee with respect to our Pre-Incentive Fee NII. The Income Incentive Fee is calculated and payable quarterly in arrears based on the Pre-Incentive Fee NII for the immediately preceding fiscal quarter. Payments based on Pre-Incentive Fee NII will be based on the Pre-Incentive Fee NII earned for the quarter. Pre-Incentive Fee NII, expressed as a rate of return on the value of our net assets (defined as total assets less liabilities) at the end of the immediately preceding fiscal quarter, will be compared to a "hurdle rate" of 2.0% per quarter (8.0% annualized). We will pay RGC an Income Incentive Fee with respect to our Pre-Incentive Fee NII in each calendar quarter as follows: (1) no Income Incentive Fee in any calendar quarter in which our Pre-Incentive Fee NII does not exceed the hurdle rate of 2.0%; (2) 80% of our Pre-Incentive Fee NII with respect to that portion of such Pre-Incentive Fee NII, if any, that exceeds the hurdle rate but is less than 2.667% in any calendar quarter (10.668% annualized) (the portion of our Pre-Incentive Fee NII that exceeds the hurdle but is less than 2.667% is referred to as the "catch-up"; the "catch-up" is meant to provide RGC with 20.0% of our Pre-Incentive Fee NII as if a hurdle did not apply if our Pre-Incentive Fee NII exceeds 2.667% in any calendar quarter (10.668% annualized)); and (3) 20.0% of the amount of our Pre-Incentive Fee NII, if any, that exceeds 2.667% in any calendar quarter (10.668% annualized) payable to RGC (once the hurdle is reached and the catch-up is achieved, 20.0% of all Pre-Incentive Fee NII thereafter is allocated to RGC). Under the Capital Gains Fee, we will pay RGC, as of the end of each calendar year, 20.0% of our aggregate cumulative realized capital gains, if any, from the date of our election to be regulated as a BDC through the end of that calendar year, computed net of our aggregate cumulative realized capital losses and aggregate cumulative unrealized capital depreciation through the end of such year, less the aggregate amount of any previously paid Capital Gains Fee. For additional information, refer to "Note 3 - Related Party Agreements and Transactions." | ||||||||||||||||||||||||||
Management Fees [Percent] | 3.02% | ||||||||||||||||||||||||||
Interest Expenses on Borrowings [Percent] | 9.09% | ||||||||||||||||||||||||||
Incentive Fees [Percent] | 3.24% | ||||||||||||||||||||||||||
Other Annual Expenses [Abstract] | |||||||||||||||||||||||||||
Other Annual Expenses [Percent] | 1.51% | ||||||||||||||||||||||||||
Total Annual Expenses [Percent] | 16.86% | ||||||||||||||||||||||||||
Expense Example [Table Text Block] | Example The following example demonstrates the projected dollar amount of total cumulative expenses over various periods with respect to a hypothetical investment in our common stock. In calculating the following expense amounts, we have assumed we would have no additional leverage and that our annual operating expenses would remain at the levels set forth in the table above. Transaction expenses are included in the following example. 1 year 3 years 5 years 10 years You would pay the following expenses on a $1,000 investment, assuming a 5% annual return from realized capital gains $ 169 $ 448 $ 665 $ 1,019 The foregoing table is to assist you in understanding the various costs and expenses that an investor in our common stock will bear directly or indirectly. While the example assumes, as required by the SEC, a 5% annual return, our performance will vary and may result in a return greater or less than 5%. Because the Income Incentive Fee under the Advisory Agreement is unlikely to be significant assuming a 5% annual return, the example assumes that the 5% annual return will be generated entirely through the realization of capital gains on our assets and, as a result, will trigger the payment of the Capital Gains Fee under the Advisory Agreement. The Income Incentive Fee under the Advisory Agreement, which, assuming a 5% annual return, would either not be payable or have an immaterial impact on the expense amounts shown above, is not included in the example. If we achieve sufficient returns on our investments, including through the realization of capital gains, to trigger an Income Incentive Fee of a material amount, our expenses, and returns to our investors, would be higher. In addition, while the example assumes reinvestment of all dividends and distributions at net asset value, if our Board authorizes and we declare a cash dividend, participants in our Dividend Reinvestment Plan who have not otherwise elected to receive cash will receive a number of shares of our common stock, determined by dividing the total dollar amount of the dividend payable to a participant by the market price per share of our common stock at the close of trading on the valuation date for the dividend. R efer to "Note 9 - Net Assets" for additional information regarding our Dividend Reinvestment Plan. | ||||||||||||||||||||||||||
Expense Example, Year 01 | $ 169 | ||||||||||||||||||||||||||
Expense Example, Years 1 to 3 | 448 | ||||||||||||||||||||||||||
Expense Example, Years 1 to 5 | 665 | ||||||||||||||||||||||||||
Expense Example, Years 1 to 10 | $ 1,019 | ||||||||||||||||||||||||||
Purpose of Fee Table , Note [Text Block] | The foregoing table is to assist you in understanding the various costs and expenses that an investor in our common stock will bear directly or indirectly. While the example assumes, as required by the SEC, a 5% annual return, our performance will vary and may result in a return greater or less than 5%. Because the Income Incentive Fee under the Advisory Agreement is unlikely to be significant assuming a 5% annual return, the example assumes that the 5% annual return will be generated entirely through the realization of capital gains on our assets and, as a result, will trigger the payment of the Capital Gains Fee under the Advisory Agreement. The Income Incentive Fee under the Advisory Agreement, which, assuming a 5% annual return, would either not be payable or have an immaterial impact on the expense amounts shown above, is not included in the example. If we achieve sufficient returns on our investments, including through the realization of capital gains, to trigger an Income Incentive Fee of a material amount, our expenses, and returns to our investors, would be higher. In addition, while the example assumes reinvestment of all dividends and distributions at net asset value, if our Board authorizes and we declare a cash dividend, participants in our Dividend Reinvestment Plan who have not otherwise elected to receive cash will receive a number of shares of our common stock, determined by dividing the total dollar amount of the dividend payable to a participant by the market price per share of our common stock at the close of trading on the valuation date for the dividend. R efer to "Note 9 - Net Assets" for additional information regarding our Dividend Reinvestment Plan. | ||||||||||||||||||||||||||
Basis of Transaction Fees, Note [Text Block] | Stockholder transaction expenses: Sales load (as a percentage of offering price) — % (1) Offering expenses (as a percentage of offering price) — % (2) Dividend reinvestment plan expenses — % (3) Total stockholder transaction expenses (as a percentage of offering price) — % Annual expenses (as a percentage of net assets attributable to common stock): Management Fee payable under the Advisory Agreement 3.02 % (4) (8) Incentive Fee payable under the Advisory Agreement 3.24 % (5) (8) Interest payments and fees paid on borrowed funds 9.09 % (6) (8) Other expenses 1.51 % (7) (8) Total annual expenses 16.86 % | ||||||||||||||||||||||||||
Management Fee not based on Net Assets, Note [Text Block] | (4) Assumes the base management fee will be an amount equal to 0.375% (1.50% annualized) of our average daily Gross Assets during the most recently completed calendar quarter. For additional information, refer to "Note 3 – Related Party Agreements and Transactions." | ||||||||||||||||||||||||||
General Description of Registrant [Abstract] | |||||||||||||||||||||||||||
Investment Objectives and Practices [Text Block] | Our investment objective is to maximize total return to our stockholders primarily through current income on our loan portfolio, and secondarily through capital gain on our warrants and other equity positions. We intend to achieve our investment objective by investing in high growth-potential, private companies. We typically invest in senior secured loans that generally fall into two strategies: Sponsored Growth Lending and Non-Sponsored Growth Lending. We generally receive warrants and/or other equity from our investments. We expect our investments in loans will generally range from between $10.0 million to $100.0 million, and the upper end of this range may increase as we raise additional capital. We generate revenue in the form of interest on the debt securities that we hold and distributions and capital gains on other interests that we acquire in our portfolio companies. We expect that the debt we invest in will generally have stated terms of 36 to 60 months. Interest on debt securities is generally payable monthly, primarily based on a floating rate index, and subject to certain floors determined by market rates at the time the investment is made. In some cases, some of our investments may provide for deferred interest payments or PIK interest. The principal amount of the debt securities and any accrued but unpaid interest will become due at the maturity date. Any original issue discount ("OID") or market discount or premium will be capitalized, and we will accrete or amortize such amounts as interest income. We record prepayment fees on debt investments as fee income. Dividend income, if any, will be recognized on an accrual basis to the extent that we expect to collect such amounts. | ||||||||||||||||||||||||||
Risk Factors [Table Text Block] | Item 1A. Risk F actors. An investment in our securities involves certain risks relating to our structure and investment objective. The risks set forth below are not the only risks we face, and we may face other risks that we have not yet identified, which we do not currently deem material or which are not yet predictable. If any of the following risks occur, our business, financial condition and results of operations could be materially adversely affected. In such case, our net asset value and the price of our common stock could decline, and you may lose all or part of your investment. Summary Risk Factors The risk factors described below are a summary of the principal risk factors associated with an investment in us. These are not the only risks we face. You should carefully consider these risk factors, together with the risk factors set forth in the following section, Item 1A. of this Annual Report on Form 10-K, and the other reports and documents filed by us with the SEC. Risks Related to the Economy • Political, social and economic uncertainty creates and exacerbates risks. • A renewed period of disruption in the capital markets may cause uncertain economic conditions. Such market conditions may materially and adversely affect debt and equity capital markets, which may have a negative impact on our business and operations. • Increasing level of inflation and rising interest rate could impact our portfolio company’s operations and cash flows and harm our operating results. Risks Related to Our Business and Structure • Our investment portfolio is recorded at fair value, with our Board of Directors determining, in good faith, the fair value of our investment portfolio and, as a result, there is uncertainty as to the value of our portfolio investments. • Our financial condition and results of operations depend on our ability to effectively manage and deploy capital. • We operate in a highly competitive market for investment opportunities and we may not be able to compete effectively. • We may need to raise additional capital to grow because we must distribute most of our income. • Any defaults under our Credit Facility or other borrowings, including the 2026 or 2027 Notes, could adversely affect our business. Risks Related to Our Investments • Our investments are very risky and highly speculative. • Investing in high growth-potential, private companies involves a high degree of risk, and our financial results may be affected adversely if one or more of our significant portfolio investments defaults on its loans or fails to perform as we expect. • An investment strategy focused primarily on privately held companies presents certain challenges, including the lack of available information about these companies and a greater vulnerability to economic downturns. • Inflation may adversely affect our and our portfolio companies’ business, results of operations and financial condition. Risks Related to Our Conflicts of Interest • Our strategic relationship with Oaktree may create conflicts of interest. • There are significant potential conflicts of interest which could impact our investment returns. • RGC’s liability is limited under the Advisory Agreement and we have agreed to indemnify RGC against certain liabilities, which may lead RGC to act in a riskier manner on our behalf than it would when acting for its own account. Risks Related to Our Common Stock • Shares of our common stock have traded at a discount from net asset value and may do so in the future. • A stockholder’s interest in us will be diluted if we issue additional shares, which could reduce the overall value of an investment in us. • Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock. Risks Related to RIC Tax Treatment • We will be subject to U.S. federal income tax at corporate rates if we are unable to qualify as a RIC. • We may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income. General Risks • We may experience fluctuations in our quarterly and annual results. • Government intervention in the credit markets could adversely affect our business. Risks Related to the Economy Political, social and economic uncertainty creates and exacerbates risks. Social, political, economic and other conditions and events (such as natural disasters, epidemics and pandemics, terrorism, conflicts and social unrest) will occur that create uncertainty and have significant impacts on issuers, industries, governments and other systems, including the financial markets, to which companies and their investments are exposed. As global systems, economies and financial markets are increasingly interconnected, events that once had only local impact are now more likely to have regional or even global effects. Events that occur in one country, region or financial market will, more frequently, adversely impact issuers in other countries, regions or markets, including in established markets such as the United States. These impacts can be exacerbated by failures of governments and societies to adequately respond to an emerging event or threat. Uncertainty can result in or coincide with, among other things: increased volatility in the financial markets for securities, derivatives, loans, credit and currency; a decrease in the reliability of market prices and difficulty in valuing assets (including portfolio company assets); greater fluctuations in spreads on debt investments and currency exchange rates; increased risk of default (by both government and private obligors and issuers); further social, economic, and political instability; nationalization of private enterprise; greater governmental involvement in the economy or in social factors that impact the economy; changes to governmental regulation and supervision of the loan, securities, derivatives and currency markets and market participants and decreased or revised monitoring of such markets by governments or self-regulatory organizations and reduced enforcement of regulations; limitations on the activities of investors in such markets; controls or restrictions on foreign investment, capital controls and limitations on repatriation of invested capital; the significant loss of liquidity and the inability to purchase, sell and otherwise fund investments or settle transactions (including, but not limited to, a market freeze); unavailability of currency hedging techniques; substantial, and in some periods extremely high rates of inflation, which can last many years and have substantial negative effects on credit and securities markets as well as the economy as a whole; recessions; and difficulties in obtaining and/or enforcing legal judgments. A renewed period of disruption in the capital markets may cause uncertain economic conditions. Such market conditions may materially and adversely affect debt and equity capital markets, which may have a negative impact on our business and operations. The capital markets have experienced extreme volatility in recent periods, and as a result, there has been and will likely continue to be uncertainty in the financial markets in general. Unpredictable general economic conditions may materially and adversely impact the broader financial and credit markets which could reduce the availability of debt and equity capital for the market as a whole. These conditions could continue for a prolonged period of time or worsen in the future. Given the ongoing and dynamic nature of the circumstances, it is difficult to predict the full impact that current market conditions may have on our business. The extent of such impact will depend on future developments, which are highly uncertain and current market conditions, and the related adverse local and national economic consequences, we could be subject to any of the following risks, any of which could have a material, adverse effect on our business, financial condition, liquidity, and results of operations: • Current market conditions may make it difficult to raise equity capital because, subject to some limited exceptions, as a BDC, we are generally not able to issue additional shares of our common stock at a price less than the NAV per share without first obtaining approval for such issuance from our stockholders and our independent directors. In addition, these market conditions may make it difficult to access or obtain new indebtedness with similar terms to our existing indebtedness. • Significant changes or volatility in the capital markets may also have a negative effect on the valuations of our investments. While most of our investments are not publicly traded, applicable accounting standards require us to assume as part of our valuation process that our investments are sold in a principal market to market participants (even if we plan on holding an investment through its maturity). • Significant changes in the capital markets may adversely affect the pace of our investment activity and economic activity generally. • The illiquidity of our investments may make it difficult for us to sell such investments to access capital if required, and as a result, we could realize significantly less than the value at which we have recorded our investments if we were required to sell them for liquidity purposes. An inability to raise or access capital, and any required sale of all or a portion of our investments as a result, could have a material adverse effect on our business, financial condition or results of operations. The current period of capital markets disruption and economic uncertainty may make it difficult to extend the maturity of, or refinance, our existing indebtedness or obtain new indebtedness and any failure to do so could have a material adverse effect on our business, financial condition or results of operations. Current market conditions may make it difficult to extend the maturity of or refinance our existing indebtedness or obtain new indebtedness with similar terms and any failure to do so could have a material adverse effect on our business. The debt capital that will be available to us in the future, if at all, may be at a higher cost and on less favorable terms and conditions than what we currently experience, including being at a higher cost in rising rate environments. If we are unable to raise or refinance debt, then our equity investors may not benefit from the potential for increased returns on equity resulting from leverage and we may be limited in our ability to make new commitments or to fund existing commitments to our portfolio companies. An inability to extend the maturity of, or refinance, our existing indebtedness or obtain new indebtedness could have a material adverse effect on our business, financial condition or results of operations. Economic recessions or downturns could impair our portfolio companies and harm our operating results. Many of the portfolio companies in which we make investments may be susceptible to economic slowdowns or recessions and may be unable to repay the loans we made to them during these periods. Therefore, our non-performing assets may increase and the value of our portfolio may decrease during these periods as we are required to record our investments at their current fair value. Adverse economic conditions also may decrease the value of collateral securing some of our loans and the value of our equity investments. Economic slowdowns or recessions could lead to financial losses in our portfolio and a decrease in revenues, net income and assets. Unfavorable economic conditions also could increase our and our portfolio companies’ funding costs, limit our and our portfolio companies’ access to the capital markets or result in a decision by lenders not to extend credit to us or our portfolio companies. In similar fashion, increasing or excessive levels of inflation and rising interest rates could also impair our portfolio companies cash flow and operations. These events could prevent us from increasing investments and harm our operating results. A portfolio company’s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, acceleration of the time when the loans are due and foreclosure on its secured assets, which could trigger cross-defaults under other agreements and jeopardize the portfolio company’s ability to meet its obligations under the debt that we hold. We may incur additional expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting portfolio company. In addition, if one of our portfolio companies were to go bankrupt, depending on the facts and circumstances, including the extent to which we will actually provide significant managerial assistance to that portfolio company, a bankruptcy court might subordinate all or a portion of our claim to that of other creditors. Further downgrades of the U.S. credit rating could negatively impact our liquidity, financial conditions and earnings. The U.S. debt ceiling and budget deficit concerns have raised the possibility of additional credit-rating downgrades and economic slowdowns in the United States and globally. Legislation passed in June 2023 suspends the debt ceiling through early 2025, unless Congress takes further legislative action to extend it. Downgrades by rating agencies to the U.S. government’s credit rating or concerns about its credit and deficit levels in general could cause interest rates and borrowing costs to rise, which may negatively impact both the perception of credit risk associated with our debt portfolio and our ability to access the debt markets on favorable terms. In addition, a decreased U.S. government credit rating could create broader financial turmoil and uncertainty, which may weigh heavily on our financial performance and the value of our common stock. Global economic, political and market conditions may adversely affect our business, financial condition and results of operations, including our revenue growth and profitability. Deterioration in the economic conditions in the Eurozone and other regions or countries globally and the resulting instability in global financial markets may pose a risk to our business. Financial markets have been affected at times by a number of global macroeconomic events, including the following: large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets jurisdictions, levels of non-performing loans on the balance sheets of European banks, the effect of the United Kingdom (the "U.K.") leaving the European Union (the "EU"), instability in the Chinese capital markets and the COVID-19 pandemic. Global market and economic disruptions have affected, and may in the future affect, the U.S. capital markets, which could adversely affect our business, financial condition or results of operations. We cannot assure you that market disruptions in Europe and other regions or countries, including the increased cost of funding for certain governments and financial institutions, will not impact the global economy, and we cannot assure you that assistance packages will be available, or if available, be sufficient to stabilize countries and markets in Europe or elsewhere affected by a financial crisis. To the extent uncertainty regarding any economic recovery in Europe negatively impacts consumer confidence and consumer credit factors, our business, financial condition and results of operations could be significantly and adversely affected. Moreover, there is a risk of both sector-specific and broad-based corrections and/or downturns in the equity and credit markets. Any of the foregoing could have a significant impact on the markets in which we operate and could have a material adverse impact on our business prospects and financial condition. Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, including rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the United States and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the United States and worldwide. Specifically, the ongoing conflict between Russia and Ukraine, and the ongoing conflict in the Middle East and the resulting market volatility, could adversely affect our business, financial condition or results of operations. In response to the conflict between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on our business, financial condition, cash flows and results of operations and could cause the market value of our common shares and/or debt securities to decline. These market and economic disruptions could also negatively impact the operating results of our portfolio companies. Additionally, the Federal Reserve may further raise, or may announce its intention to further raise, the Federal Funds Rate in 2024. These developments, along with the United States government’s credit and deficit concerns, global economic uncertainties and market volatility could cause interest rates to be volatile, which may negatively impact our ability to access the debt markets and capital markets on favorable terms. Risks Related to Our Business and Structure Our investment portfolio is recorded at fair value, with our Board of Directors determining, in good faith, the fair value of our investment portfolio and, as a result, there is uncertainty as to the value of our portfolio investments. Under the 1940 Act, we are required to carry our portfolio investments at market value or, if there is no readily available market value, at fair value as determined by our Board of Directors. Typically, there will not be a public market for the securities of the privately held companies in which we invest. As a result, our Board of Directors values these securities quarterly at fair value based on input from management, a third-party independent valuation firm and the audit committee of our Board of Directors (the "Audit Committee"). The fair value of such securities may meaningfully change between the date of the fair value determination by our Board of Directors, as assisted by third-party independent valuation firms and the Audit Committee, and the release of the financial results for the corresponding period and/or the next date at which fair value is determined. The determination of fair value and consequently, the amount of unrealized gains and losses in our portfolio, are to a certain degree, subjective and dependent on a valuation process approved by our Board of Directors. Certain factors that may be considered in determining the fair value of our investments include external events, such as private mergers, sales and acquisitions involving comparable companies. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. Our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Due to this uncertainty, our fair value determinations may cause our net asset value on a given date to materially understate or overstate the value that we may ultimately realize on one or more of our investments. As a result, investors purchasing our common stock based on an overstated net asset value would pay a higher price than the value of our investments might warrant. Conversely, investors selling shares of our common stock during a period in which the net asset value understates the value of our investments will receive a lower price for their shares of our common stock than the value of our investments might warrant. Our financial condition and results of operations depend on our ability to effectively manage and deploy capital. Our ability to achieve our investment objective depends on our ability to effectively manage and deploy capital, which depends, in turn, on RGC’s ability to identify, originate, evaluate and monitor, and our ability to finance and invest in, companies that meet our investment criteria. Accomplishing our investment objective on a cost-effective basis is largely a function of RGC’s handling of the investment process, its ability to provide competent, attentive and efficient services and our access to investments offering acceptable terms. In addition to monitoring the performance of our existing investments and other responsibilities under the Advisory Agreement, RGC’s investment team may also be called upon, from time to time, to provide managerial assistance to some of our portfolio companies. These demands may distract our investment team or slow the rate at which we may make investments. Even if we are able to grow and build upon our investment portfolio, any failure to manage our growth effectively could have a material adverse effect on our business, financial condition, results of operations and prospects. Our results of operations depend on many factors, including the availability of opportunities for investment, readily accessible short and long-term funding alternatives in the financial markets and economic conditions. Furthermore, if we cannot successfully operate our business or implement our investment policies and strategies as described herein, it could negatively impact our ability to pay dividends. We operate in a highly competitive market for investment opportunities and we may not be able to compete effectively. Our primary competitors for investments include both existing and newly formed debt, and to a lesser extent equity, focused public and private funds, other BDCs, commercial and investment banks, venture-oriented commercial banks, commercial financing companies and, to the extent they provide an alternative form of financing, private equity and hedge funds. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, we believe some competitors may have a lower cost of capital and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have, which could allow them to consider a wider variety of investments and establish more relationships than we can. Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC or to the distribution and other requirements we must satisfy to maintain our ability to be subject to taxation as a RIC. These characteristics could allow our competitors to consider a wider variety of investments, establish more relationships and offer better pricing and more flexible structuring than we are able to offer. In recent years, substantial investor capital has been allocated to the private credit and direct lending asset classes, creating and increasing competition among lenders. Increased competition across all segments of the private credit and direct lending markets, has reduced credit spreads, and along with historically low interest rates, has reduced investment yields and resulted in more borrower friendly terms and conditions. For instance, typically when interest rates are low and a credit cycle extended, new entrants will enter traditionally higher yielding markets creating additional competition and pressures and temporarily compressing yields. We believe the credit markets, and in particular the market for our lending strategies, are presently experiencing such pressures. New competitors, including established private credit platforms in other segments, have entered the sponsored and non-sponsored growth lending market and a similar competitive dynamic is possible. While their entry may or may not be permanent, their entry could lead to competitive pressure on our investment yields and other terms and conditions in the short-term. We do not compete primarily on the financing terms we offer and some competitors make loans with rates that are comparable or lower than our rates. We may lose some investment opportunities if we do not match our competitors’ pricing, terms and structure. However, if we match our competitors’ pricing, terms and structure, we may experience decreased net interest income, lower yields and increased risk of credit loss. As a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time, and we may not be able to identify and make investments that are consistent with our investment objective. The competitive pressures we face may have a material adverse effect on our financial condition, results of operations and cash flows. Our business model depends to a significant extent upon strong referral relationships. Any inability of RGC to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business. We depend upon RGC to maintain its relationships with venture capital and private equity firms, placement agents, investment banks, management groups and other financial institutions, and we expect to rely to a significant extent upon these relationships to provide us with potential investment opportunities. If RGC fails to maintain such existing relationships, or to develop new relationships with other sources of investment opportunities, we may not be able to grow our investment portfolio. In addition, individuals with whom RGC has relationships are not obligated to provide us with investment opportunities, and we can offer no assurance that these relationships will generate investment opportunities for us in the future. The failure of RGC to maintain existing relationships, grow new relationships, or for any of those relationships to generate investment opportunities could have an adverse effect on our business, financial condition and results of operations. We are dependent upon RGC’s key personnel for our future success. We depend on the diligence, skill and investment acumen of R. David Spreng, the founder, Chief Executive Officer and Chief Investment Officer of RGC , along with the senior officers and other investment professionals at RGC, including Thomas Raterman, our Acting President, Chief Operating Officer, Chief Financial Officer, Treasurer and Secretary, and Greg Greifeld our Acting Chief Executive Officer, and Managing Director, Deputy Chief Investment Officer, and Head of Credit at RGC. Mr. Raterman also serves as the Chief Financial Officer, and Chief Operating Officer of RGC. Mr. Spreng, Mr. Raterman, Mr. Greifeld and the other members of RGC’s senior management evaluate, negotiate, structure, close and monitor our investments. Our future success depends on the continued service of these members of RGC’s senior management. We cannot assure you that unforeseen business, medical, personal or other circumstances would not lead any such individual to terminate his or her relationship with us. The loss of Mr. Spreng, Mr. Raterman, Mr. Greifeld and/or any of the other members of RGC’s senior management could have a material adverse effect on our ability to achieve our investment objective as well as on our financial condition and results of operations. In addition, we can offer no assurance that RGC will continue indefinitely as RGC. The members of RGC’s senior management are and may in the future become affiliated with entities engaged in business activities similar to those intended to be conducted by us and may have conflicts of interest in allocating their time. RGC may also manage and sub-advise private investment funds and accounts, and may manage other such funds and accounts in the future, which have investment mandates that are similar, in whole or in part, with ours. Accordingly, RGC’s senior management may have obligations to investors in those entities, the fulfillment of which might not be in the best interests of us or our stockholders. For example, RGC’s senior management may face conflicts of interest in the allocation of investment opportunities to us and such other existing and future funds and accounts. Our success depends on the ability of RGC to attract and retain qualified personnel in a competitive environment. Our growth requires that RGC retains and attracts new investment and administrative personnel in a competitive market. RGC’s ability to attract and retain personnel with the requisite credentials, experience and skills depends on several factors including, but not limited to, its ability to offer competitive wages, benefits and professional growth opportunities. Many of the entities, including investment funds (such as venture capital funds, private equity funds and mezzanine funds) and traditional financial services companies, with which RGC competes for experienced personnel have greater resources than it possesses, which could have a negative impact on RGC’s ability to attract and retain qualified personnel and, as a result, have a material adverse effect on our business and results of operations. The compensation we pay to RGC and our Administrator was not determined on an arm’s-length basis. Thus, the terms of such compensation may be less advantageous to us than if such terms had been the subject of arm’s-length negotiations. The compensation we pay to RGC and our Administrator was not determined on an arm’s-length basis with an unaffiliated third party. As a result, the form and amount of such compensation may be less favorable to us than if the respective agreements had been entered into through arm’s-length transactions with an unaffiliated third party. In addition, we may choose not to enforce, or to enforce less vigorously, our respective rights and remedies under the Advisory Agreement and the Administration Agreement because of our desire to maintain our ongoing relationship with RGC, our Administrator and their respective affiliates. Any such decision, however, could cause us to breach our fiduciary obligations to our stockholders. Our management fee may induce RGC to purchase assets with borrowed funds and to use leverage despite any enhanced risk. The management fee payable by us to RGC may create an incentive for RGC to purchase assets with borrowed funds when it is unwise to do so or to pursue investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The management fee payable to RGC is calculated based on the amount of our gross assets, which includes assets purchased with borrowed funds or other forms of leverage. Under certain circumstances, the use of leverage may increase the likelihood of default, which would impair the value of our common stock. The capital gains portion of our incentive fee may induce RGC to make speculative investments. RGC receives the incentive fee based, in part, upon net capital gains realized on our investments. Under the incentive fee structure, RGC may benefit when we recognize capital gains and, because RGC, in certain circumstances, will determine when to sell an investment, RGC will control the timing of the recognition of such capital gains. As a result, in certain situations RGC may have a tendency to invest more capital in investments that are likely to result in capital gains as compared to income producing securities. Such a practice could result in our investing in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during economic downturns. A general increase in interest rates will likely have the effect of making it easier for RGC to receive incentive fees, without necessarily resulting in an increase in our net earnings. Given the structure of the Advisory Agreement, any general increase in interest rates can be expected to lead to higher interest rates applicable to our debt investments and will likely have the effect of making it easier for RGC to meet the quarterly hurdle rate for payment of income ince | ||||||||||||||||||||||||||
Effects of Leverage [Table Text Block] | The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns on our portfolio as of December 31, 2023, net of expenses. Leverage generally magnifies the return of stockholders when the portfolio return is positive and magnifies their losses when the portfolio return is negative. The calculations in the table below are hypothetical, and actual returns may be higher or lower than those appearing in the table below. Assumed Return on Our Portfolio (Net of Expenses) -10% -5% 0% 5% 10% Corresponding return to common stockholder (1) - 26.8 % - 16.9 % - 7.0 % 2.8 % 12.7 % (1) Assumes (i) $1.1 billion in total assets, (ii) $519.3 million in outstanding indebtedness, (iii) $547.1 million in net assets and (iv) weighted average interest rate, excluding fees (such as fees on undrawn amounts and amortization of financing costs) of 7.41% . | ||||||||||||||||||||||||||
Return at Minus Ten [Percent] | (26.80%) | ||||||||||||||||||||||||||
Return at Minus Five [Percent] | (16.90%) | ||||||||||||||||||||||||||
Return at Zero [Percent] | (7.00%) | ||||||||||||||||||||||||||
Return at Plus Five [Percent] | 2.80% | ||||||||||||||||||||||||||
Return at Plus Ten [Percent] | 12.70% | ||||||||||||||||||||||||||
Share Price [Table Text Block] | The following table sets forth the most recent fiscal quarter's NAV per share of our common stock, the high and low closing sales prices of our common stock, such sales prices as a percentage of NAV per share and quarterly distribution per share. Price Range Period NAV (1) High Low Premium/Discount of High Sales Price to NAV (2) Premium/Discount of Low Sales Price to NAV (2) Cash Distribution per Share (3) 2023 Fourth Quarter $ 13.50 $ 13.24 $ 11.90 ( 2.0 ) % ( 11.9 ) % $ 0.46 Third Quarter 14.08 13.55 12.15 ( 3.8 ) ( 13.7 ) 0.45 Second Quarter 14.17 12.63 10.60 ( 10.9 ) ( 25.2 ) 0.45 First Quarter 14.07 13.85 10.89 ( 1.6 ) ( 22.6 ) 0.45 2022 Fourth Quarter $ 14.22 $ 13.52 $ 11.31 ( 4.9 ) % ( 20.5 ) % $ 0.36 Third Quarter 14.12 13.81 11.24 ( 2.2 ) ( 20.4 ) 0.33 Second Quarter 14.14 14.51 10.98 2.6 ( 22.3 ) 0.30 First Quarter 14.45 14.77 12.21 2.2 ( 15.5 ) 0.27 2021 Fourth Quarter (4) $ 14.65 $ 13.92 $ 12.04 ( 5.0 ) % ( 17.8 ) % $ 0.25 (1) NAV per share is generally determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low sales prices. The NAVs shown are based on outstanding shares at the end of each period. (2) Calculated as the respective high or low closing price less net asset value, divided by net asset value (in each case, as of the applicable quarter). (3) Represents the dividend or distribution declared in the relevant quarter. (4) Shares of our common stock began trading on the Nasdaq Global Select Market LLC on October 21, 2021 under the trading symbol "RWAY." | ||||||||||||||||||||||||||
Lowest Price or Bid | $ 11.9 | $ 12.15 | $ 10.6 | $ 10.89 | $ 11.31 | $ 11.24 | $ 10.98 | $ 12.21 | $ 12.04 | ||||||||||||||||||
Highest Price or Bid | $ 13.24 | $ 13.55 | $ 12.63 | $ 13.85 | $ 13.52 | $ 13.81 | $ 14.51 | $ 14.77 | $ 13.92 | ||||||||||||||||||
Highest Price or Bid, Premium (Discount) to NAV [Percent] | (2.00%) | (3.80%) | (10.90%) | (1.60%) | (4.90%) | (2.20%) | 2.60% | 2.20% | (5.00%) | ||||||||||||||||||
Lowest Price or Bid, Premium (Discount) to NAV [Percent] | (11.90%) | (13.70%) | (25.20%) | (22.60%) | (20.50%) | (20.40%) | (22.30%) | (15.50%) | (17.80%) | ||||||||||||||||||
Share Price | $ 13.35 | ||||||||||||||||||||||||||
NAV Per Share | $ 13.5 | $ 13.5 | [1] | $ 14.08 | $ 14.17 | $ 14.07 | $ 14.22 | [1] | $ 14.12 | $ 14.14 | $ 14.45 | $ 14.65 | [1] | $ 13.5 | [1] | $ 14.84 | $ 14.58 | $ 15.14 | $ 14.66 | $ 10.38 | $ 15 | ||||||
Latest Premium (Discount) to NAV [Percent] | (1.10%) | ||||||||||||||||||||||||||
Risks Related To The Economy [Member] | |||||||||||||||||||||||||||
General Description of Registrant [Abstract] | |||||||||||||||||||||||||||
Risk [Text Block] | Risks Related to the Economy • Political, social and economic uncertainty creates and exacerbates risks. • A renewed period of disruption in the capital markets may cause uncertain economic conditions. Such market conditions may materially and adversely affect debt and equity capital markets, which may have a negative impact on our business and operations. • Increasing level of inflation and rising interest rate could impact our portfolio company’s operations and cash flows and harm our operating results. Risks Related to the Economy Political, social and economic uncertainty creates and exacerbates risks. Social, political, economic and other conditions and events (such as natural disasters, epidemics and pandemics, terrorism, conflicts and social unrest) will occur that create uncertainty and have significant impacts on issuers, industries, governments and other systems, including the financial markets, to which companies and their investments are exposed. As global systems, economies and financial markets are increasingly interconnected, events that once had only local impact are now more likely to have regional or even global effects. Events that occur in one country, region or financial market will, more frequently, adversely impact issuers in other countries, regions or markets, including in established markets such as the United States. These impacts can be exacerbated by failures of governments and societies to adequately respond to an emerging event or threat. Uncertainty can result in or coincide with, among other things: increased volatility in the financial markets for securities, derivatives, loans, credit and currency; a decrease in the reliability of market prices and difficulty in valuing assets (including portfolio company assets); greater fluctuations in spreads on debt investments and currency exchange rates; increased risk of default (by both government and private obligors and issuers); further social, economic, and political instability; nationalization of private enterprise; greater governmental involvement in the economy or in social factors that impact the economy; changes to governmental regulation and supervision of the loan, securities, derivatives and currency markets and market participants and decreased or revised monitoring of such markets by governments or self-regulatory organizations and reduced enforcement of regulations; limitations on the activities of investors in such markets; controls or restrictions on foreign investment, capital controls and limitations on repatriation of invested capital; the significant loss of liquidity and the inability to purchase, sell and otherwise fund investments or settle transactions (including, but not limited to, a market freeze); unavailability of currency hedging techniques; substantial, and in some periods extremely high rates of inflation, which can last many years and have substantial negative effects on credit and securities markets as well as the economy as a whole; recessions; and difficulties in obtaining and/or enforcing legal judgments. A renewed period of disruption in the capital markets may cause uncertain economic conditions. Such market conditions may materially and adversely affect debt and equity capital markets, which may have a negative impact on our business and operations. The capital markets have experienced extreme volatility in recent periods, and as a result, there has been and will likely continue to be uncertainty in the financial markets in general. Unpredictable general economic conditions may materially and adversely impact the broader financial and credit markets which could reduce the availability of debt and equity capital for the market as a whole. These conditions could continue for a prolonged period of time or worsen in the future. Given the ongoing and dynamic nature of the circumstances, it is difficult to predict the full impact that current market conditions may have on our business. The extent of such impact will depend on future developments, which are highly uncertain and current market conditions, and the related adverse local and national economic consequences, we could be subject to any of the following risks, any of which could have a material, adverse effect on our business, financial condition, liquidity, and results of operations: • Current market conditions may make it difficult to raise equity capital because, subject to some limited exceptions, as a BDC, we are generally not able to issue additional shares of our common stock at a price less than the NAV per share without first obtaining approval for such issuance from our stockholders and our independent directors. In addition, these market conditions may make it difficult to access or obtain new indebtedness with similar terms to our existing indebtedness. • Significant changes or volatility in the capital markets may also have a negative effect on the valuations of our investments. While most of our investments are not publicly traded, applicable accounting standards require us to assume as part of our valuation process that our investments are sold in a principal market to market participants (even if we plan on holding an investment through its maturity). • Significant changes in the capital markets may adversely affect the pace of our investment activity and economic activity generally. • The illiquidity of our investments may make it difficult for us to sell such investments to access capital if required, and as a result, we could realize significantly less than the value at which we have recorded our investments if we were required to sell them for liquidity purposes. An inability to raise or access capital, and any required sale of all or a portion of our investments as a result, could have a material adverse effect on our business, financial condition or results of operations. The current period of capital markets disruption and economic uncertainty may make it difficult to extend the maturity of, or refinance, our existing indebtedness or obtain new indebtedness and any failure to do so could have a material adverse effect on our business, financial condition or results of operations. Current market conditions may make it difficult to extend the maturity of or refinance our existing indebtedness or obtain new indebtedness with similar terms and any failure to do so could have a material adverse effect on our business. The debt capital that will be available to us in the future, if at all, may be at a higher cost and on less favorable terms and conditions than what we currently experience, including being at a higher cost in rising rate environments. If we are unable to raise or refinance debt, then our equity investors may not benefit from the potential for increased returns on equity resulting from leverage and we may be limited in our ability to make new commitments or to fund existing commitments to our portfolio companies. An inability to extend the maturity of, or refinance, our existing indebtedness or obtain new indebtedness could have a material adverse effect on our business, financial condition or results of operations. Economic recessions or downturns could impair our portfolio companies and harm our operating results. Many of the portfolio companies in which we make investments may be susceptible to economic slowdowns or recessions and may be unable to repay the loans we made to them during these periods. Therefore, our non-performing assets may increase and the value of our portfolio may decrease during these periods as we are required to record our investments at their current fair value. Adverse economic conditions also may decrease the value of collateral securing some of our loans and the value of our equity investments. Economic slowdowns or recessions could lead to financial losses in our portfolio and a decrease in revenues, net income and assets. Unfavorable economic conditions also could increase our and our portfolio companies’ funding costs, limit our and our portfolio companies’ access to the capital markets or result in a decision by lenders not to extend credit to us or our portfolio companies. In similar fashion, increasing or excessive levels of inflation and rising interest rates could also impair our portfolio companies cash flow and operations. These events could prevent us from increasing investments and harm our operating results. A portfolio company’s failure to satisfy financial or operating covenants imposed by us or other lenders could lead to defaults and, potentially, acceleration of the time when the loans are due and foreclosure on its secured assets, which could trigger cross-defaults under other agreements and jeopardize the portfolio company’s ability to meet its obligations under the debt that we hold. We may incur additional expenses to the extent necessary to seek recovery upon default or to negotiate new terms with a defaulting portfolio company. In addition, if one of our portfolio companies were to go bankrupt, depending on the facts and circumstances, including the extent to which we will actually provide significant managerial assistance to that portfolio company, a bankruptcy court might subordinate all or a portion of our claim to that of other creditors. Further downgrades of the U.S. credit rating could negatively impact our liquidity, financial conditions and earnings. The U.S. debt ceiling and budget deficit concerns have raised the possibility of additional credit-rating downgrades and economic slowdowns in the United States and globally. Legislation passed in June 2023 suspends the debt ceiling through early 2025, unless Congress takes further legislative action to extend it. Downgrades by rating agencies to the U.S. government’s credit rating or concerns about its credit and deficit levels in general could cause interest rates and borrowing costs to rise, which may negatively impact both the perception of credit risk associated with our debt portfolio and our ability to access the debt markets on favorable terms. In addition, a decreased U.S. government credit rating could create broader financial turmoil and uncertainty, which may weigh heavily on our financial performance and the value of our common stock. Global economic, political and market conditions may adversely affect our business, financial condition and results of operations, including our revenue growth and profitability. Deterioration in the economic conditions in the Eurozone and other regions or countries globally and the resulting instability in global financial markets may pose a risk to our business. Financial markets have been affected at times by a number of global macroeconomic events, including the following: large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets jurisdictions, levels of non-performing loans on the balance sheets of European banks, the effect of the United Kingdom (the "U.K.") leaving the European Union (the "EU"), instability in the Chinese capital markets and the COVID-19 pandemic. Global market and economic disruptions have affected, and may in the future affect, the U.S. capital markets, which could adversely affect our business, financial condition or results of operations. We cannot assure you that market disruptions in Europe and other regions or countries, including the increased cost of funding for certain governments and financial institutions, will not impact the global economy, and we cannot assure you that assistance packages will be available, or if available, be sufficient to stabilize countries and markets in Europe or elsewhere affected by a financial crisis. To the extent uncertainty regarding any economic recovery in Europe negatively impacts consumer confidence and consumer credit factors, our business, financial condition and results of operations could be significantly and adversely affected. Moreover, there is a risk of both sector-specific and broad-based corrections and/or downturns in the equity and credit markets. Any of the foregoing could have a significant impact on the markets in which we operate and could have a material adverse impact on our business prospects and financial condition. Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, including rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the United States and foreign, trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the United States and worldwide. Specifically, the ongoing conflict between Russia and Ukraine, and the ongoing conflict in the Middle East and the resulting market volatility, could adversely affect our business, financial condition or results of operations. In response to the conflict between Russia and Ukraine, the United States and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on our business, financial condition, cash flows and results of operations and could cause the market value of our common shares and/or debt securities to decline. These market and economic disruptions could also negatively impact the operating results of our portfolio companies. Additionally, the Federal Reserve may further raise, or may announce its intention to further raise, the Federal Funds Rate in 2024. These developments, along with the United States government’s credit and deficit concerns, global economic uncertainties and market volatility could cause interest rates to be volatile, which may negatively impact our ability to access the debt markets and capital markets on favorable terms. | ||||||||||||||||||||||||||
Risks Related To Our Business And Structure [Member] | |||||||||||||||||||||||||||
General Description of Registrant [Abstract] | |||||||||||||||||||||||||||
Risk [Text Block] | Risks Related to Our Business and Structure • Our investment portfolio is recorded at fair value, with our Board of Directors determining, in good faith, the fair value of our investment portfolio and, as a result, there is uncertainty as to the value of our portfolio investments. • Our financial condition and results of operations depend on our ability to effectively manage and deploy capital. • We operate in a highly competitive market for investment opportunities and we may not be able to compete effectively. • We may need to raise additional capital to grow because we must distribute most of our income. • Any defaults under our Credit Facility or other borrowings, including the 2026 or 2027 Notes, could adversely affect our business. Risks Related to Our Business and Structure Our investment portfolio is recorded at fair value, with our Board of Directors determining, in good faith, the fair value of our investment portfolio and, as a result, there is uncertainty as to the value of our portfolio investments. Under the 1940 Act, we are required to carry our portfolio investments at market value or, if there is no readily available market value, at fair value as determined by our Board of Directors. Typically, there will not be a public market for the securities of the privately held companies in which we invest. As a result, our Board of Directors values these securities quarterly at fair value based on input from management, a third-party independent valuation firm and the audit committee of our Board of Directors (the "Audit Committee"). The fair value of such securities may meaningfully change between the date of the fair value determination by our Board of Directors, as assisted by third-party independent valuation firms and the Audit Committee, and the release of the financial results for the corresponding period and/or the next date at which fair value is determined. The determination of fair value and consequently, the amount of unrealized gains and losses in our portfolio, are to a certain degree, subjective and dependent on a valuation process approved by our Board of Directors. Certain factors that may be considered in determining the fair value of our investments include external events, such as private mergers, sales and acquisitions involving comparable companies. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. Our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Due to this uncertainty, our fair value determinations may cause our net asset value on a given date to materially understate or overstate the value that we may ultimately realize on one or more of our investments. As a result, investors purchasing our common stock based on an overstated net asset value would pay a higher price than the value of our investments might warrant. Conversely, investors selling shares of our common stock during a period in which the net asset value understates the value of our investments will receive a lower price for their shares of our common stock than the value of our investments might warrant. Our financial condition and results of operations depend on our ability to effectively manage and deploy capital. Our ability to achieve our investment objective depends on our ability to effectively manage and deploy capital, which depends, in turn, on RGC’s ability to identify, originate, evaluate and monitor, and our ability to finance and invest in, companies that meet our investment criteria. Accomplishing our investment objective on a cost-effective basis is largely a function of RGC’s handling of the investment process, its ability to provide competent, attentive and efficient services and our access to investments offering acceptable terms. In addition to monitoring the performance of our existing investments and other responsibilities under the Advisory Agreement, RGC’s investment team may also be called upon, from time to time, to provide managerial assistance to some of our portfolio companies. These demands may distract our investment team or slow the rate at which we may make investments. Even if we are able to grow and build upon our investment portfolio, any failure to manage our growth effectively could have a material adverse effect on our business, financial condition, results of operations and prospects. Our results of operations depend on many factors, including the availability of opportunities for investment, readily accessible short and long-term funding alternatives in the financial markets and economic conditions. Furthermore, if we cannot successfully operate our business or implement our investment policies and strategies as described herein, it could negatively impact our ability to pay dividends. We operate in a highly competitive market for investment opportunities and we may not be able to compete effectively. Our primary competitors for investments include both existing and newly formed debt, and to a lesser extent equity, focused public and private funds, other BDCs, commercial and investment banks, venture-oriented commercial banks, commercial financing companies and, to the extent they provide an alternative form of financing, private equity and hedge funds. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, we believe some competitors may have a lower cost of capital and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have, which could allow them to consider a wider variety of investments and establish more relationships than we can. Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC or to the distribution and other requirements we must satisfy to maintain our ability to be subject to taxation as a RIC. These characteristics could allow our competitors to consider a wider variety of investments, establish more relationships and offer better pricing and more flexible structuring than we are able to offer. In recent years, substantial investor capital has been allocated to the private credit and direct lending asset classes, creating and increasing competition among lenders. Increased competition across all segments of the private credit and direct lending markets, has reduced credit spreads, and along with historically low interest rates, has reduced investment yields and resulted in more borrower friendly terms and conditions. For instance, typically when interest rates are low and a credit cycle extended, new entrants will enter traditionally higher yielding markets creating additional competition and pressures and temporarily compressing yields. We believe the credit markets, and in particular the market for our lending strategies, are presently experiencing such pressures. New competitors, including established private credit platforms in other segments, have entered the sponsored and non-sponsored growth lending market and a similar competitive dynamic is possible. While their entry may or may not be permanent, their entry could lead to competitive pressure on our investment yields and other terms and conditions in the short-term. We do not compete primarily on the financing terms we offer and some competitors make loans with rates that are comparable or lower than our rates. We may lose some investment opportunities if we do not match our competitors’ pricing, terms and structure. However, if we match our competitors’ pricing, terms and structure, we may experience decreased net interest income, lower yields and increased risk of credit loss. As a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time, and we may not be able to identify and make investments that are consistent with our investment objective. The competitive pressures we face may have a material adverse effect on our financial condition, results of operations and cash flows. Our business model depends to a significant extent upon strong referral relationships. Any inability of RGC to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business. We depend upon RGC to maintain its relationships with venture capital and private equity firms, placement agents, investment banks, management groups and other financial institutions, and we expect to rely to a significant extent upon these relationships to provide us with potential investment opportunities. If RGC fails to maintain such existing relationships, or to develop new relationships with other sources of investment opportunities, we may not be able to grow our investment portfolio. In addition, individuals with whom RGC has relationships are not obligated to provide us with investment opportunities, and we can offer no assurance that these relationships will generate investment opportunities for us in the future. The failure of RGC to maintain existing relationships, grow new relationships, or for any of those relationships to generate investment opportunities could have an adverse effect on our business, financial condition and results of operations. We are dependent upon RGC’s key personnel for our future success. We depend on the diligence, skill and investment acumen of R. David Spreng, the founder, Chief Executive Officer and Chief Investment Officer of RGC , along with the senior officers and other investment professionals at RGC, including Thomas Raterman, our Acting President, Chief Operating Officer, Chief Financial Officer, Treasurer and Secretary, and Greg Greifeld our Acting Chief Executive Officer, and Managing Director, Deputy Chief Investment Officer, and Head of Credit at RGC. Mr. Raterman also serves as the Chief Financial Officer, and Chief Operating Officer of RGC. Mr. Spreng, Mr. Raterman, Mr. Greifeld and the other members of RGC’s senior management evaluate, negotiate, structure, close and monitor our investments. Our future success depends on the continued service of these members of RGC’s senior management. We cannot assure you that unforeseen business, medical, personal or other circumstances would not lead any such individual to terminate his or her relationship with us. The loss of Mr. Spreng, Mr. Raterman, Mr. Greifeld and/or any of the other members of RGC’s senior management could have a material adverse effect on our ability to achieve our investment objective as well as on our financial condition and results of operations. In addition, we can offer no assurance that RGC will continue indefinitely as RGC. The members of RGC’s senior management are and may in the future become affiliated with entities engaged in business activities similar to those intended to be conducted by us and may have conflicts of interest in allocating their time. RGC may also manage and sub-advise private investment funds and accounts, and may manage other such funds and accounts in the future, which have investment mandates that are similar, in whole or in part, with ours. Accordingly, RGC’s senior management may have obligations to investors in those entities, the fulfillment of which might not be in the best interests of us or our stockholders. For example, RGC’s senior management may face conflicts of interest in the allocation of investment opportunities to us and such other existing and future funds and accounts. Our success depends on the ability of RGC to attract and retain qualified personnel in a competitive environment. Our growth requires that RGC retains and attracts new investment and administrative personnel in a competitive market. RGC’s ability to attract and retain personnel with the requisite credentials, experience and skills depends on several factors including, but not limited to, its ability to offer competitive wages, benefits and professional growth opportunities. Many of the entities, including investment funds (such as venture capital funds, private equity funds and mezzanine funds) and traditional financial services companies, with which RGC competes for experienced personnel have greater resources than it possesses, which could have a negative impact on RGC’s ability to attract and retain qualified personnel and, as a result, have a material adverse effect on our business and results of operations. The compensation we pay to RGC and our Administrator was not determined on an arm’s-length basis. Thus, the terms of such compensation may be less advantageous to us than if such terms had been the subject of arm’s-length negotiations. The compensation we pay to RGC and our Administrator was not determined on an arm’s-length basis with an unaffiliated third party. As a result, the form and amount of such compensation may be less favorable to us than if the respective agreements had been entered into through arm’s-length transactions with an unaffiliated third party. In addition, we may choose not to enforce, or to enforce less vigorously, our respective rights and remedies under the Advisory Agreement and the Administration Agreement because of our desire to maintain our ongoing relationship with RGC, our Administrator and their respective affiliates. Any such decision, however, could cause us to breach our fiduciary obligations to our stockholders. Our management fee may induce RGC to purchase assets with borrowed funds and to use leverage despite any enhanced risk. The management fee payable by us to RGC may create an incentive for RGC to purchase assets with borrowed funds when it is unwise to do so or to pursue investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The management fee payable to RGC is calculated based on the amount of our gross assets, which includes assets purchased with borrowed funds or other forms of leverage. Under certain circumstances, the use of leverage may increase the likelihood of default, which would impair the value of our common stock. The capital gains portion of our incentive fee may induce RGC to make speculative investments. RGC receives the incentive fee based, in part, upon net capital gains realized on our investments. Under the incentive fee structure, RGC may benefit when we recognize capital gains and, because RGC, in certain circumstances, will determine when to sell an investment, RGC will control the timing of the recognition of such capital gains. As a result, in certain situations RGC may have a tendency to invest more capital in investments that are likely to result in capital gains as compared to income producing securities. Such a practice could result in our investing in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during economic downturns. A general increase in interest rates will likely have the effect of making it easier for RGC to receive incentive fees, without necessarily resulting in an increase in our net earnings. Given the structure of the Advisory Agreement, any general increase in interest rates can be expected to lead to higher interest rates applicable to our debt investments and will likely have the effect of making it easier for RGC to meet the quarterly hurdle rate for payment of income incentive fees under the Advisory Agreement without any additional increase in relative performance on the part of RGC. This may occur without a corresponding increase in distributions to our stockholders. In addition, in view of the catch-up provision applicable to income incentive fees under the Advisory Agreement, RGC could potentially receive a significant portion of the increase in our investment income attributable to such a general increase in interest rates. If that were to occur, our increase in net earnings, if any, would likely be significantly smaller than the relative increase in RGC’s income incentive fee resulting from such a general increase in interest rates. RGC and our Administrator have the right to resign upon not more than 60 days’ notice, and we may not be able to find a suitable replacement for either within that time, or at all, resulting in a disruption in our operations that could adversely affect our financial condition, business and results of operations. RGC has the right, under the Advisory Agreement, to resign at any time upon not more than 60 days’ written notice, regardless of whether we have found a replacement. Similarly, our Administrator has the right under the Administration Agreement to resign at any time upon not more than 60 days’ written notice, regardless of whether we have found a replacement. If RGC or our Administrator were to resign, we may not be able to find a new investment adviser or administrator or hire internal management with similar expertise and ability to provide the same or equivalent services on acceptable terms prior to the resignation of RGC or our Administrator, or at all. If we are unable to do so quickly, our operations are likely to experience a disruption, our financial condition, business and results of operations, as well as our ability to pay distributions, are likely to be materially and adversely affected. In addition, the coordination of our internal management and investment or administrative activities, as applicable, are likely to suffer if we are unable to identify and reach an agreement with a single institution or group of executives having the expertise possessed by RGC, our Administrator and their respective affiliates. Even if we are able to retain comparable management, whether internal or external, the integration of such management and their lack of familiarity with our investment objective may result in additional costs and time delays that may adversely affect our financial condition, business, results of operations and cash flows. We may need to raise additional capital to grow because we must distribute most of our income. We may need additional capital to fund growth in our investments. A reduction in the availability of new capital could limit our ability to grow. We must distribute at least 90% of our investment company taxable income to our stockholders to maintain our tax treatment as a RIC. As a result, any such cash earnings may not be available to fund investment originations. We have and may, in the future, borrow under debt facilities from financial institutions and issue additional debt and equity securities. If we fail to obtain funds from such sources or from other sources to fund our investments, it could limit our ability to grow, which may have an adverse effect on the value of our securities. In addition, as a BDC, our ability to borrow or issue preferred stock may be restricted if our total assets are less than 150% of our total borrowings and preferred stock. See "— Regulations governing our operation as a BDC affect our ability to raise additional capital and the way in which we do so. As a BDC, the necessity of raising additional capital may expose us to risks, including the typical risks associated with leverage." In addition, shares of BDCs have recently traded at discounts to their net asset values. If our common stock trades below its net asset value, we will not be able to issue additional shares of our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. If additional funds are not available to us, we could be forced to curtail or cease new lending and investment activities and our net asset value could decline. A reduction in the availability of new capital or an inability on our part to access the capital markets successfully could limit our ability to grow our business and execute our business strategy fully and decrease our earnings, if any, which could have a material adverse effect on our business, financial condition, results of operations and cash flows. Any failure on our part to maintain our status as a BDC or fail to qualify as a RIC would reduce our operating flexibility. The 1940 Act imposes numerous constraints on the operations of BDCs. For example, BDCs are required to invest at least 70% of their gross assets in specified types of "qualifying assets," primarily in private U.S. companies or thinly-traded U.S. public companies, cash, cash equivalents, U.S. government securities and other high-quality debt investments that mature in one year or less. In addition, subject to certain limited exceptions, an investment in an issuer that has outstanding securities listed on a national exchange may be treated as a qualifying asset only if such issuer has a market capitalization that is less than $250.0 million at the time of such investment. Moreover, as a RIC, the treatment for which we intend to qualify annually, we are required to satisfy certain source-of-income, diversification and distribution requirements. Therefore, we may be precluded from investing in what we believe are attractive investments if such investments are not qualifying assets. Conversely, if we fail to invest a sufficient portion of our assets in qualifying assets, we could lose our status as a BDC, which would have a material adverse effect on our business, financial condition and results of operations. Similarly, these constraints could prevent us from making additional investments in existing portfolio companies, which could result in the dilution of our position, or could require us to dispose of investments at an inopportune time to comply with the 1940 Act. If we were forced to sell non-qualifying investments in the portfolio for compliance purposes, the proceeds from such sale could be significantly less than the current value of such investments. These constraints, among others, may hinder our ability to take advantage of attractive investment opportunities and to achieve our investment objective. Any failure to comply with the requirements imposed on BDCs by the 1940 Act could cause the SEC to bring an enforcement action against us and/or expose us to claims of private litigants. In addition, upon approval of a majority of our stockholders, we may elect to withdraw our status as a BDC. If we decide to withdraw our election, or if we otherwise fail to qualify, or maintain our qualification, as a BDC, we will be subject to the substantially greater regulation under the 1940 Act as a closed-end investment company. Compliance with such regulations would significantly decrease our operating flexibility and could significantly increase our costs of doing business. Regulations governing our operation as a BDC affect our ability to raise additional capital and the way in which we do so. As a BDC, the necessity of raising additional capital may expose us to risks, including the typical risks associated with leverage. We may issue debt securities or preferred stock and/or borrow money from banks or other financial institutions, which we refer to collectively as "senior securities," up to the maximum amount permitted by the 1940 Act. Under the provisions of the 1940 Act, we are generally permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 150% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. If the value of our assets decline, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss. If we issue preferred stock, the preferred stock would rank "senior" to common stock in our capital structure, preferred stockholders would have separate voting rights on certain matters and might have other rights, preferences, or privileges more favorable than those of our common stockholders, and the issuance of preferred stock could have the effect of delaying, deferring or preventing a transaction or a change of control that might involve a premium price for holders of our common stock or otherwise be in your best interest. We are generally not able to issue and sell our common stock at a price below net asset value per share. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the then-current net asset value per share of our common stock if our Board of Directors determines that such sale is in the best interests of our stockholders, and our stockholders approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board of Directors, closely approximates the market value of such securities (less any distributing commission or discount). If we raise additional funds by issuing more common stock or senior securities convertible into, or exchangeable for, our common stock, then the percentage ownership of our stockholders at that time will decrease, and you may experience dilution. We borrow money, which could magnify the potential for gain or loss on amounts invested and may increase the risk of investing in us. The use of leverage magnifies the potential for gain or loss on amounts invested and, therefore, increases the risks associated with investing in our securities. We borrow from and issue, and may continue to in the future, senior debt securities to banks, insurance companies and other lenders. Holders of these senior securities will have fixed dollar claims on our assets that are superior to the claims of our common stockholders, and we would expect such lenders to seek recovery against our assets in the event of a default. If the value of our assets increases, then leveraging would cause the net asset value attributable to our common stock to increase more sharply than it would have had we not leveraged. Conversely, if the value of our assets decreases, leveraging would cause net asset value to decline more sharply than it otherwise would have had we not leveraged. Similarly, any increase in our income in excess of interest payable on the borrowed funds would cause our net investment income to increase more than it would without the leverage, while any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Such a decline could also negatively affect our ability to make dividend payments on our common stock, scheduled debt payments or other payments related to our securities. Leverage is generally considered a speculative investment technique. Our ability to service any debt that we incur will depend largely on our financial performance and will be subject to prevailing economic conditions and competitive pressures. In addition, our common stockholders will bear the burden of any increase in our expenses, including our interest expense, as a result of leverage. As a BDC, we are generally required to meet an asset coverage ratio, defined under the 1940 Act as the ratio of our gross assets (less all liabilities and indebtedness not represented by senior securities) to our outstanding senior securities, of at least 150% after each issuance of senior securities. If this ratio declines below 150%, we may not be able to incur additional debt and could be required by law to sell a portion of our investments to repay some debt when it is disadvantageous to do so, which could have a material adverse effect on our operations, and we may not be able to make distributions. The amount of leverage that we employ will depend on RGC’s and our Board of Director's assessment of market and other factors at the time of any proposed borrowing. We cannot assure you that we will be able to obtain credit at all or on terms acceptable to us. In addition, any debt facility into which we may enter would likely impose financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to qualify as a RIC. The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns on our portfolio as of December 31, 2023, net of expenses. Leverage generally magnifies the return of stockholders when the portfolio return is positive and magnifies their losses when the portfolio return is negative. The calculations in the table below are hypothetical, and actual returns may be higher or lower than those appearing in the table below. Assumed Return on Our Portfolio (Net of Expenses) -10% -5% 0% 5% 10% Corresponding return to common stockholder (1) - 26.8 % - 16.9 % - 7.0 % 2.8 % 12.7 % (1) Assumes (i) $1.1 billion in total assets, (ii) $519.3 million in outstanding indebtedness, (iii) $547.1 million in net assets and (iv) weighted average interest rate, excluding fees (such as fees on undrawn amounts and amortization of financing costs) of 7.41% . Any defaults under our Credit Facility or other borrowings, including the 2026 or 2027 Notes, could adversely affect our business. On May 31, 2019 (as subsequently amended), we entered into a credit agreement ("Credit Facility") by and among us, as borrower, the financial institutions party thereto as lenders, KeyBank National Association, as administrative agent, syndication agent, and a lender, CIBC Bank USA, as documentation agent and a lender, MUFG Union Bank, N.A., as co-documentation agent and lender and U.S. Bank National Association, as paying agent. On December 10, 2021, we entered into a master note purchase agreement in connection with a private debt offering of $70.0 million in aggregate principal amount of 4.25% interest-bearing unsecured Series 2021A Senior Notes due 2026 (the “December 2026 Notes”). On April 13, 2023, we entered into the first supplement to the master note purchase agreement in connection with an additional private debt offering of $25.0 million in aggregate principal amount of 8.54% interest-bearing unsecured Series 2023A Senior Notes due 2026 (the “April 2026 Notes” and together with the December 2026 Notes, the “2026 Notes”). On July 28, 2022, we issued and sold $80.5 million in aggregate principal amount of 7.50% interest-bearing unsecured Notes due 2027 (the “July 2027 Notes”), pursuant to a base indenture by and between us and U.S. Bank Trust Company, National Association, as trustee, dated July 28, 2022 (the “Base Indenture”), and the first supplemental indenture thereto, dated July 28, 2022. On August 31, 2022, we issued and sold $20.0 million in aggregate principal amount of 7.00% interest-bearing unsecured Series 2022A Senior Notes due 2027 (the “August 2027 Notes”) to HCM Master Fund Limited in a private debt offering. On December 7, 2022, we issued and sold $51.75 million in aggregate principal amount of 8.00% interest-bearing unsecured Notes due 2027 (the “December 2027 Notes” and together with the July 2027 Notes and the August 2027 Notes, the “2027 Notes”), pursuant to the Base Indenture and the second supplemental indenture thereto, dated December 7, 2022. In the event we default under our Credit Facility, or other borrowings, including the 2026 Notes and 2027 Notes, our business could be adversely affected as we may be forced to sell a portion of our investments quickly and prematurely at what may be unfavorable prices to us in order to meet our outstanding payment obligations and/or support working capital requirements under such borrowing facility, any of which would have a material adverse effect on our business, financial condition, results of operations and cash flows. In addition, following any such default, the agent for the lenders under such borrowing facility could assume control of the disposition of any or all of our assets, including the selection of such assets to be disposed and the timing of such disposition, which would have a material adverse effect on our b | ||||||||||||||||||||||||||
Risks Related To Our Investments [Member] | |||||||||||||||||||||||||||
General Description of Registrant [Abstract] | |||||||||||||||||||||||||||
Risk [Text Block] | Risks Related to Our Investments • Our investments are very risky and highly speculative. • Investing in high growth-potential, private companies involves a high degree of risk, and our financial results may be affected adversely if one or more of our significant portfolio investments defaults on its loans or fails to perform as we expect. • An investment strategy focused primarily on privately held companies presents certain challenges, including the lack of available information about these companies and a greater vulnerability to economic downturns. • Inflation may adversely affect our and our portfolio companies’ business, results of operations and financial condition. Risks Related to Our Investments Our investments are very risky and highly speculative. We invest primarily in senior secured term loans and other senior debt obligations and may on occasion invest in second lien loans issued by high growth-potential companies. We also have and continue to expect to acquire warrants and other equity securities from portfolio companies in connection with our investments in loans to these companies. We invest primarily in secured loans made to companies whose debt has generally not been rated by any rating agency, although we would expect such debt, if rated, to fall below investment grade. Securities rated below investment grade are often referred to as "high yield" securities and "junk bonds," and are considered "high risk" and speculative in nature compared to debt instruments that are rated above investment grade. Senior Secured Loans. There is a risk that the collateral securing our loans may decrease in value over time, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital. In some circumstances, our liens on the collateral securing our loans could be subordinated to claims of other creditors. In addition, deterioration in a portfolio company’s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the loan. Consequently, the fact that a loan is secured does not guarantee that we will receive principal and interest payments according to the loan’s terms, or at all, or that we will be able to collect on the loan should we be compelled to enforce our remedies. Second Lien Secured Loans. In structuring our loans, we may subordinate our security interest in certain assets of a borrower to another lender, usually a bank. In these situations, all of the risks identified above in Senior Secured Loans would be true and additional risks inherent in holding a junior security position would also be present, including, but not limited to those outlined below in "Second priority liens on collateral securing loans that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. If there is a default, the value of the collateral may not be sufficient to repay in full both the first priority creditors and us." Equity Investments . When we invest in secured loans, we may acquire equity securities as well, including warrants. In addition, we may also, on a limited basis, invest directly in the equity securities of portfolio companies. The equity interests we receive may not appreciate in value and may in fact decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience. In addition, investing in small, fast-growing, private companies involves a number of significant risks, including the following: • they may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold. This failure to meet obligations may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with our investment; • they typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions, market conditions, and general economic downturns; • they are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us; • they generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, and may require substantial additional capital to support their operations, finance expansion, or maintain their competitive position. In addition, our executive officers, directors and RGC may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and • they may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding debt upon maturity. Venture lenders, in general, focus on a limited set of key financial performance metrics, including minimum liquidity, performance to plan, and investor abandonment, in lieu of a full set of financial performance covenants that do not meaningfully assess the risk of companies at the stage of development of companies in which venture lenders typically invest. As such, many of our loans could be considered covenant-lite by traditional lending standards. We use the term "covenant-lite" loans to refer generally to loans that do not require a borrower to comply with financial maintenance covenants. Generally, covenant-lite loans permit borrowers more opportunity to negatively impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following certain actions of the borrower, rather than by a deterioration in the borrower’s financial condition. Accordingly, because we make and have exposure to covenant-lite loans, we may have less protection from borrower actions and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants. Investing in high growth-potential, private companies involves a high degree of risk, and our financial results may be affected adversely if one or more of our significant portfolio investments defaults on its loans or fails to perform as we expect. We expect that our portfolio will continue to consist primarily of debt investments in privately-owned companies, and to a lesser extent equity investments in privately-owned companies. Investing in these companies involves a number of significant risks. Typically, the debt in which we intend to invest will not be initially rated by any rating agency; however, we believe that if such investments were rated, they would generally be below investment grade. Securities rated below investment grade are often referred to as "high yield" securities and "junk bonds," and are considered "high risk" and speculative in nature compared to debt instruments that are rated investment grade. Compared to larger publicly owned companies, these companies may be in a weaker financial position and may experience wider variations in their operating results, which may make them more vulnerable to economic downturns. Typically, these companies need more capital to compete; however, their access to capital is limited and their cost of capital is often higher than that of their competitors. Our portfolio companies face intense competition from larger companies with greater financial, technical, and marketing resources and their success typically depends on the managerial talents and efforts of an individual or a small group of persons. Therefore, the loss of any of its key employees could affect a portfolio company’s ability to compete effectively and harm its financial condition. Further, some of these companies conduct business in regulated industries that are susceptible to regulatory changes, resulting in increased compliance measures and possibly more susceptibility to regulatory breaches or violations. These factors could impair the cash flow of our portfolio companies and result in other events, such as bankruptcy. These events could limit a portfolio company’s ability to repay its obligations to us, which may have an adverse effect on the return on, or the recovery of, our investment in these businesses. Deterioration in a borrower’s financial condition and prospects may be accompanied by deterioration in the value of the loan’s collateral. Some of these companies cannot obtain financing from public capital markets or from traditional credit sources, such as commercial banks. Accordingly, the loans we make to these types of companies pose a higher default risk than loans made to companies that have access to traditional credit sources. An investment strategy focused primarily on privately held companies presents certain challenges, including the lack of available information about these companies and a greater vulnerability to economic downturns. We invest primarily in high growth-potential, privately held companies and these companies may not have third-party credit ratings or audited consolidated financial statements subject to public accounting standards or otherwise. Generally, little public information exists about these companies, and we are required to rely on the ability of RGC’s investment team to obtain adequate financial or other information to evaluate the potential returns from investing in these companies. Furthermore, private companies and their financial information will not generally be subject to the Sarbanes-Oxley Act and other rules that govern public companies. If we are unable to uncover all material information about these companies through our diligence and underwriting process, we may not make a fully informed investment decision. This could adversely affect our investment returns as compared to companies investing primarily in the securities of public companies. Inflation may adversely affect our and our portfolio companies’ business, results of operations and financial condition. Some of our portfolio companies may be adversely impacted during times of inflation. If such portfolio companies are unable to pass any increases in their costs along to their customers, it could adversely affect their results and impact their ability to pay interest and principal on our loans. In addition, any projected future decreases in our portfolio companies’ operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of our investments could result in future unrealized losses and therefore reduce our net assets resulting from operations. Our portfolio companies may have limited operating histories and financial resources. Our portfolio consists of investments in companies that may have relatively limited operating histories. Generally, limited public information exists about these companies, and we are required to rely on the ability of RGC’s investment team to obtain adequate information to evaluate the potential returns from investing in these companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments. These companies may be particularly vulnerable to U.S. economic downturns and may have limited access to capital. These companies also frequently have less diverse product lines and a smaller market presence than larger competitors and may experience substantial variations in operating results. These companies may face intense competition, including from companies with greater financial, technical, operational and marketing resources, and typically depend upon the expertise and experience of a single individual executive or a small management team. Our success depends, in large part, upon the abilities of the key management personnel of our portfolio companies, who are responsible for the day-to-day operations of our portfolio companies. Competition for qualified personnel is intense at any stage of a company’s development, but even more so at the growth stage of the companies we typically invest in. The inability to attract and retain and/or the loss of one or more key managers can hinder or delay a company’s implementation of its business plan and harm its financial condition, which could negatively affect our investment returns. In addition, our existing and future portfolio companies may compete with each other for investment or business opportunities and the success of one could negatively impact the other. Furthermore, some of our portfolio companies do business in regulated industries and could be affected by changes in government regulation. Accordingly, these factors could impair their cash flow or result in other events, such as bankruptcy, which could limit their ability to repay their obligations to us, and may materially and adversely affect the return on, or the recovery of, our investment. As a result, we may lose our entire investment in any of our portfolio companies. The financial projections of our portfolio companies could prove inaccurate. We generally evaluate the capital structure of portfolio companies on the basis of financial projections prepared by the management of such portfolio companies. These projected operating results are normally based primarily on judgments of the management of the portfolio companies. In all cases, projections are only estimates of future results that are based upon assumptions made at the time that the projections are developed. General economic conditions, which are not predictable with accuracy, along with other macroeconomic factors and specific factors of the portfolio company, may cause actual performance to fall short of the financial projections that were used to establish a given portfolio company’s capital structure. Because of the leverage that is typically employed by our portfolio companies, this could cause a substantial decrease in the value of our investment in the portfolio company. The inaccuracy of financial projections of portfolio companies could thus cause our performance to fall short of our expectations. Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies. We invest primarily in senior secured loans made to high growth-potential private companies but, on occasion make second lien loans to portfolio companies. Our portfolio companies may have, or may be permitted to incur, other debt that ranks equally with, or in some cases senior to, the debt in which we invest. By their terms, such debt instruments may entitle the holders to receive payment of interest or principal on or before the dates on which we are entitled to receive payments with respect to the debt instruments in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization, or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt instruments in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization, or bankruptcy of the relevant portfolio company. In the case of second lien loans that we make to portfolio companies, we would not recover any of our principal amount of the loan until the first lien holder is fully repaid, which would likely result in us recovering less or no amounts due on our loan and, in turn, could have a materials adverse effect on our operations and financial condition. There may be circumstances in which our debt investments could be subordinated to claims of other creditors or we could be subject to lender liability claims. Even though we intend to structure most of our debt investments as secured loans, if one of our portfolio companies were to go bankrupt, depending on the facts and circumstances, and based upon principles of equitable subordination as defined by existing case law, a bankruptcy court could subordinate all or a portion of our claim to that of other creditors and transfer any lien securing such subordinated claim to the bankruptcy estate. The principles of equitable subordination defined by case law have generally indicated that a claim may be subordinated only if its holder is guilty of misconduct or where the senior loan is re-characterized as an equity investment and the senior lender has actually provided significant managerial assistance to the bankrupt debtor. In our case, we may, if requested to do so, provide managerial assistance to our portfolio companies. We may also be subject to lender liability claims for actions taken by us with respect to a borrower’s business or instances where we exercise control over the borrower. It is possible that we could become subject to a lender’s liability claim, including as a result of actions taken in rendering significant managerial assistance or actions to compel and collect payments from the borrower outside the ordinary course of business. Second priority liens on collateral securing loans that we make to our portfolio companies may be subject to control by senior creditors with first priority liens. If there is a default, the value of the collateral may not be sufficient to repay in full both the first priority creditors and us. Certain loans that we make will be secured by a second priority security interest in the same collateral pledged by a portfolio company to secure senior debt owed by the portfolio company to commercial banks or other traditional lenders. Often the senior lender has procured covenants from the portfolio company prohibiting the incurrence of additional secured debt without the senior lender’s consent. Prior to and as a condition of permitting the portfolio company to borrow money from us secured by the same collateral pledged to the senior lender, the senior lender may require assurances that it will control the disposition of any collateral in the event of bankruptcy or other default. In many such cases, the senior lender will require us to enter into an intercreditor agreement prior to permitting the portfolio company to borrow from us. Typically the intercreditor agreements we will be requested to execute will expressly subordinate our debt instruments to those held by the senior lender and further provide that the senior lender will control: (1) the commencement of foreclosure or other proceedings to liquidate and collect on the collateral; (2) the nature, timing, and conduct of foreclosure or other collection proceedings; (3) the amendment of any collateral document; (4) the release of the security interests in respect of any collateral; and (5) the waiver of defaults under any security agreement. Because of the control we may cede to senior lenders under intercreditor agreements we may enter, we may be unable to realize the proceeds of any collateral securing some of our loans. We may be subject to risks associated with our investments in covenant-lite loans. Venture lenders, in general, focus on a limited set of key financial performance metrics, including minimum liquidity, performance to plan, and investor abandonment, in lieu of a full set of financial performance covenants that do not meaningfully assess the risk of companies at the stage of development of companies in which venture lenders typically invest. As such, many of our loans could be considered covenant-lite by traditional lending standards. We have made and may in the future make or obtain significant exposure to covenant-lite loans, which generally are loans that do not require a borrower to comply with financial maintenance covenants, and may not include terms that allow the lender to monitor the financial performance of the borrower, including financial ratios, and declare a default if certain financial criteria are breached. While these loans may still contain other collateral protections, a covenant-lite loan may carry more risk than a covenant-heavy loan made by the same borrower as it does not require the borrower to provide affirmation that certain specific financial tests have been satisfied on a routine basis as is generally required under a covenant-heavy loan agreement. Generally, covenant-lite loans permit borrowers more opportunity to negatively impact lenders because their covenants, if any, tend to be incurrence-based, which means they are only tested and can only be breached following certain actions of the borrower, rather than by a deterioration in the borrower’s financial condition. Our investment in or exposure to a covenant-lite loan may potentially hinder our ability to reprice credit risk associated with the issuer and reduce our ability to restructure a problematic loan and mitigate potential loss. As a result, our exposure to losses may be increased, which could result in an adverse impact on our revenues, net income and net asset value. The lack of liquidity in our investments may adversely affect our business. We typically invest in companies whose securities are not publicly traded, and whose securities will be subject to legal and other restrictions on resale or will otherwise be less liquid than publicly traded securities. There is typically no established trading market for the securities in which we invest. The illiquidity of these investments may make it difficult for us to sell these investments when desired. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we had previously recorded these investments. As a result, we do not expect to achieve liquidity in our investments in the near-term and, in particular, with respect to the equity securities we acquire in our portfolio companies. Our investments are typically subject to contractual or legal restrictions on resale or are otherwise illiquid because there is no established trading market for such investments. The illiquidity of our investments may make it difficult for us to dispose of them at a favorable price or at all, and we may suffer losses as a result. Our failure to make follow-on investments in our portfolio companies could impair the value of our portfolio. Following an initial investment in a portfolio company, we may make additional investments in that portfolio company as "follow-on" investments, in order to: (1) increase or maintain in whole or in part our equity ownership percentage; (2) exercise warrants, options, or convertible securities that were acquired in the original or a subsequent financing; or (3) attempt to preserve or enhance the value of our investment. However, we may elect not to make follow-on investments or lack sufficient funds to make those investments. We will have the discretion to make any follow-on investments, subject to the availability of capital resources. The failure to make follow-on investments may, in some circumstances, jeopardize the continued viability of a portfolio company and our initial investment or may result in a missed opportunity for us to increase our participation in a successful operation. Even if we have sufficient capital to make a desired follow-on investment, we may elect not to make a follow-on investment because we do not want to increase our concentration of risk, we prefer other opportunities, we are subject to BDC requirements that would prevent such follow-on investments, or the follow-on investment would affect our qualification as a RIC. Our portfolio may lack diversification among portfolio companies, which subjects us to a risk of significant loss if one or more of these companies default on their repayment obligations under any of their debt instruments. Our portfolio may hold a limited number of portfolio companies. Beyond the asset diversification requirements associated with our qualification as a RIC, we do not have fixed guidelines for diversification, and our investments may be concentrated in relatively few companies. As our portfolio is less diversified than the portfolios of some larger funds, we are more susceptible to failure if a single loan fails. As a result, if a significant loan fails to perform as expected, our business, financial condition, results of operation and cash flows could be more negatively affected and the magnitude of the loss could be more significant than if we had made smaller investments in more companies. Similarly, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Our portfolio may be concentrated in a limited number of industries, which will subject us to a risk of significant loss if there is a downturn in a particular industry in which a number of our investments are concentrated. Our portfolio is concentrated in a limited number of industries. We invest primarily in companies focused in technology, life sciences, healthcare information and services, business services, financial services, select consumer services and products and other high growth industries. A downturn in any particular industry in which we are invested could significantly impact the aggregate returns we realize. As our portfolio may be less diversified than the portfolios of other investment vehicles, we may be more susceptible to losses if a single loan is not repaid. Similarly, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Our portfolio may lack diversification among our Sponsored Growth Lending and Non-Sponsored Growth Lending strategies and among sponsors within the Sponsored Growth Lending strategy. Our objective is to build a balanced portfolio with diversification among sponsored and non-sponsored transactions, diversification among sponsors within the Sponsored Growth Lending strategy, and diversification among industry, geography, and stage of development generally, which we believe will contribute to a favorable risk adjusted return for the portfolio viewed as a whole. If we are unable to achieve diversification or retain it, we may not achieve favorable risk adjusted returns for the portfolio viewed as a whole. We invest in sectors including technology, life sciences, healthcare information and services, business services, financial services, select consumer services and products and other high-growth industries, which are subject to specific risks related to each. We intend to continue to invest the largest portions of our portfolio in technology, life sciences, healthcare information and services, business services, financial services, select consumer services and products and other high-growth industries. Our portfolio companies may address needs in technology-related industries and markets. We expect that our technology portfolio will consist of companies that commercialize and integrate products targeted at technology-related markets. There are risks in investing in companies that target technology-related markets, including rapid and sometimes dramatic price erosion of products, the reliance on capital and debt markets to finance large capital outlays, including fabrication facilities, the reliance on partners outside of the United States, particularly in Asia, and inherent cyclicality of the technology market in general. As a result of multiple factors, access to capital may be difficult or impossible for companies in our portfolio that are pursuing these markets. We may be subject to risks associated with our investments in life sciences-related companies. Our life sciences portfolio consists primarily of companies that commercialize and integrate products in life sciences-related industries, including biotechnology, drug discovery, drug delivery, bioinformatics and medical devices. There are risks in investing in companies that target life sciences-related industries, including, but not limited to, the uncertainty of timing and results of clinical trials to demonstrate the safety and efficacy of products; failure to obtain any required regulatory approval of products; failure to develop manufacturing processes that meet regulatory standards; competition, in particular from companies that develop rival products; and the ability to protect proprietary technology. Adverse developments in any of these areas may adversely affect the value of our life sciences portfolio. This life sciences industry is dominated by large multinational corporations with substantially greater financial and technical resources than generally will be available to our portfolio companies. Such large corporations may be better able to adapt to the challenges presented by continuing rapid and major scientific, regulatory and technological changes as well as related changes in governmental and third-party reimbursement policies. Within the life sciences industry, the development of products generally is a costly and time-consuming process. Many highly promising products ultimately fail to prove to be safe and effective. There can be no assurance that the research or product development efforts of our portfolio companies or those of their collaborative partners will be successfully completed, that specific products can be manufactured in adequate quantities at an acceptable cost and with appropriate quality, or that such products can be successfully marketed or achieve customer acceptance. There can be no assurance that a product will be relevant and/or be competitive with products from other companies following the costly, time-consuming process of its development. The research, development, manufacturing, and marketing of products developed by some life sciences companies are subject to extensive regulation by numerous government authorities in the United States and other countries. There can be no assurance that products developed by the portfolio companies will ever be approved by such governmental authorities. Many life sciences portfolio companies will depend heavily upon intellectual property for their competitive position. There can be no assurance that the portfolio companies will be able to obtain patents for key inventions. Moreover, within the life sciences industry, patent challenges are frequent. Even if patents held by the portfolio companies are upheld, any challenges thereto may be costly and distracting to the portfolio companies’ management. Some of the life sciences portfolio companies will be at least partially dependent for their success upon governmental and third-party reimbursement policies that are under constant review and are subject to change at any time. Any such change could adversely affect the viability of one or more portfolio companies. Technology-related sectors, including those involving data processing and outsourced services, in which we invest are subject to many risks, including volatility, intense competition, decreasing life cycles, product obsolescence, changing consumer preferences and periodic downturns. Given the experience of RGC’s senior investment professionals within the technology space, a number of the companies in which we intend to invest operate in technology-related sectors. The revenue, income (or losses) and valuations of technology-related companies can and often do fluctuate suddenly and dramatically. In addition, because of rapid technological change, the average selling prices of products and some services provided by technology-related sectors have historically decreased over their productive lives. As a result, the average selling prices of products and services offered by our portfolio companies that operated in technology-related sectors may decrea | ||||||||||||||||||||||||||
Risks Related To Our Conflicts Of Interest [Member] | |||||||||||||||||||||||||||
General Description of Registrant [Abstract] | |||||||||||||||||||||||||||
Risk [Text Block] | Risks Related to Our Conflicts of Interest • Our strategic relationship with Oaktree may create conflicts of interest. • There are significant potential conflicts of interest which could impact our investment returns. • RGC’s liability is limited under the Advisory Agreement and we have agreed to indemnify RGC against certain liabilities, which may lead RGC to act in a riskier manner on our behalf than it would when acting for its own account. Risks Related to Our Conflicts of Interest Our strategic relationship with Oaktree may create conflicts of interest. As of December 31, 2023, OCM Holders owned 40.7% of our outstanding common stock. Pursuant to an irrevocable proxy, the shares of our common stock held by OCM Growth must be voted in the same manner that our other stockholders vote their shares. OCM Growth has a right to nominate a member of our Board of Directors for election for so long as OCM Growth holds shares of our common stock in an amount equal to, in the aggregate, at least one-third (33.33%) of OCM Growth’s initial $125.0 million capital commitment to us, which percentage shall be determined based on the dollar value of the shares of common stock owned by OCM Growth. OCM Growth holds the right to appoint a nominee to the Board of Directors, subject to the conditions previously described, regardless of the Company's size (e.g., assets under management or market capitalization) or the beneficial ownership interests of other stockholders. Further, to the extent OCM Growth’s share ownership falls below one-third of its initial $125.0 million capital commitment under any circumstances, OCM Growth will no longer have the right to appoint a director nominee and will use reasonable efforts to cause such nominee to resign immediately (subject to his or her existing fiduciary duties). Gregory M. Share serves on our Board of Directors as OCM Growth’s director nominee and is considered an interested director. In addition, OCM Growth owns a minority interest in RGC and has the right to appoint a member of RGC’s board of managers as well as a member of RGC’s Investment Committee. Mr. Share serves on RGC’s board of managers and investment committee on behalf of OCM Growth. Mr. Share is Managing Director of Oaktree's Global Opportunities Group in Los Angeles and we expect that he will continue to engage in investment advisory activities for Oaktree, which could result in a conflict of interest and may distract him from his responsibilities to us and RGC. As a result of the relationship with Oaktree and OCM Growth, we are presumed to be an affiliate of Oaktree and OCM Growth under the 1940 Act. As a result, we are not able to invest in the same portfolio companies in which any funds managed by Oaktree or OCM Growth invest without seeking exemptive relief from the SEC. There are significant potential conflicts of interest which could impact our investment returns. Our executive officers and directors, as well as the current and future members of RGC, may serve as officers, directors or principals of other entities that operate in the same or a related line of business as we do. Accordingly, they may have obligations to investors in those entities, the fulfillment of which obligations may not be in the best interests of us or our stockholders. In the course of our investing activities, we pay management and incentive fees to RGC and reimburse our Administrator for certain expenses it incurs on our behalf. As a result, investors in our common stock invest on a "gross" basis and receive distributions on a "net" basis after expenses, resulting in a lower rate of return than an investor might achieve through direct investments. Accordingly, there may be times when the management team of RGC will have interests that differ from those of our stockholders, giving rise to a conflict. We entered into a license agreement with RGC (the "License Agreement") pursuant to which RGC has granted us a personal, non-exclusive, royalty-free right and license to use the name "Runway Growth Finance". Under the License Agreement, we have the right to use the "Runway Growth Finance" name for so long as RGC or one of its affiliates remains our investment adviser. Other than with respect to this limited license, we have no legal right to the "Runway Growth Finance" name. In addition, we pay our Administrator, a wholly-owned subsidiary of RGC, our allocable portion of overhead and other expenses incurred by our Administrator in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing accounting and compliance functions. These arrangements may create conflicts of interest that our Board of Directors must monitor. RGC’s liability is limited under the Advisory Agreement and we have agreed to indemnify RGC against certain liabilities, which may lead RGC to act in a riskier manner on our behalf than it would when acting for its own account. Under the Advisory Agreement, RGC has not assumed any responsibility to us other than to render the services called for under that agreement. It is not responsible for any action of our Board of Directors in following or declining to follow RGC’s advice or recommendations. Under the Advisory Agreement, RGC and its professionals and any person controlling or controlled by RGC are not liable to us, any subsidiary of ours, our directors, our stockholders or any subsidiary’s stockholders or partners for acts or omissions performed in accordance with and pursuant to the Advisory Agreement, except those resulting from acts constituting gross negligence, willful misfeasance, bad faith or reckless disregard of the duties that RGC owes to us under the Advisory Agreement. In addition, as part of the Advisory Agreement, we will indemnify RGC and its professionals from and against any claims or liabilities, including reasonable legal fees and other expenses reasonably incurred, arising out of or in connection with our business and operations or any action taken or omitted on our behalf pursuant to authority granted by the Advisory Agreement, except where attributable to gross negligence, willful misfeasance, bad faith or reckless disregard of such person’s duties under the Advisory Agreement. The valuation process for certain of our investments may create a conflict of interest. For the majority of our investments, no market-based price quotation is available. As a result, our Board of Directors determines the fair value of these securities in good faith as described in "— Our portfolio securities may not have a readily available market price and, in such a case, we will value these securities at fair value as determined in good faith under procedures adopted by our Board of Directors, which valuation is inherently subjective and may not reflect what we may actually realize for the sale of the investment." In connection with that determination, RGC’s investment team provides our Board of Directors with valuation recommendations based upon the most recent and available information, which generally includes industry outlook, capitalization, consolidated financial statements and projected financial results of each portfolio company. Our Board of Directors utilizes the services of certain independent third-party valuation firms to aid it in determining the fair value of these investments. The Board of Directors discusses valuations and determines the fair value in good faith based on the input of RGC, the Audit Committee of the Board of Directors and the applicable third-party valuation firm. The participation of RGC’s investment team in our valuation process, and the pecuniary interest in RGC by certain members of our Board of Directors, could result in a conflict of interest as RGC’s base management fee is based, in part, on the value of our average adjusted gross assets, and RGC’s incentive fee is based, in part, on realized gains and realized and unrealized losses. We may pay our Adviser an incentive fee on certain investments that include a deferred interest feature. We underwrite our loans to generally include an end-of-term payment, a PIK interest payment and/or original issue discount. Our end-of-term payments are contractual and fixed interest payments due at the maturity date of the loan, including upon prepayment, and are generally a fixed percentage of the original principal balance of the loan. The portion of our end-of-term payments, which equal the difference between our yield-to-maturity and the stated interest rate on the loan, are recognized as non-cash income or original issue discount until they are paid. In addition, in connection with our equity-related investments, we may be required to accrue original issue discount, which decreases the balance on our secured loans by an amount equal to the value of the warrant investment we receive in connection with the applicable secured loan over its lifetime. Under these types of investments, we accrue interest during the life of the loan on the end-of-term payment, PIK interest payment and/or original issue discount but do not receive the cash income from the investment until the end of the term. However, our pre-incentive fee net investment income, which is used to calculate the income portion of our incentive fee, includes accrued interest. Thus, a portion of this incentive fee is based on income that we have not yet received in cash, such as an end-of-term payment, a PIK interest payment and/or original issue discount. | ||||||||||||||||||||||||||
Risks Related to Our Common Stock [Member] | |||||||||||||||||||||||||||
General Description of Registrant [Abstract] | |||||||||||||||||||||||||||
Risk [Text Block] | Risks Related to Our Common Stock • Shares of our common stock have traded at a discount from net asset value and may do so in the future. • A stockholder’s interest in us will be diluted if we issue additional shares, which could reduce the overall value of an investment in us. • Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock. Risks Related to our Common Stock Shares of our common stock have traded at a discount from net asset value and may do so in the future. Our common stock has at times traded below our net asset value per share since our IPO on October 25, 2021. Our shares may also trade at a discount to net asset value in the future. The possibility that our shares of common stock may trade at a discount from net asset value over the long term is separate and distinct from the risk that our net asset value will decrease. We cannot predict whether shares of our common stock will trade above, at or below our net asset value. If our common stock trades below our net asset value, we will generally not be able to issue additional shares of our common stock without first obtaining the approval for such issuance from our stockholders and our Independent Directors. As a result, we may be forced to curtail or cease our new lending and investment activities, our net asset value could decrease, and our level of distributions could be impacted. A stockholder’s interest in us will be diluted if we issue additional shares, which could reduce the overall value of an investment in us. Our stockholders do not have preemptive rights to purchase any shares we issue in the future. Our charter authorizes us to issue up to 100.0 million shares of common stock. Pursuant to our charter, a majority of our entire Board of Directors may amend our charter to increase the number of shares of common stock we may issue without stockholder approval. Our Board of Directors may elect to sell additional shares in the future or issue equity interests in private offerings. To the extent we issue additional equity interests at or below net asset value, your percentage ownership interest in us may be diluted. In addition, depending upon the terms and pricing of any additional offerings and the value of our investments, you may also experience dilution in the book value and fair value of your shares. Under the 1940 Act, we generally are prohibited from issuing or selling our common stock at a price below net asset value per share, which may be a disadvantage as compared with certain public companies. We may, however, sell our common stock, or warrants, options, or rights to acquire our common stock, at a price below the current net asset value of our common stock if our Board of Directors and independent directors determine that such sale is in our best interests and the best interests of our stockholders, and our stockholders approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our Board of Directors, closely approximates the fair value of such securities (less any distributing commission or discount). If we raise additional funds by issuing common stock or senior securities convertible into, or exchangeable for, our common stock, then the percentage ownership of our stockholders at that time will decrease and you will experience dilution. Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock. Any shares of our common stock that were outstanding prior to the completion of the IPO are "restricted securities" under the meaning of Rule 144 promulgated under the Securities Act and may only be sold if such sale is registered under the Securities Act or exempt from registration, including the exemption under Rule 144. As of December 31, 2023, OCM Holders owned 40.7% of our total outstanding shares. Subject to applicable securities laws, including Rule 144, sales of substantial amounts of our common stock, or the perception that such sales could occur, could adversely affect the prevailing market prices for our common stock. If these sales occur, it could impair our ability to raise additional capital through the sale of equity securities should we desire to do so. We cannot predict what effect, if any, future sales of securities, or the availability of securities for future sales, will have on the market price of our common stock prevailing from time to time. Investing in our common stock involves a high degree of risk. The investments we make in accordance with our investment objective may result in a higher amount of risk than alternative investment options, including volatility or loss of principal. Our investments in portfolio companies may be highly speculative and aggressive and, therefore, an investment in our common stock may not be suitable for someone with lower risk tolerance. The market value of our common stock may fluctuate significantly. The market value and liquidity, if any, of the market for shares of our common stock may be significantly affected by numerous factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include: • changes in the value of our portfolio of investments and derivative instruments as a result of changes in market factors, such as interest rate shifts, and also portfolio specific performance, such as portfolio company defaults, among other reasons; • changes in regulatory policies or tax guidelines, particularly with respect to RICs or BDCs; • loss of RIC or BDC status; • distributions that exceed our net investment income and net income as reported according to U.S. GAAP; • changes in earnings or variations in operating results; • changes in accounting guidelines governing valuation of our investments; • any shortfall in revenue or net income or any increase in losses from levels expected by investors; • departure of our Adviser or certain of its key personnel; • general economic trends and other external factors; and • loss of a major funding source. The amount of any distributions we may make is uncertain. We may not be able to pay you distributions, or be able to sustain distributions at any particular level, and our distributions per share, if any, may not grow over time, and our distributions per share may be reduced. We have not established any limit on the extent to which we may use borrowings, if any, to sustain distributions and we may also use offering proceeds to fund distributions (which may reduce the amount of capital we ultimately invest in portfolio companies). Subject to our Board of Director’s discretion and applicable legal restrictions, we intend to authorize and declare cash distributions and pay such distributions on a quarterly basis. We expect to pay distributions out of assets legally available for distribution. However, we cannot assure you that we will achieve investment results that will allow us to make a consistent targeted level of distributions or year-to-year increases in distributions. Our ability to pay distributions might be adversely affected by the impact of the risks described herein. In addition, the inability to satisfy the asset coverage test applicable to us as a BDC under the 1940 Act can limit our ability to pay distributions. Distributions from offering proceeds also could reduce the amount of capital we ultimately invest in debt or equity securities of portfolio companies. We cannot assure you that we will pay distributions to our stockholders in the future. See "Business — Regulation as a Business Development Company" in Part I, Item 1 of this Form 10-K. Distributions on our common stock may exceed our taxable earnings and profits. Therefore, portions of the distributions that we pay may represent a return of capital to you. A return of capital is a return of a portion of your original investment in shares of our common stock. As a result, a return of capital will (i) lower your adjusted tax basis in your shares and thereby increase the amount of capital gain (or decrease the amount of capital loss) realized upon a subsequent sale or redemption of such shares, and (ii) reduce the amount of funds we have for investment in portfolio companies. We may pay our distributions from offering proceeds in anticipation of future cash flow, which may constitute a return of your capital and will lower your adjusted tax basis in your shares, thereby increasing the amount of capital gain (or decreasing the amount of capital loss) realized upon a subsequent sale or redemption of such shares, even if such shares have not increased in value or have, in fact, lost value. Stockholders may experience dilution in the net asset value of their shares if they do not participate in our Dividend Reinvestment Plan and if our shares are trading at a discount to net asset value. All distributions declared in cash payable to stockholders that are participants in our Dividend Reinvestment Plan will be automatically reinvested in shares of our common stock. In addition, stockholders who elect not to participate in our Dividend Reinvestment Plan may experience accretion to the net asset value of their shares if our shares are trading at a premium to net asset value and dilution if our shares are trading at a discount to net asset value. The level of accretion or discount would depend on various factors, including the proportion of our stockholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to stockholders. If we issue preferred stock or convertible debt securities, the net asset value of our common stock may become more volatile. We may issue preferred stock or convertible debt in the future. We cannot assure you that the issuance of preferred stock and/or convertible debt securities would result in a higher yield or return to the holders of our common stock. The issuance of preferred stock or convertible debt would likely cause the net asset value of our common stock to become more volatile. If the dividend rate on the preferred stock, or the interest rate on the convertible debt securities, were to approach the net rate of return on our investment portfolio, the benefit of such leverage to the holders of our common stock would be reduced. If the dividend rate on the preferred stock, or the interest rate on the convertible debt securities, were to exceed the net rate of return on our portfolio, the use of leverage would result in a lower rate of return to the holders of common stock than if we had not issued the preferred stock or convertible debt securities. Any decline in the net asset value of our investment would be borne entirely by the holders of our common stock. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease in net asset value to the holders of our common stock than if we were not leveraged through the issuance of preferred stock or debt securities. This decline in net asset value would also tend to cause a greater decline in the market price, if any, for our common stock. There is also a risk that, in the event of a sharp decline in the value of our net assets, we would be in danger of failing to maintain required asset coverage ratios, which may be required by the preferred stock or convertible debt, or our current investment income might not be sufficient to meet the dividend requirements on the preferred stock or the interest payments on the debt securities. In order to counteract such an event, we might need to liquidate investments in order to fund the redemption of some or all of the preferred stock or convertible debt. In addition, we would pay (and the holders of our common stock would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred stock, debt securities, convertible debt, or any combination of these securities. Holders of preferred stock or convertible debt may have different interests than holders of common stock and may at times have disproportionate influence over our affairs. Provisions of the MGCL and of our charter and bylaws could deter takeover attempts and have an adverse impact on the price of our common stock. Under Maryland General Corporation Law (the "MGCL") and our charter and bylaws contain provisions that may discourage, delay or make more difficult a change in control of us or the removal of our directors. We are subject to the Maryland Business Combination Act, subject to any applicable requirements of the 1940 Act. Our Board has adopted a resolution exempting from the Business Combination Act any business combination between us and any other person, subject to prior approval of such business combination by our Board, including approval by a majority of our disinterested directors. If the resolution exempting business combinations is repealed or our Board does not approve a business combination, the Business Combination Act may discourage third parties from trying to acquire control of us and increase the difficulty of consummating such an offer. Our bylaws exempt from the Maryland Control Share Acquisition Act (the "Control Share Act") acquisitions of our stock by any person. If we amend our bylaws to repeal the exemption from the Control Share Act, the Control Share Act also may make it more difficult for a third party to obtain control of us and increase the difficulty of consummating such a transaction. The SEC staff has rescinded its position that, under the 1940 Act, an investment company may not avail itself of the Control Share Act. As a result, we will amend our bylaws to be subject to the Control Share Act only if our Board of Directors determines it would be in our best interests. We have also adopted measures that may make it difficult for a third party to obtain control of us, including provisions of our charter classifying our Board in three classes serving staggered three-year terms, and authorizing our Board to classify or reclassify shares of our stock in one or more classes or series, to cause the issuance of additional shares of our stock, to amend our bylaws without stockholder approval and to increase or decrease the number of shares of stock that we have authority to issue. These provisions, as well as other provisions of our charter and bylaws, may delay, defer or prevent a transaction or a change in control that might otherwise be in the best interests of our stockholders. Our Board of Directors is authorized to reclassify any unissued shares of common stock into one or more classes of preferred stock, which could convey special rights and privileges to its owners. Under the MGCL and our charter, our Board of Directors is authorized to classify and reclassify any authorized but unissued shares of stock into one or more classes of stock, including preferred stock. Prior to the issuance of shares of each class or series, the Board of Directors is required by Maryland law and our charter to set the terms, preferences, conversion or other rights, voting powers, restrictions, limitations as to dividends or other distributions, qualifications and terms or conditions of redemption for each class or series. Thus, the Board of Directors could authorize the issuance of shares of preferred stock with terms and conditions which could have the effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for holders of our common stock or otherwise be in their best interest. The cost of any such reclassification would be borne by our existing common stockholders. Certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred stock. For example, holders of preferred stock would vote separately from the holders of common stock on a proposal to cease operations as a BDC. In addition, the 1940 Act provides that holders of preferred stock are entitled to vote separately from holders of common stock to elect two preferred stock directors. We currently have no plans to issue preferred stock, but may determine to do so in the future. The issuance of preferred stock convertible into shares of common stock might also reduce the net income per share and net asset value per share of our common stock upon conversion, provided, that we will only be permitted to issue such convertible preferred stock to the extent we comply with the requirements of Section 61 of the 1940 Act, including obtaining common stockholder approval. These effects, among others, could have an adverse effect on an investment in our common stock. Certain investors are limited in their ability to make significant investments in us. Private funds that are excluded from the definition of "investment company" either pursuant to Section 3(c)(1) or 3(c)(7) of the 1940 Act are restricted from acquiring directly or through a controlled entity more than 3% of our total outstanding voting stock (measured at the time of the acquisition). Investment companies registered under the 1940 Act and BDCs are also generally subject to this restriction as well as other limitations under the 1940 Act that would restrict the amount that they are able to invest in our securities. Our business and operations could be negatively affected if we become subject to any securities litigation or stockholder activism, which could cause us to incur significant expense, hinder execution of investment strategy and impact our stock price. In the past, following periods of volatility in the market price of a company’s securities, securities class action litigation has often been brought against that company. Stockholder activism, which could take many forms or arise in a variety of situations, has been increasing in the BDC space in recent years. While we are currently not subject to any securities litigation or stockholder activism, due to the potential volatility of our stock price and for a variety of other reasons, we may in the future become the target of securities litigation or stockholder activism. Securities litigation and stockholder activism, including potential proxy contests, could result in substantial costs and divert management’s and our Board of Director’s attention and resources from our business. Additionally, such securities litigation and stockholder activism could give rise to perceived uncertainties as to our future, adversely affect our relationships with service providers and make it more difficult to attract and retain qualified personnel. Also, we may be required to incur significant legal fees and other expenses related to any securities litigation and activist stockholder matters. Further, our stock price could be subject to significant fluctuation or otherwise be adversely affected by the events, risks and uncertainties of any securities litigation and stockholder activism. | ||||||||||||||||||||||||||
Risks Related To RIC Tax Treatment [Member] | |||||||||||||||||||||||||||
General Description of Registrant [Abstract] | |||||||||||||||||||||||||||
Risk [Text Block] | Risks Related to RIC Tax Treatment • We will be subject to U.S. federal income tax at corporate rates if we are unable to qualify as a RIC. • We may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income. Risks Related to RIC Tax Treatment We will be subject to U.S. federal income tax at corporate rates if we are unable to qualify as a RIC. Although we have elected to be treated as a RIC under Subchapter M of the Code, no assurance can be given that we will be able to qualify as and maintain our qualification as a RIC. To maintain our tax treatment as a RIC, we must meet the 90% Gross Income Test, Diversification Tests, and the Annual Distribution Requirement described above. Failure to meet the Diversification Tests may result in our having to dispose of certain investments quickly in order to prevent the loss of our qualification as a RIC. Because most of our investments will be in private companies, and therefore will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could result in substantial losses. Because we may use debt financing, we are subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources, we could fail to qualify for tax treatment as a RIC. If we fail to qualify as a RIC for any reason and therefore become subject to U.S. federal income tax at corporate rates, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions. We may have difficulty paying our required distributions if we recognize income before or without receiving cash representing such income. For U.S. federal income tax purposes, we will include in our taxable income certain amounts that we have not yet received in cash, such as original issue discount, which may arise if we receive warrants in connection with the origination of a loan or possibly in other circumstances, or contractual PIK interest, which represents contractual interest added to the loan balance and due at the end of the loan term. Such original issue discount or increases in loan balances as a result of contractual PIK arrangements will be included in our taxable income before we receive any corresponding cash payments. We also may be required to include in our taxable income certain other amounts that we will not receive in cash. Since, in certain cases, we may recognize taxable income before or without receiving corresponding cash payments, we may have difficulty meeting the Annual Distribution Requirement necessary to maintain our qualification as a RIC. Accordingly, to satisfy our RIC distribution requirements, we may have to sell some of our investments at times and/or at prices we would not consider advantageous, raise additional debt or equity capital or forgo new investment opportunities. If we are not able to obtain cash from other sources, we may fail to qualify for tax treatment as a RIC and thus become subject to U.S. federal income tax at corporate rates. For additional discussion regarding the tax implications of our election to be taxed as a RIC, please see "Business — Certain U.S. Federal Income Tax Considerations — Taxation of the Company" in Part I, Item 1 of this Form 10-K. Due to ongoing healthcare emergencies or other disruptions in the economy, we may reduce or defer our dividends and choose to incur U.S. federal excise tax in order preserve cash and maintain flexibility. As a BDC, we are not required to make any distributions to stockholders other than in connection with our election to be taxed as a RIC under subchapter M of the Code. In order to maintain our tax treatment as a RIC, we must meet the Annual Distribution Requirement. If we qualify for taxation as a RIC, we generally will not be subject to U.S. federal income tax at corporate rates on our investment company taxable income and net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) that we timely distribute to stockholders. We will be subject to a 4% U.S. federal excise tax on undistributed earnings of a RIC unless we distribute each calendar year at least the sum of (i) 98% of our ordinary income for the calendar year, (ii) 98.2% of our capital gains in excess of capital losses for the one-year period ending on October 31 of the calendar year, and (iii) any ordinary income and net capital gains for preceding years that were not distributed during such years and on which we paid no federal income tax. Under the Code, we may satisfy certain of our RIC distributions with dividends paid after the end of the current year. In particular, if we pay a distribution in January of the following year that was declared in October, November, or December of the current year and is payable to stockholders of record in the current year, the dividend will be treated for all US federal tax purposes as if it were paid on December 31 of the current year. In addition, under the Code, we may pay dividends, referred to as "spillback dividends," that are paid during the following taxable year that will allow us to maintain our qualification for taxation as a RIC and eliminate our liability for U.S. federal income tax. Under these spillback dividend procedures, we may defer distribution of income earned during the current year until December of the following year. For example, we may defer distributions of income earned during 2023 until as late as December 31, 2024. If we choose to pay a spillback dividend, we will incur the nondeductible 4% U.S. federal excise tax on some or all of the distribution. Due to ongoing healthcare emergencies or other disruptions in the economy, we may take certain actions with respect to the timing and amounts of our distributions in order to preserve cash and maintain flexibility. For example, we may reduce our dividends and/or defer our dividends to the following taxable year. If we defer our dividends, we may choose to utilize the spillback dividend rules discussed above and incur the 4% U.S. federal excise tax on such amounts. To further preserve cash, we may combine these reductions or deferrals of dividends with one or more distributions that are payable partially in our stock as discussed below under "—We may choose to pay distributions in our own stock, including in connection with our Dividend Reinvestment Plan, in which case you may be required to pay U.S. federal income tax in excess of the cash you receive." We may choose to pay distributions in our own stock, including in connection with our Dividend Reinvestment Plan, in which case you may be required to pay U.S. federal income tax in excess of the cash you receive. We may distribute taxable distributions that are payable in cash or shares of our common stock, including in connection with our Dividend Reinvestment Plan. Under certain applicable provisions of the Code and published IRS guidance, distributions payable from a publicly offered RIC that are payable in cash or in shares of stock at the election of stockholders may be treated as taxable distributions. The IRS has issued a revenue procedure indicating that this rule will apply if the total amount of cash to be distributed is not less than 20% of the total distribution. Under this revenue procedure, if too many stockholders elect to receive their distributions in cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of the distribution paid in shares of our common stock). We currently expect to qualify as a publicly offered RIC. If we qualify as a publicly offered RIC and decide to make any distributions consistent with this revenue procedures that are payable in part in shares of our common stock, taxable stockholders receiving such distributions will be required to include the full amount of the distribution (whether received in cash, stock or a combination thereof) as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain distribution) to the extent of our current and accumulated earnings and profits for U.S. federal income tax purposes. As a result, a U.S. stockholder may be required to pay U.S. federal income tax with respect to such distributions in excess of any cash received. If a U.S. stockholder sells the stock it receives as a distribution in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the distribution, depending on the net asset value of our stock at the time of the sale. Furthermore, with respect to non-U.S. stockholders, we may be required to withhold U.S. federal tax with respect to such distributions, including in respect of all or a portion of such distribution that is payable in stock. In addition, if a significant number of our stockholders sell shares of our common stock in order to pay U.S. federal income taxes owed on distributions, it may put downward pressure on the net asset value of our common stock. If we are not treated as a "publicly offered regulated investment company," as defined in the Code, certain U.S. stockholders will be treated as having received a dividend from us in the amount of such U.S. stockholders’ allocable share of the management and incentive fees paid to RGC and certain of our other expenses, and these fees and expenses will be treated as miscellaneous itemized deductions of such U.S. stockholders. A "publicly offered RIC" is a RIC whose shares are either (i) continuously offered pursuant to a public offering, (ii) regularly traded on an established securities market or (iii) held by at least 500 persons at all times during the taxable year. We expect to be treated as a "publicly offered regulated investment company" as a result of shares of our common stock being treated as regularly traded on an established securities market. However, we cannot assure you that we will be treated as a publicly offered regulated investment company for all years. If we are not treated as a publicly offered regulated investment company for any calendar year, each U.S. stockholder that is an individual, trust or estate will be treated as having received a dividend from us in the amount of such U.S. stockholder’s allocable share of the management and incentive fees paid to RGC and certain of our other expenses for the calendar year, and will be deductible by such shareholder only to the extent permitted under the limitations described below. For non-corporate U.S. stockholders, including individuals, trusts, and estates, significant limitations generally apply to the deductibility of certain expenses of a non-publicly offered RIC. In particular, these expenses, referred to as miscellaneous itemized deductions, currently are not deductible by non-corporate U.S. stockholders (and beginning in 2026, will be deductible only to non-corporate U.S. stockholders to the extent they exceed 2% of such non-corporate U.S. stockholders’ adjusted gross income, and will not be deductible for alternative minimum tax purposes). | ||||||||||||||||||||||||||
General Risks [Member] | |||||||||||||||||||||||||||
General Description of Registrant [Abstract] | |||||||||||||||||||||||||||
Risk [Text Block] | General Risks • We may experience fluctuations in our quarterly and annual results. • Government intervention in the credit markets could adversely affect our business. General Risks We may experience fluctuations in our quarterly and annual results. We may experience fluctuations in our quarterly and annual operating results due to a number of factors, including, but not limited to, our ability or inability to make investments in companies that meet our investment criteria, the interest rate payable on the debt securities we acquire, the level of portfolio dividend and fee income, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, the degree to which we encounter competition in our markets and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods. Government intervention in the credit markets could adversely affect our business. The central banks and, in particular, the U.S. Federal Reserve, have taken unprecedented steps since the financial crises of 2008-2009 and again related to the COVID-19 global pandemic and rising inflation rates. It is impossible to predict if, how, and to what extent the United States and other governments would further intervene in the credit markets. Such intervention is often prompted by politically sensitive issues involving family homes, student loans, real estate speculation, credit card receivables, pandemics, etc., and could, as a result, be contrary to what we would predict from an "economically rational" perspective. Political uncertainty could adversely affect our business U.S. and non-U.S. markets could experience political uncertainty and/or change that subjects investments to heightened risks, including, for instance, the risks related to the elections in the U.S. or the effect on world leaders and governments of the COVID-19 pandemic. These heightened risks could also include: increased risk of default (by both government and private issuers); greater social, trade, economic and political instability (including the risk of war or terrorist activity); greater governmental involvement in the economy; greater governmental supervision and regulation of the securities markets and market participants resulting in increased expenses related to compliance; greater fluctuations in currency exchange rates; controls or restrictions on foreign investment and/or trade, capital controls and limitations on repatriation of invested capital and on the ability to exchange currencies; inability to purchase and sell investments or otherwise settle security or derivative transactions (i.e., a market freeze); unavailability of currency hedging techniques; and slower clearance. During times of political uncertainty and/or change, global markets often become more volatile. There could also be a lower level of monitoring and regulation of markets while a country is experiencing political uncertainty and/or change, and the activities of investors in such markets and enforcement of existing regulations could become more limited. Markets experiencing political uncertainty and/or change could have substantial, and in some periods extremely high, rates of inflation for many years. Inflation and rapid fluctuations in inflation rates typically have negative effects on such countries’ economies and markets. Tax laws could change materially, and any changes in tax laws could have an unpredictable effect on us, our investments and our investors. There can be no assurance that political changes will not cause us or our investors to suffer losses. Terrorist attacks, acts of war or widespread health emergencies or natural disasters may affect any market for our common stock, impact the businesses in which we invest and harm our business, operating results and financial condition. Terrorist acts, acts of war, widespread health emergencies or natural disasters may disrupt our operations, as well as the operations of the businesses in which we invest. Such acts have created, and continue to create, economic and political uncertainties and have contributed to global economic instability. Future terrorist activities, military or security operations, widespread health emergencies or natural disasters could further weaken the domestic/global economies and create additional uncertainties, which may negatively impact the businesses in which we invest directly or indirectly and, in turn, could have a material adverse impact on our business, operating results and financial condition. Losses from terrorist attacks, natural disasters and widespread health emergencies are generally uninsurable. We are subject to risks in using custodians, administrators and other agents. We depend on the services of custodians, administrators and other agents to carry out certain securities transactions and administrative services for us. In the event of the insolvency of a custodian, we may not be able to recover equivalent assets in full as we will rank among the custodian’s unsecured creditors in relation to assets which the custodian borrows, lends or otherwise uses. In addition, our cash held with a custodian may not be segregated from the custodian’s own cash, and we therefore may rank as unsecured creditors in relation thereto. The inability to recover assets from the custodian could have a material impact on our performance. Changes in laws or regulations governing our business or the businesses of our portfolio companies, changes in the interpretation thereof or newly enacted laws or regulations, and any failure by us or our portfolio companies to comply with these laws or regulations may adversely affect our business and the businesses of our portfolio companies. We and our portfolio companies are subject to laws and regulations at the U.S. federal, state and local levels and, in some cases, foreign levels. These laws and regulations, as well as their interpretation, could change from time to time, including as the result of interpretive guidance or other directives from the U.S. President and others in the executive branch, and new laws, regulations and interpretations could also come into effect. For example, the current U.S. presidential administration could support an enhanced regulatory agenda that imposes greater costs on all sectors and on financial services companies in particular. Any such new or changed laws or regulations could have a material adverse effect on our business, and political uncertainty could increase regulatory uncertainty in the near term. Any such new or changed laws or regulations could have a material adverse effect on our business or the business of our portfolio companies. The legal, tax and regulatory environment for BDCs, investment advisers and the instruments that they utilize (including derivative instruments) is continuously evolving. In addition, as private equity firms become more influential participants in the U.S. and global financial markets and economy generally, there recently has been pressure for greater governmental scrutiny and/or regulation of the private equity industry. It is uncertain as to what form and in what jurisdictions such enhanced scrutiny and/or regulation, if any, on the private equity industry may ultimately take. Therefore, there can be no assurance as to whether any such scrutiny or initiatives will have an adverse impact on the private equity industry, including our ability to effect operating improvements or restructurings of our portfolio companies or otherwise achieve our objectives. Over the last several years, there also has been an increase in regulatory attention to the extension of credit outside of the traditional banking sector, raising the possibility that some portion of the non-bank financial sector will be subject to new regulation. While it cannot be known at this time whether any regulation will be implemented or what form it will take, increased regulation of non-bank credit extension could negatively impact our operating results or financial condition, impose additional costs on us, intensify the regulatory supervision of us or otherwise adversely affect our business. Additionally, any changes to the laws and regulations governing our operations relating to permitted investments may cause us to alter our investment strategy in order to avail ourselves of new or different opportunities. Such changes could result in material differences to the strategies and plans set forth herein and may result in our investment focus shifting from the areas of expertise of RGC’s investment team to other types of investments in which the investment team may have less expertise or little or no experience. Thus, any such changes, if they occur, could have a material adverse effect on our results of operations and the value of your investment. Internal and external cyber threats, as well as other disasters, could impair our ability to conduct business effectively. The occurrence of a disaster, such as a cyber-attack against us or against a third-party that has access to our data or networks, a natural catastrophe, an industrial accident, failure of our disaster recovery systems, or consequential employee error, could have an adverse effect on our ability to communicate or conduct business, negatively impacting our operations and financial condition. This adverse effect can become particularly acute if those events affect our electronic data processing, transmission, storage, and retrieval systems, or impact the availability, integrity, or confidentiality of our data. We depend heavily upon computer systems to perform necessary business functions. Despite our implementation of a variety of security measures, our computer systems, networks, and data, like those of other companies, could be subject to cyber-attacks and unauthorized access, use, alteration, or destruction, such as from physical and electronic break-ins or unauthorized tampering. If one or more of these events occurs, it could potentially jeopardize the confidential, proprietary, and other information processed, stored in, and transmitted through our computer systems and networks. Such an attack could cause interruptions or malfunctions in our operations, which could result in financial losses, litigation, regulatory penalties, client dissatisfaction or loss, reputational damage, and increased costs associated with mitigation of damages and remediation. Third parties with which we do business may also be sources of cybersecurity or other technological risk. We outsource certain functions and these relationships allow for the storage and processing of our information, as well as client, counterparty, employee, and borrower information. While we engage in actions to reduce our exposure resulting from outsourcing, ongoing threats may result in unauthorized access, loss, exposure, destruction, or other cybersecurity incidents that adversely affects our data, resulting in increased costs and other consequences as described above. We and our service providers continue to be impacted by an increase in the ability of employees to work from external locations, including their homes. Policies of extended periods of remote working, whether by us or our service providers, could strain technology resources, introduce operational risks and otherwise heighten the risks described above. Remote working environments may be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts. Accordingly, the risks described above, are heightened under the current conditions. Cybersecurity risks and cyber incidents may adversely affect our business by causing a disruption to our operations, a compromise or corruption of our confidential information and/or damage to our business relationships, all of which could negatively impact our business, results of operations or financial condition. A cyber incident is considered to be any adverse event that threatens the confidentiality, integrity or availability of our information resources. These incidents may be an intentional attack or an unintentional event and could involve gaining unauthorized access to our information systems for purposes of misappropriating assets, stealing confidential information, corrupting data or causing operational disruption. The result of these incidents may include disrupted operations, misstated or unreliable financial data, liability for stolen information, misappropriation of assets, increased cybersecurity protection and insurance costs, litigation and damage to our business relationships. Any such attack could result in significant losses, reputational damage, litigation, regulatory fines or penalties, or otherwise adversely affect our business, financial condition or results of operations. In addition, we may be required to expend significant additional resources to modify our protective measures and to investigate and remediate vulnerabilities or other exposures arising from operational and security risks. We face risks posed to our information systems, both internal and those provided to us by third-party service providers. We and RGC have implemented processes, procedures and internal controls to help mitigate cybersecurity risks and cyber intrusions, but these measures, as well as our increased awareness of the nature and extent of a risk of a cyber incident, may be ineffective and do not guarantee that a cyber incident will not occur or that our financial results, operations or confidential information will not be negatively impacted by such an incident. Third parties with which we do business (including those that provide services to us) may also be sources or targets of cybersecurity or other technological risks. We outsource certain functions, and these relationships allow for the storage and processing of our information and assets, as well as certain investor, counterparty, employee and borrower information. While we engage in actions to reduce our exposure resulting from outsourcing, ongoing threats may result in unauthorized access, loss, exposure or destruction of data, or other cybersecurity incidents, with increased costs and other consequences, including those described above. Privacy and information security laws and regulation changes, and compliance with those changes, may also result in cost increases due to system changes and the development of new administrative processes. We are subject to risks related to corporate social responsibility. Our business faces increasing public scrutiny related to environmental, social and governance ("ESG") activities. We risk damage to our brand and reputation if we fail to act responsibly in a number of areas, such as environmental stewardship, corporate governance and transparency and considering ESG factors in our investment processes. Adverse incidents with respect to ESG activities could impact the value of our brand, the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations. Additionally, new regulatory initiatives related to ESG could adversely affect our business. We cannot predict how new tax legislation will affect us, our investments, or our stockholders, and any such legislation could adversely affect our business. Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. The Biden Administration has proposed significant changes to the existing U.S. tax rules, and there are a number of proposals in Congress that would similarly modify the existing U.S. tax rules. The likelihood of any such legislation being enacted is uncertain, but new legislation and any U.S. Treasury regulations, administrative interpretations or court decisions interpreting such legislation could significantly and negatively affect our ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to us and our investors of such qualification, or could have other adverse consequences. Investors are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our common stock. | ||||||||||||||||||||||||||
[1] All per share activity, excluding dividends, is calculated based on the weighted-average shares outstanding for the relevant period. |
Organization
Organization | 12 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization | Note 1 — Organization Runway Growth Finance Corp. (formerly known as Runway Growth Credit Fund Inc.) (the "Company"), is a Maryland corporation that was formed on August 31, 2015. On August 18, 2021, the Company changed its name to "Runway Growth Finance Corp." from "Runway Growth Credit Fund Inc." The Company is an externally managed, non-diversified, closed-end investment company that has elected to be regulated as a business development company ("BDC") under the Investment Company Act of 1940, as amended (the "1940 Act"). In addition, the Company has elected to be treated, currently qualifies, and intends to continue to qualify annually, as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code"). The Company was formed primarily to lend to, and selectively invest in, high growth-potential companies in technology, life sciences, healthcare information and services, business services, financial services, select consumer services and products in other high-growth industries in the United States. The Company’s investment objective is to maximize its total return to its stockholders primarily through current income on its loan portfolio, and secondarily through capital gain (loss) on its warrants and other equity positions. The Company’s investment activities are managed by its external investment adviser, Runway Growth Capital LLC ("RGC"). The Company’s administrator, Runway Administrator Services LLC (the "Administrator") is a wholly owned subsidiary of RGC and provides administrative services necessary for the Company to operate. On October 25, 2021, the Company closed its initial public offering ("IPO"), issuing 6,850,000 shares of its common stock at a public offering price of $ 14.60 per share. Net of underwriting fees and offering costs, the Company received net proceeds of $ 93.0 million. The Company's common stock began trading on the Nasdaq Global Select Market LLC on October 21, 2021 under the symbol “RWAY”. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Significant of Accounting Policies | Note 2 — Summary of Significant Accounting Policies Basis of Presentation The accompanying consolidated financial statements of the Company are prepared on the accrual basis of accounting in conformity with U.S. Generally Accepted Accounting Principles ("U.S. GAAP") and pursuant to the requirements for reporting on Form 10‑K and Regulation S-X under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Company is an investment company following the specialized accounting and reporting guidance specified in the Financial Accounting Standards Board’s ("FASB") Accounting Standards Codification ("ASC") Topic 946, Financial Services — Investment Companies. Certain items in the December 31, 2022 and December 31, 2021 consolidated financial statements have been reclassified to conform to the December 31, 2023 presentation with no effect on the Total net assets on the Consolidated Statements of Assets and Liabilities, no effect on the Net increase (decrease) in net assets resulting from operations on the Consolidated Statements of Operations, and no effect to the Net increase (decrease) in cash and cash equivalents on the Consolidated Statements of Cash Flows. Principles of Consolidation Under ASC 946, the Company is precluded from consolidating portfolio company investments, including those in which it has a controlling interest, unless the portfolio company is another investment company. An exception to this general principle occurs if the Company holds a controlling interest in an operating company that provides all or substantially all of its services directly to the Company or to its portfolio companies. None of the portfolio investments made by the Company qualify for this exception. Therefore, the Company’s investment portfolio is carried on the Consolidated Statements of Assets and Liabilities at fair value, as discussed further in “Note 4 — Investments,” with any adjustments to fair value recognized as “Net unrealized gain (loss) on investments” on the Consolidated Statements of Operations. Effective December 31, 2023, the Company completed a credit bid resulting in the acquisition of Pivot3, Inc.’s assets in consideration for the Company’s outstanding senior secured term loan to Pivot3, Inc. As of December 31, 2023, the cost basis of the senior secured term loan to Pivot3, Inc. was $ 18.0 million and the fair value of Pivot3, Inc.’s asset was $ 0.95 million, resulting in a realized loss of approximately $ 17.0 million. The public sale of the collateral included (1) all issued and outstanding equity interest of Pivot3, Inc. and (2) intangible assets. Pursuant to the credit bid purchase agreement, the Company directed that the Pivot3, Inc. pledged equity be transferred to P3 Holdco LLC (“P3 Holdco”), a wholly owned subsidiary of the Company, and the assets be contributed to Pivot3, Inc. (resulting in Pivot3, Inc. becoming a wholly-owned subsidiary of P3 Holdco). The Company’s consolidated operations include the activities of its wholly owned subsidiary, P3 Holdco and P3 Holdco’s wholly owned subsidiary Pivot3, Inc. The subsidiaries are consolidated and included in the Company’s consolidated financial statements and the assets of Pivot3, Inc. are recorded at fair value. All intercompany balances and transactions have been eliminated. Refer to the Schedule of Investments for the Company’s equity interest in Pivot3, Inc. as of December 31, 2023. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of income and expense during the reporting period. Changes in the economic and regulatory environment, financial markets, the credit worthiness of our portfolio companies, and any other parameters used in determining these estimates and assumptions could cause actual results to differ from these estimates and assumptions. Cash and Cash Equivalents Cash consists solely of funds deposited with financial institutions, while cash equivalents consists of short-term liquid investments in money market funds. Cash and cash equivalents are carried at cost, which approximates fair value. As of December 31, 2023, t he Company did no t have any cash equivalents invested in money market funds. As of December 31, 2022, $ 5.6 million was invested in money market funds. Interest earned in money market funds are recorded in Other income on the Consolidated Statements of Operations. Debt and Deferred Debt Costs The debt of the Company is carried at amortized cost, which is comprised of the principal amount borrowed, net of unamortized debt issuance costs on the Consolidated Statements of Assets and Liabilities. Debt issuance costs are fees and other direct incremental costs incurred by the Company in relation to debt financing and are recognized as Unamortized deferred debt costs as a reduction to total debt on the Consolidated Statements of Assets and Liabilities and amortized over the life of the related debt instrument, or the life of the cost respective service if shorter, using the straight-line method, which closely approximates the effective yield method. To the extent there are no outstanding borrowings, the deferred debt costs are presented as an asset on the Consolidated Statements of Assets and Liabilities. Amortization of deferred debt costs and interest expense on the outstanding principal balance are recorded in Interest and other deferred financing expenses on the Consolidated Statements of Operations. Accrued but unpaid interest is included within Interest payable on the Consolidated Statements of Assets and Liabilities. For more information, refer to “Note 7 – Borrowings.” Segments The Company lends to and invests in customers in various industries. The Company separately evaluates the performance of each of its lending and investment relationships. However, because each of these loan and investment relationships has similar business and economic characteristics, they have been aggregated into a single lending and investment segment. All applicable segment disclosures are included in or can be derived from the Company’s consolidated financial statements. Investment Transactions and Related Investment Income Security transactions, if any, are recorded on a trade-date basis. Realized gains or losses from the repayment or sale of investments are measured using the specific identification method. The amortized cost basis of investments represents the original cost adjusted for the accretion/amortization of discounts and premiums and upfront loan origination fees. The Company reports changes from the prior period in fair value of investments that are measured at fair value as a component of net change in unrealized gain (loss) on investments on the Consolidated Statements of Operations. Dividend income is recorded on an accrual basis to the extent that such amounts are payable and expected to be collected. Dividend income is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. Interest income, if any, adjusted for amortization of market premium and accretion of market discount, is recorded on an accrual basis to the extent that the Company expects to collect such amounts. Original issue discount (“OID”), principally representing the estimated fair value of detachable equity, warrants or contractual success fees obtained in conjunction with the Company’s debt investments, loan origination fees, end of term payments, and market discount or premium are capitalized and accreted or amortized into interest income over the life of the respective security using the effective interest method. Loan origination fees received in connection with the closing of investments are reported as unearned income, which is included as amortized cost of the investment; the unearned income from such fees is accreted into interest income over the contractual life of the loan based on the effective interest method. Upon prepayment of a debt investment, any unamortized loan origination fees, end-of-term payments, and unamortized market discounts are recorded as interest income and any prepayment penalties are recorded as fee income. Upon amending terms of an existing investment, any amendment fees charged are recorded as fee income. The Company currently holds, and expects to hold in the future, some investments in its portfolio that contain payment-in-kind ("PIK") interest provisions. PIK interest is computed at the contractual rate specified in each loan agreement and is added to the principal balance of the loan, rather than being paid to the Company in cash, and is recorded as interest income. Thus, the actual collection of PIK interest may be deferred until the time of debt principal repayment. PIK interest, which is a non-cash source of income, is included in the Company’s taxable income and therefore affects the amount of income the Company is required to distribute to stockholders to maintain its qualification as a RIC for U.S. federal income tax purposes, even though the Company has not yet collected the cash. For the years ended December 31, 2023, December 31, 2022, and December 31, 2021, approximately 12.2 % , 8.0 % , and 4.2 % , respectively, of the Company's total investment income was attributable to non-cash PIK interest. Investments Denominated in Foreign Currency At each balance sheet date, portfolio company investments denominated in foreign currencies are translated into U.S. dollars using the spot exchange rate on the last business day of the period. Purchases and sales of foreign portfolio company investments, and any income from such investments, are translated into U.S. dollars using the rates of exchange prevailing on the respective dates of such transactions. As of December 31, 2023, the Company held one investment denominated in a foreign currency. As of December 31, 2022, the Company did not hold any investments denominated in a foreign currency. Although the fair values of foreign portfolio company investments and the fluctuation in such fair values are translated into U.S. dollars using the applicable foreign exchange rates described above, the Company does not isolate the portion of the change in fair value resulting from foreign currency exchange rates fluctuations from the change in fair value of the underlying investment. All fluctuations in fair value are included in Net change in unrealized gain (loss) on investments on the Company’s Consolidated Statements of Operations. Non-Accrual of Investments Debt investments are placed on non-accrual status when principal, interest, and other obligations become materially past due or when it is probable that principal, interest, or other obligations will not be collected in full. At the point of non-accrual, the Company will cease recognizing interest income on the debt investment until all principal and interest due have been paid or the Company believes the borrower has demonstrated the ability to repay its current and future contractual obligations. Additionally, any OID associated with the debt investment is no longer accreted to interest income as of the date the loan is placed on non-accrual status. Any payments received on non-accrual loans are first applied to principal prior to recovery of any foregone interest or end of term payment fees. Non-accrual loans are restored to accrual status when past due principal or interest are paid, and, in management’s judgment are likely to remain current. The Company may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection such that the Company will be made whole on the investment, inclusive of interest and end of term payment fees. During the years ended December 31, 2023 and December 31, 2022, the Company had no t written off any accrued interest. As of December 31, 2023, we had no loans on non-accrual status as our single loan to Pivot3, Inc. was realized. For more information, refer to "Note 2 — Summary of Significant Accounting Policies, Principles of Consolidation." As of December 31, 2022 , the Company had one loan to Pivot3, Inc. on non-accrual status. The loan, with a cost basis of $ 19.2 million and a fair value of $ 9.3 million represents 0.8 % of the Company’s total investment portfolio. From being placed on non-accrual status through December 31, 2022, cumulative interest of $ 3.6 million would be receivable and $ 0.3 million OID would be accreted into the cost basis, for a total of $ 3.9 million not recorded in interest income from control investments on the Statement of Operations. As of December 31, 2021 , the Company had six loans to Mojix, Inc. and one loan to Pivot3, Inc., on non-accrual status. The loans, with an aggregate cost basis of $ 30.3 million and a fair value of $ 28.3 million, represents 3.9 % of the Company’s total investment portfolio. From being placed on non-accrual status through December 31, 2021 , cumulative interest of $ 4.1 million would be receivable and $ 0.7 million OID would be accreted into the cost basis, for a total of $ 4.8 million not recorded in interest income from control investments on the Statement of Operations. Fair Value Measurements The Company measures the value of its financial instruments at fair value in accordance with ASC Topic 820, Fair Value Measurements and Disclosure (“ASC Topic 820”), issued by the FASB. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. With the exception of the Company’s borrowings, which are reported at amortized cost, all assets and liabilities approximate fair value on the Statements of Assets and Liabilities. For more information on financial instruments reported at cost, refer to "Note 5 – Fair Value of Financial Instruments." ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below: • Level 1 — Valuations are based on quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date. • Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly and model-based valuation techniques for which all significant inputs are observable. • Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models incorporating significant unobservable inputs, such as discounted cash flow models and other similar valuations techniques. The valuation of Level 3 assets and liabilities generally requires significant management judgment due to the inability to observe inputs to valuation. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, a financial instrument’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the instrument. Under ASC Topic 820, the fair value measurement also assumes that the transaction to sell an asset or liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset, which may be a hypothetical market, and excludes transaction costs. The principal market for any asset or liability is the market with the greatest volume and level of activity for such asset in which the reporting entity would or could sell or transfer the asset or liability. In determining the principal market for an asset or liability under ASC Topic 820, it is assumed that the reporting entity has access to such market as of the measurement date. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable and willing and able to transact. Rule 2a-5 under the 1940 Act established requirements for determining fair value of a BDC's investments in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards, in compliance with certain conditions, to designate certain parties to perform fair value determinations, subject to board oversight. Rule 2a-5 also defines when market quotations are "readily available" for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. The SEC also adopted new Rule 31a-4 under the 1940 Act ("Rule 31a-4"), which provides the recordkeeping requirements associated with fair value determinations. The Company's Board of Directors has not designated a valuation designee. Investment Valuation Techniques With respect to investments for which market quotations are not readily available, the Company undertakes a multi-step valuation process each quarter, as described below: • The quarterly valuation process begins with each portfolio company investment being initially valued by RGC’s investment professionals that are responsible for the portfolio investment; • Preliminary valuation conclusions are then documented and discussed with RGC’s senior investment team; • At least once annually, the valuation for each portfolio investment is reviewed by an independent valuation firm. Certain investments, however, may not be evaluated annually by an independent valuation firm if the net asset value and other aspects of such investments in the aggregate do not exceed certain thresholds; • The Audit Committee then reviews these preliminary valuations from RGC and the independent valuation firm, if any, and makes a recommendation to the Company's Board of Directors regarding such valuations; and • The Company’s Board of Directors reviews the recommended preliminary valuations and determines the fair value of each investment in the Company’s portfolio, in good faith, based on the input of RGC, the independent valuation firm(s) and the Audit Committee. The Company’s investments are primarily loans made to and equity and warrants of small, fast-growing companies focused in technology, life sciences, health care information and services, business services and other high-growth industries. These investments are considered Level 3 assets under ASC Topic 820 because there is no known or accessible market or market indices for these types of debt and equity instruments and, thus, RGC’s senior investment team must estimate the fair value of these investment securities based on models utilizing unobservable inputs. The Audit Committee of the Company’s Board of Directors assists the Board of Directors in valuing investments that are not publicly traded or for which current market values are not readily available. Investments for which market quotations are readily available are valued using market quotations, which are generally obtained from independent pricing services, broker-dealers or market makers. With respect to portfolio investments for which market quotations are not readily available, the Company’s Board of Directors, with the assistance of the Audit Committee, RGC and its senior investment team and independent valuation agents, is responsible for determining, in good faith, the fair value in accordance with the valuation policy approved by the Board of Directors. If more than one valuation method is used to measure fair value, the results are evaluated and weighted, as appropriate, considering the reasonableness of the range indicated by those results. The Company considers a range of fair values based upon the valuation techniques utilized and selects the value within that range that was most representative of fair value based on current market conditions as well as other factors RGC’s senior investment team considers relevant. The Company’s Board of Directors makes this fair value determination on a quarterly basis and any other time when a decision regarding the fair value of the portfolio investments is required. A determination of fair value involves subjective judgments and estimates and depends on the facts and circumstances. Due to the inherent uncertainty of determining the fair value of portfolio investments that do not have a readily available market value, the fair value of the investments may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material. Valuation methodologies involve a significant degree of judgment. There is no single standard for determining the fair value of investments that do not have an active public market. Valuations of privately held investments are inherently uncertain, as they are based on estimates, and their values may fluctuate over time. The determination of fair value may differ materially from the values that would have been used if an active market for these investments existed. In some cases, the fair value of such investments is best expressed as a range of values derived utilizing different methodologies from which a fair value may then be determined. Debt Investments To determine the fair value of the Company’s debt investments, the Company compares the cost basis of the debt investment, which includes OID, to the resulting fair value determined using a discounted cash flow model, unless another model is more appropriate based on the circumstances at the measurement date. The discounted cash flow approach entails analyzing the interest rate spreads for recently completed financing transactions that are similar in nature to the Company’s investments, in order to determine a comparable range of effective market interest rates for its investments. The range of interest rate spreads utilized is based on borrowers with similar credit profiles. All remaining expected cash flows of the investment are discounted using this range of interest rates to determine a range of fair values for the debt investment. This valuation process includes, among other things, evaluating the underlying investment performance, the portfolio company’s current financial condition and ability to raise additional capital, as well as macro-economic events that may impact valuations. These events include, but are not limited to, current market yields and interest rate spreads of similar securities as of the measurement date. Significant increases (decreases) in these unobservable inputs could result in a significantly higher (lower) fair value measurements. Under certain circumstances, the Company may use an alternative technique to value the debt investments to be acquired by the Company that better reflects the fair value of the investment, such as the price paid or realized in a recently completed transaction or a binding offer received in an arms-length transaction, the use of multiple probability-weighted cash flow models when the expected future cash flows contain elements of variability or estimates of proceeds that would be received in a liquidation scenario. Warrants Fair value of warrants is primarily determined using a Black Scholes option-pricing model. Privately held warrants and equity-related securities are valued based on an analysis of various factors including, but not limited to, the following: • Underlying enterprise value of the issuer is estimated based on information available, including any information regarding the most recent rounds of issuer funding. Valuation techniques to determine enterprise value include market multiple approaches, income approaches or approaches that utilize recent rounds of financing and the portfolio company’s capital structure to determine enterprise value. Valuation techniques are also utilized to allocate the enterprise fair value of a portfolio company to the specific class of common or preferred stock exercisable in the warrant. Such techniques take into account the rights and preferences of the portfolio company’s securities, expected exit scenarios, and volatility associated with such outcomes to allocate the fair value to the specific class of stock held in the portfolio. Such techniques include Option Pricing Models, or “OPM,” including back-solve techniques, Probability Weighted Expected Return Models, or “PWERM,” and other techniques as determined to be appropriate. • Volatility, or the amount of uncertainty or risk about the size of the changes in the warrant price, is based on comparable publicly traded companies within indices similar in nature to the underlying company issuing the warrant. Significant increases (decreases) in this unobservable input could result in a significantly lower (higher) fair value, but a significantly higher or lower fair value measurement of any of the Company’s portfolio investments may occur regardless of whether there is a significant increase or decrease in this unobservable input. • The risk-free interest rates are derived from the U.S. Treasury yield curve. The risk-free interest rates are calculated based on a weighted average of the risk-free interest rates that correspond closest to the expected remaining life of the warrant. Significant increases (decreases) in this unobservable input could result in a significantly higher (lower) fair value, but a significantly higher or lower fair value measurement of any of the Company’s portfolio investments may occur regardless of whether there is a significant increase (decrease) in this unobservable input. • Other adjustments, including a marketability discount on private company warrants, are estimated based on judgment about the general industry environment. Significant increases (decreases) in this unobservable input could result in a significantly lower (higher) fair value, but a significantly higher or lower fair value measurement of any of the Company’s portfolio investments may occur regardless of whether there is a significant increase (decrease) in this unobservable input. • Historical portfolio experience on cancellations and exercises of warrants are utilized as the basis for determining the estimated life of the warrants in each financial reporting period. Warrants may be exercised in the event of acquisitions, mergers or initial public offerings, and cancelled due to events such as bankruptcies, restructuring activities or additional financings. These events cause the expected remaining life assumption to be shorter than the contractual term of the warrants. Significant increases (decreases) in this unobservable input could result in a significantly higher (lower) fair value, but a significantly higher or lower fair value measurement of any of the Company’s portfolio investments may occur regardless of whether there is a significant increase (decrease) in this unobservable input. Under certain circumstances, the Company may use an alternative technique to value warrants that better reflects the warrants’ fair values, such as an expected settlement of a warrant in the near term, a model that incorporates a put feature associated with the warrant, or the price paid or realized in a recently completed transaction or binding offer received in an arms-length transaction. The fair value may be determined based on the expected proceeds to be received from such settlement or based on the net present value of the expected proceeds from the put option. Equity Investments The fair value of an equity investment in a privately held company is initially the face value of the amount invested. The Company adjusts the fair value of equity investments in private companies upon the completion of a new third-party round of equity financing subsequent to the Company’s investment. The Company may make adjustments to fair value, absent a new equity financing event, based upon positive or negative changes in a portfolio company’s financial or operational performance. The Company may also reference comparable transactions and/or secondary market transactions in connection with its determination of fair value. The fair value of an equity investment in a publicly traded company is based upon the closing public share price on the date of measurement. These assets are recorded at fair value on a recurring basis. Investment Classification The Company classifies its investments by level of affiliation and control. As defined in the 1940 Act, investee companies are deemed as affiliated investments when a company or individual possesses, or has the right to acquire within 60 days or less, beneficial ownership of 5.0 % or more of the outstanding voting securities of an investee company. Control investments are those where the investor has the ability or power to exercise a controlling influence over the management or policies of an investee company. Control is generally deemed to exist when a company or individual possesses, or has the right to acquire within 60 days or less, beneficial ownership of more than 25.0 % of the outstanding voting securities of an investee company, or maintains greater than 50 % representation on the investee company's board of directors. Investments are recognized when the Company assumes an obligation to acquire a financial instrument and assumes the risks for gains or losses related to that instrument. Investments are derecognized when the Company assumes an obligation to sell a financial instrument and foregoes the risks for gains or losses related to that instrument. Specifically, the Company records all security transactions on a trade date basis. Investments in other, non-security financial instruments, such as limited partnerships or private companies, are recorded on the basis of subscription date or redemption date, as applicable. Amounts for investments recognized or derecognized but not yet settled will be reported on the Consolidated Statements of Assets and Liabilities. Income Taxes The Company elected to be treated as a RIC under Subchapter M of the Code beginning with its taxable year ended December 31, 2016, currently qualifies as a RIC, and intends to qualify annually for the tax treatment applicable to RICs. A RIC generally is not subject to U.S. federal income taxes on distributed income and gains so long as it meets certain source-of-income and asset diversification requirements and it distributes at least 90% of its net ordinary income and net short-term capital gains in excess of its net long-term capital losses, if any, to its stockholders. So long as the Company maintains its status as a RIC, it generally will not be subject to U.S. federal income tax on any ordinary income or capital gains that it distributes at least annually to its stockholders as dividends. Rather, any tax liability related to income earned by the Company represents obligations of the Company’s investors and will not be reflected in the consolidated financial statements of the Company. The Company intends to make sufficient distributions to maintain its RIC status each year and it does not anticipate paying any material U.S. federal income taxes in the future. Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward such taxable income in excess of current year dividend distributions from such current year taxable income into the next tax year and pay a 4 % excise tax on such income, as required. If the Company determines that the estimated current year taxable income will exceed the estimated dividend distributions for the current year from such income, the Company accrues excise tax on estimated excess taxable income as such taxable income is earned. Differences between taxable income and net increase in net assets resulting from operations either can be temporary, meaning they will reverse in the future, or permanent. In accordance with Section 946-205-45-3 of the ASC, permanent tax dif |
Related Party Agreements and Tr
Related Party Agreements and Transactions | 12 Months Ended |
Dec. 31, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Agreements and Transactions | Note 3 — Related Party Agreements and Transactions Second Amended and Restated Advisory Agreement On November 29, 2016, the Company’s Board of Directors approved an investment advisory agreement between RGC and the Company, under which RGC, subject to the overall supervision of the Board of Directors, manages the day-to-day operations of and provides investment advisory services to the Company (together with a subsequent amendment thereto, the “Prior Advisory Agreement”). On August 3, 2017, the Board of Directors approved certain amendments to the Prior Advisory Agreement (the “First Amended and Restated Advisory Agreement”) and recommended that the Company’s stockholders approve the First Amended and Restated Advisory Agreement. The First Amended and Restated Advisory Agreement became effective on September 12, 2017 upon approval by the stockholders at a special meeting of stockholders of the Company. On April 7, 2021, the Board of Directors approved certain additional amendments to the advisory agreement (the “Advisory Agreement”) at a virtual meeting and recommended that the Company’s stockholders approve the Advisory Agreement. In reliance upon certain exemptive relief granted by the SEC in connection with the global COVID-19 pandemic, the Board of Directors undertook to ratify the Advisory Agreement at its next in-person meeting which was held in July 2021. The Advisory Agreement became effective on May 27, 2021 upon approval by the stockholders at a special meeting of stockholders of the Company. The Advisory Agreement amended the Prior Advisory Agreement to include certain revisions to the management and incentive fee calculation mechanisms and clarify language relating to liquidity events. On May 2, 2023, the Company's Board of Directors renewed the Advisory agreement for a period of twelve months commencing May 27, 2023. Under the terms of the Advisory Agreement, RGC: • determines the composition of the Company’s portfolio, the nature and timing of the changes to the portfolio and the manner of implementing such changes; • identifies, evaluates and negotiates the structure of the investments the Company makes; • executes, closes and monitors the investments the Company makes; • determines the securities and other assets that the Company will purchase, retain or sell; • performs due diligence on prospective investments; and • provides the Company with other such investment advisory, research and related services as the Company may, from time to time, reasonably require for the investment of its funds. Pursuant to the Advisory Agreement, the Company pays RGC a fee for its investment advisory and management services consisting of two components — a base management fee and an incentive fee. The cost of both the base management fee and incentive fee are ultimately borne by the Company’s stockholders. Base Management Fee The base management fee is payable on the first day of each calendar quarter and is calculated on the Company's "Gross Assets" which, for purposes of the Advisory Agreement, is defined as the Company’s gross assets, including assets purchased with borrowed funds or other forms of leverage, as well as any PIK interest, as of the end of the most recently completed fiscal quarter. The base management fee will be an amount equal to 0.375 % ( 1.50 % annualized) of the Company’s average daily Gross Assets during the most recently completed calendar quarter, so long as the aggregate amount of the Company’s Gross Assets as of the end of the most recently completed calendar quarter is equal to or greater than $ 1.0 billion. If the aggregate amount of the Company’s Gross Assets as of the end of the most recently completed calendar quarter is less than $ 1.0 billion but equal to or greater than $ 500.0 million, the base management fee will be an amount equal to 0.40 % ( 1.60 % annualized) of the Company’s average daily Gross Assets during the most recently completed calendar quarter. If the aggregate amount of the Company’s Gross Assets as of the end of the most recently completed calendar quarter is less than $ 500.0 million, the base management fee will be an amount equal to 0.4375 % ( 1.75 % annualized) of the Company’s average daily Gross Assets during the most recently completed calendar quarter. For the year ended December 31, 2023 , RGC earned base management fees at a rate of 1.50 % per annum, amounting to $ 16.7 million For the years ended December 31, 2022 and 2021 , RGC earned base management fees at a rate of 1.60 % per annum, amounting to $ 11.9 million and $ 9.0 million , respectively. Incentive Fee The incentive fee, which provides RGC with a share of the income that RGC generates for the Company, consists of an investment-income component and a capital-gains component, which are largely independent of each other, with the result that one component may be payable even if the other is not. Under the investment-income component (the “Income Incentive Fee”), the Company pays RGC each quarter an incentive fee with respect to the Company’s pre-incentive fee net investment income ("Pre-Incentive Fee NII"). The Income Incentive Fee is calculated and payable quarterly in arrears based on the Pre-Incentive Fee NII for the immediately preceding fiscal quarter. Payments based on Pre-Incentive Fee NII will be based on the Pre-Incentive Fee NII earned for the quarter. For this purpose, Pre-Incentive Fee NII means interest income, dividend income and any other income (including any other fees, such as commitment, origination, structuring, diligence, managerial and consulting fees or other fees that the Company receives from portfolio companies) that the Company accrues during the fiscal quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under the amended and restated administration were deferred incentive fees payable, both of which are included in incentive fees payable on the Consolidated Statements of Assets and Liabilities agreement with the Administrator (the “Administration Agreement”), and any dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-Incentive Fee NII includes, in the case of investments with a deferred interest feature (such as OID accretion, debt instruments with pay in kind interest and zero coupon securities), accrued income the Company has not yet received in cash; provided, however, that the portion of the Income Incentive Fee attributable to deferred interest features will be paid, only if and to the extent received in cash, and any accrual thereof will be reversed if and to the extent such interest is reversed in connection with any write off or similar treatment of the investment giving rise to any deferred interest accrual, applied in each case in the order such interest was accrued. Such subsequent payments in respect of previously accrued income will not reduce the amounts payable for any quarter pursuant to the calculation of the Income Incentive Fee described above. Pre-Incentive Fee NII does not include any realized or unrealized capital gains (losses). Pre-Incentive Fee NII , expressed as a rate of return on the value of the Company’s net assets (defined as total assets less liabilities) at the end of the immediately preceding fiscal quarter, will be compared to a “hurdle rate” of 2.0 % per quarter ( 8.0 % annualized). The Company pays RGC an Income Incentive Fee with respect to the Company’s Pre-Incentive Fee NII in each calendar quarter as follows: (1) no Income Incentive Fee in any calendar quarter in which the Company’s Pre-Incentive Fee NII does not exceed the hurdle rate of 2.0 %; (2) 80 % of the Company’s Pre-Incentive Fee NII with respect to that portion of such Pre-Incentive Fee NII , if any, that exceeds the hurdle rate but is less than 2.667 % in any calendar quarter ( 10.668 % annualized) (the portion of the Company’s Pre-Incentive Fee NII that exceeds the hurdle but is less than 2.667 % is referred to as the “catch-up”; the “catch-up” is meant to provide RGC with 20.0 % of the Company’s Pre-Incentive Fee NII as if a hurdle did not apply if the Company’s Pre-Incentive Fee NII exceeds 2.667 % in any calendar quarter ( 10.668 % annualized)); and (3) 20.0 % of the amount of the Company’s Pre-Incentive Fee NII , if any, that exceeds 2.667 % in any calendar quarter ( 10.668 % annualized) payable to RGC (once the hurdle is reached and the catch-up is achieved, 20.0 % of all Pre-Incentive Fee NII thereafter is allocated to RGC). Until the consummation of a Spin-Off transaction (defined below), in the event that (a) the sum of the Company’s cumulative net realized losses since the date of the Company’s election to be regulated as a BDC exceeded 2.0 % of the total non-control/non-affiliate investments made by the Company since the date of the Company’s election to be regulated as a BDC through the end of the quarter and (b) the Pre-Incentive Fee NII adjusted to include any realized capital gains and losses (“Adjusted Pre-Incentive Fee NII ”), expressed as an annualized rate of return on the value of the Company’s average daily net assets (defined as total assets less liabilities), since the Company’s election to be regulated as a BDC through the end of the quarter was less than 10.0 %, no Income Incentive Fee would be payable for such quarter until the first subsequent quarter in which either (x) the sum of the Company’s cumulative net realized losses since the date of the Company’s election to be regulated as a BDC was equal to or less than 2.0 % of the total non-control/non-affiliate investments made by the Company since the date of the Company’s election to be regulated as a BDC through the end of such subsequent quarter or (y) the Adjusted Pre-Incentive Fee NII , expressed as an annualized rate of return on the value of the Company’s average daily net assets (defined as total assets less liabilities), since the Company’s election to be regulated as a BDC through the of the end of the quarter equals or exceeds 10.0 %; provided, however, that in no event would any Income Incentive Fee be payable for any prior quarter after the three-year anniversary of the end of such quarter. For purposes of the Advisory Agreement, a “Spin-Off transaction” includes either a transaction whereby (a) the Company offers its stockholders the option to elect to either (i) retain their ownership of shares of the Company’s common stock, or (ii) exchange their shares of the Company’s common stock for shares of common stock in a newly formed entity (the “Public Fund”) that will elect to be regulated as a BDC under the 1940 Act and treated as a RIC under Subchapter M of the Code (the “Public Fund Spin Off”); or (b) the Company completes a listing of the Company’s securities on any securities exchange (an “Exchange Listing”). Under the capital gains component of the incentive fee (the “Capital Gains Fee”), the Company will pay RGC, as of the end of each calendar year, 20.0 % of the Company’s aggregate cumulative realized capital gains, if any, from the date of the Company’s election to be regulated as a BDC through the end of that calendar year, computed net of the Company’s aggregate cumulative realized capital losses and aggregate cumulative unrealized capital losses through the end of such year, less the aggregate amount of any previously paid Capital Gains Fee. For the foregoing purpose, the Company’s “aggregate cumulative realized capital gains” will not include any unrealized gains. If such amount is negative, then no Capital Gains Fee will be payable for such year. For the year ended December 31, 2023, RGC earned incentive fees of $ 19.0 million , $ 14.1 million of which was payable in cash, and $ 4.9 million was accrued and generated from deferred interest. For the year ended December 31, 2022, RGC earned incentive fees of $ 13.2 million , $ 11.0 million of which were payable in cash, and $ 2.2 million were accrued and generated from deferred interest. For the year ended December 31, 2021, RGC earned incentive fees of $ 9.2 million , $ 7.4 million of which was payable in cash, and $ 1.8 million were accrued and generated from deferred interest. All incentive fees accrued and generated from deferred interest (i.e., PIK and certain discount accretion) are not payable until receipt of respective cash by the Company. As of December 31, 2023, $ 3.3 million were payable in cash and $ 9.2 million were deferred incentive fees payable, both of which are included in incentive fees payable on the Consolidated Statements of Assets and Liabilities. As of December 31, 2022, $ 3.8 million of incentive fees payable were payable in cash, and $ 5.0 million were deferred incentive fees payable, both of which are included in incentive fees payable on the Consolidated Statements of Assets and Liabilities. The capital gains incentive fee consists of fees related to realized gains and losses and unrealized capital losses. With respect to the incentive fee expense accrual related to the capital gains incentive fee, U.S. GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized gains in the calculation, as a capital gains incentive fee would be payable if such unrealized gains were realized even though such unrealized gains are not permitted to be considered in calculating the fee actually payable under the Advisory Agreement. As of each of December 31, 2023 and December 31, 2022 , there was no capital gains incentive fee accrued, earned or payable to RGC under the Advisory Agreement. Spin-Off Incentive Fee The Income Incentive Fee will be payable in connection with a Public Fund Spin-Off as follows. The Income Incentive Fee will be calculated as of the date of the completion of each Public Fund Spin-Off and will equal the amount of Income Incentive Fee that would be payable to RGC if (1) all of the Company’s investments were liquidated for their current value and any unamortized deferred portfolio investment-related fees would be deemed accelerated, (2) the proceeds from such liquidation were used to pay all of the Company’s outstanding liabilities, and (3) the remainder were distributed to the Company’s stockholders and paid as incentive fee in accordance with the Income Incentive Fee described in clauses (1) and (2) above for determining the amount of the Income Incentive Fee; provided, however, that in no event will the Income Incentive Fee paid in connection with the completion of the Public Fund Spin-Off (x) include the portion of the Income Incentive Fee attributable to deferred interest features of a particular investment that is not transferred pursuant to the Public Fund Spin-Off until such time as the deferred interest is received in cash, or (y) exceed 20.0 % of the Company’s Pre-Incentive Fee NII accrued by the Company for the fiscal quarter as of the date of the completion of the Public-Fund Spin-Off. The Company will make the payment of the Income Incentive Fee paid in connection with the completion of the Public Fund Spin-Off in cash on or immediately following the date of the completion of the Public-Fund Spin-Off. After the Public Fund Spin-Off, all calculations relating to the incentive fee payable will be made beginning on the day immediately following the completion of the Public Fund Spin-Off without taking into account the exchanged shares of the Company’s common stock (or contributions, distributions or proceeds relating thereto). The Capital Gains Fee will be payable in respect of the exchanged shares of the Company’s common stock in connection with the Public Fund Spin-Off and will be calculated as of the date of the completion of the Public Fund Spin-Off as if such date were a calendar year-end for purposes of calculating and paying the Capital Gains Fee. No Income Incentive Fee or Capital Gains Fee will be payable in connection with the Public Fund Spin-Off unless, on the date of the completion of the Public Fund Spin-Off, the sum of the Company’s (i) Pre-Incentive Fee NII and (ii) realized capital gains less realized capital losses and unrealized capital losses from the date of the Company’s election to be regulated as a BDC through, and including, the date of the completion of the Public Fund Spin-Off, is greater than 8.0 % of the cumulative net investments made by the Company since the Company’s election to be regulated as a BDC. Administration Agreement The Company reimburses the Administrator for the allocable portion of overhead expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including furnishing the Company with office facilities, equipment and clerical, bookkeeping and recordkeeping services at such facilities, as well as providing other administrative services. In addition, the Company reimburses the Administrator for the fees and expenses associated with performing compliance functions, and the Company’s allocable portion of the compensation of the Company’s Chief Financial Officer, Chief Compliance Officer and any administrative support staff, as well as any expenses paid by the Administrator on the Company's behalf. For the year ended December 31, 2023, the Company incurred $ 2.1 million of Administration Agreement expenses, of which $ 0.8 million was payable to a third-party service provider and $ 1.3 million was overhead allocation expense. As of December 31, 2023, the Company had accrued a net payable to the Administrator of $ 0.4 million and a payable to the third-party administrator of $ 0.2 million , which are included in Accrued expenses and other liabilities on the Consolidated Statements of Assets and Liabilities. For the year ended December 31, 2022, the Company incurred $ 1.8 million of Administration Agreement expenses, of which $ 0.8 million was payable to a third-party service provider and $ 1.0 million was overhead allocation expense. As of December 31, 2022, the Company had accrued a net payable to the Administrator of $ 0.4 million and a payable to the third-party administrator of $ 0.2 million , which are included in Accrued expenses and other liabilities on the Consolidated Statements of Assets and Liabilities. For the year ended December 31, 2021, the Company incurred $ 1.6 million of Administration Agreement expenses, of which $ 0.7 million was payable to a third-party service provider and $ 0.9 million was overhead allocation expense. As of December 31, 2021, the Company had accrued a net payable to the Administrator of $ 0.2 million and a payable to the third-party administrator of $ 0.3 million , which are included in Accrued expenses and other liabilities on the Consolidated Statements of Assets and Liabilities. License Agreement The Company has entered into a license agreement with RGC (the “License Agreement”) pursuant to which RGC has granted the Company a personal, non-exclusive, royalty-free right and license to use the name “Runway Growth Finance.” Under the License Agreement, the Company has the right to use the “Runway Growth Finance” name for so long as RGC or one of its affiliates remains the Company’s investment adviser. Other than with respect to this limited license, the Company has no legal right to the “Runway Growth Finance” name. Strategic Relationship In December 2016, the Company and RGC entered into a strategic relationship with Oaktree Capital Management, L.P (“Oaktree”). In connection with the strategic relationship, OCM Growth Holdings ("OCM Growth") purchased an aggregate of 14,571,334 shares of the Company's common stock for an aggregate purchase price of $ 219.3 million in the Company's Initial Private Offering and Second Private Offering. Oaktree Opportunities Fund Xb Holdings (Delaware), L.P. ("Oaktree Opportunities") purchased 24,100 shares of the Company common stock in secondary transactions in 2020 and 2022. As of December 31, 2023, OCM Growth and Oaktree Opportunities Fund Xb Holdings (Delaware), L.P. (together with OCM Growth, the “OCM Holders”), each an affiliate of Oaktree, own 16,473,290 shares and 18,878 shares of our common stock, respectively, or 40.7 % of the Company's outstanding shares. Pursuant to an irrevocable proxy, certain shares held by OCM Growth must be voted in the same proportion that the Company's other stockholders vote their shares. Of the 16,492,168 shares of Company’s common stock owned by the OCM Holders, 15,588,549 shares, or approximately 38.5 % of the Company’s outstanding shares, are subject to this proxy voting arrangement. In connection with OCM Growth’s commitment, the Company entered into a stockholder agreement, dated December 15, 2016, with OCM Growth, pursuant to which OCM Growth has a right to nominate a member of the Company’s Board of Directors for election for so long as OCM Growth holds shares of the Company’s common stock in an amount equal to, in the aggregate, at least one-third ( 33 %) of OCM Growth’s initial $ 125.0 million capital commitment. Gregory M. Share, Managing Director of Oaktree's Global Opportunities Group in Los Angeles, serves on the Company’s Board of Directors as OCM Growth’s director nominee and is considered an interested director. OCM Growth also holds a minority interest in RGC and has the right to appoint a member of RGC’s board of managers and a member of RGC’s investment committee. Mr. Share is OCM Growth’s appointee to RGC’s board of managers and investment committee. |
Investments
Investments | 12 Months Ended |
Dec. 31, 2023 | |
Investments, All Other Investments [Abstract] | |
Investments | Note 4 — Investments Control and Affiliate Investments The Company classifies its investment portfolio by level of affiliation and control in accordance with the requirements of the 1940 Act. As defined in the 1940 Act, investee companies are deemed as affiliated investments when a company or individual possesses, or has the right to acquire within 60 days or less, beneficial ownership of 5.0 % or more of the outstanding voting securities of an investee company. Control investments are those where the investor has the ability or power to exercise a controlling influence over the management or policies of an investee company. Control is generally deemed to exist when a company or individual possesses, or has the right to acquire within 60 days or less, beneficial ownership of more than 25.0 % of the outstanding voting securities of an investee company, or maintains greater than 50 % representation on the investee company's board of directors. The Company’s affiliate and control investments as of December 31, 2023 along with the transactions during the year ended December 31, 2023 are as follows (in thousands): For the Year Ended December 31, 2023 Investment Income Earned 2023 Fair Value as of December 31, 2022 Gross (1) Gross (2) Net Realized Gain (Loss) Net Change in Unrealized Gain (Loss) Fair Value as of December 31, 2023 (3) Portfolio Company Investment Investment Affiliate Investments Debt Investments Gynesonics, Inc. Senior Secured SOFR+ 8.75 %, 8.00 % ceiling, 5.00 % ETP, due 11/30/2026 $ 2,105 $ — $ 25,897 $ — $ — $ ( 2,311 ) $ 23,586 Total Debt Investments 2,105 — 25,897 — — ( 2,311 ) 23,586 Equity Investments Coginiti Corp Equity Common Stock — 1,174 — — — ( 318 ) 856 Gynesonics, Inc. Equity Series A-2 Preferred Stock — — 25,000 — — ( 3,539 ) 21,461 Equity Series A-1 Preferred Stock — — 3,100 — — 1,477 4,577 Total Equity Investments — 1,174 28,100 — — ( 2,380 ) 26,894 Warrants Coginiti Corp Warrants Common Stock — 910 — — — ( 247 ) 663 Gynesonics, Inc. Warrants Success fee — — 313 — — — 313 Total Warrants — 910 313 — — ( 247 ) 976 Total Affiliate Investments $ 2,105 $ 2,084 $ 54,310 $ — $ — $ ( 4,938 ) $ 51,456 Control Investments Debt Investments Pivot3, Inc. Senior Secured LIBOR+ 8.50 % PIK, 11.00 % floor, 4.00 % ETP, due 10/15/2023 — 9,290 — ( 2,158 ) ( 17,014 ) 9,882 — Total Debt Investments — 9,290 — ( 2,158 ) ( 17,014 ) 9,882 — Equity Investments Pivot3, Inc. Equity Equity Interest — — 950 — — — 950 Total Equity Investments — — 950 — — — 950 Total Control Investments $ — $ 9,290 $ 950 $ ( 2,158 ) $ ( 17,014 ) $ 9,882 $ 950 (1) Gross additions includes increases in the basis of investments resulting from new portfolio investments, PIK interest, accretion of original issue discount (“OID”), the exchange of one or more existing investments for one or more new investments and the movement of an existing portfolio company into this category from a different category. (2) Gross reductions include decreases in the basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing investments for one or more new investments and the movement of an existing portfolio company out of this category into a different category. (3) All investments in the portfolio companies, which as of December 31, 2023 represented 9.58 % of the Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors. The Company’s affiliate and control investments as of December 31, 2022 along with the transactions during the year ended December 31, 2022 are as follows (in thousands): For the Year Ended December 31, 2022 Amount of Investment Income Earned 2022 Fair Value as of December 31, 2021 Gross Additions (1) Gross Reductions (2) Net Realized Gain (Loss) Net Change in Unrealized Gain (Loss) Fair Value as of December 31, 2022 (3) Portfolio Company Investment Description Affiliate Investments Debt Investments Coginiti Corp LIBOR+ 9.50 % PIK, 10.81 % floor, due 12/15/2022 $ 109 $ — $ 930 $ ( 930 ) $ — $ — $ — Total Debt Investments 109 — 930 ( 930 ) — — — Equity Investments Coginiti Corp Common Stock — — 4,551 — — ( 3,377 ) 1,174 Total Equity Investments — — 4,551 — — ( 3,377 ) 1,174 Warrants Coginiti Corp Warrant for Common Stock, exercise price $ 0.01 /share, expires 3/9/2030 — — 1,009 — — ( 99 ) 910 Total Warrants — — 1,009 — — ( 99 ) 910 Total Affiliate Investments $ 109 $ — $ 6,490 $ ( 930 ) $ — $ ( 3,476 ) $ 2,084 Control Investments Debt Investments Mojix, Inc. LIBOR+ 12.00 % , 12.00 % cash cap, 5 % ETP, due 1/15/2025 $ 2,287 $ 7,568 $ 1,987 $ ( 8,489 ) $ — $ ( 1,066 ) $ — LIBOR+ 12.00 % , 12.00 % cash cap, 5 % ETP, due 1/15/2025 744 2,523 647 ( 2,818 ) — ( 352 ) — LIBOR+ 12.00 % , 12.00 % cash cap, 5 % ETP, due 1/15/2025 184 630 160 ( 704 ) — ( 86 ) — LIBOR+ 12.00 % , 12.00 % cash cap, 5 % ETP, due 1/15/2025 185 629 161 ( 703 ) — ( 87 ) — LIBOR+ 12.00 % , 12.00 % cash cap, 5 % ETP, due 1/15/2025 374 1,253 327 ( 1,400 ) — ( 180 ) — LIBOR+ 12.00 % , 12.00 % cash cap, 5 % ETP, due 1/15/2025 291 1,008 266 ( 1,090 ) — ( 184 ) — Pivot3, Inc. LIBOR+ 8.50 % PIK, 11.00 % floor, due 11/15/2022 — 14,650 — — — ( 5,360 ) 9,290 Total Debt Investments 4,065 28,261 3,548 ( 15,204 ) — ( 7,315 ) 9,290 Equity Investments Mojix, Inc. Series A-1 Preferred Stock 32 870 — ( 800 ) — ( 70 ) — Pivot3 Holdings, Inc. Series 1 Preferred Stock — — — — ( 2,000 ) 2,000 — Total Equity Investments 32 870 — ( 800 ) ( 2,000 ) 1,930 — Warrants Mojix, Inc. Warrant for Common Stock, exercise price $ 1.286 /share, expires 12/13/2030 — — — ( 119 ) — 119 — Warrant for Common Stock, exercise price $ 2.1286 /share, expires 12/13/2030 — — — ( 298 ) — 298 — Warrant for Common Stock, exercise price $ 5.57338 /share, expires 12/13/2030 — — — ( 829 ) — 829 — Total Warrants — — — ( 1,246 ) — 1,246 — Total Control Investments $ 4,097 $ 29,131 $ 3,548 $ ( 17,250 ) $ ( 2,000 ) $ ( 4,139 ) $ 9,290 (1) Gross additions includes increases in the basis of investments resulting from new portfolio investments, PIK interest, accretion of original issue discount (“OID”), the exchange of one or more existing investments for one or more new investments and the movement of an existing portfolio company into this category from a different category. (2) Gross reductions include decreases in the basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing Investments for one or more new investments and the movement of an existing portfolio company out of this category into a different category. (3) All investments in the portfolio company, which as of December 31, 2022 represented 1.97 % of the Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors. Portfolio Composition The following tables show the fair value of the Company's portfolio of investment, excluding U.S. Treasury Bills (in thousands) by geographic region and industry as of December 31, 2023 and December 31, 2022: December 31, 2023 December 31, 2022 Geographic Region Investments at Fair Value Percentage of Net Assets Investments at Fair Value Percentage of Net Assets United States Western United States $ 404,541 73.94 % $ 346,372 60.13 % Northeastern United States 239,444 43.77 351,654 61.04 Midwestern United States 130,784 23.91 74,745 12.98 South Central United States 87,814 16.05 85,000 14.76 Northwestern United States 25,514 4.66 72,615 12.61 Southeastern United States 820 0.15 74,797 12.98 Total United States 888,917 162.48 1,005,183 174.50 United Kingdom 76,839 14.05 60,783 10.55 Germany 44,587 8.15 46,499 8.07 Canada 14,667 2.68 13,844 2.40 Total $ 1,025,010 187.36 % $ 1,126,309 195.52 % December 31, 2023 December 31, 2022 Industry Investments at Fair Value Percentage of Net Assets Investments at Fair Value Percentage of Net Assets Application Software $ 200,645 36.67 % 184,084 31.96 % Health Care Technology 182,200 33.30 240,844 41.81 Human Resource & Employment Services 114,602 20.95 97,788 16.98 System Software 113,517 20.74 78,274 13.58 Data Processing & Outsourced Services 106,785 19.52 97,404 16.91 Internet Software and Services 98,462 18.00 149,780 26.00 Property & Casualty Insurance 75,205 13.75 49,440 8.58 Internet & Direct Marketing Retail 55,588 10.16 55,986 9.72 Electronic Equipment & Instruments 27,535 5.04 78,114 13.56 Education Services 25,796 4.72 25,305 4.39 Health Care Equipment 15,524 2.83 27,433 4.76 Asset Management & Custody Banks 8,021 1.47 - - Technology Hardware, Storage & Peripherals 570 0.10 1,068 0.19 Specialized Consumer Services 373 0.07 796 0.14 Advertising 136 0.03 - - Biotechnology 51 0.01 39,925 6.93 Computer & Electronics Retail - - 68 0.01 Total $ 1,025,010 187.36 % $ 1,126,309 195.52 % Derivative Financial Instruments In the normal course of business, the Company may utilize derivative contracts in connection with its investment activities. Investments in derivative contracts are subject to additional risks that can result in a loss of all or part of an investment. The derivative activities and exposure to derivative contracts primarily involve equity price risks. In addition to the primary underlying risk, additional counterparty risk exists due to the potential inability of counterparties to meet the terms of their contracts. Warrants provide exposure and potential gains upon equity gains of the portfolio company’s equity value. A warrant has a limited life and expires on a certain date. As a warrant’s expiration date approaches, the time value of the warrant will decline. In addition, if the stock underlying the warrant declines in price, the intrinsic value of an “in the money” warrant will decline. Further, if the price of the stock underlying the warrant does not exceed the strike price of the warrant on the expiration date, the warrant will expire worthless. As a result, there is the potential for the entire value of an investment in a warrant to be lost. The Company’s volume of warrant investment activity is closely correlated to its primary senior secured loans to portfolio companies. For the year ended December 31, 2023, the Company had net realized gain (loss) of $( 1.4 ) million and a net unrealized gain (loss) of $( 5.2 ) million from its investments in warrants. For the year ended December 31, 2022, the Company had net realized gain (loss) of $( 0.9 ) million and a net unrealized gain (loss) of $( 2.3 ) million from its investments in warrants. For the year ended December 31, 2021, the Company had net realized gain (loss) of $ 0.8 million and a net unrealized gain (loss) of $ 2.8 million f rom its investments in warrants. Realized gains (losses) from warrants are included in the respective control, affiliate, or non-control/non-affiliate Net realized gain (loss) on investments on the Statement of Operations. Net change in unrealized gain (loss) from investments in warrants is included in the respective control, affiliate, or non-control/non-affiliate Net change in unrealized gain (loss) on investments on the Statement of Operations. Counterparty risk exists from the potential failure of an issuer of warrants to settle its exercised warrants. The maximum risk of loss from counterparty risk is the fair value of the contracts and the purchase price of the warrants. The Company’s Board of Directors considers the effects of counterparty risk when determining the fair value of its investments in warrants. |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Note 5 — Fair Value of Financial Instruments The Company’s assets recorded at fair value have been categorized based upon a fair value hierarchy in accordance with ASC Topic 820. Refer to "Note 2 — Summary of Significant Accounting Policies" for a discussion of the Company’s policies. Investments measured at fair value on a recurring basis are categorized in the tables below based upon the lowest level of significant input to the valuations as of December 31, 2023 and 2022, (in thousands): As of December 31, 2023 Level 1 Level 2 Level 3 Total Portfolio Investments Senior Secured Term Loans $ — $ — $ 964,099 $ 964,099 Second Lien Term Loans — — 14,399 14,399 Convertible Note — — 1,357 1,357 Preferred Stock 3,553 — 26,285 29,838 Common Stock 548 — 872 1,420 Equity Interest — — 950 950 Warrants — 109 12,838 12,947 Total Portfolio Investments 4,101 109 1,020,800 1,025,010 U.S. Treasury Bill — 41,999 — 41,999 Total $ 4,101 $ 42,108 $ 1,020,800 $ 1,067,009 As of December 31, 2022 Level 1 Level 2 Level 3 Total Portfolio Investments Senior Secured Term Loans $ — $ — $ 1,080,121 $ 1,080,121 Second Lien Term Loans — — 13,654 13,654 Preferred Stock 12,335 — 347 12,682 Common Stock 501 1,422 1,174 3,097 Warrants — 105 16,650 16,755 Total Portfolio Investments 12,836 1,527 1,111,946 1,126,309 Cash equivalents 5,590 — — 5,590 Total $ 18,426 $ 1,527 $ 1,111,946 $ 1,131,899 The Company transfers investments in and out of Levels 1, 2 and 3 as of the beginning balance sheet date, based on changes in the use of observable and unobservable inputs utilized to perform the valuation for the period. During the period ended December 31, 2023, and December 31, 2022 , the Company had common stock investments with restrictions lifted, resulting in an asset transfer out of Level 2 and into Level 1 at the fair value of $ 1.4 million and $ 5.4 million, respective ly. During the period ended December 31, 2023, the Company had warrant investments in a portfolio company that went public, resulting in asset transfers out of Level 3 and into Level 2 at the fair value of $ 0.9 million. During the period ended December 31, 2022, the Company had warrant investments converted to common stock investments, resulting in asset transfers out of Level 3 and into Level 2 at the fair value of $ 2.2 million. The following table presents a rollforward of Level 3 assets measured at fair value as of December 31, 2023 (in thousands): Senior Secured Term Loans Second Lien Convertible Notes Preferred Common Equity Interest Warrants Total Fair value at December 31, 2022 $ 1,080,121 13,654 $ — $ 347 $ 1,174 $ — $ 16,650 $ 1,111,946 Transfers in(out) of Level 3 — — — — — — ( 891 ) ( 891 ) Purchases of investments (1) 166,660 — 1,357 28,220 16 950 2,851 200,054 PIK interest 19,413 511 — — — — — 19,924 Sales or prepayments of investments (1) ( 289,034 ) — — — — — ( 44 ) ( 289,078 ) Scheduled principal repayments of investments ( 7,331 ) — — — — — — ( 7,331 ) Amortization of fixed income premiums or accretion of discounts 8,527 114 — — — — — 8,641 Net realized gain (loss) ( 17,013 ) — — — — — ( 1,374 ) ( 18,387 ) Net change in unrealized gain (loss) 2,756 120 — ( 2,282 ) ( 318 ) — ( 4,354 ) ( 4,078 ) Fair value at December 31, 2023 $ 964,099 14,399 $ 1,357 $ 26,285 872 950 12,838 $ 1,020,800 Net change in unrealized gain (loss) on Level 3 investments still held as of December 31, 2023 $ ( 7,746 ) 121 — ( 2,282 ) ( 317 ) — ( 5,893 ) $ ( 16,117 ) (1) Net of reorganization and restructuring of investments. The following table presents a rollforward of Level 3 assets measured at fair value as of December 31, 2022 (in thousands): Senior Secured Term Loans Second Lien Term Loans Preferred Stock Common Stock Warrants Total Fair value at December 31, 2021 $ 623,054 $ 12,873 $ 1,332 $ — $ 20,087 $ 657,346 Transfers in(out) of Level 3 — — — — ( 2,239 ) ( 2,239 ) Purchases of investments (1) 614,636 — — 4,551 3,404 622,591 PIK interest 7,994 661 — — — 8,655 Sales or prepayments of investments ( 151,905 ) — ( 800 ) — ( 1,508 ) ( 154,213 ) Scheduled repayments of investments ( 9,754 ) — — — — ( 9,754 ) Amortization of fixed income premiums or accretion of discounts 6,743 120 — — — 6,863 Net realized gain (loss) — — ( 2,000 ) — ( 851 ) ( 2,851 ) Net change in unrealized gain (loss) ( 10,647 ) — 1,815 ( 3,377 ) ( 2,243 ) ( 14,452 ) Fair Value at December 31, 2022 $ 1,080,121 $ 13,654 $ 347 $ 1,174 $ 16,650 $ 1,111,946 Net change in unrealized gain (loss) on Level 3 investments still held as of December 31, 2022 $ ( 9,752 ) $ — $ ( 115 ) $ ( 3,377 ) $ ( 4,889 ) $ ( 18,133 ) (1) Net of reorganization and restructuring of investments . The following table provides quantitative information regarding Level 3 fair value measurements as of December 31, 2023 (in thousands): Description Fair Value Valuation Technique Unobservable Inputs Range (Weighted Average) Senior Secured Term Loans (1) $ 904,739 Discounted Cash Flow analysis Discount rate 10.8 % - 22.2 % ( 15.0 %) Origination yield 10.8 % - 19.9 % ( 13.6 %) Revenue multiples 0.29 x - 7.49 x ( 3.66 x) 59,360 PWERM Discount rate 20.3 % - 46.5 % ( 28.8 %) Origination yield 10.8 % - 29.7 % ( 17.3 %) Revenue multiples 0.95 x - 3.16 x ( 1.89 x) Second Lien Term Loans (1) 14,399 Discounted Cash Flow analysis Discount rate 16.1 % - 16.1 % ( 16.1 %) Origination yield 13.1 % - 13.1 % ( 13.1 %) Convertible Notes 1,357 PWERM Discount rate 45.0 % - 45.0 % ( 45.0 %) Origination yield 10.8 % - 10.8 % ( 10.8 %) Preferred Stock 120 Recent private market and merger and acquisition transaction prices N/A N/A 26,038 PWERM Risk-Free Rate 4.7 % - 4.7 % ( 4.7 %) Average industry volatility 40.0 % - 40.0 % ( 40.0 %) Estimated time to exit 2.0 - 2.0 ( 2.0 years) Revenue multiples 4.46 x - 4.46 x ( 4.46 x) 127 Waterfall Approach Estimated time to exit 3.0 - 3.0 ( 3.0 years) Revenue multiples 4.00 x - 4.00 x ( 4.00 x) Common Stock 16 Recent private market and merger and acquisition transaction prices N/A N/A 856 Option Pricing Model Risk-free interest rate 4.3 % - 4.3 % ( 4.3 %) Average industry volatility 35.0 % - 35.0 % ( 35.0 %) Estimated time to exit 5.0 - 5.0 ( 5.0 years) Revenue multiples 3.28 x - 3.28 x ( 3.28 x) Equity Interest 950 PWERM Discount rate 20.0 % - 20.0 % ( 20.0 %) Warrants (2) 7,075 Option Pricing Model Risk-free interest rate 3.8 % - 5.3 % ( 4.5 %) Average industry volatility 25.0 % - 108.8 % ( 45.4 %) Estimated time to exit 0.8 - 8.2 ( 3.1 years) Revenue multiples 0.95 x - 7.49 x ( 3.95 x) 3,912 PWERM (3) N/A N/A 1,851 Waterfall Approach Estimated time to exit 3.0 - 3.0 ( 3.0 years) Revenue multiples 2.58 x - 4.00 x ( 3.39 x) Total Level 3 Investments $ 1,020,800 The following table provides quantitative information regarding Level 3 fair value measurements as of December 31, 2022 (in thousands): Description Fair Value Valuation Technique Unobservable Inputs Range (Weighted Average) Senior Secured Term Loans (1) $ 1,053,748 Discounted Cash Flow analysis Discount rate 11.1 % - 28.0 % ( 15.2 %) Origination yield 10.5 % - 19.3 % ( 12.9 %) 26,373 PWERM Discount rate 27.4 % - 37.4 % ( 30.9 %) Second Lien Term Loans (1) 13,654 Discounted Cash Flow analysis Discount rate 16.1 % - 16.1 % ( 16.1 %) Origination yield 12.2 % - 12.2 % ( 12.2 %) Preferred Stock 347 Recent private market and merger and acquisition transaction prices N/A N/A Common Stock 1,174 Recent private market and merger and acquisition transaction prices N/A N/A Warrants (2) 10,246 Option Pricing Model Risk-free interest rate 2.7 % - 4.9 % ( 4.3 %) Average industry volatility 25.0 % - 98.4 % ( 49.0 %) Estimated time to exit 0.5 - 5.0 ( 2.2 years) Revenue multiples 1.16 x - 88.63 x ( 5.47 x) 6,404 PWERM (3) Discount rate 20.0 % - 40.0 % ( 34.6 %) Revenue multiples 2.35 x - 199.38 x ( 13.10 x) Total Level 3 Investments $ 1,111,946 (1) The significant unobservable inputs used in the fair value measurement of the Company’s debt securities are origination yields and discount rates. The origination yield is defined as the initial market price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The discount rate is related to company-specific characteristics such as underlying investment performance, projected cash flows, and other characteristics of the investment. Significant increases or decreases in the inputs in isolation may result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. However, a significantly higher or lower fair value measurement of any of the Company’s portfolio investments may occur regardless of whether there is a significant increase or decrease in the unobservable inputs. (2) The significant unobservable inputs used in the fair value measurement of the Company’s warrant and equity-related securities are inputs used in the OPM, which include industry volatility, risk free interest rate and estimated time to exit. The Equity Allocation model and the Black Scholes model were the main OPMs used during the years ended December 31, 2023 and December 31, 2022. Probability Weighted Expected Return Models (“PWERM”) and other techniques were used as determined appropriate. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. However, a significantly higher or lower fair value measurement of any of the Company’s portfolio investments may occur regardless of whether there is a significant increase (decrease) in the unobservable inputs. For some investments, additional consideration may be given to data from the last round of financing or merger/acquisition events near the measurement date. (3) Warrant investments using a PWERM valuation technique contain success fees, in which case the inputs are not applicable because the nature of a success fee is a fixed payout dependent on certain liquidation events. Fair Value of Financial Instruments Reported at Cost The fair value of the Company’s Credit Facility, April 2026 Notes, July 2027 Notes, August 2027 Notes, and December 2027 Notes (as defined in "Note 7 – Borrowings") is estimated using the relative market yield approach. The fair value of the Company's Credit Facility, December 2026 Notes and August 2027 Notes are estimated using Level 3 inputs by discounting remaining payments using comparable market rates or market quotes for similar instruments at the measurement date. The fair value of the Company's July 2027 Notes and December 2027 Notes is based on vendor pricing received by the Company, which is considered a Level 2 input, and reflects the market close price of the notes traded on the Nasdaq Global Select Market LLC under the symbol "RWAYL" and "RWAYZ", respectively. As of both December 31, 2023, and December 31, 2022, the carrying values of the Credit Facility, April 2026 Notes, July 2027 Notes, August 2027 Notes, and December 2027 Notes approximate fair value. As of December 31, 2023, the fair value of the December 2026 Notes was approximately $ 63.8 million and the carrying value was approximately $ 69.4 million , net of unamortized deferred debt costs of $ 0.6 million . As of December 31, 2022 , the fair value of the December 2026 Notes was approximately $ 57.0 million and the carrying value was approximately $ 69.2 million , net of unamortized deferred debt costs of $ 0.8 million . |
Concentration of Credit Risk
Concentration of Credit Risk | 12 Months Ended |
Dec. 31, 2023 | |
Risks and Uncertainties [Abstract] | |
Concentration of Credit Risk | Note 6 — Concentration of Credit Risk In the normal course of business, the Company maintains its cash balances at large, high credit-quality financial institutions, which at times may exceed federally insured limits. The Company is subject to credit risk to the extent that any financial institution with which it conducts business is unable to fulfill contractual obligations on its behalf. The Company monitors the financial condition of those financial institutions and believes that risk of loss associated with any uninsured balance is remote. In the event that a portfolio company completely fails to perform according to the terms of their loan agreement, the amount of loss due to credit risk from the Company's investments would equal the sum of the Company’s recorded investments in the portfolio company and the portion of unfunded commitments currently eligible to be drawn. Refer to "Note 8 – Commitments and Contingencies" for a summary of the aggregate balance of unfunded commitments as of December 31, 2023. The Company predominantly collateralizes its investments by obtaining a first priority security interest in a portfolio company’s assets, which may include its intellectual property. As of December 31, 2023 and December 31, 2022 , the Company’s five largest debt investments in portfolio companies represented approximately 38.0 % and 30.0 % , respectively, of the total fair value of the Company’s debt investments in portfolio companies. As of December 31, 2023 and December 31, 2022, the Company had debt investments in 14 and 16 portfolio companies, respectively, that represented 5 % or more of the Company’s net assets. |
Borrowings
Borrowings | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Borrowings | Note 7 — Borrowings The following table shows the Company's borrowings as of December 31, 2023 and December 31, 2022 (in thousands): December 31, 2023 December 31, 2022 Total Commitment Principal Deferred Debt Cost (1) Carrying Value Total Commitment Principal Deferred Debt Cost (1) Carrying Value Credit Facility $ 550,000 $ 272,000 $ ( 4,434 ) $ 267,566 $ 425,000 $ 337,000 $ ( 4,640 ) $ 332,360 April 2026 Notes 25,000 25,000 ( 277 ) 24,723 — — — — December 2026 Notes 70,000 70,000 ( 573 ) 69,427 70,000 70,000 ( 818 ) 69,182 July 2027 Notes 80,500 80,500 ( 1,924 ) 78,576 80,500 80,500 ( 2,380 ) 78,120 August 2027 Notes 20,000 20,000 ( 511 ) 19,489 20,000 20,000 ( 653 ) 19,347 December 2027 Notes 51,750 51,750 ( 1,453 ) 50,297 51,750 51,750 ( 1,802 ) 49,948 Total $ 797,250 $ 519,250 $ ( 9,172 ) $ 510,078 $ 647,250 $ 559,250 $ ( 10,293 ) $ 548,957 (1) Net of accumulated amortization. For the years ended December 31, 2023, December 31, 2022 and December 31, 2021, the components of interest expense, amortization of deferred debt costs, unused fees on the Credit Facility (as defined below), and any other costs associated with the Company's borrowings were as follows (dollars in thousands): Interest Expense Amortization of Unused Facility and (1) Total Interest and Other Debt Financing Expenses Weighted Average Year Ended December 31, 2023 Credit Facility $ 22,559 $ 1,664 $ 1,474 $ 25,697 9.24 % April 2026 Notes 1,530 87 — 1,617 8.98 December 2026 Notes 2,975 210 — 3,185 4.55 July 2027 Notes 6,038 557 — 6,595 8.19 August 2027 Notes 1,400 142 — 1,542 7.71 December 2027 Notes 4,140 367 — 4,507 8.71 Total $ 38,642 $ 3,027 $ 1,474 $ 43,143 8.32 % Year Ended December 31, 2022 Credit Facility $ 7,713 $ 921 $ 1,615 $ 10,249 7.60 % December 2026 Notes 2,734 182 — 2,916 4.52 July 2027 Notes 2,566 219 — 2,785 8.04 August 2027 Notes 467 44 — 511 7.64 December 2027 Notes 276 24 — 300 8.44 Total $ 13,756 $ 1,390 $ 1,615 $ 16,761 6.86 % Year Ended December 31, 2021 Credit Facility $ 2,492 $ 467 $ 1,126 $ 4,085 5.82 % December 2026 Notes 52 5 — 57 4.69 Total $ 2,544 $ 472 $ 1,126 $ 4,142 5.80 % (1) Unused facility and other fees for the year ended December 31, 2022 include supplemental fees of $ 0.2 million, which were predominantly incurred in the first half of 2022 and were nonrecurring in nature. Credit Facility On May 31, 2019, the Company entered into a Credit Agreement with KeyBank National Association, acting as administrative agent and syndication agent and the other lenders party thereto, which initially provided the Company with a $ 100.0 million commitment, subject to borrowing base requirements (as amended and restated from time to time, the “Credit Facility”). As of December 31, 2023 , the Company had $ 550.0 million in total commitments available under the Credit Facility, subject to an accordion feature that allows the Company to increase the total commitments under the Credit Facility up to $ 600.0 million. The availability period under the Credit Facility expires on April 20, 2025 and is followed by a one-year amortization period. The stated maturity date under the Credit Facility is April 20, 2026 , unless extended. Borrowings under the Credit Facility bear interest on a per annum rate equal to the Adjusted Term Secured Overnight Financing Rate (“SOFR”) plus an applicable margin rate that ranges from 2.95 % to 3.35 % per annum depending on the Company’s leverage ratio and number of eligible loans in the collateral pool. The Credit Facility provides for a variable advance rate of up to 65 % on eligible term loans. The Company also pays an unused commitment fee that ranges from 0.25 % to 1.00 % per annum based on the total unused lender commitments under the Credit Facility. The Credit Facility is collateralized by all eligible investment assets held by the Company. The Credit Facility contains representations, warranties, and affirmative and negative covenants customary for secured financings of this type, including certain financial covenants such as a consolidated tangible net worth requirement and a required asset coverage ratio. For the years ended December 31, 2023 and December 31, 2022, the weighted average outstanding principal balance was $ 278.2 million and $ 134.9 million , respectively, and the weighted average effective interest rate was 8.15 % a nd 5.89 %, respectively. 2026 Notes On December 10, 2021, the Company entered into a master note purchase agreement, completing a private debt offering of $ 70.0 million in aggregate principal amount of 4.25 % interest-bearing unsecured Series 2021A Senior Notes due 2026 (the “December 2026 Notes”) to institutional accredited investors (as defined in Regulation D under the Securities Act of 1933, as amended (the "Securities Act")). The December 2026 Notes were issued in two closings; the initial issuance of $ 20.0 million closed on December 10, 2021 and the second issuance of $ 50.0 million closed on February 10, 2022. On April 13, 2023, the Company completed the first supplement to the master note purchase agreement, resulting in an additional private debt offering of $ 25.0 million in aggregate principal amount of 8.54 % interest-bearing unsecured Series 2023A Senior Notes due 2026 (the “April 2026 Notes”) to institutional accredited investors (as defined in the Securities Act). The December 2026 Notes and the April 2026 Notes (collectively the "2026 Notes") are subject to a 1.00 % increase in the respective interest rates in the event that, subject to certain exceptions, the 2026 Notes cease to have an investment grade rating or receive an investment grade rating below the Investment Grade (as defined in the master note purchase agreement). The 2026 Notes are general unsecured obligations of the Company that rank pari passu with all outstanding and future unsecured unsubordinated indebtedness issued by the Company. December 2026 Notes The December 2026 Notes bear an interest rate of 4.25 % per year and are due on December 10, 2026 , unless redeemed, purchased or prepaid prior to such date by the Company or its affiliates in accordance with their terms. Interest on the December 2026 Notes will be due semiannually in arrears on June 10 and December 10 of each year, commencing on June 10, 2022. Aggregate costs in connection with the December 2026 Notes issuance wer e $ 1.0 million, and were capitalized and deferred. As of December 31, 2023 and December 31, 2022, unamortized deferred debt costs related to the December 2026 Notes were $ 0.6 million and $ 0.8 million , respectively. April 2026 Notes The April 2026 Notes bear an interest rate of 8.54 % per year and are due on April 13, 2026 , unless redeemed, purchased or prepaid prior to such date by the Company or its affiliates in accordance with their terms. Interest on the April 2026 Notes will be due semiannually in arrears on April 13 and October 13 of each year, commencing on October 13, 2023. Aggregate costs in connection with the April 2026 Notes issuance were $ 0.4 million, and were capitalized and deferred. As of December 31, 2023 and December 31, 2022 , unamortized deferred debt costs related to the April 2026 Notes were $ 0.3 million and $ 0.0 million , respectively. 2027 Notes July 2027 Notes On July 28, 2022, the Company issued and sold $ 80.5 million in aggregate principal amount of 7.50 % interest-bearing unsecured Notes due 2027 (the “July 2027 Notes”) under its shelf Registration Statement on Form N-2. The July 2027 Notes were issued pursuant to the Base Indenture dated July 28, 2022 (the “Base Indenture”) and First Supplemental Indenture, dated July 28, 2022 (together with the Base Indenture, the “Indenture”), between the Company and the Trustee, U.S. Bank Trust Company, National Association. The July 2027 Notes bear an interest rate of 7.50 % per year and are due on July 28, 2027 . Interest on the 2027 Notes will be due quarterly in arrears on March 1, June 1, September 1 and December 1 of each year, commencing September 1, 2022. The July 2027 Notes may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after July 28, 2024, at a redemption price of $ 25 per July 2027 Note plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to the date fixed for redemption. The July 2027 Notes are general unsecured obligations of the Company that rank pari passu with the Company's existing and future unsecured, unsubordinated indebtedness. Aggregate costs in connection with the July 2027 Notes issuance, including the underwriter’s discount and commissions, w ere $ 2.7 million, a nd were capitalized and deferred. As of December 31, 2023 and December 31, 2022, unamortized deferred debt costs related to the July 2027 Notes were $ 1.9 million and $ 2.4 million , respectively. August 2027 Notes On August 31, 2022, the Company issued and sold a private debt offering of $ 20.0 million in aggregate principal amount of 7.00 % interest-bearing unsecured Series 2022A Senior Notes due 2027 (the “August 2027 Notes”) to HCM Master Fund Limited. The August 2027 Notes bear an interest rate of 7.00 % per year and are due on August 31, 2027 , unless redeemed, purchased or prepaid prior to such date by the Company or its affiliates in accordance with their terms. Interest on the August 2027 Notes will be due semiannually in arrears on February 15 and August 15 of each year, commencing on February 15, 2023. The August 2027 Notes are general unsecured obligations of the Company that rank pari passu with all outstanding and future unsecured unsubordinated indebtedness issued by the Company. Aggregate costs in connection with the August 2027 Notes issuance were $ 0.7 million, and were capitalized and deferred. As of December 31, 2023 and December 31, 2022, unamortized deferred debt costs related to the August 2027 Notes were $ 0.5 million and $ 0.7 million , respectively. December 2027 Notes On December 7, 2022, the Company issued and sold $ 51.75 million in aggregate principal amount of 8.00 % interest-bearing unsecured Notes due December 2027 (the "December 2027 Notes") under its shelf Registration Statement on Form N-2. The December 2027 Notes were issued pursuant to the Base Indenture dated July 28, 2022 (the "Base Indenture") and Second Supplemental Indenture, dated December 7, 2022 (together with the Base Indenture, the "Indenture"), between the Company and the Trustee, U.S. Bank Trust Company, National Association. The December 2027 Notes bear an interest rate of 8.0 % per year and are due on December 28, 2027 . Interest on the 2027 Notes will be due quarterly in arrears on March 1, June 1, September 1, and December 1 of each year, commencing March 1, 2023. The December 2027 Notes may be redeemed in whole or in part at any time or from time to time at the Company's option on or after December 31, 2024, at a redemption price of $ 25 per December 2027 Note plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to the date fixed for redemption. The December 2027 Notes are general unsecured obligations of the Company that rank pari passu with the Company's existing and future unsecured, unsubordinated indebtedness. Aggregate costs in connection with the December 2027 Notes issuance, including the underwriter's discount and commissions, were $ 1.8 million, and were capitalized and deferred. As of December 31, 2023 and December 31, 2022, unamortized deferred debt costs related to the December 2027 Notes were $ 1.5 million and $ 1.8 million , respectively. Senior Securities Information about the Company’s senior securities is shown in the following table for the fiscal years ended December 31, 2023 , 2022, 2021, 2020, 2019 and 2018 (in thousands). No senior securities were outstanding for the fiscal years ended December 31, 2017 and prior. Class and Period Total Amount Outstanding Exclusive of Treasury Securities (1) Asset Coverage per Unit (2) Involuntary Liquidating Preference per Unit (3) Average Market Value per Unit (4) 2027 Notes December 31, 2023 $ 152,250 $ 4,593 — N/A December 31, 2022 $ 152,250 $ 4,784 — N/A December 31, 2021 $ — $ — — N/A December 31, 2020 $ — $ — — N/A December 31, 2019 $ — $ — — N/A December 31, 2018 $ — $ — — N/A 2026 Notes December 31, 2023 $ 95,000 $ 6,759 — N/A December 31, 2022 $ 70,000 $ 9,229 — N/A December 31, 2021 $ 20,000 $ 31,310 — N/A December 31, 2020 $ — $ — — N/A December 31, 2019 $ — $ — — N/A December 31, 2018 $ — $ — — N/A Credit Facility December 31, 2023 $ 272,000 $ 3,011 — N/A December 31, 2022 $ 337,000 $ 2,709 — N/A December 31, 2021 $ 61,000 $ 10,938 — N/A December 31, 2020 $ 99,000 $ 5,710 — N/A December 31, 2019 $ 61,000 $ 7,169 — N/A December 31, 2018 $ — $ — — N/A Credit Facility - CIBC (5) December 31, 2023 $ — $ — — N/A December 31, 2022 $ — $ — — N/A December 31, 2021 $ — $ — — N/A December 31, 2020 $ — $ — — N/A December 31, 2019 $ — $ — — N/A December 31, 2018 $ 59,500 $ 3,813 — N/A Total December 31, 2023 $ 519,250 $ 2,054 — N/A December 31, 2022 $ 559,250 $ 2,030 — N/A December 31, 2021 $ 81,000 $ 8,484 — N/A December 31, 2020 $ 99,000 $ 5,710 — N/A December 31, 2019 $ 61,000 $ 7,169 — N/A December 31, 2018 $ 59,500 $ 3,813 — N/A (1) Total amount of each class of senior securities outstanding at the end of the period presented . (2) A sset coverage per unit is the ratio of the carrying value of total assets, less all liabilities excluding indebtedness represented by senior securities in this table to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is express in terms of dollar amounts per $1,000 of indebtedness and is calculated on a consolidated basis. (3) The amount to which such class of senior security would be entitled upon the Company’s involuntary liquidation in preference to any security junior to it. The "—" in this column indicates information that the SEC expressly does not require to be disclosed for certain types of senior securities. (4) Not applicable because the senior securities are not registered for public trading. (5) On June 22, 2018, the Company entered into the Credit Facility with CIBC. On May 31, 2019, in conjunction with securing and entering into the new Credit Facility, the Company terminated the Credit Facility with CIBC . |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 8 — Commitments and Contingencies Commitments The following table provides the Company’s contractual obligations as of December 31, 2023 (in thousands): Payments Due by Period Contractual Obligations (1) Total Less than 1 Year 1-3 years 3-5 years More than 5 Years Borrowings (2) Credit Facility $ 272,000 $ — $ 272,000 $ — $ — 2026 Notes 95,000 — 95,000 — — 2027 Notes 152,250 — — 152,250 — Total Borrowings 519,250 — 367,000 152,250 — Deferred Incentive Fees 9,165 2,567 3,919 2,548 131 Total $ 528,415 $ 2,567 $ 370,919 $ 154,798 $ 131 (1) Excludes interest payable on borrowings, accrued expenses, and commitments to extend credit to the Company’s portfolio companies. (2) Amounts represent future principal repayments and not the carrying value of each liability (refer to “Note 7 – Borrowings”). The following table provides the Company’s contractual obligations as of December 31, 2022 (in thousands): Payments Due by Period Contractual Obligations (1) Total Less than 1 Year 1-3 years 3-5 years More than 5 Years Borrowings (2) Credit Facility $ 337,000 $ — $ — $ 337,000 $ — 2026 Notes 70,000 — — 70,000 — 2027 Notes 152,250 — — 152,250 — Total Borrowings 559,250 — — 559,250 — Deferred Incentive Fees 5,009 674 1,760 1,023 1,552 Total $ 564,259 $ 674 $ 1,760 $ 560,273 $ 1,552 (1) Excludes interest payable on borrowings, accrued expenses, and commitments to extend credit to the Company’s portfolio companies. (2) Amounts represent future principal repayments and not the carrying value of each liability (refer to “Note 7 – Borrowings”). Contingencies The Company are not currently subject to any material legal proceedings, nor, to its knowledge, is any material legal proceeding threatened against it. From time to time, the Company may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of its rights under contracts with its portfolio companies. The Company's business is also subject to extensive regulation, which may result in regulatory proceedings against us. While the outcome of any such legal proceedings cannot be predicted with certainty, the Company does not expect that any such proceedings will have a material effect upon its financial condition or results of operations. Off-balance Sheet Arrangements In the normal course of business, the Company may enter into investment agreements under which it commits to make an investment in a portfolio company at some future date or over a specified period of time. These unfunded contractual commitments to provide funds to portfolio companies are not reflected on our balance sheet. The availability of such unfunded loan commitments is subject to the specific terms and conditions of each contract, which may include, among other things, portfolio company performance requirements and time-based cancellation provisions. As a result, only a portion of unfunded commitments is currently eligible to be drawn. The Company's unfunded loan commitments to provide debt financing to its portfolio companies amounted to $ 201.5 million and $ 315.7 million as of December 31, 2023 and December 31, 2022, respectively, shown in the table below (in thousands): Portfolio Company Investment Type December 31, 2023 December 31, 2022 3PL Central LLC (dba Extensiv) Senior Secured Term Loan $ 11,500 $ 15,000 Betterment Holdings, Inc. Senior Secured Term Loan 5,000 — Blueshift Labs, Inc. Senior Secured Term Loan 14,500 — Bombora, Inc. Senior Secured Term Loan 2,000 — Brivo, Inc. Senior Secured Term Loan 6,000 16,000 CloudPay, Inc. Senior Secured Term Loan — 15,000 Dtex Systems, Inc. Senior Secured Term Loan — 15,000 EBR Systems, Inc. Senior Secured Term Loan 10,000 30,000 Intellisite Holdings, Inc. (dba Epic IO Technologies, Inc.) Senior Secured Term Loan — 6,000 Interactions Corporation Senior Secured Term Loan 10,000 10,000 Kin Insurance, Inc. Senior Secured Term Loan — 25,000 Linxup, LLC Senior Secured Term Loan 7,500 — Madison Reed, Inc. Senior Secured Term Loan 1,200 2,400 Moximed, Inc. Senior Secured Term Loan 15,000 15,000 Nalu Medical, Inc. Senior Secured Term Loan 15,000 25,000 Revelle Aesthetics, Inc. Senior Secured Term Loan — 12,500 Route 92 Medical, Inc. Senior Secured Term Loan 20,000 42,000 SetPoint Medical Corporation Senior Secured Term Loan 40,000 40,000 Skillshare, Inc. Senior Secured Term Loan 10,000 15,000 Snagajob.com, Inc. Senior Secured Term Loan 6,785 6,785 Snagajob.com, Inc. Convertible Note 2,035 — Synack, Inc. Senior Secured Term Loan 25,000 25,000 Total unused commitments to extend financing $ 201,520 $ 315,685 |
Net Assets
Net Assets | 12 Months Ended |
Dec. 31, 2023 | |
Equity [Abstract] | |
Net Assets | Note 9 — Net Assets The Company has the authority to issue 100,000,000 shares of common stock, $ 0.01 par value per share. In October 2015, in connection with the Company's formation, the Company issued and sold 1,667 shares of common stock to R. David Spreng, the President and Chief Executive Officer of the Company and Chairman of the Company's Board of Directors, for an aggregate purchase price of $ 25 thousand. Private Common Stock Offerings On December 1, 2017, the Company completed its initial private offering ("Initial Private Offering") , in which the Company issued 18,241,157 shares of its common stock to stockholders for a total purchase price of $ 275.0 million in reliance on exemptions from the registration requirements of the Securities Act, and other applicable securities laws. Beginning October 15, 2019 and ending September 29, 2021, the Company had completed multiple closings under its second private offering (the "Second Private Offering") and had accepted aggregate capital commitments of $ 181.7 million. In connection with the Second Private Offering the Company has issued 9,617,379 shares of its common stock for a total purchase price of $ 144.3 million. Concurrent with the IPO, all undrawn commitments under the Second Private Offering were cancelled. On March 31, 2020 and March 24, 2021, the Company had issued in aggregate 22,564 shares as an additional direct investment by Runway Growth Holdings LLC, an affiliate of RGC, at a per-share price of $ 15.00 for total proceeds of $ 0.3 million in a private offering pursuant to an exemption from registration under Regulation D of the Securities Act. Initial Public Offering On October 25, 2021, the Company closed its IPO, issuing 6,850,000 shares of its common stock at a public offering price of $ 14.60 per share. Net of underwriting fees and offering costs, the Company received net cash proceeds of $ 93.0 million. The Company’s common stock began trading on the Nasdaq Global Select Market LLC on October 21, 2021 under the symbol “RWAY”. Repurchase Program On February 24, 2022, the Board of Directors approved a repurchase program (the “Initial Repurchase Program”) under which the Company could have repurchased up to $ 25.0 million of its outstanding common stock. Under the Initial Repurchase Program, the Company could have repurchased shares at management’s discretion from time to time in open-market transactions, in accordance with all applicable securities laws and regulations. As of December 31, 2022, the Company had repurchased 871,345 shares of the Company's common stock under the Initial Repurchase Program for an aggregate purchase price of $ 10.8 million . No shares were repurchased during the year ended December 31, 2023. The Board of Directors did not renew t he Initial Repurchase Program, and it expired on February 24, 2023 . On November 2, 2023, the Board of Directors approved a new share repurchase program (the "Repurchase Program"), under which the Company may repurchase up to $ 25.0 million of the Company's outstanding shares of common stock. Under the Repurchase Program, purchases may be made at management’s discretion from time to time in open-market transactions, in accordance with all applicable securities laws and regulations. As of December 31, 2023, the Company has no t repurchased any shares in connection with the Initial Repurchase Program. If not renewed, the Repurchase Program will terminate upon the earlier of (i) November 2, 2024 and (ii) the repurchase of $ 25.0 million of the Company's shares of common stock. Distributions The Company intends to pay quarterly distributions to its stockholders out of assets legally available for distribution. All distributions will be paid at the discretion of the Board of Directors and will depend on the Company's earnings, financial condition, maintenance of RIC status for income tax purposes, compliance with applicable BDC regulations and such other factors as the Board of Directors may deem relevant from time to time. For the year ended December 31, 2023, the Company declared and paid dividends in the amount of $ 73.3 million , of which $ 70.8 million was distributed in cash and the remainder distributed in shares to stockholders pursuant to the Company’s Dividend Reinvestment Plan. For the year ended December 31, 2022, the Company declared dividends in the amount of $ 51.6 million , of which $ 40.7 million was distributed in cash and the remainder distributed in shares to stockholders pursuant to the Company’s Dividend Reinvestment Plan. For the year ended December 31, 2021, the Company declared dividends in the amount of $ 44.9 million, of which $ 17.9 million was distributed in cash and the remainder distributed in shares to stockholders pursuant to the Company’s Dividend Reinvestment Plan. Dividend Reinvestment Plan The Company maintains a dividend reinvestment plan for common stockholders (the "Dividend Reinvestment Plan"). The Company's Dividend Reinvestment Plan is administered by its transfer agent on behalf of the Company's record holders and participating brokerage firms. Brokerage firms and other financial intermediaries may decide not to participate in the Company's Dividend Reinvestment Plan but may provide a similar distribution reinvestment plan for their clients. The share requirements of the Dividend Reinvestment Plan may be satisfied through the issuance of new common shares or through open market purchases of common shares by the Company. During the years ended December 31, 2023, December 31, 2022, and December 31, 2021, the Company purchased 204,658 , 781,498 , and 1,830,974 shares of common stock in the open market under the Dividend Reinvestment Plan for a total o f $ 2.5 million , $ 10.9 million and $ 27.0 million, respectively. The following table summarizes the distributions declared and paid since inception through December 31, 2023 : Declaration Date Type Record Date Payment Date Amount per Share May 3, 2018 Quarterly May 15, 2018 May 31, 2018 $ 0.15 July 26, 2018 Quarterly August 15, 2018 August 31, 2018 $ 0.25 November 1, 2018 Quarterly October 31, 2018 November 15, 2018 $ 0.35 March 22, 2019 Quarterly March 22, 2019 March 26, 2019 $ 0.40 May 2, 2019 Quarterly May 7, 2019 May 21, 2019 $ 0.45 May 2, 2019 Quarterly May 31, 2019 July 16, 2019 $ 0.46 July 30, 2019 Quarterly August 5, 2019 August 26, 2019 $ 0.45 September 27, 2019 Quarterly September 30, 2019 November 12, 2019 $ 0.04 December 9, 2019 Quarterly December 10, 2019 December 23, 2019 $ 0.40 March 5, 2020 Quarterly March 6, 2020 March 20, 2020 $ 0.40 May 7, 2020 Quarterly May 8, 2020 May 21, 2020 $ 0.35 August 5, 2020 Quarterly August 6, 2020 August 20, 2020 $ 0.36 October 1, 2020 Quarterly October 1, 2020 November 12, 2020 $ 0.38 March 4, 2021 Quarterly March 5, 2021 March 19, 2021 $ 0.37 April 29, 2021 Quarterly April 30, 2021 May 13, 2021 $ 0.37 July 19, 2021 Quarterly July 20, 2021 August 12, 2021 $ 0.34 October 28, 2021 Quarterly November 8, 2021 November 22, 2021 $ 0.25 February 24, 2022 Quarterly March 8, 2022 March 22, 2022 $ 0.27 April 28, 2022 Quarterly May 10, 2022 May 24, 2022 $ 0.30 July 28, 2022 Quarterly August 9, 2022 August 23, 2022 $ 0.33 October 27, 2022 Quarterly November 8, 2022 November 22, 2022 $ 0.36 February 23, 2023 Quarterly March 7, 2023 March 21, 2023 $ 0.40 February 23, 2023 Supplemental March 7, 2023 March 21, 2023 $ 0.05 May 2, 2023 Quarterly May 15, 2023 May 31, 2023 $ 0.40 May 2, 2023 Supplemental May 15, 2023 May 31, 2023 $ 0.05 August 1, 2023 Quarterly August 15, 2023 August 31, 2023 $ 0.40 August 1, 2023 Supplemental August 15, 2023 August 31, 2023 $ 0.05 November 1, 2023 Quarterly November 13, 2023 November 28, 2023 $ 0.40 November 1, 2023 Supplemental November 13, 2023 November 28, 2023 $ 0.06 |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Note 10 — Income Taxes The Company elected to be treated as a RIC under Subchapter M of the Code starting with its taxable year ended December 31, 2016. The Company currently qualifies and intends to qualify annually for the tax treatment applicable to RICs. A RIC generally is not subject to U.S. federal income taxes on distributed income and gains so long as it meets certain source-of-income and asset diversification requirements and it distributes at least 90 % of its net ordinary income and net short-term capital gains in excess of its net long-term capital losses, if any, to its stockholders. So long as the Company maintains its status as a RIC, it generally will not be subject to U.S. federal income tax on any ordinary income or capital gains that it distributes at least annually to its stockholders as dividends. Rather, any tax liability related to income earned by the Company represents obligations of the Company’s investors and will not be reflected in the consolidated financial statements of the Company. The Company intends to make sufficient distributions to maintain its RIC status each year and it does not anticipate paying any material United States federal income taxes in the future. Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward such taxable income in excess of current year dividend distributions from such current year taxable income into the next tax year and pay a 4 % excise tax on such income, as required. If the Company determines that the estimated current year taxable income will exceed the estimated dividend distributions for the current year from such income, the Company will accrue excise tax on estimated excess taxable income as such taxable income is earned. For the years ended December 31, 2023, 2022, and 2021, the Company recorded an expense of $ 0.7 million , $ 0.3 million , and $ 0.0 million , respectively, for U.S. federal excise tax, which is included in tax expense in the statement of operations. Differences between taxable income and net increase in net assets resulting from operations either can be temporary, meaning they will reverse in the future, or permanent. In accordance with Section 946‑205‑45‑3 of the ASC, permanent tax differences are reclassified from accumulated undistributed earnings to paid-in-capital at the end of each year and have no impact on total net assets. For the years ended December 31, 2023, 2022, and 2021, the Company reclassified for book purposes amounts arising from permanent book/tax differences primarily related to non-deductible excise taxes paid as follows (in thousands): Years Ended December 31, 2023 2022 2021 Additional paid-in capital $ ( 664 ) $ ( 290 ) $ — Accumulated undistributed earnings 664 290 — For U.S. federal income tax purposes, distributions paid to stockholders are reported as ordinary income, return of capital, long term capital gains or a combination thereof. The tax character of distributions paid for the years ended December 31, 2023, 2022, and 2021 was as follows (in thousands): Years Ended December 31, 2023 2022 2021 Ordinary income $ 73,322 $ 51,593 $ 44,943 Long-term capital gain — — — Return of capital — — — The following table sets forth the tax cost basis and the estimated aggregate gross unrealized gain (loss) on investments for federal income tax purposes as of and for the years ended December 31, 2023, 2022 and 2021 (in thousands): Years Ended December 31, 2023 2022 2021 Tax cost of investments $ 1,105,481 $ 1,149,902 $ 726,969 Unrealized gain on a tax basis $ 11,239 $ 9,207 $ 23,598 Unrealized loss on a tax basis ( 49,711 ) ( 32,800 ) ( 21,050 ) Net unrealized gain (loss) on a tax basis $ ( 38,472 ) $ ( 23,593 ) $ 2,548 At December 31, 2023, 2022 and 2021, the components of distributable earnings on a tax basis detailed below differ from the amounts reflected in the Company’s Consolidated Statements of Assets and Liabilities by temporary and other book/tax differences, primarily relating to the tax treatment of debt modifications, as follows (in thousands): Years Ended December 31, 2023 2022 2021 Undistributed ordinary income $ 17,726 $ 10,473 $ 329 Undistributed capital gains — — — Capital loss carry forwards ( 26,726 ) ( 6,011 ) ( 2,931 ) Late year losses — — — Other accumulated losses ( 165 ) ( 189 ) ( 213 ) Net unrealized gain (loss) on a tax basis ( 38,472 ) ( 23,593 ) 2,548 Accumulated earnings/(deficit) on a tax basis $ ( 47,637 ) $ ( 19,320 ) $ ( 267 ) For tax purposes, net realized capital losses may be carried over to offset future capital gains, if any. Funds are permitted to carry forward capital losses for an indefinite period, and such losses will retain their character as either short-term or long-term capital losses. For the years ended December 31, 2023, 2022 and 2021 , the Company utilized capital loss carryforward in the amount of $ 0 , $ 0 , and $ 1.4 million , respectively, to offset realized capital gains. The Company accounts for income taxes in conformity with ASC Topic 740 — Income Taxes ("ASC 740"). ASC 740 provides guidelines for how uncertain tax positions should be recognized, measured, presented and disclosed in the consolidated financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions deemed to meet a "more-likely-than-not" threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the Consolidated Statements of Operations. There were no material uncertain income tax positions at December 31, 2023, December 31, 2022 or December 31, 2021. Although the Company files federal and state tax returns, the Company's major tax jurisdiction is federal. The previous three tax year-ends and the interim tax period since then remain subject to examination by the Internal Revenue Service. If the Company does not distribute (or is not deemed to have distributed) each calendar year the sum of (1) 98 % of its net ordinary income for each calendar year, (2) 98.2 % of its capital gain net income for the one-year period ending October 31 in that calendar year and (3) any income recognized, but not distributed, in preceding years (the "Minimum Distribution Amount"), the Company will generally be required to pay a U.S. federal excise tax equal to 4 % of the amount by which the Minimum Distribution Amount exceeds the distributions for the year. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions from such taxable income, the Company accrues excise taxes, if any, on estimated excess taxable income as taxable income is earned using an annual effective excise tax rate. The annual effective U.S. federal excise tax rate is determined by dividing the estimated annual excise tax by the estimated annual taxable income. If the Company does not qualify to be treated as a RIC for any taxable year, the Company will be taxed as a regular corporation (a “C corporation”) under subchapter C of the Code for such taxable year. If the Company has previously qualified as a RIC but is subsequently unable to qualify, and certain amelioration provisions are not applicable, the Company would be subject to U.S. federal income tax on all of its taxable income (including its net capital gains) at regular corporate rates. The Company would not be able to deduct distributions to stockholders, nor would it be required to make distributions. In order to requalify as a RIC, in addition to the other requirements discussed above, the Company would be required to distribute all of its previously undistributed earnings attributable to the period it failed to qualify by the end of the first year that it intends to requalify. If the Company fails to requalify for a period greater than two taxable years, it may be subject to U.S. federal income tax at corporate tax rates on any net built-in gains with respect to certain of its assets (i.e., the excess of the aggregate gains, including items of income, over aggregate losses that would have been realized with respect to such assets if the Company had been liquidated) that it elects to recognize on requalification or when recognized over the next five years. |
Financial Highlights
Financial Highlights | 12 Months Ended |
Dec. 31, 2023 | |
Investment Company, Financial Highlights [Abstract] | |
Financial Highlights | Note 11 — Financial Highlights The following table sets forth the financial highlights for the years ended December 31, 2016 through 2023 (in thousands, except for per share data and ratios): Years Ended December 31, 2023 2022 2021 2020 2019 2018 2017 2016 Per Share Data (1) : Net asset value at beginning of period $ 14.22 $ 14.65 $ 14.84 $ 14.58 $ 15.14 $ 14.66 $ 10.38 $ 15.00 Net investment income 1.93 1.46 1.30 1.38 1.95 1.26 ( 0.66 ) ( 83.81 ) Net realized gain (loss) ( 0.45 ) ( 0.03 ) 0.12 ( 0.19 ) 0.03 - - - Net change in unrealized gain (loss) ( 0.39 ) ( 0.64 ) ( 0.09 ) 0.52 ( 0.50 ) - 0.14 ( 0.01 ) Total from investment operations 1.09 0.79 1.33 1.71 1.48 1.26 ( 0.52 ) ( 83.82 ) Distributions ( 1.81 ) ( 1.26 ) ( 1.33 ) ( 1.49 ) ( 2.20 ) ( 0.75 ) - - Offering costs - - ( 0.21 ) - ( 0.03 ) - - - Accretion (dilution) (2) - 0.04 0.02 0.04 0.19 ( 0.03 ) 4.80 79.20 Net asset value at end of period $ 13.50 $ 14.22 $ 14.65 $ 14.84 $ 14.58 $ 15.14 $ 14.66 $ 10.38 Ratio/Supplemental Data: Total return based on net asset value (3) 7.67 % 5.67 % 7.68 % 12.00 % 10.83 % 8.39 % 41.23 % ( 30.80 ) % Total return based on market value (4) 24.50 % 0.23 % N/A N/A N/A N/A N/A N/A Ratio of net investment income to average net assets (5)(6) 13.62 % 10.14 % 8.74 % 9.44 % 12.85 % 8.30 % ( 4.56 ) % ( 595.90 ) % Ratio of total operating expenses to average net assets (5)(6) 14.96 % 8.13 % 5.23 % 4.85 % 6.58 % 6.42 % 12.46 % 595.90 % Ratio of total operating expenses, excluding incentive fees, to average net assets (5) 11.64 % 5.90 % 3.41 % 3.05 % 3.64 % 5.42 % 12.46 % 595.90 % Ratio of net increase (decrease) in net assets resulting from operations to average net assets (5) 7.72 % 5.47 % 8.97 % 11.65 % 9.74 % 8.34 % ( 3.56 ) % ( 595.90 ) % Portfolio turnover rate (7) 18.61 % 19.17 % 52.05 % 26.31 % 35.72 % 14.08 % 206.80 % N/A Net assets at beginning of period $ 576,052 $ 606,195 $ 466,244 $ 376,313 $ 167,369 $ 127,040 $ 3,477 $ 25 Net assets at end of period $ 547,071 $ 576,052 $ 606,195 $ 466,244 $ 376,313 $ 167,369 $ 127,040 $ 3,477 Weighted average net assets $ 574,594 $ 589,669 $ 508,836 $ 403,188 $ 283,774 $ 141,046 $ 40,389 $ 152 Weighted average shares outstanding for the period, basic 40,509,269 40,971,242 34,183,358 27,617,425 18,701,021 9,300,960 2,795,274 10,774 (1) All per share activity, excluding dividends, is calculated based on the weighted-average shares outstanding for the relevant period. (2) Accretion (dilution) represents the effect of issuance of common stock and repurchase of treasury stock. (3) Total return based on net asset value is calculated as the change in net asset value per share during the period plus dividends per share, divided by the beginning net asset values per share. (4) Total return based on market value is calculated as the change in market value per share during the period plus dividends per share, divided by the beginning market value per share. For the periods 2021 and prior, total return based on market value is not applicable as the Company was not yet public for the entirety of the period. (5) The ratios are calculated based on weighted average net assets for the relevant period. (6) The ratio includes incentive fees and as incentive fees are performance driven, the amount expensed in future periods may vary significantly and is dependent on overall investment performance, early terminations, scheduled prepayments and other liquidity events. (7) The portfolio turnover rate for the period is calculated by taking the lesser of investment portfolio purchases or sales during the period, divided by the average investment portfolio value during the period. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 12 — Subsequent Events The Company evaluated events subsequent to December 31, 2023 through March 7, 2024, the date the consolidated financial statements were issued. Effective January 1, 2024, the Company placed one loan to Mingle Healthcare Solutions, Inc. on non-accrual status , representing an outstanding principal of $ 4.3 million at a fair market value of $ 3.8 million as of December 31, 2023. The loan comprised 0.37 % of the total fair value of the investment portfolio, excluding U.S. Treasury Bills, as of December 31, 2023 On February 1, 2024 , the Company’s board of directors declared an ordinary distribution of $ 0.40 per share and a supplemental distribution of $ 0.07 per share for stockholders of record as of February 12, 2024 , payable on February 28, 2024 . On February 14, 2024, the Company received a partial prepayment of $ 7.1 million from MarleySpoon SE on its senior secured loan. On March 7, 2024, the Company and Cadma Capital Partners LLC entered into a Limited Liability Company Agreement to co-manage Runway-Cadma I LLC (the "Joint Venture"). The Joint Venture is expected to invest in various types of investments, including, but not limited to, first and second lien senior secured term loans, including delayed draw and multi-tranche loans, and secured revolving credit facilities. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying consolidated financial statements of the Company are prepared on the accrual basis of accounting in conformity with U.S. Generally Accepted Accounting Principles ("U.S. GAAP") and pursuant to the requirements for reporting on Form 10‑K and Regulation S-X under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Company is an investment company following the specialized accounting and reporting guidance specified in the Financial Accounting Standards Board’s ("FASB") Accounting Standards Codification ("ASC") Topic 946, Financial Services — Investment Companies. Certain items in the December 31, 2022 and December 31, 2021 consolidated financial statements have been reclassified to conform to the December 31, 2023 presentation with no effect on the Total net assets on the Consolidated Statements of Assets and Liabilities, no effect on the Net increase (decrease) in net assets resulting from operations on the Consolidated Statements of Operations, and no effect to the Net increase (decrease) in cash and cash equivalents on the Consolidated Statements of Cash Flows. |
Principles of Consolidation | Principles of Consolidation Under ASC 946, the Company is precluded from consolidating portfolio company investments, including those in which it has a controlling interest, unless the portfolio company is another investment company. An exception to this general principle occurs if the Company holds a controlling interest in an operating company that provides all or substantially all of its services directly to the Company or to its portfolio companies. None of the portfolio investments made by the Company qualify for this exception. Therefore, the Company’s investment portfolio is carried on the Consolidated Statements of Assets and Liabilities at fair value, as discussed further in “Note 4 — Investments,” with any adjustments to fair value recognized as “Net unrealized gain (loss) on investments” on the Consolidated Statements of Operations. Effective December 31, 2023, the Company completed a credit bid resulting in the acquisition of Pivot3, Inc.’s assets in consideration for the Company’s outstanding senior secured term loan to Pivot3, Inc. As of December 31, 2023, the cost basis of the senior secured term loan to Pivot3, Inc. was $ 18.0 million and the fair value of Pivot3, Inc.’s asset was $ 0.95 million, resulting in a realized loss of approximately $ 17.0 million. The public sale of the collateral included (1) all issued and outstanding equity interest of Pivot3, Inc. and (2) intangible assets. Pursuant to the credit bid purchase agreement, the Company directed that the Pivot3, Inc. pledged equity be transferred to P3 Holdco LLC (“P3 Holdco”), a wholly owned subsidiary of the Company, and the assets be contributed to Pivot3, Inc. (resulting in Pivot3, Inc. becoming a wholly-owned subsidiary of P3 Holdco). The Company’s consolidated operations include the activities of its wholly owned subsidiary, P3 Holdco and P3 Holdco’s wholly owned subsidiary Pivot3, Inc. The subsidiaries are consolidated and included in the Company’s consolidated financial statements and the assets of Pivot3, Inc. are recorded at fair value. All intercompany balances and transactions have been eliminated. Refer to the Schedule of Investments for the Company’s equity interest in Pivot3, Inc. as of December 31, 2023. |
Use of Estimates | Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of income and expense during the reporting period. Changes in the economic and regulatory environment, financial markets, the credit worthiness of our portfolio companies, and any other parameters used in determining these estimates and assumptions could cause actual results to differ from these estimates and assumptions. |
Cash and Cash Equivalents | Cash and Cash Equivalents Cash consists solely of funds deposited with financial institutions, while cash equivalents consists of short-term liquid investments in money market funds. Cash and cash equivalents are carried at cost, which approximates fair value. As of December 31, 2023, t he Company did no t have any cash equivalents invested in money market funds. As of December 31, 2022, $ 5.6 million was invested in money market funds. Interest earned in money market funds are recorded in Other income on the Consolidated Statements of Operations. |
Debt and Deferred Debt Costs | Debt and Deferred Debt Costs The debt of the Company is carried at amortized cost, which is comprised of the principal amount borrowed, net of unamortized debt issuance costs on the Consolidated Statements of Assets and Liabilities. Debt issuance costs are fees and other direct incremental costs incurred by the Company in relation to debt financing and are recognized as Unamortized deferred debt costs as a reduction to total debt on the Consolidated Statements of Assets and Liabilities and amortized over the life of the related debt instrument, or the life of the cost respective service if shorter, using the straight-line method, which closely approximates the effective yield method. To the extent there are no outstanding borrowings, the deferred debt costs are presented as an asset on the Consolidated Statements of Assets and Liabilities. Amortization of deferred debt costs and interest expense on the outstanding principal balance are recorded in Interest and other deferred financing expenses on the Consolidated Statements of Operations. Accrued but unpaid interest is included within Interest payable on the Consolidated Statements of Assets and Liabilities. For more information, refer to “Note 7 – Borrowings.” |
Segments | Segments The Company lends to and invests in customers in various industries. The Company separately evaluates the performance of each of its lending and investment relationships. However, because each of these loan and investment relationships has similar business and economic characteristics, they have been aggregated into a single lending and investment segment. All applicable segment disclosures are included in or can be derived from the Company’s consolidated financial statements. |
Investment Transactions and Related Investment Income | Investment Transactions and Related Investment Income Security transactions, if any, are recorded on a trade-date basis. Realized gains or losses from the repayment or sale of investments are measured using the specific identification method. The amortized cost basis of investments represents the original cost adjusted for the accretion/amortization of discounts and premiums and upfront loan origination fees. The Company reports changes from the prior period in fair value of investments that are measured at fair value as a component of net change in unrealized gain (loss) on investments on the Consolidated Statements of Operations. Dividend income is recorded on an accrual basis to the extent that such amounts are payable and expected to be collected. Dividend income is recorded on the record date for private portfolio companies or on the ex-dividend date for publicly traded portfolio companies. Interest income, if any, adjusted for amortization of market premium and accretion of market discount, is recorded on an accrual basis to the extent that the Company expects to collect such amounts. Original issue discount (“OID”), principally representing the estimated fair value of detachable equity, warrants or contractual success fees obtained in conjunction with the Company’s debt investments, loan origination fees, end of term payments, and market discount or premium are capitalized and accreted or amortized into interest income over the life of the respective security using the effective interest method. Loan origination fees received in connection with the closing of investments are reported as unearned income, which is included as amortized cost of the investment; the unearned income from such fees is accreted into interest income over the contractual life of the loan based on the effective interest method. Upon prepayment of a debt investment, any unamortized loan origination fees, end-of-term payments, and unamortized market discounts are recorded as interest income and any prepayment penalties are recorded as fee income. Upon amending terms of an existing investment, any amendment fees charged are recorded as fee income. The Company currently holds, and expects to hold in the future, some investments in its portfolio that contain payment-in-kind ("PIK") interest provisions. PIK interest is computed at the contractual rate specified in each loan agreement and is added to the principal balance of the loan, rather than being paid to the Company in cash, and is recorded as interest income. Thus, the actual collection of PIK interest may be deferred until the time of debt principal repayment. PIK interest, which is a non-cash source of income, is included in the Company’s taxable income and therefore affects the amount of income the Company is required to distribute to stockholders to maintain its qualification as a RIC for U.S. federal income tax purposes, even though the Company has not yet collected the cash. For the years ended December 31, 2023, December 31, 2022, and December 31, 2021, approximately 12.2 % , 8.0 % , and 4.2 % , respectively, of the Company's total investment income was attributable to non-cash PIK interest. |
Investments Denominated in Foreign Currency | Investments Denominated in Foreign Currency At each balance sheet date, portfolio company investments denominated in foreign currencies are translated into U.S. dollars using the spot exchange rate on the last business day of the period. Purchases and sales of foreign portfolio company investments, and any income from such investments, are translated into U.S. dollars using the rates of exchange prevailing on the respective dates of such transactions. As of December 31, 2023, the Company held one investment denominated in a foreign currency. As of December 31, 2022, the Company did not hold any investments denominated in a foreign currency. Although the fair values of foreign portfolio company investments and the fluctuation in such fair values are translated into U.S. dollars using the applicable foreign exchange rates described above, the Company does not isolate the portion of the change in fair value resulting from foreign currency exchange rates fluctuations from the change in fair value of the underlying investment. All fluctuations in fair value are included in Net change in unrealized gain (loss) on investments on the Company’s Consolidated Statements of Operations. |
Non-Accrual of Investments | Non-Accrual of Investments Debt investments are placed on non-accrual status when principal, interest, and other obligations become materially past due or when it is probable that principal, interest, or other obligations will not be collected in full. At the point of non-accrual, the Company will cease recognizing interest income on the debt investment until all principal and interest due have been paid or the Company believes the borrower has demonstrated the ability to repay its current and future contractual obligations. Additionally, any OID associated with the debt investment is no longer accreted to interest income as of the date the loan is placed on non-accrual status. Any payments received on non-accrual loans are first applied to principal prior to recovery of any foregone interest or end of term payment fees. Non-accrual loans are restored to accrual status when past due principal or interest are paid, and, in management’s judgment are likely to remain current. The Company may make exceptions to this policy if the investment has sufficient collateral value and is in the process of collection such that the Company will be made whole on the investment, inclusive of interest and end of term payment fees. During the years ended December 31, 2023 and December 31, 2022, the Company had no t written off any accrued interest. As of December 31, 2023, we had no loans on non-accrual status as our single loan to Pivot3, Inc. was realized. For more information, refer to "Note 2 — Summary of Significant Accounting Policies, Principles of Consolidation." As of December 31, 2022 , the Company had one loan to Pivot3, Inc. on non-accrual status. The loan, with a cost basis of $ 19.2 million and a fair value of $ 9.3 million represents 0.8 % of the Company’s total investment portfolio. From being placed on non-accrual status through December 31, 2022, cumulative interest of $ 3.6 million would be receivable and $ 0.3 million OID would be accreted into the cost basis, for a total of $ 3.9 million not recorded in interest income from control investments on the Statement of Operations. As of December 31, 2021 , the Company had six loans to Mojix, Inc. and one loan to Pivot3, Inc., on non-accrual status. The loans, with an aggregate cost basis of $ 30.3 million and a fair value of $ 28.3 million, represents 3.9 % of the Company’s total investment portfolio. From being placed on non-accrual status through December 31, 2021 , cumulative interest of $ 4.1 million would be receivable and $ 0.7 million OID would be accreted into the cost basis, for a total of $ 4.8 million not recorded in interest income from control investments on the Statement of Operations. |
Fair Value Measurements | Fair Value Measurements The Company measures the value of its financial instruments at fair value in accordance with ASC Topic 820, Fair Value Measurements and Disclosure (“ASC Topic 820”), issued by the FASB. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. With the exception of the Company’s borrowings, which are reported at amortized cost, all assets and liabilities approximate fair value on the Statements of Assets and Liabilities. For more information on financial instruments reported at cost, refer to "Note 5 – Fair Value of Financial Instruments." ASC Topic 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. ASC Topic 820 also provides guidance regarding a fair value hierarchy, which prioritizes information used to measure fair value and the effect of fair value measurements on earnings and provides for enhanced disclosures determined by the level within the hierarchy of information used in the valuation. In accordance with ASC Topic 820, these inputs are summarized in the three levels listed below: • Level 1 — Valuations are based on quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date. • Level 2 — Valuations are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly and model-based valuation techniques for which all significant inputs are observable. • Level 3 — Valuations based on inputs that are unobservable and significant to the overall fair value measurement. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models incorporating significant unobservable inputs, such as discounted cash flow models and other similar valuations techniques. The valuation of Level 3 assets and liabilities generally requires significant management judgment due to the inability to observe inputs to valuation. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, a financial instrument’s level within the fair value hierarchy is based on the lowest level of observable input that is significant to the fair value measurement. The assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the instrument. Under ASC Topic 820, the fair value measurement also assumes that the transaction to sell an asset or liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset, which may be a hypothetical market, and excludes transaction costs. The principal market for any asset or liability is the market with the greatest volume and level of activity for such asset in which the reporting entity would or could sell or transfer the asset or liability. In determining the principal market for an asset or liability under ASC Topic 820, it is assumed that the reporting entity has access to such market as of the measurement date. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable and willing and able to transact. Rule 2a-5 under the 1940 Act established requirements for determining fair value of a BDC's investments in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards, in compliance with certain conditions, to designate certain parties to perform fair value determinations, subject to board oversight. Rule 2a-5 also defines when market quotations are "readily available" for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. The SEC also adopted new Rule 31a-4 under the 1940 Act ("Rule 31a-4"), which provides the recordkeeping requirements associated with fair value determinations. The Company's Board of Directors has not designated a valuation designee. |
Investment Valuation Techniques | Investment Valuation Techniques With respect to investments for which market quotations are not readily available, the Company undertakes a multi-step valuation process each quarter, as described below: • The quarterly valuation process begins with each portfolio company investment being initially valued by RGC’s investment professionals that are responsible for the portfolio investment; • Preliminary valuation conclusions are then documented and discussed with RGC’s senior investment team; • At least once annually, the valuation for each portfolio investment is reviewed by an independent valuation firm. Certain investments, however, may not be evaluated annually by an independent valuation firm if the net asset value and other aspects of such investments in the aggregate do not exceed certain thresholds; • The Audit Committee then reviews these preliminary valuations from RGC and the independent valuation firm, if any, and makes a recommendation to the Company's Board of Directors regarding such valuations; and • The Company’s Board of Directors reviews the recommended preliminary valuations and determines the fair value of each investment in the Company’s portfolio, in good faith, based on the input of RGC, the independent valuation firm(s) and the Audit Committee. The Company’s investments are primarily loans made to and equity and warrants of small, fast-growing companies focused in technology, life sciences, health care information and services, business services and other high-growth industries. These investments are considered Level 3 assets under ASC Topic 820 because there is no known or accessible market or market indices for these types of debt and equity instruments and, thus, RGC’s senior investment team must estimate the fair value of these investment securities based on models utilizing unobservable inputs. The Audit Committee of the Company’s Board of Directors assists the Board of Directors in valuing investments that are not publicly traded or for which current market values are not readily available. Investments for which market quotations are readily available are valued using market quotations, which are generally obtained from independent pricing services, broker-dealers or market makers. With respect to portfolio investments for which market quotations are not readily available, the Company’s Board of Directors, with the assistance of the Audit Committee, RGC and its senior investment team and independent valuation agents, is responsible for determining, in good faith, the fair value in accordance with the valuation policy approved by the Board of Directors. If more than one valuation method is used to measure fair value, the results are evaluated and weighted, as appropriate, considering the reasonableness of the range indicated by those results. The Company considers a range of fair values based upon the valuation techniques utilized and selects the value within that range that was most representative of fair value based on current market conditions as well as other factors RGC’s senior investment team considers relevant. The Company’s Board of Directors makes this fair value determination on a quarterly basis and any other time when a decision regarding the fair value of the portfolio investments is required. A determination of fair value involves subjective judgments and estimates and depends on the facts and circumstances. Due to the inherent uncertainty of determining the fair value of portfolio investments that do not have a readily available market value, the fair value of the investments may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material. Valuation methodologies involve a significant degree of judgment. There is no single standard for determining the fair value of investments that do not have an active public market. Valuations of privately held investments are inherently uncertain, as they are based on estimates, and their values may fluctuate over time. The determination of fair value may differ materially from the values that would have been used if an active market for these investments existed. In some cases, the fair value of such investments is best expressed as a range of values derived utilizing different methodologies from which a fair value may then be determined. Debt Investments To determine the fair value of the Company’s debt investments, the Company compares the cost basis of the debt investment, which includes OID, to the resulting fair value determined using a discounted cash flow model, unless another model is more appropriate based on the circumstances at the measurement date. The discounted cash flow approach entails analyzing the interest rate spreads for recently completed financing transactions that are similar in nature to the Company’s investments, in order to determine a comparable range of effective market interest rates for its investments. The range of interest rate spreads utilized is based on borrowers with similar credit profiles. All remaining expected cash flows of the investment are discounted using this range of interest rates to determine a range of fair values for the debt investment. This valuation process includes, among other things, evaluating the underlying investment performance, the portfolio company’s current financial condition and ability to raise additional capital, as well as macro-economic events that may impact valuations. These events include, but are not limited to, current market yields and interest rate spreads of similar securities as of the measurement date. Significant increases (decreases) in these unobservable inputs could result in a significantly higher (lower) fair value measurements. Under certain circumstances, the Company may use an alternative technique to value the debt investments to be acquired by the Company that better reflects the fair value of the investment, such as the price paid or realized in a recently completed transaction or a binding offer received in an arms-length transaction, the use of multiple probability-weighted cash flow models when the expected future cash flows contain elements of variability or estimates of proceeds that would be received in a liquidation scenario. Warrants Fair value of warrants is primarily determined using a Black Scholes option-pricing model. Privately held warrants and equity-related securities are valued based on an analysis of various factors including, but not limited to, the following: • Underlying enterprise value of the issuer is estimated based on information available, including any information regarding the most recent rounds of issuer funding. Valuation techniques to determine enterprise value include market multiple approaches, income approaches or approaches that utilize recent rounds of financing and the portfolio company’s capital structure to determine enterprise value. Valuation techniques are also utilized to allocate the enterprise fair value of a portfolio company to the specific class of common or preferred stock exercisable in the warrant. Such techniques take into account the rights and preferences of the portfolio company’s securities, expected exit scenarios, and volatility associated with such outcomes to allocate the fair value to the specific class of stock held in the portfolio. Such techniques include Option Pricing Models, or “OPM,” including back-solve techniques, Probability Weighted Expected Return Models, or “PWERM,” and other techniques as determined to be appropriate. • Volatility, or the amount of uncertainty or risk about the size of the changes in the warrant price, is based on comparable publicly traded companies within indices similar in nature to the underlying company issuing the warrant. Significant increases (decreases) in this unobservable input could result in a significantly lower (higher) fair value, but a significantly higher or lower fair value measurement of any of the Company’s portfolio investments may occur regardless of whether there is a significant increase or decrease in this unobservable input. • The risk-free interest rates are derived from the U.S. Treasury yield curve. The risk-free interest rates are calculated based on a weighted average of the risk-free interest rates that correspond closest to the expected remaining life of the warrant. Significant increases (decreases) in this unobservable input could result in a significantly higher (lower) fair value, but a significantly higher or lower fair value measurement of any of the Company’s portfolio investments may occur regardless of whether there is a significant increase (decrease) in this unobservable input. • Other adjustments, including a marketability discount on private company warrants, are estimated based on judgment about the general industry environment. Significant increases (decreases) in this unobservable input could result in a significantly lower (higher) fair value, but a significantly higher or lower fair value measurement of any of the Company’s portfolio investments may occur regardless of whether there is a significant increase (decrease) in this unobservable input. • Historical portfolio experience on cancellations and exercises of warrants are utilized as the basis for determining the estimated life of the warrants in each financial reporting period. Warrants may be exercised in the event of acquisitions, mergers or initial public offerings, and cancelled due to events such as bankruptcies, restructuring activities or additional financings. These events cause the expected remaining life assumption to be shorter than the contractual term of the warrants. Significant increases (decreases) in this unobservable input could result in a significantly higher (lower) fair value, but a significantly higher or lower fair value measurement of any of the Company’s portfolio investments may occur regardless of whether there is a significant increase (decrease) in this unobservable input. Under certain circumstances, the Company may use an alternative technique to value warrants that better reflects the warrants’ fair values, such as an expected settlement of a warrant in the near term, a model that incorporates a put feature associated with the warrant, or the price paid or realized in a recently completed transaction or binding offer received in an arms-length transaction. The fair value may be determined based on the expected proceeds to be received from such settlement or based on the net present value of the expected proceeds from the put option. Equity Investments The fair value of an equity investment in a privately held company is initially the face value of the amount invested. The Company adjusts the fair value of equity investments in private companies upon the completion of a new third-party round of equity financing subsequent to the Company’s investment. The Company may make adjustments to fair value, absent a new equity financing event, based upon positive or negative changes in a portfolio company’s financial or operational performance. The Company may also reference comparable transactions and/or secondary market transactions in connection with its determination of fair value. The fair value of an equity investment in a publicly traded company is based upon the closing public share price on the date of measurement. These assets are recorded at fair value on a recurring basis. |
Investment Classification | Investment Classification The Company classifies its investments by level of affiliation and control. As defined in the 1940 Act, investee companies are deemed as affiliated investments when a company or individual possesses, or has the right to acquire within 60 days or less, beneficial ownership of 5.0 % or more of the outstanding voting securities of an investee company. Control investments are those where the investor has the ability or power to exercise a controlling influence over the management or policies of an investee company. Control is generally deemed to exist when a company or individual possesses, or has the right to acquire within 60 days or less, beneficial ownership of more than 25.0 % of the outstanding voting securities of an investee company, or maintains greater than 50 % representation on the investee company's board of directors. Investments are recognized when the Company assumes an obligation to acquire a financial instrument and assumes the risks for gains or losses related to that instrument. Investments are derecognized when the Company assumes an obligation to sell a financial instrument and foregoes the risks for gains or losses related to that instrument. Specifically, the Company records all security transactions on a trade date basis. Investments in other, non-security financial instruments, such as limited partnerships or private companies, are recorded on the basis of subscription date or redemption date, as applicable. Amounts for investments recognized or derecognized but not yet settled will be reported on the Consolidated Statements of Assets and Liabilities. |
Income Taxes | Income Taxes The Company elected to be treated as a RIC under Subchapter M of the Code beginning with its taxable year ended December 31, 2016, currently qualifies as a RIC, and intends to qualify annually for the tax treatment applicable to RICs. A RIC generally is not subject to U.S. federal income taxes on distributed income and gains so long as it meets certain source-of-income and asset diversification requirements and it distributes at least 90% of its net ordinary income and net short-term capital gains in excess of its net long-term capital losses, if any, to its stockholders. So long as the Company maintains its status as a RIC, it generally will not be subject to U.S. federal income tax on any ordinary income or capital gains that it distributes at least annually to its stockholders as dividends. Rather, any tax liability related to income earned by the Company represents obligations of the Company’s investors and will not be reflected in the consolidated financial statements of the Company. The Company intends to make sufficient distributions to maintain its RIC status each year and it does not anticipate paying any material U.S. federal income taxes in the future. Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward such taxable income in excess of current year dividend distributions from such current year taxable income into the next tax year and pay a 4 % excise tax on such income, as required. If the Company determines that the estimated current year taxable income will exceed the estimated dividend distributions for the current year from such income, the Company accrues excise tax on estimated excess taxable income as such taxable income is earned. Differences between taxable income and net increase in net assets resulting from operations either can be temporary, meaning they will reverse in the future, or permanent. In accordance with Section 946-205-45-3 of the ASC, permanent tax differences are reclassified from accumulated undistributed earnings to paid-in-capital at the end of each year and have no impact on total net assets. For more information, refer to "Note 10 – Income Taxes." |
Per Share Information | Per Share Information Basic and diluted earnings (loss) per common share is calculated using the weighted-average number of common shares outstanding for the period presented. For the years ended December 31, 2023, 2022, and 2021 , basic and diluted earnings (loss) per share of common stock were the same because there were no potentially dilutive securities outstanding. Per share data is based on the weighted-average shares outstanding. |
Comprehensive Income | Comprehensive Income The Company reports all changes in comprehensive income in the Consolidated Statements of Operations. The Company did no t have other comprehensive income in 2023, 2022, or 2021 . The Company’s comprehensive income is equal to its Net increase in net assets resulting from operations. |
Distributions | Distributions Distributions to common stockholders are recorded on the applicable record date. The amount, if any, to be distributed to common stockholders is determined by the Board of Directors each quarter and is generally based upon the Company’s earnings estimated by management. Net realized capital gains, if any, are generally distributed at least annually. For more information, refer to "Note 9 – Net Assets." |
Organization and Offering Costs | Organization and Offering Costs Organization costs include, among other things, the cost of organizing as a Maryland corporation, including the cost of legal services and other fees pertaining to the Company's organization, all of which are expensed as incurred. Offering costs include, among other things, legal fees and other costs pertaining to the preparation of the Company’s public and private offering materials as well as travel-related expenses related to the Company’s public and private offerings. Pursuant to the Advisory Agreement (as defined in "Note 3 – Related Party Agreements and Transactions"), the Company and RGC agreed that organization and offering costs incurred in connection with the Initial Private Offering (as defined in "Note 9 – Net Assets") would be borne by the Company up to a maximum amount of $ 1.0 million, provided that the amount of such costs in excess of $ 1.0 million would be paid by RGC. As of December 31, 2016, the Company had already incurred the maximum amount of $ 1.0 million in organization and offering costs incurred in connection with the Initial Private Offering. Offering costs related to the Second Private Offering (as defined in "Note 9 – Net Assets") were accumulated and charged to additional paid in capital at the time of closing beginning in 2019. These offering costs related to the Second Private Offering were subject to a cap of $ 0.6 million, excluding placement agent fees which had no cap, of which the Company will bear the cost. At the completion of the Second Private Offering, the Company had accumulated and reco rded $ 0.7 million in offering costs and $ 0.2 million i n placement agent fees related to the Second Private Offering. Under the terms of the Second Private Offering, offering costs in excess of $ 0.6 million, excluding placement agent fees, were reimbursed by RGC. Offering costs related to the IPO were accumulated and charged to additional paid in capital at the time of closing in October 2021. The Company had accumulated and recorded $ 7.0 million of offering costs related to the Company’s IPO. The offering costs were fully born by the Company and included underwriting fees, legal fees, and other costs pertaining to the preparation of the Company’s offering materials as well as travel-related expenses. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In June 2022, the FASB issued ASU 2022-03, “Fair Value Measurement (Topic 820) - Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions”, which was issued to (1) clarify the guidance in Topic 820, Fair Value Measurement, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, (2) to amend a related illustrative example, and (3) to introduce new disclosure requirements for equity securities subject to contractual sale restrictions that are measured at fair value in accordance with Topic 820. The new guidance is effective for interim and annual periods beginning after December 15, 2023. The Company does not anticipate the new standard will have a material impact to the consolidated financial statements and related disclosures. In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”. ASU No. 2023-07 requires disclosures to include significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), a description of other segment items by reportable segment and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. The ASU requires all annual disclosures currently required by Topic 280 to be included in interim periods and is applicable to entities with a single reportable segment. ASU No. 2023-07 will be effective for the Company in fiscal year 2024 for annual reporting and in the first quarter of fiscal 2025 for interim reporting. Retrospective application is required for all prior periods presented in the consolidated financial statements. The Company does not anticipate the new standard will have a material impact to the consolidated financial statements and related disclosures. |
Investments (Tables)
Investments (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Investments, All Other Investments [Abstract] | |
Schedule of Transactions Related to Company's Affiliate and Control Investments | The Company’s affiliate and control investments as of December 31, 2023 along with the transactions during the year ended December 31, 2023 are as follows (in thousands): For the Year Ended December 31, 2023 Investment Income Earned 2023 Fair Value as of December 31, 2022 Gross (1) Gross (2) Net Realized Gain (Loss) Net Change in Unrealized Gain (Loss) Fair Value as of December 31, 2023 (3) Portfolio Company Investment Investment Affiliate Investments Debt Investments Gynesonics, Inc. Senior Secured SOFR+ 8.75 %, 8.00 % ceiling, 5.00 % ETP, due 11/30/2026 $ 2,105 $ — $ 25,897 $ — $ — $ ( 2,311 ) $ 23,586 Total Debt Investments 2,105 — 25,897 — — ( 2,311 ) 23,586 Equity Investments Coginiti Corp Equity Common Stock — 1,174 — — — ( 318 ) 856 Gynesonics, Inc. Equity Series A-2 Preferred Stock — — 25,000 — — ( 3,539 ) 21,461 Equity Series A-1 Preferred Stock — — 3,100 — — 1,477 4,577 Total Equity Investments — 1,174 28,100 — — ( 2,380 ) 26,894 Warrants Coginiti Corp Warrants Common Stock — 910 — — — ( 247 ) 663 Gynesonics, Inc. Warrants Success fee — — 313 — — — 313 Total Warrants — 910 313 — — ( 247 ) 976 Total Affiliate Investments $ 2,105 $ 2,084 $ 54,310 $ — $ — $ ( 4,938 ) $ 51,456 Control Investments Debt Investments Pivot3, Inc. Senior Secured LIBOR+ 8.50 % PIK, 11.00 % floor, 4.00 % ETP, due 10/15/2023 — 9,290 — ( 2,158 ) ( 17,014 ) 9,882 — Total Debt Investments — 9,290 — ( 2,158 ) ( 17,014 ) 9,882 — Equity Investments Pivot3, Inc. Equity Equity Interest — — 950 — — — 950 Total Equity Investments — — 950 — — — 950 Total Control Investments $ — $ 9,290 $ 950 $ ( 2,158 ) $ ( 17,014 ) $ 9,882 $ 950 (1) Gross additions includes increases in the basis of investments resulting from new portfolio investments, PIK interest, accretion of original issue discount (“OID”), the exchange of one or more existing investments for one or more new investments and the movement of an existing portfolio company into this category from a different category. (2) Gross reductions include decreases in the basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing investments for one or more new investments and the movement of an existing portfolio company out of this category into a different category. (3) All investments in the portfolio companies, which as of December 31, 2023 represented 9.58 % of the Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors. The Company’s affiliate and control investments as of December 31, 2022 along with the transactions during the year ended December 31, 2022 are as follows (in thousands): For the Year Ended December 31, 2022 Amount of Investment Income Earned 2022 Fair Value as of December 31, 2021 Gross Additions (1) Gross Reductions (2) Net Realized Gain (Loss) Net Change in Unrealized Gain (Loss) Fair Value as of December 31, 2022 (3) Portfolio Company Investment Description Affiliate Investments Debt Investments Coginiti Corp LIBOR+ 9.50 % PIK, 10.81 % floor, due 12/15/2022 $ 109 $ — $ 930 $ ( 930 ) $ — $ — $ — Total Debt Investments 109 — 930 ( 930 ) — — — Equity Investments Coginiti Corp Common Stock — — 4,551 — — ( 3,377 ) 1,174 Total Equity Investments — — 4,551 — — ( 3,377 ) 1,174 Warrants Coginiti Corp Warrant for Common Stock, exercise price $ 0.01 /share, expires 3/9/2030 — — 1,009 — — ( 99 ) 910 Total Warrants — — 1,009 — — ( 99 ) 910 Total Affiliate Investments $ 109 $ — $ 6,490 $ ( 930 ) $ — $ ( 3,476 ) $ 2,084 Control Investments Debt Investments Mojix, Inc. LIBOR+ 12.00 % , 12.00 % cash cap, 5 % ETP, due 1/15/2025 $ 2,287 $ 7,568 $ 1,987 $ ( 8,489 ) $ — $ ( 1,066 ) $ — LIBOR+ 12.00 % , 12.00 % cash cap, 5 % ETP, due 1/15/2025 744 2,523 647 ( 2,818 ) — ( 352 ) — LIBOR+ 12.00 % , 12.00 % cash cap, 5 % ETP, due 1/15/2025 184 630 160 ( 704 ) — ( 86 ) — LIBOR+ 12.00 % , 12.00 % cash cap, 5 % ETP, due 1/15/2025 185 629 161 ( 703 ) — ( 87 ) — LIBOR+ 12.00 % , 12.00 % cash cap, 5 % ETP, due 1/15/2025 374 1,253 327 ( 1,400 ) — ( 180 ) — LIBOR+ 12.00 % , 12.00 % cash cap, 5 % ETP, due 1/15/2025 291 1,008 266 ( 1,090 ) — ( 184 ) — Pivot3, Inc. LIBOR+ 8.50 % PIK, 11.00 % floor, due 11/15/2022 — 14,650 — — — ( 5,360 ) 9,290 Total Debt Investments 4,065 28,261 3,548 ( 15,204 ) — ( 7,315 ) 9,290 Equity Investments Mojix, Inc. Series A-1 Preferred Stock 32 870 — ( 800 ) — ( 70 ) — Pivot3 Holdings, Inc. Series 1 Preferred Stock — — — — ( 2,000 ) 2,000 — Total Equity Investments 32 870 — ( 800 ) ( 2,000 ) 1,930 — Warrants Mojix, Inc. Warrant for Common Stock, exercise price $ 1.286 /share, expires 12/13/2030 — — — ( 119 ) — 119 — Warrant for Common Stock, exercise price $ 2.1286 /share, expires 12/13/2030 — — — ( 298 ) — 298 — Warrant for Common Stock, exercise price $ 5.57338 /share, expires 12/13/2030 — — — ( 829 ) — 829 — Total Warrants — — — ( 1,246 ) — 1,246 — Total Control Investments $ 4,097 $ 29,131 $ 3,548 $ ( 17,250 ) $ ( 2,000 ) $ ( 4,139 ) $ 9,290 (1) Gross additions includes increases in the basis of investments resulting from new portfolio investments, PIK interest, accretion of original issue discount (“OID”), the exchange of one or more existing investments for one or more new investments and the movement of an existing portfolio company into this category from a different category. (2) Gross reductions include decreases in the basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing Investments for one or more new investments and the movement of an existing portfolio company out of this category into a different category. (3) All investments in the portfolio company, which as of December 31, 2022 represented 1.97 % of the Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors. |
Schedule of Fair Value of Portfolio of Investment, excluding U.S. Treasury Bills by Geographic Region and Industry | The following tables show the fair value of the Company's portfolio of investment, excluding U.S. Treasury Bills (in thousands) by geographic region and industry as of December 31, 2023 and December 31, 2022: December 31, 2023 December 31, 2022 Geographic Region Investments at Fair Value Percentage of Net Assets Investments at Fair Value Percentage of Net Assets United States Western United States $ 404,541 73.94 % $ 346,372 60.13 % Northeastern United States 239,444 43.77 351,654 61.04 Midwestern United States 130,784 23.91 74,745 12.98 South Central United States 87,814 16.05 85,000 14.76 Northwestern United States 25,514 4.66 72,615 12.61 Southeastern United States 820 0.15 74,797 12.98 Total United States 888,917 162.48 1,005,183 174.50 United Kingdom 76,839 14.05 60,783 10.55 Germany 44,587 8.15 46,499 8.07 Canada 14,667 2.68 13,844 2.40 Total $ 1,025,010 187.36 % $ 1,126,309 195.52 % December 31, 2023 December 31, 2022 Industry Investments at Fair Value Percentage of Net Assets Investments at Fair Value Percentage of Net Assets Application Software $ 200,645 36.67 % 184,084 31.96 % Health Care Technology 182,200 33.30 240,844 41.81 Human Resource & Employment Services 114,602 20.95 97,788 16.98 System Software 113,517 20.74 78,274 13.58 Data Processing & Outsourced Services 106,785 19.52 97,404 16.91 Internet Software and Services 98,462 18.00 149,780 26.00 Property & Casualty Insurance 75,205 13.75 49,440 8.58 Internet & Direct Marketing Retail 55,588 10.16 55,986 9.72 Electronic Equipment & Instruments 27,535 5.04 78,114 13.56 Education Services 25,796 4.72 25,305 4.39 Health Care Equipment 15,524 2.83 27,433 4.76 Asset Management & Custody Banks 8,021 1.47 - - Technology Hardware, Storage & Peripherals 570 0.10 1,068 0.19 Specialized Consumer Services 373 0.07 796 0.14 Advertising 136 0.03 - - Biotechnology 51 0.01 39,925 6.93 Computer & Electronics Retail - - 68 0.01 Total $ 1,025,010 187.36 % $ 1,126,309 195.52 % |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Assets and Liabilities Measured at Fair Value | Investments measured at fair value on a recurring basis are categorized in the tables below based upon the lowest level of significant input to the valuations as of December 31, 2023 and 2022, (in thousands): As of December 31, 2023 Level 1 Level 2 Level 3 Total Portfolio Investments Senior Secured Term Loans $ — $ — $ 964,099 $ 964,099 Second Lien Term Loans — — 14,399 14,399 Convertible Note — — 1,357 1,357 Preferred Stock 3,553 — 26,285 29,838 Common Stock 548 — 872 1,420 Equity Interest — — 950 950 Warrants — 109 12,838 12,947 Total Portfolio Investments 4,101 109 1,020,800 1,025,010 U.S. Treasury Bill — 41,999 — 41,999 Total $ 4,101 $ 42,108 $ 1,020,800 $ 1,067,009 As of December 31, 2022 Level 1 Level 2 Level 3 Total Portfolio Investments Senior Secured Term Loans $ — $ — $ 1,080,121 $ 1,080,121 Second Lien Term Loans — — 13,654 13,654 Preferred Stock 12,335 — 347 12,682 Common Stock 501 1,422 1,174 3,097 Warrants — 105 16,650 16,755 Total Portfolio Investments 12,836 1,527 1,111,946 1,126,309 Cash equivalents 5,590 — — 5,590 Total $ 18,426 $ 1,527 $ 1,111,946 $ 1,131,899 |
Schedule of Level 3 Assets measured at Fair Value | The following table presents a rollforward of Level 3 assets measured at fair value as of December 31, 2023 (in thousands): Senior Secured Term Loans Second Lien Convertible Notes Preferred Common Equity Interest Warrants Total Fair value at December 31, 2022 $ 1,080,121 13,654 $ — $ 347 $ 1,174 $ — $ 16,650 $ 1,111,946 Transfers in(out) of Level 3 — — — — — — ( 891 ) ( 891 ) Purchases of investments (1) 166,660 — 1,357 28,220 16 950 2,851 200,054 PIK interest 19,413 511 — — — — — 19,924 Sales or prepayments of investments (1) ( 289,034 ) — — — — — ( 44 ) ( 289,078 ) Scheduled principal repayments of investments ( 7,331 ) — — — — — — ( 7,331 ) Amortization of fixed income premiums or accretion of discounts 8,527 114 — — — — — 8,641 Net realized gain (loss) ( 17,013 ) — — — — — ( 1,374 ) ( 18,387 ) Net change in unrealized gain (loss) 2,756 120 — ( 2,282 ) ( 318 ) — ( 4,354 ) ( 4,078 ) Fair value at December 31, 2023 $ 964,099 14,399 $ 1,357 $ 26,285 872 950 12,838 $ 1,020,800 Net change in unrealized gain (loss) on Level 3 investments still held as of December 31, 2023 $ ( 7,746 ) 121 — ( 2,282 ) ( 317 ) — ( 5,893 ) $ ( 16,117 ) (1) Net of reorganization and restructuring of investments. The following table presents a rollforward of Level 3 assets measured at fair value as of December 31, 2022 (in thousands): Senior Secured Term Loans Second Lien Term Loans Preferred Stock Common Stock Warrants Total Fair value at December 31, 2021 $ 623,054 $ 12,873 $ 1,332 $ — $ 20,087 $ 657,346 Transfers in(out) of Level 3 — — — — ( 2,239 ) ( 2,239 ) Purchases of investments (1) 614,636 — — 4,551 3,404 622,591 PIK interest 7,994 661 — — — 8,655 Sales or prepayments of investments ( 151,905 ) — ( 800 ) — ( 1,508 ) ( 154,213 ) Scheduled repayments of investments ( 9,754 ) — — — — ( 9,754 ) Amortization of fixed income premiums or accretion of discounts 6,743 120 — — — 6,863 Net realized gain (loss) — — ( 2,000 ) — ( 851 ) ( 2,851 ) Net change in unrealized gain (loss) ( 10,647 ) — 1,815 ( 3,377 ) ( 2,243 ) ( 14,452 ) Fair Value at December 31, 2022 $ 1,080,121 $ 13,654 $ 347 $ 1,174 $ 16,650 $ 1,111,946 Net change in unrealized gain (loss) on Level 3 investments still held as of December 31, 2022 $ ( 9,752 ) $ — $ ( 115 ) $ ( 3,377 ) $ ( 4,889 ) $ ( 18,133 ) (1) Net of reorganization and restructuring of investments . |
Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements | The following table provides quantitative information regarding Level 3 fair value measurements as of December 31, 2023 (in thousands): Description Fair Value Valuation Technique Unobservable Inputs Range (Weighted Average) Senior Secured Term Loans (1) $ 904,739 Discounted Cash Flow analysis Discount rate 10.8 % - 22.2 % ( 15.0 %) Origination yield 10.8 % - 19.9 % ( 13.6 %) Revenue multiples 0.29 x - 7.49 x ( 3.66 x) 59,360 PWERM Discount rate 20.3 % - 46.5 % ( 28.8 %) Origination yield 10.8 % - 29.7 % ( 17.3 %) Revenue multiples 0.95 x - 3.16 x ( 1.89 x) Second Lien Term Loans (1) 14,399 Discounted Cash Flow analysis Discount rate 16.1 % - 16.1 % ( 16.1 %) Origination yield 13.1 % - 13.1 % ( 13.1 %) Convertible Notes 1,357 PWERM Discount rate 45.0 % - 45.0 % ( 45.0 %) Origination yield 10.8 % - 10.8 % ( 10.8 %) Preferred Stock 120 Recent private market and merger and acquisition transaction prices N/A N/A 26,038 PWERM Risk-Free Rate 4.7 % - 4.7 % ( 4.7 %) Average industry volatility 40.0 % - 40.0 % ( 40.0 %) Estimated time to exit 2.0 - 2.0 ( 2.0 years) Revenue multiples 4.46 x - 4.46 x ( 4.46 x) 127 Waterfall Approach Estimated time to exit 3.0 - 3.0 ( 3.0 years) Revenue multiples 4.00 x - 4.00 x ( 4.00 x) Common Stock 16 Recent private market and merger and acquisition transaction prices N/A N/A 856 Option Pricing Model Risk-free interest rate 4.3 % - 4.3 % ( 4.3 %) Average industry volatility 35.0 % - 35.0 % ( 35.0 %) Estimated time to exit 5.0 - 5.0 ( 5.0 years) Revenue multiples 3.28 x - 3.28 x ( 3.28 x) Equity Interest 950 PWERM Discount rate 20.0 % - 20.0 % ( 20.0 %) Warrants (2) 7,075 Option Pricing Model Risk-free interest rate 3.8 % - 5.3 % ( 4.5 %) Average industry volatility 25.0 % - 108.8 % ( 45.4 %) Estimated time to exit 0.8 - 8.2 ( 3.1 years) Revenue multiples 0.95 x - 7.49 x ( 3.95 x) 3,912 PWERM (3) N/A N/A 1,851 Waterfall Approach Estimated time to exit 3.0 - 3.0 ( 3.0 years) Revenue multiples 2.58 x - 4.00 x ( 3.39 x) Total Level 3 Investments $ 1,020,800 The following table provides quantitative information regarding Level 3 fair value measurements as of December 31, 2022 (in thousands): Description Fair Value Valuation Technique Unobservable Inputs Range (Weighted Average) Senior Secured Term Loans (1) $ 1,053,748 Discounted Cash Flow analysis Discount rate 11.1 % - 28.0 % ( 15.2 %) Origination yield 10.5 % - 19.3 % ( 12.9 %) 26,373 PWERM Discount rate 27.4 % - 37.4 % ( 30.9 %) Second Lien Term Loans (1) 13,654 Discounted Cash Flow analysis Discount rate 16.1 % - 16.1 % ( 16.1 %) Origination yield 12.2 % - 12.2 % ( 12.2 %) Preferred Stock 347 Recent private market and merger and acquisition transaction prices N/A N/A Common Stock 1,174 Recent private market and merger and acquisition transaction prices N/A N/A Warrants (2) 10,246 Option Pricing Model Risk-free interest rate 2.7 % - 4.9 % ( 4.3 %) Average industry volatility 25.0 % - 98.4 % ( 49.0 %) Estimated time to exit 0.5 - 5.0 ( 2.2 years) Revenue multiples 1.16 x - 88.63 x ( 5.47 x) 6,404 PWERM (3) Discount rate 20.0 % - 40.0 % ( 34.6 %) Revenue multiples 2.35 x - 199.38 x ( 13.10 x) Total Level 3 Investments $ 1,111,946 (1) The significant unobservable inputs used in the fair value measurement of the Company’s debt securities are origination yields and discount rates. The origination yield is defined as the initial market price of an investment in a hypothetical market to hypothetical market participants where buyers and sellers are willing participants. The discount rate is related to company-specific characteristics such as underlying investment performance, projected cash flows, and other characteristics of the investment. Significant increases or decreases in the inputs in isolation may result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. However, a significantly higher or lower fair value measurement of any of the Company’s portfolio investments may occur regardless of whether there is a significant increase or decrease in the unobservable inputs. (2) The significant unobservable inputs used in the fair value measurement of the Company’s warrant and equity-related securities are inputs used in the OPM, which include industry volatility, risk free interest rate and estimated time to exit. The Equity Allocation model and the Black Scholes model were the main OPMs used during the years ended December 31, 2023 and December 31, 2022. Probability Weighted Expected Return Models (“PWERM”) and other techniques were used as determined appropriate. Significant increases (decreases) in the inputs in isolation would result in a significantly higher (lower) fair value measurement, depending on the materiality of the investment. However, a significantly higher or lower fair value measurement of any of the Company’s portfolio investments may occur regardless of whether there is a significant increase (decrease) in the unobservable inputs. For some investments, additional consideration may be given to data from the last round of financing or merger/acquisition events near the measurement date. (3) Warrant investments using a PWERM valuation technique contain success fees, in which case the inputs are not applicable because the nature of a success fee is a fixed payout dependent on certain liquidation events. |
Borrowings (Tables)
Borrowings (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of Borrowings | The following table shows the Company's borrowings as of December 31, 2023 and December 31, 2022 (in thousands): December 31, 2023 December 31, 2022 Total Commitment Principal Deferred Debt Cost (1) Carrying Value Total Commitment Principal Deferred Debt Cost (1) Carrying Value Credit Facility $ 550,000 $ 272,000 $ ( 4,434 ) $ 267,566 $ 425,000 $ 337,000 $ ( 4,640 ) $ 332,360 April 2026 Notes 25,000 25,000 ( 277 ) 24,723 — — — — December 2026 Notes 70,000 70,000 ( 573 ) 69,427 70,000 70,000 ( 818 ) 69,182 July 2027 Notes 80,500 80,500 ( 1,924 ) 78,576 80,500 80,500 ( 2,380 ) 78,120 August 2027 Notes 20,000 20,000 ( 511 ) 19,489 20,000 20,000 ( 653 ) 19,347 December 2027 Notes 51,750 51,750 ( 1,453 ) 50,297 51,750 51,750 ( 1,802 ) 49,948 Total $ 797,250 $ 519,250 $ ( 9,172 ) $ 510,078 $ 647,250 $ 559,250 $ ( 10,293 ) $ 548,957 (1) Net of accumulated amortization. |
Schedule of Components of Interest Expense Amortization of Deferred Debt Costs, Unused Fees on Credit Facility and Other Costs | For the years ended December 31, 2023, December 31, 2022 and December 31, 2021, the components of interest expense, amortization of deferred debt costs, unused fees on the Credit Facility (as defined below), and any other costs associated with the Company's borrowings were as follows (dollars in thousands): Interest Expense Amortization of Unused Facility and (1) Total Interest and Other Debt Financing Expenses Weighted Average Year Ended December 31, 2023 Credit Facility $ 22,559 $ 1,664 $ 1,474 $ 25,697 9.24 % April 2026 Notes 1,530 87 — 1,617 8.98 December 2026 Notes 2,975 210 — 3,185 4.55 July 2027 Notes 6,038 557 — 6,595 8.19 August 2027 Notes 1,400 142 — 1,542 7.71 December 2027 Notes 4,140 367 — 4,507 8.71 Total $ 38,642 $ 3,027 $ 1,474 $ 43,143 8.32 % Year Ended December 31, 2022 Credit Facility $ 7,713 $ 921 $ 1,615 $ 10,249 7.60 % December 2026 Notes 2,734 182 — 2,916 4.52 July 2027 Notes 2,566 219 — 2,785 8.04 August 2027 Notes 467 44 — 511 7.64 December 2027 Notes 276 24 — 300 8.44 Total $ 13,756 $ 1,390 $ 1,615 $ 16,761 6.86 % Year Ended December 31, 2021 Credit Facility $ 2,492 $ 467 $ 1,126 $ 4,085 5.82 % December 2026 Notes 52 5 — 57 4.69 Total $ 2,544 $ 472 $ 1,126 $ 4,142 5.80 % (1) Unused facility and other fees for the year ended December 31, 2022 include supplemental fees of $ 0.2 million, which were predominantly incurred in the first half of 2022 and were nonrecurring in nature. |
Schedule of Senior Securities Outstanding | Information about the Company’s senior securities is shown in the following table for the fiscal years ended December 31, 2023 , 2022, 2021, 2020, 2019 and 2018 (in thousands). No senior securities were outstanding for the fiscal years ended December 31, 2017 and prior. Class and Period Total Amount Outstanding Exclusive of Treasury Securities (1) Asset Coverage per Unit (2) Involuntary Liquidating Preference per Unit (3) Average Market Value per Unit (4) 2027 Notes December 31, 2023 $ 152,250 $ 4,593 — N/A December 31, 2022 $ 152,250 $ 4,784 — N/A December 31, 2021 $ — $ — — N/A December 31, 2020 $ — $ — — N/A December 31, 2019 $ — $ — — N/A December 31, 2018 $ — $ — — N/A 2026 Notes December 31, 2023 $ 95,000 $ 6,759 — N/A December 31, 2022 $ 70,000 $ 9,229 — N/A December 31, 2021 $ 20,000 $ 31,310 — N/A December 31, 2020 $ — $ — — N/A December 31, 2019 $ — $ — — N/A December 31, 2018 $ — $ — — N/A Credit Facility December 31, 2023 $ 272,000 $ 3,011 — N/A December 31, 2022 $ 337,000 $ 2,709 — N/A December 31, 2021 $ 61,000 $ 10,938 — N/A December 31, 2020 $ 99,000 $ 5,710 — N/A December 31, 2019 $ 61,000 $ 7,169 — N/A December 31, 2018 $ — $ — — N/A Credit Facility - CIBC (5) December 31, 2023 $ — $ — — N/A December 31, 2022 $ — $ — — N/A December 31, 2021 $ — $ — — N/A December 31, 2020 $ — $ — — N/A December 31, 2019 $ — $ — — N/A December 31, 2018 $ 59,500 $ 3,813 — N/A Total December 31, 2023 $ 519,250 $ 2,054 — N/A December 31, 2022 $ 559,250 $ 2,030 — N/A December 31, 2021 $ 81,000 $ 8,484 — N/A December 31, 2020 $ 99,000 $ 5,710 — N/A December 31, 2019 $ 61,000 $ 7,169 — N/A December 31, 2018 $ 59,500 $ 3,813 — N/A (1) Total amount of each class of senior securities outstanding at the end of the period presented . (2) A sset coverage per unit is the ratio of the carrying value of total assets, less all liabilities excluding indebtedness represented by senior securities in this table to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is express in terms of dollar amounts per $1,000 of indebtedness and is calculated on a consolidated basis. (3) The amount to which such class of senior security would be entitled upon the Company’s involuntary liquidation in preference to any security junior to it. The "—" in this column indicates information that the SEC expressly does not require to be disclosed for certain types of senior securities. (4) Not applicable because the senior securities are not registered for public trading. (5) On June 22, 2018, the Company entered into the Credit Facility with CIBC. On May 31, 2019, in conjunction with securing and entering into the new Credit Facility, the Company terminated the Credit Facility with CIBC . |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Summary of Payments Due by Period | The following table provides the Company’s contractual obligations as of December 31, 2023 (in thousands): Payments Due by Period Contractual Obligations (1) Total Less than 1 Year 1-3 years 3-5 years More than 5 Years Borrowings (2) Credit Facility $ 272,000 $ — $ 272,000 $ — $ — 2026 Notes 95,000 — 95,000 — — 2027 Notes 152,250 — — 152,250 — Total Borrowings 519,250 — 367,000 152,250 — Deferred Incentive Fees 9,165 2,567 3,919 2,548 131 Total $ 528,415 $ 2,567 $ 370,919 $ 154,798 $ 131 (1) Excludes interest payable on borrowings, accrued expenses, and commitments to extend credit to the Company’s portfolio companies. (2) Amounts represent future principal repayments and not the carrying value of each liability (refer to “Note 7 – Borrowings”). The following table provides the Company’s contractual obligations as of December 31, 2022 (in thousands): Payments Due by Period Contractual Obligations (1) Total Less than 1 Year 1-3 years 3-5 years More than 5 Years Borrowings (2) Credit Facility $ 337,000 $ — $ — $ 337,000 $ — 2026 Notes 70,000 — — 70,000 — 2027 Notes 152,250 — — 152,250 — Total Borrowings 559,250 — — 559,250 — Deferred Incentive Fees 5,009 674 1,760 1,023 1,552 Total $ 564,259 $ 674 $ 1,760 $ 560,273 $ 1,552 (1) Excludes interest payable on borrowings, accrued expenses, and commitments to extend credit to the Company’s portfolio companies. (2) Amounts represent future principal repayments and not the carrying value of each liability (refer to “Note 7 – Borrowings”). |
Schedule of Unfunded Commitments to Extend Financing | The Company's unfunded loan commitments to provide debt financing to its portfolio companies amounted to $ 201.5 million and $ 315.7 million as of December 31, 2023 and December 31, 2022, respectively, shown in the table below (in thousands): Portfolio Company Investment Type December 31, 2023 December 31, 2022 3PL Central LLC (dba Extensiv) Senior Secured Term Loan $ 11,500 $ 15,000 Betterment Holdings, Inc. Senior Secured Term Loan 5,000 — Blueshift Labs, Inc. Senior Secured Term Loan 14,500 — Bombora, Inc. Senior Secured Term Loan 2,000 — Brivo, Inc. Senior Secured Term Loan 6,000 16,000 CloudPay, Inc. Senior Secured Term Loan — 15,000 Dtex Systems, Inc. Senior Secured Term Loan — 15,000 EBR Systems, Inc. Senior Secured Term Loan 10,000 30,000 Intellisite Holdings, Inc. (dba Epic IO Technologies, Inc.) Senior Secured Term Loan — 6,000 Interactions Corporation Senior Secured Term Loan 10,000 10,000 Kin Insurance, Inc. Senior Secured Term Loan — 25,000 Linxup, LLC Senior Secured Term Loan 7,500 — Madison Reed, Inc. Senior Secured Term Loan 1,200 2,400 Moximed, Inc. Senior Secured Term Loan 15,000 15,000 Nalu Medical, Inc. Senior Secured Term Loan 15,000 25,000 Revelle Aesthetics, Inc. Senior Secured Term Loan — 12,500 Route 92 Medical, Inc. Senior Secured Term Loan 20,000 42,000 SetPoint Medical Corporation Senior Secured Term Loan 40,000 40,000 Skillshare, Inc. Senior Secured Term Loan 10,000 15,000 Snagajob.com, Inc. Senior Secured Term Loan 6,785 6,785 Snagajob.com, Inc. Convertible Note 2,035 — Synack, Inc. Senior Secured Term Loan 25,000 25,000 Total unused commitments to extend financing $ 201,520 $ 315,685 |
Net Assets (Tables)
Net Assets (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Equity [Abstract] | |
Summary of Distributions Declared and Paid | The following table summarizes the distributions declared and paid since inception through December 31, 2023 : Declaration Date Type Record Date Payment Date Amount per Share May 3, 2018 Quarterly May 15, 2018 May 31, 2018 $ 0.15 July 26, 2018 Quarterly August 15, 2018 August 31, 2018 $ 0.25 November 1, 2018 Quarterly October 31, 2018 November 15, 2018 $ 0.35 March 22, 2019 Quarterly March 22, 2019 March 26, 2019 $ 0.40 May 2, 2019 Quarterly May 7, 2019 May 21, 2019 $ 0.45 May 2, 2019 Quarterly May 31, 2019 July 16, 2019 $ 0.46 July 30, 2019 Quarterly August 5, 2019 August 26, 2019 $ 0.45 September 27, 2019 Quarterly September 30, 2019 November 12, 2019 $ 0.04 December 9, 2019 Quarterly December 10, 2019 December 23, 2019 $ 0.40 March 5, 2020 Quarterly March 6, 2020 March 20, 2020 $ 0.40 May 7, 2020 Quarterly May 8, 2020 May 21, 2020 $ 0.35 August 5, 2020 Quarterly August 6, 2020 August 20, 2020 $ 0.36 October 1, 2020 Quarterly October 1, 2020 November 12, 2020 $ 0.38 March 4, 2021 Quarterly March 5, 2021 March 19, 2021 $ 0.37 April 29, 2021 Quarterly April 30, 2021 May 13, 2021 $ 0.37 July 19, 2021 Quarterly July 20, 2021 August 12, 2021 $ 0.34 October 28, 2021 Quarterly November 8, 2021 November 22, 2021 $ 0.25 February 24, 2022 Quarterly March 8, 2022 March 22, 2022 $ 0.27 April 28, 2022 Quarterly May 10, 2022 May 24, 2022 $ 0.30 July 28, 2022 Quarterly August 9, 2022 August 23, 2022 $ 0.33 October 27, 2022 Quarterly November 8, 2022 November 22, 2022 $ 0.36 February 23, 2023 Quarterly March 7, 2023 March 21, 2023 $ 0.40 February 23, 2023 Supplemental March 7, 2023 March 21, 2023 $ 0.05 May 2, 2023 Quarterly May 15, 2023 May 31, 2023 $ 0.40 May 2, 2023 Supplemental May 15, 2023 May 31, 2023 $ 0.05 August 1, 2023 Quarterly August 15, 2023 August 31, 2023 $ 0.40 August 1, 2023 Supplemental August 15, 2023 August 31, 2023 $ 0.05 November 1, 2023 Quarterly November 13, 2023 November 28, 2023 $ 0.40 November 1, 2023 Supplemental November 13, 2023 November 28, 2023 $ 0.06 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Schedule of Tax Differences Primarily Related to Non-Deductible Excise Taxes Paid | For the years ended December 31, 2023, 2022, and 2021, the Company reclassified for book purposes amounts arising from permanent book/tax differences primarily related to non-deductible excise taxes paid as follows (in thousands): Years Ended December 31, 2023 2022 2021 Additional paid-in capital $ ( 664 ) $ ( 290 ) $ — Accumulated undistributed earnings 664 290 — |
Summary of Tax Character of Distributions Paid | The tax character of distributions paid for the years ended December 31, 2023, 2022, and 2021 was as follows (in thousands): Years Ended December 31, 2023 2022 2021 Ordinary income $ 73,322 $ 51,593 $ 44,943 Long-term capital gain — — — Return of capital — — — |
Tax Cost Basis and Estimated Aggregate Gross Unrealized Gain (Loss) on Investments for Federal Income Tax Purposes | The following table sets forth the tax cost basis and the estimated aggregate gross unrealized gain (loss) on investments for federal income tax purposes as of and for the years ended December 31, 2023, 2022 and 2021 (in thousands): Years Ended December 31, 2023 2022 2021 Tax cost of investments $ 1,105,481 $ 1,149,902 $ 726,969 Unrealized gain on a tax basis $ 11,239 $ 9,207 $ 23,598 Unrealized loss on a tax basis ( 49,711 ) ( 32,800 ) ( 21,050 ) Net unrealized gain (loss) on a tax basis $ ( 38,472 ) $ ( 23,593 ) $ 2,548 |
Summary of Components of Distributable Earnings on a Tax Basis | At December 31, 2023, 2022 and 2021, the components of distributable earnings on a tax basis detailed below differ from the amounts reflected in the Company’s Consolidated Statements of Assets and Liabilities by temporary and other book/tax differences, primarily relating to the tax treatment of debt modifications, as follows (in thousands): Years Ended December 31, 2023 2022 2021 Undistributed ordinary income $ 17,726 $ 10,473 $ 329 Undistributed capital gains — — — Capital loss carry forwards ( 26,726 ) ( 6,011 ) ( 2,931 ) Late year losses — — — Other accumulated losses ( 165 ) ( 189 ) ( 213 ) Net unrealized gain (loss) on a tax basis ( 38,472 ) ( 23,593 ) 2,548 Accumulated earnings/(deficit) on a tax basis $ ( 47,637 ) $ ( 19,320 ) $ ( 267 ) |
Financial Highlights (Tables)
Financial Highlights (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Investment Company, Financial Highlights [Abstract] | |
Schedule of Financial Highlights | The following table sets forth the financial highlights for the years ended December 31, 2016 through 2023 (in thousands, except for per share data and ratios): Years Ended December 31, 2023 2022 2021 2020 2019 2018 2017 2016 Per Share Data (1) : Net asset value at beginning of period $ 14.22 $ 14.65 $ 14.84 $ 14.58 $ 15.14 $ 14.66 $ 10.38 $ 15.00 Net investment income 1.93 1.46 1.30 1.38 1.95 1.26 ( 0.66 ) ( 83.81 ) Net realized gain (loss) ( 0.45 ) ( 0.03 ) 0.12 ( 0.19 ) 0.03 - - - Net change in unrealized gain (loss) ( 0.39 ) ( 0.64 ) ( 0.09 ) 0.52 ( 0.50 ) - 0.14 ( 0.01 ) Total from investment operations 1.09 0.79 1.33 1.71 1.48 1.26 ( 0.52 ) ( 83.82 ) Distributions ( 1.81 ) ( 1.26 ) ( 1.33 ) ( 1.49 ) ( 2.20 ) ( 0.75 ) - - Offering costs - - ( 0.21 ) - ( 0.03 ) - - - Accretion (dilution) (2) - 0.04 0.02 0.04 0.19 ( 0.03 ) 4.80 79.20 Net asset value at end of period $ 13.50 $ 14.22 $ 14.65 $ 14.84 $ 14.58 $ 15.14 $ 14.66 $ 10.38 Ratio/Supplemental Data: Total return based on net asset value (3) 7.67 % 5.67 % 7.68 % 12.00 % 10.83 % 8.39 % 41.23 % ( 30.80 ) % Total return based on market value (4) 24.50 % 0.23 % N/A N/A N/A N/A N/A N/A Ratio of net investment income to average net assets (5)(6) 13.62 % 10.14 % 8.74 % 9.44 % 12.85 % 8.30 % ( 4.56 ) % ( 595.90 ) % Ratio of total operating expenses to average net assets (5)(6) 14.96 % 8.13 % 5.23 % 4.85 % 6.58 % 6.42 % 12.46 % 595.90 % Ratio of total operating expenses, excluding incentive fees, to average net assets (5) 11.64 % 5.90 % 3.41 % 3.05 % 3.64 % 5.42 % 12.46 % 595.90 % Ratio of net increase (decrease) in net assets resulting from operations to average net assets (5) 7.72 % 5.47 % 8.97 % 11.65 % 9.74 % 8.34 % ( 3.56 ) % ( 595.90 ) % Portfolio turnover rate (7) 18.61 % 19.17 % 52.05 % 26.31 % 35.72 % 14.08 % 206.80 % N/A Net assets at beginning of period $ 576,052 $ 606,195 $ 466,244 $ 376,313 $ 167,369 $ 127,040 $ 3,477 $ 25 Net assets at end of period $ 547,071 $ 576,052 $ 606,195 $ 466,244 $ 376,313 $ 167,369 $ 127,040 $ 3,477 Weighted average net assets $ 574,594 $ 589,669 $ 508,836 $ 403,188 $ 283,774 $ 141,046 $ 40,389 $ 152 Weighted average shares outstanding for the period, basic 40,509,269 40,971,242 34,183,358 27,617,425 18,701,021 9,300,960 2,795,274 10,774 (1) All per share activity, excluding dividends, is calculated based on the weighted-average shares outstanding for the relevant period. (2) Accretion (dilution) represents the effect of issuance of common stock and repurchase of treasury stock. (3) Total return based on net asset value is calculated as the change in net asset value per share during the period plus dividends per share, divided by the beginning net asset values per share. (4) Total return based on market value is calculated as the change in market value per share during the period plus dividends per share, divided by the beginning market value per share. For the periods 2021 and prior, total return based on market value is not applicable as the Company was not yet public for the entirety of the period. (5) The ratios are calculated based on weighted average net assets for the relevant period. (6) The ratio includes incentive fees and as incentive fees are performance driven, the amount expensed in future periods may vary significantly and is dependent on overall investment performance, early terminations, scheduled prepayments and other liquidity events. (7) The portfolio turnover rate for the period is calculated by taking the lesser of investment portfolio purchases or sales during the period, divided by the average investment portfolio value during the period. |
Organization - Additional Infor
Organization - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |
Oct. 25, 2021 | Dec. 31, 2021 | |
Class Of Stock [Line Items] | ||
Proceeds from Issuance of Common Stock | $ 119,294 | |
IPO | ||
Class Of Stock [Line Items] | ||
Issuance of common stock, Shares | 6,850,000 | |
Offering price | $ 14.6 | |
Proceeds from Issuance of Common Stock | $ 93,000 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies - Additional Information (Details) | 1 Months Ended | 12 Months Ended | ||||
Dec. 31, 2016 USD ($) | Oct. 31, 2021 USD ($) | Dec. 31, 2023 USD ($) shares | Dec. 31, 2022 USD ($) Loan shares | Dec. 31, 2021 USD ($) Loan shares | Dec. 31, 2019 USD ($) | |
Summary Of Significant Accounting Policies [Line Items] | ||||||
Investment cost | $ 1,106,849,000 | $ 1,150,602,000 | ||||
Investment owned, fair value | $ 1,067,009,000 | $ 1,126,309,000 | ||||
PIK Income as a % of net investment income | 12.20% | 8% | 4.20% | |||
Payment of excise tax percentage | 4% | |||||
Percentage of minimum beneficial ownership of voting securities for control | 25% | |||||
Percentage of minimum board representation for control | 50% | |||||
Percentage of beneficial ownership of voting securities for affiliation | 5% | |||||
Potentially dilutive securities outstanding | shares | 0 | 0 | 0 | |||
Other comprehensive income | $ 0 | $ 0 | $ 0 | |||
Mojix Inc | ||||||
Summary Of Significant Accounting Policies [Line Items] | ||||||
Number of loans | Loan | 6 | |||||
Cash Equivalents | ||||||
Summary Of Significant Accounting Policies [Line Items] | ||||||
Investments in money market funds | 0 | 5,600,000 | ||||
Second Private Offering | ||||||
Summary Of Significant Accounting Policies [Line Items] | ||||||
Offering cost excluding placement agent fees | $ 600,000 | |||||
Placement agent fees | 200,000 | |||||
Offering cost | 700,000 | |||||
IPO | ||||||
Summary Of Significant Accounting Policies [Line Items] | ||||||
Offering cost | $ 7,000,000 | |||||
Maximum | Second Private Offering | ||||||
Summary Of Significant Accounting Policies [Line Items] | ||||||
Offering cost | $ 600,000 | |||||
Maximum | Initial Private Offering | ||||||
Summary Of Significant Accounting Policies [Line Items] | ||||||
Adjustment to additional paid in capital stock issued issuance costs | $ 1,000,000 | |||||
Minimum | Initial Private Offering | Runway Growth Holdings LLC | ||||||
Summary Of Significant Accounting Policies [Line Items] | ||||||
Adjustment to additional paid in capital stock issued issuance costs | $ 1,000,000 | |||||
Pivot3, Inc. | ||||||
Summary Of Significant Accounting Policies [Line Items] | ||||||
Write off accrued interest | 0 | $ 0 | ||||
Number of loans | Loan | 1 | 1 | ||||
Aggregate principal funded on non-accrual status | $ 19,200,000 | $ 30,300,000 | ||||
Fair value on non-accrual status | $ 9,300,000 | $ 28,300,000 | ||||
Percentage of investment portfolio on non-accrual status | 0.80% | 3.90% | ||||
Cumulative interest on investments | $ 3,900,000 | $ 4,800,000 | ||||
Pivot3, Inc. | Senior Secured Term Loan | ||||||
Summary Of Significant Accounting Policies [Line Items] | ||||||
Investment cost | 18,000,000 | |||||
Investment owned, fair value | 950,000 | |||||
Realized loss | $ 17,000,000 | |||||
Pivot3, Inc. | Cash Interest Income | ||||||
Summary Of Significant Accounting Policies [Line Items] | ||||||
Cumulative interest on investments | 3,600,000 | 4,100,000 | ||||
Pivot3, Inc. | OID Accretion Interest Income | ||||||
Summary Of Significant Accounting Policies [Line Items] | ||||||
Cumulative interest on investments | $ 300,000 | $ 700,000 |
Related Party Agreements and _2
Related Party Agreements and Transactions - Additional Information (Details) | 12 Months Ended | 36 Months Ended | ||
Dec. 31, 2023 USD ($) Component shares | Dec. 31, 2022 USD ($) shares | Dec. 31, 2021 USD ($) | Dec. 31, 2022 USD ($) shares | |
Related Party Transaction [Line Items] | ||||
Gross assets | $ 1,079,153,000 | $ 1,141,766,000 | $ 1,141,766,000 | |
Management fees | 16,711,000 | 11,882,000 | $ 8,989,000 | |
Incentive fees | 19,046,000 | 13,183,000 | 9,232,000 | |
Incentive fees payable | 12,500,000 | 8,808,000 | $ 8,808,000 | |
Administration agreement expenses | $ 2,125,000 | $ 1,838,000 | 1,566,000 | |
Issuance of common stock, value | $ 119,294,000 | |||
Common stock, shares outstanding | shares | 40,509,269 | 40,509,269 | 40,509,269 | |
Scenario, Pre-incentive fee net income less than 2.0% | ||||
Related Party Transaction [Line Items] | ||||
Incentive fees | $ 0 | |||
Advisory Agreement | ||||
Related Party Transaction [Line Items] | ||||
Percentage of base management fee | 1.50% | 1.60% | 1.60% | |
Number of fees components | Component | 2 | |||
Management fees | $ 16,700,000 | $ 11,900,000 | $ 9,000,000 | |
Percentage of incentive fee quarterly catch-up hurdle rate | 2.667% | |||
Percentage of incentive fee annual catch-up hurdle rate | 10.668% | |||
Percentage of pre-incentive fee net investment income | 20% | |||
Incentive fee income | $ 0 | |||
Percentage of aggregate cumulative realized capital gains | 20% | |||
Capital gains fee | $ 0 | |||
Incentive fees | 19,000,000 | 13,200,000 | 9,200,000 | |
Capital gains incentive fee accrued | $ 0 | 0 | $ 0 | |
Percentage of minimum pre-incentive fee net investment income accrued | 20% | |||
Percentage of minimum cumulative net investments realized capital gain loss | 8% | |||
Advisory Agreement | Minimum | ||||
Related Party Transaction [Line Items] | ||||
Percentage of non-affiliate investments | 2% | |||
Percentage of adjusted pre-incentive fee net investment income | 10% | |||
Advisory Agreement | Maximum | ||||
Related Party Transaction [Line Items] | ||||
Percentage of non-affiliate investments | 2% | |||
Percentage of adjusted pre-incentive fee net investment income | 10% | |||
Advisory Agreement | Scenario, more than $500M but less than $1B | ||||
Related Party Transaction [Line Items] | ||||
Percentage of base management fee | 1.60% | |||
Advisory Agreement | Scenario, more than $500M but less than $1B | Minimum | ||||
Related Party Transaction [Line Items] | ||||
Gross assets | $ 500,000,000 | |||
Advisory Agreement | Scenario, more than $500M but less than $1B | Maximum | ||||
Related Party Transaction [Line Items] | ||||
Gross assets | $ 1,000,000,000 | |||
Advisory Agreement | Scenario, up to $500M | ||||
Related Party Transaction [Line Items] | ||||
Percentage of base management fee | 1.75% | |||
Advisory Agreement | Scenario, up to $500M | Maximum | ||||
Related Party Transaction [Line Items] | ||||
Gross assets | $ 500,000,000 | |||
Advisory Agreement | Scenario, more than $1B | ||||
Related Party Transaction [Line Items] | ||||
Percentage of base management fee | 1.50% | |||
Advisory Agreement | Scenario, more than $1B | Minimum | ||||
Related Party Transaction [Line Items] | ||||
Gross assets | $ 1,000,000,000 | |||
Advisory Agreement | Scenario, Minimum | ||||
Related Party Transaction [Line Items] | ||||
Percentage of incentive fee quarterly hurdle rate | 2% | |||
Percentage of incentive fee annual hurdle rate | 8% | |||
Advisory Agreement | Scenario, Pre-incentive fee net income less than 2.0% | ||||
Related Party Transaction [Line Items] | ||||
Percentage of incentive fee quarterly hurdle rate | 2% | |||
Advisory Agreement | Scenario, 80% of the portion of pre-incentive fee net income that is between 2.0% and 2.667% | ||||
Related Party Transaction [Line Items] | ||||
Percentage of incentive fee quarterly catch-up hurdle rate | 2.667% | |||
Percentage of pre-incentive fee net investment income | 80% | |||
Advisory Agreement | Scenario, 80% of the portion of pre-incentive fee net income that is between 2.0% and 2.667% | Maximum | ||||
Related Party Transaction [Line Items] | ||||
Percentage of incentive fee quarterly catch-up hurdle rate | 2.667% | |||
Percentage of incentive fee annual catch-up hurdle rate | 10.668% | |||
Advisory Agreement | Scenario, 20% of portion of pre-incentive fee net income that is over 2.667% | ||||
Related Party Transaction [Line Items] | ||||
Percentage of pre-incentive fee net investment income | 20% | |||
Advisory Agreement | Scenario, 20% of portion of pre-incentive fee net income that is over 2.667% | Minimum | ||||
Related Party Transaction [Line Items] | ||||
Percentage of incentive fee quarterly catch-up hurdle rate | 2.667% | |||
Percentage of incentive fee annual catch-up hurdle rate | 10.668% | |||
Advisory Agreement | Payable in Cash | ||||
Related Party Transaction [Line Items] | ||||
Incentive fees | $ 14,100,000 | 11,000,000 | 7,400,000 | |
Incentive fees payable | 3,300,000 | 3,800,000 | 3,800,000 | |
Advisory Agreement | Deferred Payments | ||||
Related Party Transaction [Line Items] | ||||
Incentive fees | 4,900,000 | 2,200,000 | 1,800,000 | |
Incentive fees payable | $ 9,165,000 | 5,009,000 | 5,009,000 | |
Advisory Agreement | Quarterly Base Rate | Scenario, more than $500M but less than $1B | ||||
Related Party Transaction [Line Items] | ||||
Percentage of base management fee | 0.40% | |||
Advisory Agreement | Quarterly Base Rate | Scenario, up to $500M | ||||
Related Party Transaction [Line Items] | ||||
Percentage of base management fee | 0.4375% | |||
Advisory Agreement | Quarterly Base Rate | Scenario, more than $1B | ||||
Related Party Transaction [Line Items] | ||||
Percentage of base management fee | 0.375% | |||
Administration Agreement | ||||
Related Party Transaction [Line Items] | ||||
Administration agreement expenses | $ 2,100,000 | 1,800,000 | 1,600,000 | |
Administration Agreement | Third-party service provider | ||||
Related Party Transaction [Line Items] | ||||
Administration agreement expenses | 800,000 | 800,000 | 700,000 | |
Administration Agreement | Overhead allocation expense | ||||
Related Party Transaction [Line Items] | ||||
Accrued expenses | 200,000 | 200,000 | 300,000 | 200,000 |
Administration agreement expenses | 1,300,000 | 1,000,000 | 900,000 | |
Administration Agreement | Affiliated Entity | Third-party service provider | ||||
Related Party Transaction [Line Items] | ||||
Accrued expenses | $ 400,000 | $ 400,000 | $ 200,000 | $ 400,000 |
Oaktree Capital Management, L.P | ||||
Related Party Transaction [Line Items] | ||||
Common stock, shares outstanding | shares | 16,492,168 | |||
Percentage of common stock shares issued and outstanding | 40.70% | |||
Percentage of common stock initial capital commitment | 33% | |||
Common stock initial capital commitment | $ 125,000,000 | |||
Oaktree Capital Management, L.P | Initial and Second Private Offering | ||||
Related Party Transaction [Line Items] | ||||
Issuance of common stock, Shares | shares | 14,571,334 | |||
Issuance of common stock, value | $ 219,300,000 | |||
Oaktree Capital Management, L.P | Shares Subject to Proxy Voting | ||||
Related Party Transaction [Line Items] | ||||
Common stock, shares outstanding | shares | 15,588,549 | |||
Percentage of common stock shares issued and outstanding | 38.50% | |||
OCM Growth Holding, LLC | ||||
Related Party Transaction [Line Items] | ||||
Common stock, shares outstanding | shares | 16,473,290 | |||
Oaktree Opportunities Fund Xb Holding, L.P. | ||||
Related Party Transaction [Line Items] | ||||
Common stock, shares outstanding | shares | 18,878 | |||
Oaktree Opportunities Fund Xb Holding, L.P. | Secondary Transactions | ||||
Related Party Transaction [Line Items] | ||||
Issuance of common stock, Shares | shares | 24,100 |
Investments - Additional Inform
Investments - Additional Information (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Investments, All Other Investments [Abstract] | |||
Percentage of beneficial ownership of voting securities for affiliation | 5% | ||
Percentage of minimum beneficial ownership of voting securities for control | 25% | ||
Percentage of minimum board representation for control | 50% | ||
Net realized gain/(loss) | $ (1.4) | $ (0.9) | $ 0.8 |
Net unrealized gain (loss) | $ (5.2) | $ (2.3) | $ 2.8 |
Investments - Transactions Rela
Investments - Transactions Related to Company's Affiliate and Control Investments (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |||||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | ||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Net investment income | $ 78,275 | $ 59,796 | $ 44,492 | |||
Fair Value, Beginning Balance | 1,126,309 | |||||
Net realized gain (loss) on investments | (18,387) | (1,061) | 4,172 | |||
Net change in unrealized gain (loss) on investments | (15,547) | (26,485) | (3,045) | |||
Fair Value, Ending Balance | 1,067,009 | 1,126,309 | ||||
Investment, Identifier [Axis]: Affiliate Investments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Net investment income | 2,105 | 109 | ||||
Fair Value, Beginning Balance | [1] | 2,084 | ||||
Gross Additions | 54,310 | [2] | 6,490 | [3] | ||
Gross Reductions | [4] | (930) | ||||
Net change in unrealized gain (loss) on investments | (4,938) | (3,476) | ||||
Fair Value, Ending Balance | 51,456 | [5] | 2,084 | [1] | ||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Net investment income | 2,105 | 109 | ||||
Gross Additions | 25,897 | [2] | 930 | [3] | ||
Gross Reductions | [4] | $ (930) | ||||
Net change in unrealized gain (loss) on investments | (2,311) | |||||
Fair Value, Ending Balance | [5] | 23,586 | ||||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments Coginiti Corp | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 15, 2022 | |||||
Investment Interest PIK | 9.50% | |||||
Investment Floor Rate | 10.81% | |||||
Net investment income | $ 109 | |||||
Gross Additions | [3] | 930 | ||||
Gross Reductions | [4] | (930) | ||||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments Health Care Technology | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | $ 23,586 | |||||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments Health Care Technology Gynesonics, Inc. Investment Type Senior Secured SOFR+8.75%, 8.00% ceiling, 5.00% ETP Initial Acquisition Date 3/1/2023 Maturity Date 11/30/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 8.75% | |||||
Investment Ceiling Rate | 8% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Nov. 30, 2026 | |||||
Fair Value, Ending Balance | $ 23,586 | |||||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments Senior Secured Gynesonics, Inc. | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 8.75% | |||||
Investment Ceiling Rate | 8% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Nov. 30, 2026 | |||||
Net investment income | $ 2,105 | |||||
Gross Additions | [2] | 25,897 | ||||
Net change in unrealized gain (loss) on investments | (2,311) | |||||
Fair Value, Ending Balance | [5] | 23,586 | ||||
Investment, Identifier [Axis]: Affiliate Investments Debt investments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 23,586 | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | [1] | 1,174 | ||||
Gross Additions | 28,100 | [2] | 4,551 | [3] | ||
Net change in unrealized gain (loss) on investments | (2,380) | (3,377) | ||||
Fair Value, Ending Balance | 26,894 | [5] | 1,174 | [1] | ||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Application Software | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 1,174 | |||||
Fair Value, Ending Balance | 856 | 1,174 | ||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Application Software Coginiti Corp Common Stock Initial Acquisition Date 3/9/2020 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 1,174 | |||||
Fair Value, Ending Balance | 1,174 | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Coginiti Corp | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | [1] | 1,174 | ||||
Gross Additions | [3] | 4,551 | ||||
Net change in unrealized gain (loss) on investments | (3,377) | |||||
Fair Value, Ending Balance | [1] | 1,174 | ||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Coginiti Corp Common Stock | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 1,174 | |||||
Net change in unrealized gain (loss) on investments | (318) | |||||
Fair Value, Ending Balance | 856 | [5] | 1,174 | |||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Gynesonics, Inc. Series A-1 Preferred Stock | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Gross Additions | [2] | 3,100 | ||||
Net change in unrealized gain (loss) on investments | 1,477 | |||||
Fair Value, Ending Balance | [5] | 4,577 | ||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Gynesonics, Inc. Series A-2 Preferred Stock | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Gross Additions | [2] | 25,000 | ||||
Net change in unrealized gain (loss) on investments | (3,539) | |||||
Fair Value, Ending Balance | [5] | 21,461 | ||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 26,894 | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments Application Software Coginiti Corp, Investment Type Equity Common Stock Initial Acquisition Date 3/9/2020 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 856 | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments Health Care Technology | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 26,038 | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments Health Care Technology Gynesonics, Inc. Investment Type Equity Series A-1 Preferred Stock Initial Acquisition Date 10/24/2023 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 4,577 | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments Health Care Technology Gynesonics, Inc. Investment Type Equity Series A-2 Preferred Stock Initial Acquisition Date 3/1/2023 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 21,461 | |||||
Investment, Identifier [Axis]: Affiliate Investments Warrants | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | [1] | 910 | ||||
Gross Additions | 313 | [2] | 1,009 | [3] | ||
Net change in unrealized gain (loss) on investments | (247) | (99) | ||||
Fair Value, Ending Balance | 976 | [5] | 910 | [1] | ||
Investment, Identifier [Axis]: Affiliate Investments Warrants Application Software | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 910 | |||||
Fair Value, Ending Balance | 663 | $ 910 | ||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Application Software Coginiti Corp Common Stock Initial Acquisition Date 3/9/2020 Maturity Date 3/9/2030 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 09, 2030 | |||||
Fair Value, Beginning Balance | $ 910 | |||||
Fair Value, Ending Balance | $ 910 | |||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Application Software Coginiti Corp Investment Type Warrants Common Stock Initial Acquisition Date 3/9/2020 Maturity Date 3/9/2030 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 09, 2030 | |||||
Fair Value, Ending Balance | $ 663 | |||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Coginiti Corp | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Warrant, exercise price | $ 0.01 | |||||
Warrant, expiration date | Mar. 09, 2030 | |||||
Fair Value, Beginning Balance | [1] | 910 | ||||
Gross Additions | [3] | $ 1,009 | ||||
Net change in unrealized gain (loss) on investments | (247) | (99) | ||||
Fair Value, Ending Balance | 663 | [5] | 910 | [1] | ||
Investment, Identifier [Axis]: Affiliate Investments Warrants Gynesonics, Inc. | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Gross Additions | [2] | 313 | ||||
Fair Value, Ending Balance | [5] | 313 | ||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Health Care Technology | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | $ 313 | |||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Health Care Technology Gynesonics, Inc. Investment Type Warrants Success Fee Initial Acquisition Date 3/1/2023 Maturity Date 3/1/2030 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 01, 2030 | |||||
Fair Value, Ending Balance | $ 313 | |||||
Investment, Identifier [Axis]: Control Investments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Net investment income | 4,097 | |||||
Fair Value, Beginning Balance | 9,290 | [1] | 29,131 | |||
Gross Additions | 950 | [2] | 3,548 | [3] | ||
Gross Reductions | (2,158) | [6] | (17,250) | [4] | ||
Net realized gain (loss) on investments | (17,014) | (2,000) | ||||
Net change in unrealized gain (loss) on investments | 9,882 | (4,139) | ||||
Fair Value, Ending Balance | 950 | [5] | 9,290 | [1] | 29,131 | |
Investment, Identifier [Axis]: Control Investments Debt Investments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Net investment income | 4,065 | |||||
Fair Value, Beginning Balance | 9,290 | [1] | 28,261 | |||
Gross Additions | [3] | 3,548 | ||||
Gross Reductions | (2,158) | [6] | (15,204) | [4] | ||
Net realized gain (loss) on investments | (17,014) | |||||
Net change in unrealized gain (loss) on investments | 9,882 | (7,315) | ||||
Fair Value, Ending Balance | 9,290 | [1] | 28,261 | |||
Investment, Identifier [Axis]: Control Investments Debt Investments Data Processing & Outsourced Services | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 9,290 | |||||
Fair Value, Ending Balance | $ 9,290 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Data Processing & Outsourced Services Pivot3, Inc. LIBOR+8.50% PIK, 11.00% floor, 4.00% ETP Initial Acquisition Date 5/13/2019 Maturity Date 1/15/2023 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment Interest ETP | 4% | |||||
Maturity Date | Jan. 15, 2023 | |||||
Investment Interest PIK | 8.50% | |||||
Investment Floor Rate | 11% | |||||
Fair Value, Beginning Balance | 9,290 | |||||
Fair Value, Ending Balance | $ 9,290 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Five | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 12% | |||||
Investment Interest Cash Cap | 12% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Jan. 15, 2025 | |||||
Net investment income | $ 374 | |||||
Fair Value, Beginning Balance | 1,253 | |||||
Gross Additions | [3] | 327 | ||||
Gross Reductions | [4] | (1,400) | ||||
Net change in unrealized gain (loss) on investments | $ (180) | |||||
Fair Value, Ending Balance | 1,253 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Four | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 12% | |||||
Investment Interest Cash Cap | 12% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Jan. 15, 2025 | |||||
Net investment income | $ 185 | |||||
Fair Value, Beginning Balance | 629 | |||||
Gross Additions | [3] | 161 | ||||
Gross Reductions | [4] | (703) | ||||
Net change in unrealized gain (loss) on investments | $ (87) | |||||
Fair Value, Ending Balance | 629 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc One | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 12% | |||||
Investment Interest Cash Cap | 12% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Jan. 15, 2025 | |||||
Net investment income | $ 2,287 | |||||
Fair Value, Beginning Balance | 7,568 | |||||
Gross Additions | [3] | 1,987 | ||||
Gross Reductions | [4] | (8,489) | ||||
Net change in unrealized gain (loss) on investments | $ (1,066) | |||||
Fair Value, Ending Balance | 7,568 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Six | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 12% | |||||
Investment Interest Cash Cap | 12% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Jan. 15, 2025 | |||||
Net investment income | $ 291 | |||||
Fair Value, Beginning Balance | 1,008 | |||||
Gross Additions | [3] | 266 | ||||
Gross Reductions | [4] | (1,090) | ||||
Net change in unrealized gain (loss) on investments | $ (184) | |||||
Fair Value, Ending Balance | 1,008 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Three | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 12% | |||||
Investment Interest Cash Cap | 12% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Jan. 15, 2025 | |||||
Net investment income | $ 184 | |||||
Fair Value, Beginning Balance | 630 | |||||
Gross Additions | [3] | 160 | ||||
Gross Reductions | [4] | (704) | ||||
Net change in unrealized gain (loss) on investments | $ (86) | |||||
Fair Value, Ending Balance | 630 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Two | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 12% | |||||
Investment Interest Cash Cap | 12% | |||||
Investment Interest ETP | 5% | |||||
Maturity Date | Jan. 15, 2025 | |||||
Net investment income | $ 744 | |||||
Fair Value, Beginning Balance | 2,523 | |||||
Gross Additions | [3] | 647 | ||||
Gross Reductions | [4] | (2,818) | ||||
Net change in unrealized gain (loss) on investments | $ (352) | |||||
Fair Value, Ending Balance | 2,523 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Pivot3, Inc | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Nov. 15, 2022 | |||||
Investment Interest PIK | 8.50% | |||||
Investment Floor Rate | 11% | |||||
Fair Value, Beginning Balance | $ 9,290 | [1] | $ 14,650 | |||
Net change in unrealized gain (loss) on investments | (5,360) | |||||
Fair Value, Ending Balance | 9,290 | [1] | 14,650 | |||
Investment, Identifier [Axis]: Control Investments Debt Investments Pivot3, Inc. | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment Interest ETP | 4% | |||||
Maturity Date | Oct. 15, 2023 | |||||
Investment Interest PIK | 8.50% | |||||
Investment Floor Rate | 11% | |||||
Fair Value, Beginning Balance | $ 9,290 | |||||
Gross Reductions | [6] | (2,158) | ||||
Net realized gain (loss) on investments | (17,014) | |||||
Net change in unrealized gain (loss) on investments | 9,882 | |||||
Fair Value, Ending Balance | 9,290 | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Net investment income | 32 | |||||
Fair Value, Beginning Balance | 870 | |||||
Gross Additions | [2] | 950 | ||||
Gross Reductions | [4] | (800) | ||||
Net realized gain (loss) on investments | (2,000) | |||||
Net change in unrealized gain (loss) on investments | 1,930 | |||||
Fair Value, Ending Balance | 950 | [5] | 870 | |||
Investment, Identifier [Axis]: Control Investments Equity Investments Data Processing & Outsourced Services | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 950 | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments Data Processing & Outsourced Services Pivot3, Inc. Investment Type Equity Equity Interest Initial Acquisition Date 12/31/2023 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 950 | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments Mojix, Inc. Series A-1 Preferred Stock | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Net investment income | 32 | |||||
Fair Value, Beginning Balance | 870 | |||||
Gross Reductions | [4] | (800) | ||||
Net change in unrealized gain (loss) on investments | (70) | |||||
Fair Value, Ending Balance | $ 870 | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments Pivot3 Holdings, Inc Series 1 Preferred Stock | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Net realized gain (loss) on investments | (2,000) | |||||
Net change in unrealized gain (loss) on investments | $ 2,000 | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments Pivot3, Inc. | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Gross Additions | [2] | 950 | ||||
Fair Value, Ending Balance | [5] | $ 950 | ||||
Investment, Identifier [Axis]: Control Investments Warrants Mojix, Inc One | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Warrant, exercise price | $ 1.286 | |||||
Warrant, expiration date | Dec. 13, 2030 | |||||
Gross Reductions | [4] | $ (119) | ||||
Net change in unrealized gain (loss) on investments | $ 119 | |||||
Investment, Identifier [Axis]: Control Investments Warrants Mojix, Inc Three | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Warrant, exercise price | $ 5.57338 | |||||
Warrant, expiration date | Dec. 13, 2030 | |||||
Gross Reductions | [4] | $ (829) | ||||
Net change in unrealized gain (loss) on investments | $ 829 | |||||
Investment, Identifier [Axis]: Control Investments Warrants Mojix, Inc Two | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Warrant, exercise price | $ 2.1286 | |||||
Warrant, expiration date | Dec. 13, 2030 | |||||
Gross Reductions | [4] | $ (298) | ||||
Net change in unrealized gain (loss) on investments | 298 | |||||
Investment, Identifier [Axis]: Control Investments, Warrants | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Gross Reductions | [4] | (1,246) | ||||
Net change in unrealized gain (loss) on investments | 1,246 | |||||
Investment, Identifier [Axis]: Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software Blueshift Labs, Inc. Investment Type Senior Secured Interest Rate SOFR+6.25%, 11.25% floor, 2.00% PIK, 1.50% ETP Initial Acquisition Date 12/19/2023 Maturity Date 12/15/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 6.25% | |||||
Investment Interest ETP | 1.50% | |||||
Maturity Date | Dec. 15, 2028 | |||||
Investment Interest PIK | 2% | |||||
Investment Floor Rate | 11.25% | |||||
Fair Value, Ending Balance | $ 25,083 | |||||
Investment, Identifier [Axis]: Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services Interactions Corporation Investment Type Senior Secured Interest Rate SOFR+9.26%, 9.76% floor, 3.4375% ETP Initial Acquisition Date 6/24/2022 Maturity Date 6/15/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 9.26% | |||||
Investment Interest ETP | 3.4375% | |||||
Maturity Date | Jun. 15, 2027 | |||||
Investment Floor Rate | 9.76% | |||||
Fair Value, Ending Balance | $ 39,945 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 1,114,935 | |||||
Fair Value, Ending Balance | 972,604 | 1,114,935 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 1,084,485 | |||||
Fair Value, Ending Balance | 1,084,485 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 954,912 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 176,582 | |||||
Fair Value, Ending Balance | 196,540 | $ 176,582 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software Circadence Corporation Investment Type Senior Secured Interest Rate SOFR+9.50% PIK, 12.26% floor, 7.50% ETP Initial Acquisition Date 12/20/2018 Maturity Date 12/15/2023 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment Interest ETP | 7.50% | |||||
Maturity Date | Dec. 15, 2023 | |||||
Investment Interest PIK | 9.50% | |||||
Investment Floor Rate | 12.26% | |||||
Fair Value, Beginning Balance | $ 17,083 | |||||
Fair Value, Ending Balance | $ 17,083 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software Circadence Corporation Investment Type Senior Secured Interest Rate SOFR+9.50%, 12.26% floor, 10.00% cash cap, 7.50% ETP Initial Acquisition Date 12/20/2018 Maturity Date 3/15/2024 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 9.50% | |||||
Investment Interest Cash Cap | 10% | |||||
Investment Interest ETP | 7.50% | |||||
Maturity Date | Mar. 15, 2024 | |||||
Investment Floor Rate | 12.26% | |||||
Fair Value, Ending Balance | $ 19,028 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software Dtex Systems, Inc. Investment Type Senior Secured Interest Rate SOFR+9.25%, 9.75% floor, 1.75% ETP Initial Acquisition Date 6/1/2021 Maturity Date 6/1/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 9.25% | |||||
Investment Interest ETP | 1.75% | |||||
Maturity Date | Jun. 01, 2025 | |||||
Investment Floor Rate | 9.75% | |||||
Fair Value, Beginning Balance | 10,033 | |||||
Fair Value, Ending Balance | $ 10,033 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software FiscalNote, Inc. Investment Type Senior Secured Interest Rate PRIME+5.00%, 9.00% floor, 1.00% PIK, 4.25% ETP Initial Acquisition Date 10/19/2020 Maturity Date 7/15/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 5% | |||||
Investment Interest ETP | 4.25% | |||||
Maturity Date | Jul. 15, 2027 | |||||
Investment Interest PIK | 1% | |||||
Investment Floor Rate | 9% | |||||
Fair Value, Beginning Balance | $ 64,466 | |||||
Fair Value, Ending Balance | $ 64,466 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software FiscalNote, Inc. Investment Type Senior Secured Interest Rate PRIME+5.00%, 9.00% floor, 1.00% PIK, 5.75% ETP Initial Acquisition Date 10/19/2020 Maturity Date 7/15/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 5% | |||||
Investment Interest ETP | 5.75% | |||||
Maturity Date | Jul. 15, 2027 | |||||
Investment Interest PIK | 1% | |||||
Investment Floor Rate | 9% | |||||
Fair Value, Ending Balance | $ 64,615 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software VTX Intermediate Holdings, Inc. (dba VertexOne) Investment Type Senior Secured Interest Rate SOFR+9.00%, 9.50% floor, 10.00% cash cap, 4.50% ETP Initial Acquisition Date 12/28/2021 Maturity Date 12/28/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 9% | |||||
Investment Interest Cash Cap | 10% | |||||
Investment Interest ETP | 4.50% | |||||
Maturity Date | Dec. 28, 2026 | |||||
Investment Floor Rate | 9.50% | |||||
Fair Value, Ending Balance | $ 87,814 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software VTX Intermediate Holdings, Inc. (dba VertexOne) Investment Type Senior Secured Interest Rate SOFR+9.00%, 9.50% floor, 4.50% ETP Initial Acquisition Date 12/28/2021 Maturity Date 12/28/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 9% | |||||
Investment Interest ETP | 4.50% | |||||
Maturity Date | Dec. 28, 2026 | |||||
Investment Floor Rate | 9.50% | |||||
Fair Value, Beginning Balance | 85,000 | |||||
Fair Value, Ending Balance | $ 85,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Asset Management & Custody Banks | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | $ 7,860 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Asset Management & Custody Banks Betterment Holdings, Inc. Investment Type Senior Secured Interest Rate PRIME+4.50%, 8.50% floor Initial Acquisition Date 10/6/2023 Maturity Date 10/6/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 4.50% | |||||
Maturity Date | Oct. 06, 2027 | |||||
Investment Floor Rate | 8.50% | |||||
Fair Value, Ending Balance | $ 7,860 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Biotechnology | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 39,709 | |||||
Fair Value, Ending Balance | $ 39,709 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Biotechnology Mustang Bio, Inc. Investment Type Senior Secured Interest Rate SOFR+8.75%, 9.25% floor, 3.50% ETP Initial Acquisition Date 3/4/2022 Maturity Date 4/15/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 8.75% | |||||
Investment Interest ETP | 3.50% | |||||
Maturity Date | Apr. 15, 2027 | |||||
Investment Floor Rate | 9.25% | |||||
Fair Value, Beginning Balance | 29,709 | |||||
Fair Value, Ending Balance | $ 29,709 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Biotechnology TRACON Pharmaceuticals, Inc. Investment Type Senior Secured Interest Rate PRIME+5.00%, 8.50% floor, 4.25% ETP Initial Acquisition Date 9/2/2022 Maturity Date 9/1/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 5% | |||||
Investment Interest ETP | 4.25% | |||||
Maturity Date | Sep. 01, 2026 | |||||
Investment Floor Rate | 8.50% | |||||
Fair Value, Beginning Balance | 10,000 | |||||
Fair Value, Ending Balance | $ 10,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 86,182 | |||||
Fair Value, Ending Balance | $ 104,581 | $ 86,182 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services Elevate Services, Inc. Investment Type Senior Secured Interest Rate SOFR+7.50%, 12.78% floor Initial Acquisition Date 7/10/2023 Maturity Date 7/10/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 7.50% | |||||
Maturity Date | Jul. 10, 2027 | |||||
Investment Floor Rate | 12.78% | |||||
Fair Value, Ending Balance | $ 19,424 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services Interactions Corporation Investment Type Senior Secured Interest Rate SOFR+9.26%, 9.76% floor, 3.4375% ETP Initial Acquisition Date 6/24/2022 Maturity Date 6/15/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 9.26% | |||||
Investment Interest ETP | 3.4375% | |||||
Maturity Date | Jun. 15, 2027 | |||||
Investment Floor Rate | 9.76% | |||||
Fair Value, Beginning Balance | 39,504 | |||||
Fair Value, Ending Balance | $ 39,504 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services ShareThis, Inc. Investment Type Senior Secured Interest Rate SOFR+8.25%, 10.86% floor, 3.00% ETP Initial Acquisition Date 8/18/2020 Maturity Date 7/15/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 8.25% | |||||
Investment Interest ETP | 3% | |||||
Maturity Date | Jul. 15, 2025 | |||||
Investment Floor Rate | 10.86% | |||||
Fair Value, Beginning Balance | $ 1,007 | |||||
Fair Value, Ending Balance | $ 1,007 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services ShareThis, Inc. Investment Type Senior Secured Interest Rate SOFR+8.25%, 10.86% floor, 3.00% ETP Initial Acquisition Date 8/18/2020 Maturity Date 9/30/2024 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 8.25% | |||||
Investment Interest ETP | 3% | |||||
Maturity Date | Sep. 30, 2024 | |||||
Investment Floor Rate | 10.86% | |||||
Fair Value, Ending Balance | $ 947 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services ShareThis, Inc. Investment Type Senior Secured Interest Rate SOFR+9.25%, 11.86% floor, 3.00% ETP Initial Acquisition Date 12/3/2018 Maturity Date 7/15/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 9.25% | |||||
Investment Interest ETP | 3% | |||||
Maturity Date | Jul. 15, 2025 | |||||
Investment Floor Rate | 11.86% | |||||
Fair Value, Beginning Balance | $ 21,150 | |||||
Fair Value, Ending Balance | $ 21,150 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services ShareThis, Inc. Investment Type Senior Secured Interest Rate SOFR+9.25%, 11.86% floor, 3.00% ETP Initial Acquisition Date 12/3/2018 Maturity Date 9/30/2024 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 9.25% | |||||
Investment Interest ETP | 3% | |||||
Maturity Date | Sep. 30, 2024 | |||||
Investment Floor Rate | 11.86% | |||||
Fair Value, Ending Balance | $ 19,895 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services Vesta Payment Solutions, Inc. Investment Type Senior Secured Interest Rate SOFR+7.00%, 9.00% floor, 3.00% ETP Initial Acquisition Date 11/29/2022 Maturity Date 11/15/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 7% | 7% | ||||
Investment Interest ETP | 3% | 3% | ||||
Maturity Date | Nov. 15, 2026 | Nov. 15, 2026 | ||||
Investment Floor Rate | 9% | 9% | ||||
Fair Value, Beginning Balance | $ 24,521 | |||||
Fair Value, Ending Balance | 24,370 | $ 24,521 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Education Services | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 25,305 | |||||
Fair Value, Ending Balance | $ 25,796 | $ 25,305 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Education Services Turning Tech Intermediate, Inc. (dba Echo 360, Inc.) Investment Type Senior Secured Interest Rate SOFR+8.50%, 9.00% floor, 13.00% cash cap, 3.00% ETP Initial Acquisition Date 6/22/2021 Maturity Date 12/14/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 8.50% | 8.50% | ||||
Investment Interest Cash Cap | 13% | 13% | ||||
Investment Interest ETP | 3% | 3% | ||||
Maturity Date | Dec. 14, 2025 | Dec. 14, 2025 | ||||
Investment Floor Rate | 9% | 9% | ||||
Fair Value, Beginning Balance | $ 25,305 | |||||
Fair Value, Ending Balance | 25,796 | $ 25,305 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Electronic Equipment & Instruments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 77,551 | |||||
Fair Value, Ending Balance | $ 26,790 | $ 77,551 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Electronic Equipment & Instruments Brivo, Inc. Investment Type Senior Secured Interest Rate SOFR+6.85%, 10.89% floor, 3.00% ETP Initial Acquisition Date 10/20/2022 Maturity Date 10/20/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 6.85% | |||||
Investment Interest ETP | 3% | |||||
Maturity Date | Oct. 20, 2027 | |||||
Investment Floor Rate | 10.89% | |||||
Fair Value, Ending Balance | $ 26,790 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Electronic Equipment & Instruments Brivo,Inc. Investment Type Senior Secured Interest Rate SOFR+6.85%, 10.89% floor, 50% of interest PIK, 3.00% ETP Initial Acquisition Date 10/20/2022 Maturity Date 10/20/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 6.85% | |||||
Investment Interest ETP | 3% | |||||
Maturity Date | Oct. 20, 2027 | |||||
Investment Interest PIK | 50% | |||||
Investment Floor Rate | 10.89% | |||||
Fair Value, Beginning Balance | 43,912 | |||||
Fair Value, Ending Balance | $ 43,912 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Electronic Equipment & Instruments Intellisite Holdings, Inc. (dba Epic IO Technologies, Inc.) Investment Type Senior Secured Interest Rate SOFR+9.75%, 10.25% floor, 2.00% ETP Initial Acquisition Date 12/17/2021 Maturity Date 12/17/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 9.75% | |||||
Investment Interest ETP | 2% | |||||
Maturity Date | Dec. 17, 2025 | |||||
Investment Floor Rate | 10.25% | |||||
Fair Value, Beginning Balance | 33,639 | |||||
Fair Value, Ending Balance | $ 33,639 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Equipment | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 27,149 | |||||
Fair Value, Ending Balance | $ 15,284 | $ 27,149 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Equipment Moximed, Inc. Investment Type Senior Secured Interest Rate PRIME+5.25%, 8.75% floor, 3.50% ETP Initial Acquisition Date 6/24/2022 Maturity Date 7/1/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 5.25% | 5.25% | ||||
Investment Interest ETP | 3.50% | 3.50% | ||||
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027 | ||||
Investment Floor Rate | 8.75% | 8.75% | ||||
Fair Value, Beginning Balance | $ 14,772 | |||||
Fair Value, Ending Balance | 15,284 | $ 14,772 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Equipment Revelle Aesthetics, Inc. Investment Type Senior Secured Interest Rate PRIME+5.50%, 8.75% floor, 4.00% ETP Initial Acquisition Date 3/30/2022 Maturity Date 4/1/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 5.50% | |||||
Investment Interest ETP | 4% | |||||
Maturity Date | Apr. 01, 2027 | |||||
Investment Floor Rate | 8.75% | |||||
Fair Value, Beginning Balance | 12,377 | |||||
Fair Value, Ending Balance | $ 12,377 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 225,915 | |||||
Fair Value, Ending Balance | 126,204 | $ 225,915 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Allurion Technologies, Inc. Investment Type Senior Secured Interest Rate PRIME+6.44%, 9.50% floor, 3.00% ETP Initial Acquisition Date 12/30/2021 Maturity Date 12/30/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 6.44% | |||||
Investment Interest ETP | 3% | |||||
Maturity Date | Dec. 30, 2026 | |||||
Investment Floor Rate | 9.50% | |||||
Fair Value, Beginning Balance | $ 54,715 | |||||
Fair Value, Ending Balance | $ 54,715 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology EBR Systems, Inc. Investment Type Senior Secured Interest Rate PRIME+4.90%, 8.90% floor, 4.50% ETP Initial Acquisition Date 6/30/2022 Maturity Date 6/15/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 4.90% | 4.90% | ||||
Investment Interest ETP | 4.50% | 4.50% | ||||
Maturity Date | Jun. 15, 2027 | Jun. 15, 2027 | ||||
Investment Floor Rate | 8.90% | 8.90% | ||||
Fair Value, Beginning Balance | $ 19,648 | |||||
Fair Value, Ending Balance | 40,337 | $ 19,648 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Gynesonics, Inc. Investment Type Senior Secured Interest Rate SOFR+8.75%, 9.25% floor, 3.50% ETP Initial Acquisition Date 12/1/2020 Maturity Date 12/1/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 8.75% | |||||
Investment Interest ETP | 3.50% | |||||
Maturity Date | Dec. 01, 2025 | |||||
Investment Floor Rate | 9.25% | |||||
Fair Value, Beginning Balance | 50,022 | |||||
Fair Value, Ending Balance | $ 50,022 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Mingle Healthcare Solutions, Inc. Investment Type Senior Secured Interest Rate SOFR+9.50%, 12.01% floor, .25% PIK, 10.50% ETP Initial Acquisition Date 8/15/2018 Maturity Date 12/15/2023 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 9.50% | |||||
Investment Interest ETP | 10.50% | |||||
Maturity Date | Dec. 15, 2023 | |||||
Investment Interest PIK | 0.25% | |||||
Investment Floor Rate | 12.01% | |||||
Fair Value, Beginning Balance | $ 3,821 | |||||
Fair Value, Ending Balance | $ 3,821 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Mingle Healthcare Solutions, Inc. Investment Type Senior Secured Interest Rate SOFR+9.75%, 12.26% floor, 10.50% ETP Initial Acquisition Date 8/15/2018 Maturity Date 12/15/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 9.75% | |||||
Investment Interest ETP | 10.50% | |||||
Maturity Date | Dec. 15, 2026 | |||||
Investment Floor Rate | 12.26% | |||||
Fair Value, Ending Balance | $ 3,791 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Nalu Medical, Inc. Investment Type Senior Secured Interest Rate PRIME+2.70%, 6.70% floor, 2.00% PIK, 4.50% ETP Initial Acquisition Date 10/12/2022 Maturity Date 10/12/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 2.70% | 2.70% | ||||
Investment Interest ETP | 4.50% | 4.50% | ||||
Maturity Date | Oct. 12, 2027 | Oct. 12, 2027 | ||||
Investment Interest PIK | 2% | 2% | ||||
Investment Floor Rate | 6.70% | 6.70% | ||||
Fair Value, Beginning Balance | $ 19,756 | |||||
Fair Value, Ending Balance | $ 21,191 | $ 19,756 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Route 92 Medical, Inc. Investment Type Senior Secured Interest Rate SOFR+8.48%, 8.98% floor, 3.95% ETP Initial Acquisition Date 8/17/2021 Maturity Date 7/1/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 8.48% | 8.48% | ||||
Investment Interest ETP | 3.95% | 3.95% | ||||
Maturity Date | Jul. 01, 2026 | Jul. 01, 2026 | ||||
Investment Floor Rate | 8.98% | 8.98% | ||||
Fair Value, Beginning Balance | $ 12,843 | |||||
Fair Value, Ending Balance | $ 35,435 | $ 12,843 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology SetPoint Medical Corporation Investment Type Senior Secured Interest Rate SOFR+5.75%, 9.00% floor, 4.00% ETP Initial Acquisition Date 12/29/2022 Maturity Date 12/1/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 5.75% | 5.75% | ||||
Investment Interest ETP | 4% | 4% | ||||
Maturity Date | Dec. 01, 2027 | Dec. 01, 2027 | ||||
Investment Floor Rate | 9% | 9% | ||||
Fair Value, Beginning Balance | $ 24,802 | |||||
Fair Value, Ending Balance | 25,450 | $ 24,802 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology VERO Biotech LLC Investment Type Senior Secured Interest Rate SOFR+9.05%, 9.55% floor, 3.00% ETP Initial Acquisition Date 12/29/2020 Maturity Date 12/1/2024 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 9.05% | |||||
Investment Interest ETP | 3% | |||||
Maturity Date | Dec. 01, 2024 | |||||
Investment Floor Rate | 9.55% | |||||
Fair Value, Beginning Balance | 40,308 | |||||
Fair Value, Ending Balance | $ 40,308 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Human Resource & Employment Services | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 96,478 | |||||
Fair Value, Ending Balance | $ 112,006 | $ 96,478 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Human Resource & Employment Services CloudPay, Inc. Investment Type Senior Secured Interest Rate PRIME+6.25%, 10.25% floor, 2.00% ETP Initial Acquisition Date 9/26/2022 Maturity Date 8/17/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 6.25% | 6.25% | ||||
Investment Interest ETP | 2% | 2% | ||||
Maturity Date | Aug. 17, 2027 | Aug. 17, 2027 | ||||
Investment Floor Rate | 10.25% | 10.25% | ||||
Fair Value, Beginning Balance | $ 59,693 | |||||
Fair Value, Ending Balance | $ 75,465 | $ 59,693 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Human Resource & Employment Services Snagajob.com, Inc. Investment Type Senior Secured Interest Rate SOFR+8.50% PIK, 9.00% floor, 2.75% ETP Initial Acquisition Date 9/29/2021 Maturity Date 9/1/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment Interest ETP | 2.75% | |||||
Maturity Date | Sep. 01, 2025 | |||||
Investment Interest PIK | 8.50% | |||||
Investment Floor Rate | 9% | |||||
Fair Value, Ending Balance | $ 36,541 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Human Resource & Employment Services Snagajob.com, Inc. Investment Type Senior Secured Interest Rate SOFR+8.50%, 9.00% floor, 9.00% cash cap, 2.75% ETP Initial Acquisition Date 9/29/2021 Maturity Date 9/1/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 8.50% | |||||
Investment Interest Cash Cap | 9% | |||||
Investment Interest ETP | 2.75% | |||||
Maturity Date | Sep. 01, 2025 | |||||
Investment Floor Rate | 9% | |||||
Fair Value, Beginning Balance | 36,785 | |||||
Fair Value, Ending Balance | $ 36,785 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 55,853 | |||||
Fair Value, Ending Balance | $ 55,309 | $ 55,853 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail Madison Reed, Inc. Investment Type Senior Secured Interest Rate PRIME+4.75%, 11.00% floor, 11.00% cash cap, 3.00% ETP Initial Acquisition Date 12/16/2022 Maturity Date 12/16/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 4.75% | |||||
Investment Interest Cash Cap | 11% | |||||
Investment Interest ETP | 3% | |||||
Maturity Date | Dec. 16, 2026 | |||||
Investment Floor Rate | 11% | |||||
Fair Value, Ending Balance | $ 10,847 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail Madison Reed, Inc. Investment Type Senior Secured Interest Rate PRIME+4.75%, 11.00% floor, 3.00% ETP Initial Acquisition Date 12/16/2022 Maturity Date 12/16/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 4.75% | |||||
Investment Interest ETP | 3% | |||||
Maturity Date | Dec. 16, 2026 | |||||
Investment Floor Rate | 11% | |||||
Fair Value, Beginning Balance | 9,353 | |||||
Fair Value, Ending Balance | $ 9,353 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail Marley Spoon AG Investment Type Senior Secured Interest Rate SOFR+8.50%, 1.25% PIK, 9.26% floor Initial Acquisition Date 6/30/2021 Maturity Date 6/15/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 8.50% | |||||
Maturity Date | Jun. 15, 2025 | |||||
Investment Interest PIK | 1.25% | |||||
Investment Floor Rate | 9.26% | |||||
Fair Value, Beginning Balance | $ 46,500 | |||||
Fair Value, Ending Balance | $ 46,500 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail Marley Spoon SE Investment Type Senior Secured Interest Rate SOFR+7.50%, 8.26% floor, 1.25% PIK Initial Acquisition Date 6/30/2021 Maturity Date 6/15/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 7.50% | |||||
Maturity Date | Jun. 15, 2026 | |||||
Investment Interest PIK | 1.25% | |||||
Investment Floor Rate | 8.26% | |||||
Fair Value, Ending Balance | $ 44,462 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 146,535 | |||||
Fair Value, Ending Balance | $ 96,820 | $ 146,535 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Bombora, Inc. Investment Type Senior Secured Interest Rate SOFR+4.75%, 6.75% floor, 3.25% PIK, 0.96% ETP Initial Acquisition Date 12/26/2023 Maturity Date 1/15/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 4.75% | |||||
Investment Interest ETP | 0.96% | |||||
Maturity Date | Jan. 15, 2028 | |||||
Investment Interest PIK | 3.25% | |||||
Investment Floor Rate | 6.75% | |||||
Fair Value, Ending Balance | $ 27,879 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Bombora, Inc. Investment Type Senior Secured Interest Rate SOFR+5.00%, 5.76% floor, 3.75% PIK, 2.00% ETP Initial Acquisition Date 3/31/2021 Maturity Date 3/31/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 5% | |||||
Investment Interest ETP | 2% | |||||
Maturity Date | Mar. 31, 2025 | |||||
Investment Interest PIK | 3.75% | |||||
Investment Floor Rate | 5.76% | |||||
Fair Value, Beginning Balance | 21,337 | |||||
Fair Value, Ending Balance | $ 21,337 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Fidelis Cybersecurity, Inc. Investment Type Senior Secured Interest Rate SOFR+11.00%, 12.00% floor, 2.39% ETP Initial Acquisition Date 3/25/2022 Maturity Date 5/13/2024 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 11% | |||||
Investment Interest ETP | 2% | |||||
Maturity Date | May 13, 2024 | |||||
Investment Floor Rate | 12% | |||||
Fair Value, Beginning Balance | 8,692 | |||||
Fair Value, Ending Balance | $ 8,692 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Fidelis Cybersecurity, Inc. Investment Type Senior Secured Interest Rate SOFR+11.00%, 12.00% floor, 2.39% ETP Initial Acquisition Date 5/13/2021 Maturity Date 5/13/2024 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 11% | |||||
Investment Interest ETP | 2.39% | |||||
Maturity Date | May 13, 2024 | |||||
Investment Floor Rate | 12% | |||||
Fair Value, Beginning Balance | 11,857 | |||||
Fair Value, Ending Balance | $ 11,857 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services INRIX, Inc. Investment Type Senior Secured Interest Rate SOFR+9.00%, 9.76% floor, 2.50% ETP Initial Acquisition Date 11/15/2021 Maturity Date 11/15/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 9% | |||||
Investment Interest ETP | 2.50% | |||||
Maturity Date | Nov. 15, 2025 | |||||
Investment Floor Rate | 9.76% | |||||
Fair Value, Beginning Balance | $ 45,329 | |||||
Fair Value, Ending Balance | $ 45,329 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Skillshare, Inc. Investment Type Senior Secured Interest Rate SOFR+6.50%, 10.72% floor, 3.00% ETP Initial Acquisition Date 11/8/2022 Maturity Date 11/8/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 6.50% | 6.50% | ||||
Investment Interest ETP | 3% | 3% | ||||
Maturity Date | Nov. 08, 2026 | Nov. 08, 2026 | ||||
Investment Floor Rate | 10.72% | 10.72% | ||||
Fair Value, Beginning Balance | $ 24,414 | |||||
Fair Value, Ending Balance | 29,183 | $ 24,414 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Synack, Inc. Investment Type Senior Secured Interest Rate PRIME+4.25%, 8.25% floor Initial Acquisition Date 6/30/2022 Maturity Date 6/30/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 4.25% | |||||
Maturity Date | Jun. 30, 2027 | |||||
Investment Floor Rate | 8.25% | |||||
Fair Value, Beginning Balance | $ 34,906 | |||||
Fair Value, Ending Balance | $ 34,906 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Synack, Inc. Investment Type Senior Secured Interest Rate SOFR+7.00%, 11.07% floor, 1.00% ETP Initial Acquisition Date 12/29/2023 Maturity Date 12/29/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 7% | |||||
Investment Interest ETP | 1% | |||||
Maturity Date | Dec. 29, 2028 | |||||
Investment Floor Rate | 11.07% | |||||
Fair Value, Ending Balance | $ 39,758 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Property & Casualty Insurance | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 49,143 | |||||
Fair Value, Ending Balance | $ 74,767 | $ 49,143 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Property & Casualty Insurance Kin Insurance, Inc. Investment Type Senior Secured Interest Rate PRIME+6.25%, 12.50% floor, 3.00% ETP Initial Acquisition Date 9/26/2022 Maturity Date 9/15/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 6.25% | 6.25% | ||||
Investment Interest ETP | 3% | 3% | ||||
Maturity Date | Sep. 15, 2026 | Sep. 15, 2026 | ||||
Investment Floor Rate | 12.50% | 12.50% | ||||
Fair Value, Beginning Balance | $ 49,143 | |||||
Fair Value, Ending Balance | 74,767 | $ 49,143 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 78,083 | |||||
Fair Value, Ending Balance | $ 112,955 | $ 78,083 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software 3PL Central LLC Investment Type Senior Secured Interest Rate SOFR+4.50%, 6.50 floor, 2.50% PIK, 2.00% ETP Initial Acquisition Date 11/9/2022 Maturity Date 11/9/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 4.50% | 4.50% | ||||
Investment Interest ETP | 2% | 2% | ||||
Maturity Date | Nov. 09, 2027 | Nov. 09, 2027 | ||||
Investment Interest PIK | 2.50% | 2.50% | ||||
Investment Floor Rate | 6.50% | 6.50% | ||||
Fair Value, Beginning Balance | $ 64,429 | |||||
Fair Value, Ending Balance | $ 69,066 | $ 64,429 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software Dejero Labs Inc. Investment Type Second Lien Interest Rate SOFR+8.00%, 8.50% floor, 2.00% PIK, 3.00% ETP Initial Acquisition Date 12/22/2021 Maturity Date 12/22/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 8% | |||||
Investment Interest ETP | 3% | |||||
Maturity Date | Dec. 22, 2025 | |||||
Investment Interest PIK | 2% | |||||
Investment Floor Rate | 8.50% | |||||
Fair Value, Ending Balance | $ 14,399 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software Dejero Labs Inc. Investment Type Senior Lien Interest Rate SOFR+5.00%, 5.50 floor, 5.00% PIK, 3.00% ETP Initial Acquisition Date 12/22/2021 Maturity Date 12/22/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 5% | |||||
Investment Interest ETP | 3% | |||||
Maturity Date | Dec. 22, 2025 | |||||
Investment Interest PIK | 5% | |||||
Investment Floor Rate | 5.50% | |||||
Fair Value, Beginning Balance | $ 13,654 | |||||
Fair Value, Ending Balance | $ 13,654 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software Linxup, LLC Investment Type Senior Secured Interest Rate PRIME+3.25%, 11.75% floor, 2.25% ETP Initial Acquisition Date 11/03/2023 Maturity Date 11/15/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Investment, Spread | 3.25% | |||||
Investment Interest ETP | 2.25% | |||||
Maturity Date | Nov. 15, 2027 | |||||
Investment Floor Rate | 11.75% | |||||
Fair Value, Ending Balance | $ 29,490 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 14,605 | |||||
Fair Value, Ending Balance | 5,721 | 14,605 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Advertising | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 136 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Advertising Minute Media Inc. Investment Type Equity Common Stock Initial Acquisition Date 12/13/2023 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 16 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Advertising Minute Media Inc. Investment Type Equity Preferred Stock Initial Acquisition Date 12/13/2023 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 120 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Application Software | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 1,769 | |||||
Fair Value, Ending Balance | 390 | 1,769 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Application Software Aria Systems, Inc. Investment Type Equity Series G Preferred Stock Initial Acquisition Date 7/10/2018 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 347 | |||||
Fair Value, Ending Balance | 127 | 347 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Application Software FiscalNote, Inc. Investment Type Equity Common Stock Initial Acquisition Date 10/19/2020 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 1,422 | |||||
Fair Value, Ending Balance | 263 | 1,422 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Health Care Technology | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 12,335 | |||||
Fair Value, Ending Balance | 3,553 | 12,335 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Health Care Technology CareCloud, Inc. Investment Type Equity 11% Series A Cumulative Redeemable Perpetual Initial Acquisition Date 1/8/2020 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 12,335 | |||||
Fair Value, Ending Balance | 12,335 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Health Care Technology CareCloud, Inc. Investment Type Equity 11% Series A Cumulative Redeemable Perpetual Preferred Stock Initial Acquisition Date 1/8/2020 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 3,553 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Human Resource & Employment Services | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | $ 1,357 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Human Resource & Employment Services Snagajob.com, Inc. Investment Type Equity Convertible Note Initial Acquisition Date 10/26/2023 Maturity Date 12/31/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 31, 2026 | |||||
Fair Value, Ending Balance | $ 1,357 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Internet & Direct Marketing Retail | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 125 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Internet & Direct Marketing Retail Marley Spoon SE Investment Type Equity Common Stock Initial Acquisition Date 7/7/2023 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 125 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Technology Hardware, Storage & Peripherals | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 501 | |||||
Fair Value, Ending Balance | 160 | 501 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Technology Hardware, Storage & Peripherals Quantum Corporation Investment Type Equity Common Stock Initial Acquisition Date 8/13/2021 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 501 | |||||
Fair Value, Ending Balance | 160 | 501 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 15,845 | |||||
Fair Value, Ending Balance | 11,971 | $ 15,845 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Advertising STN Video Inc. Class B Non-Voting Stock Initial Acquisition Date 6/30/2017 Maturity Date 6/30/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 30, 2027 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 3,649 | |||||
Fair Value, Ending Balance | $ 2,196 | $ 3,649 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software 3DNA Corp. (dba NationBuilder) Investment Type Warrants Series C-1 Preferred Stock Initial Acquisition Date 12/28/2018 Maturity Date 12/28/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 28, 2028 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software 3DNA Corp. (dba NationBuilder) Series C-1 Preferred Stock Initial Acquisition Date 12/28/2018 Maturity Date 12/28/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 28, 2028 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Aria Systems, Inc. Investment Type Warrants Series G Preferred Stock Initial Acquisition Date 6/29/2018 Maturity Date 6/29/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 29, 2028 | |||||
Fair Value, Ending Balance | $ 1,048 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Aria Systems, Inc. Series G Preferred Stock Initial Acquisition Date 6/29/2018 Maturity Date 6/29/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 29, 2028 | |||||
Fair Value, Beginning Balance | 2,865 | |||||
Fair Value, Ending Balance | $ 2,865 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Blueshift Labs, Inc. Investment Type Warrants Success fee Initial Acquisition Date 12/19/2023 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | $ 167 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Investment Type Warrants Series A-6 Preferred Stock Initial Acquisition Date 10/31/2019 Maturity Date 10/31/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Oct. 31, 2029 | |||||
Fair Value, Ending Balance | $ 12 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Investment Type Warrants Series A-6 Preferred Stock Initial Acquisition Date 12/20/2018 Maturity Date 12/20/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 20, 2028 | |||||
Fair Value, Ending Balance | $ 48 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Investment Type Warrants Success fee Initial Acquisition Date 12/21/2023 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 283 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Series A-6 Preferred Stock Initial Acquisition Date 10/31/2019 Maturity Date 10/31/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Oct. 31, 2029 | |||||
Fair Value, Beginning Balance | 22 | |||||
Fair Value, Ending Balance | $ 22 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Series A-6 Preferred Stock Initial Acquisition Date 12/20/2018 Maturity Date 12/20/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 20, 2028 | |||||
Fair Value, Beginning Balance | $ 87 | |||||
Fair Value, Ending Balance | $ 87 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Dtex Systems, Inc. Investment Type Warrants Series C-Prime Preferred Stock Initial Acquisition Date 6/1/2018 Maturity Date 6/1/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 01, 2025 | |||||
Fair Value, Ending Balance | $ 233 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Dtex Systems, Inc. Series C-Prime Preferred Stock Initial Acquisition Date 6/1/2018 Maturity Date 6/1/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 01, 2025 | |||||
Fair Value, Beginning Balance | 214 | |||||
Fair Value, Ending Balance | $ 214 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Dtex Systems, Inc. Series C-Prime Preferred Stock Initial Acquisition Date 7/11/2019 Maturity Date 7/11/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jul. 11, 2026 | |||||
Fair Value, Beginning Balance | $ 356 | |||||
Fair Value, Ending Balance | $ 356 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Dtex Systems, Inc.Investment Type Warrants Series C-Prime Preferred Stock Initial Acquisition Date 7/11/2019 Maturity Date 7/11/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jul. 11, 2026 | |||||
Fair Value, Ending Balance | $ 389 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software FiscalNote, Inc. Earnout Initial Acquisition Date 7/29/2022 Maturity Date 7/29/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jul. 29, 2027 | |||||
Fair Value, Beginning Balance | $ 105 | |||||
Fair Value, Ending Balance | $ 105 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software FiscalNote, Inc. Investment Type Warrants Earnout Initial Acquisition Date 7/29/2022 Maturity Date 7/29/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jul. 29, 2027 | |||||
Fair Value, Ending Balance | $ 16 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Porch Group, Inc. Earnout Initial Acquisition Date 12/23/2020 Maturity Date 12/23/2023 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 23, 2023 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Asset Management & Custody Banks | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | $ 161 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Asset Management & Custody Banks Betterment Holdings, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 10/6/2023 Maturity Date 10/6/2033 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Oct. 06, 2033 | |||||
Fair Value, Ending Balance | $ 146 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Asset Management & Custody Banks Betterment Holdings, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 10/6/2023 Maturity Date 10/6/2033 one | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Oct. 06, 2033 | |||||
Fair Value, Ending Balance | $ 15 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 216 | |||||
Fair Value, Ending Balance | 51 | $ 216 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology Mustang Bio, Inc. Common Stock Initial Acquisition Date 3/4/2022 Maturity Date 3/4/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 04, 2032 | |||||
Fair Value, Beginning Balance | $ 59 | |||||
Fair Value, Ending Balance | $ 59 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology Mustang Bio, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 3/4/2022 Maturity Date 3/4/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 04, 2032 | |||||
Fair Value, Ending Balance | $ 39 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology TRACON Pharmaceuticals, Inc. Common Stock Initial Acquisition Date 9/2/2022 Maturity Date 9/2/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Sep. 02, 2032 | |||||
Fair Value, Beginning Balance | $ 157 | |||||
Fair Value, Ending Balance | $ 157 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology TRACON Pharmaceuticals, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 9/2/2022 Maturity Date 9/2/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Sep. 02, 2032 | |||||
Fair Value, Ending Balance | $ 12 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Computer & Electronics Retail | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | $ 68 | |||||
Fair Value, Ending Balance | $ 68 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Computer & Electronics Retail Massdrop, Inc. Investment Type Warrants Series B Preferred Stock Initial Acquisition Date 7/22/2019 Maturity Date 7/22/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jul. 22, 2029 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Computer & Electronics Retail Massdrop, Inc. Series B Preferred Stock Initial Acquisition Date 7/22/2019 Maturity Date 7/22/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jul. 22, 2029 | |||||
Fair Value, Beginning Balance | $ 68 | |||||
Fair Value, Ending Balance | $ 68 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 1,932 | |||||
Fair Value, Ending Balance | $ 1,254 | $ 1,932 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services Elevate Services, Inc. Investment Type Warrants Series C Preferred Stock Initial Acquisition Date 7/10/2023 Maturity Date 7/10/2033 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jul. 10, 2033 | |||||
Fair Value, Ending Balance | $ 384 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services Interactions Corporation Common Stock Initial Acquisition Date 6/24/2022 Maturity Date 6/24/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 24, 2032 | |||||
Fair Value, Beginning Balance | $ 204 | |||||
Fair Value, Ending Balance | $ 204 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services Interactions Corporation Investment Type Warrants Common Stock Initial Acquisition Date 6/24/2022 Maturity Date 6/24/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 24, 2032 | |||||
Fair Value, Ending Balance | $ 67 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services ShareThis, Inc. Investment Type Warrants Series D-3 Preferred Stock Initial Acquisition Date 12/3/2018 Maturity Date 12/3/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 03, 2028 | |||||
Fair Value, Ending Balance | $ 803 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services ShareThis, Inc. Series D-3 Preferred Stock Initial Acquisition Date 12/3/2018 Maturity Date 12/3/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 03, 2028 | |||||
Fair Value, Beginning Balance | 1,728 | |||||
Fair Value, Ending Balance | $ 1,728 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 563 | |||||
Fair Value, Ending Balance | $ 745 | $ 563 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments Brivo, Inc. Investment Type Warrants Series A-2 Preferred Stock Initial Acquisition Date 10/20/2022 Maturity Date 10/20/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Oct. 20, 2032 | |||||
Fair Value, Ending Balance | $ 322 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments Brivo, Inc. Series A-2 Preferred Stock Initial Acquisition Date 10/20/2022 Maturity Date 10/20/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Oct. 20, 2032 | |||||
Fair Value, Beginning Balance | $ 107 | |||||
Fair Value, Ending Balance | $ 107 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments Epic IO Technologies, Inc. Investment Type Warrants Success fee Initial Acquisition Date 12/17/2021 Maturity Date 12/17/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 17, 2028 | |||||
Fair Value, Ending Balance | $ 423 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments Epic IO Technologies, Inc. Success fee Initial Acquisition Date 12/17/2021 Maturity Date 12/17/2024 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 17, 2024 | |||||
Fair Value, Beginning Balance | 456 | |||||
Fair Value, Ending Balance | $ 456 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 284 | |||||
Fair Value, Ending Balance | $ 240 | $ 284 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment Moximed, Inc. Investment Type Warrants Series C Preferred Stock Initial Acquisition Date 6/24/2022 Maturity Date 6/24/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 24, 2032 | |||||
Fair Value, Ending Balance | $ 138 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment Moximed, Inc. Series C Preferred Stock Initial Acquisition Date 6/24/2022 Maturity Date 6/24/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 24, 2032 | |||||
Fair Value, Beginning Balance | $ 163 | |||||
Fair Value, Ending Balance | $ 163 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment Revelle Aesthetics, Inc. Investment Type Warrants Series A-2 Preferred Stock Initial Acquisition Date 3/30/2022 Maturity Date 3/30/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 30, 2032 | |||||
Fair Value, Ending Balance | $ 102 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment Revelle Aesthetics, Inc. Series A-2 Preferred Stock Initial Acquisition Date 3/30/2022 Maturity Date 3/30/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 30, 2032 | |||||
Fair Value, Beginning Balance | 121 | |||||
Fair Value, Ending Balance | $ 121 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 2,594 | |||||
Fair Value, Ending Balance | $ 2,506 | $ 2,594 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 09/15/2022 Maturity Date 1/22/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jan. 22, 2025 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 3/30/2021 Maturity Date 1/22/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jan. 22, 2025 | |||||
Fair Value, Ending Balance | $ 15 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 6/14/2022 Maturity Date 1/22/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jan. 22, 2025 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Investment Type Warrants Earnout Initial Acquisition Date 8/2/2023 Maturity Date 8/1/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Aug. 01, 2028 | |||||
Fair Value, Ending Balance | $ 77 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Series C Preferred Stock Initial Acquisition Date 3/30/2021 Maturity Date 3/30/2031 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 30, 2031 | |||||
Fair Value, Beginning Balance | 632 | |||||
Fair Value, Ending Balance | $ 632 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Series D-1 Preferred Stock Initial Acquisition Date 6/14/2022 Maturity Date 3/30/2031 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 30, 2031 | |||||
Fair Value, Beginning Balance | $ 259 | |||||
Fair Value, Ending Balance | $ 259 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology CareCloud, Inc. Common Stock Initial Acquisition Date 1/8/2020 Maturity Date 1/8/2023 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jan. 08, 2023 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology EBR Systems, Inc. Investment Type Warrants Success fee Initial Acquisition Date 6/30/2022 Maturity Date 6/30/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 30, 2032 | |||||
Fair Value, Ending Balance | $ 690 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology EBR Systems, Inc. Success fee Initial Acquisition Date 6/30/2022 Maturity Date 6/30/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 30, 2032 | |||||
Fair Value, Beginning Balance | 305 | |||||
Fair Value, Ending Balance | $ 305 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Gynesonics, Inc. Series G Convertible Preferred Stock Initial Acquisition Date 11/19/2021 Maturity Date 11/19/2031 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Nov. 19, 2031 | |||||
Fair Value, Beginning Balance | $ 446 | |||||
Fair Value, Ending Balance | $ 446 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Mingle Healthcare Solutions, Inc. Investment Type Warrants Series CC Preferred Stock Initial Acquisition Date 8/15/2018 Maturity Date 8/15/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Aug. 15, 2028 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Mingle Healthcare Solutions, Inc. Series CC Preferred Stock Initial Acquisition Date 8/15/2018 Maturity Date 8/15/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Aug. 15, 2028 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Nalu Medical, Inc. Investment Type Warrants Series D-2 Preferred Stock Initial Acquisition Date 10/12/2022 Maturity Date 10/12/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Oct. 12, 2032 | |||||
Fair Value, Ending Balance | $ 99 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Nalu Medical, Inc. Series D-2 Preferred Stock Initial Acquisition Date 10/12/2022 Maturity Date 10/12/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Oct. 12, 2032 | |||||
Fair Value, Beginning Balance | $ 137 | |||||
Fair Value, Ending Balance | $ 137 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Route 92 Medical, Inc. Investment Type Warrants Success Fee Initial Acquisition Date 8/17/2021 Maturity Date 8/17/2031 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Aug. 17, 2031 | |||||
Fair Value, Ending Balance | $ 897 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Route 92 Medical, Inc. Success fee Initial Acquisition Date 8/17/2021 Maturity Date 8/17/2031 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Aug. 17, 2031 | |||||
Fair Value, Beginning Balance | $ 297 | |||||
Fair Value, Ending Balance | $ 297 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology SetPoint Medical Corporation Investment Type Warrants Series B Preferred Stock Initial Acquisition Date 12/29/2022 Maturity Date 12/29/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 29, 2032 | |||||
Fair Value, Ending Balance | $ 199 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology SetPoint Medical Corporation Investment Type Warrants Series B Preferred Stock Initial Acquisition Date 6/29/2021 Maturity Date 6/29/2031 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 29, 2031 | |||||
Fair Value, Ending Balance | $ 133 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology SetPoint Medical Corporation Series B Preferred Stock Initial Acquisition Date 12/29/2022 Maturity Date 12/29/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 29, 2032 | |||||
Fair Value, Beginning Balance | 74 | |||||
Fair Value, Ending Balance | $ 74 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology SetPoint Medical Corporation Series B Preferred Stock Initial Acquisition Date 6/29/2021 Maturity Date 6/29/2031 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 29, 2031 | |||||
Fair Value, Beginning Balance | $ 50 | |||||
Fair Value, Ending Balance | $ 50 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology VERO Biotech LLC Investment Type Warrants Success Fee Initial Acquisition Date 12/29/2020 Maturity Date 12/29/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 29, 2025 | |||||
Fair Value, Ending Balance | $ 396 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology VERO Biotech LLC Success fee Initial Acquisition Date 12/29/2020 Maturity Date 12/29/2025 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 29, 2025 | |||||
Fair Value, Beginning Balance | 394 | |||||
Fair Value, Ending Balance | $ 394 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 1,310 | |||||
Fair Value, Ending Balance | $ 1,239 | $ 1,310 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Investment Type Warrants Series B Preferred Stock Initial Acquisition Date 6/30/2020 Maturity Date 6/30/2030 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 30, 2030 | |||||
Fair Value, Ending Balance | $ 1,001 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Investment Type Warrants Series D Preferred Stock Initial Acquisition Date 8/17/2021 Maturity Date 8/17/2031 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Aug. 17, 2031 | |||||
Fair Value, Ending Balance | $ 95 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Investment Type Warrants Series D Preferred Stock Initial Acquisition Date 9/26/2022 Maturity Date 9/26/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Sep. 26, 2032 | |||||
Fair Value, Ending Balance | $ 143 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Series B Preferred Stock Initial Acquisition Date 6/30/2020 Maturity Date 6/30/2030 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 30, 2030 | |||||
Fair Value, Beginning Balance | 920 | |||||
Fair Value, Ending Balance | $ 920 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Series D Preferred Stock Initial Acquisition Date 8/17/2021 Maturity Date 8/17/2031 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Aug. 17, 2031 | |||||
Fair Value, Beginning Balance | $ 170 | |||||
Fair Value, Ending Balance | $ 170 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services Snagajob.com, Inc. Investment Type Warrants Warrant for Series B-1 Preferred Stock Initial Acquisition Date 9/29/2021 Maturity Date 9/29/2031 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Sep. 29, 2031 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services Snagajob.com, Inc. Series B-1 Preferred Stock Initial Acquisition Date 9/29/2021 Maturity Date 9/29/2031 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Sep. 29, 2031 | |||||
Fair Value, Beginning Balance | $ 220 | |||||
Fair Value, Ending Balance | $ 220 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet & Direct Marketing Retail | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 133 | |||||
Fair Value, Ending Balance | 154 | 133 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet & Direct Marketing Retail Madison Reed, Inc. Investment Type Warrants Success fee Initial Acquisition Date 12/16/2022 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 154 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet & Direct Marketing Retail Madison Reed, Inc. Success fee Initial Acquisition Date 12/16/2022 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 133 | |||||
Fair Value, Ending Balance | 133 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 3,245 | |||||
Fair Value, Ending Balance | 1,642 | $ 3,245 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Bombora, Inc. Common Stock Initial Acquisition Date 3/31/2021 Maturity Date 3/31/2031 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 31, 2031 | |||||
Fair Value, Beginning Balance | $ 248 | |||||
Fair Value, Ending Balance | $ 248 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Bombora, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 12/26/2023 Maturity Date 12/26/2033 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 26, 2033 | |||||
Fair Value, Ending Balance | $ 41 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Bombora, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 3/31/2021 Maturity Date 3/31/2031 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 31, 2031 | |||||
Fair Value, Ending Balance | $ 104 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Fidelis Cybersecurity, Inc. Common Stock Initial Acquisition Date 3/25/2022 Maturity Date 3/25/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 25, 2032 | |||||
Fair Value, Beginning Balance | $ 100 | |||||
Fair Value, Ending Balance | $ 100 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Fidelis Cybersecurity, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 3/25/2022 Maturity Date 3/25/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 25, 2032 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services INRIX, Inc. Common Stock Initial Acquisition Date 7/26/2019 Maturity Date 7/26/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jul. 26, 2029 | |||||
Fair Value, Beginning Balance | $ 2,198 | |||||
Fair Value, Ending Balance | $ 2,198 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services INRIX, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 7/26/2019 Maturity Date 7/26/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jul. 26, 2029 | |||||
Fair Value, Ending Balance | $ 735 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Longtail Ad Solutions, Inc. (dba JW Player) Common Stock Initial Acquisition Date 12/12/2019 Maturity Date 12/12/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 12, 2029 | |||||
Fair Value, Beginning Balance | $ 345 | |||||
Fair Value, Ending Balance | $ 345 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Longtail Ad Solutions, Inc. (dba JW Player) Investment Type Warrants Common Stock Initial Acquisition Date 12/12/2019 Maturity Date 12/12/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 12, 2029 | |||||
Fair Value, Ending Balance | $ 321 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Skillshare, Inc. Investment Type Warrants Success Fee Initial Acquisition Date 11/8/2022 Maturity Date 11/8/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Nov. 08, 2026 | |||||
Fair Value, Ending Balance | $ 294 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Skillshare, Inc. Success fee Initial Acquisition Date 11/8/2022 Maturity Date 11/8/2026 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Nov. 08, 2026 | |||||
Fair Value, Beginning Balance | 225 | |||||
Fair Value, Ending Balance | $ 225 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Synack, Inc. Common Stock Initial Acquisition Date 6/30/2022 Maturity Date 6/30/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 30, 2032 | |||||
Fair Value, Beginning Balance | $ 129 | |||||
Fair Value, Ending Balance | $ 129 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Synack, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 12/29/2023 Maturity Date 6/30/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 30, 2032 | |||||
Fair Value, Ending Balance | $ 147 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 297 | |||||
Fair Value, Ending Balance | $ 438 | $ 297 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance Kin Insurance, Inc. Investment Type Warrants Series D-3 Preferred Stock Initial Acquisition Date 5/5/2023 Maturity Date 9/26/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Sep. 26, 2032 | |||||
Fair Value, Ending Balance | $ 81 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance Kin Insurance, Inc. Investment Type Warrants Series D-3 Preferred Stock Initial Acquisition Date 8/25/2023 Maturity Date 9/26/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Sep. 26, 2032 | |||||
Fair Value, Ending Balance | $ 65 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance Kin Insurance, Inc. Investment Type Warrants Series D-3 Preferred Stock Initial Acquisition Date 9/26/2022 Maturity Date 9/26/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Sep. 26, 2032 | |||||
Fair Value, Ending Balance | $ 292 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance Kin Insurance, Inc. Series D-3 Preferred Stock Initial Acquisition Date 9/26/2022 Maturity Date 9/26/2032 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Sep. 26, 2032 | |||||
Fair Value, Beginning Balance | 297 | |||||
Fair Value, Ending Balance | $ 297 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 796 | |||||
Fair Value, Ending Balance | $ 373 | $ 796 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services AllClear ID, Inc. Common Stock Initial Acquisition Date 9/1/2017 Maturity Date 9/1/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Sep. 01, 2027 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services AllClear ID, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 10/17/2018 Maturity Date 8/31/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Aug. 31, 2027 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services AllClear ID, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 8/31/2017 Maturity Date 8/31/2027 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Aug. 31, 2027 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services Credit Sesame, Inc. Common Stock Initial Acquisition Date 1/7/2020 Maturity Date 1/7/2030 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jan. 07, 2030 | |||||
Fair Value, Beginning Balance | $ 796 | |||||
Fair Value, Ending Balance | $ 796 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services Credit Sesame, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 1/7/2020 Maturity Date 1/7/2030 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jan. 07, 2030 | |||||
Fair Value, Ending Balance | $ 373 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | 191 | |||||
Fair Value, Ending Balance | 562 | $ 191 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software Dejero Labs Inc. Common Stock Initial Acquisition Date 5/31/2019 Maturity Date 5/31/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | May 31, 2029 | |||||
Fair Value, Beginning Balance | $ 191 | |||||
Fair Value, Ending Balance | $ 191 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software Dejero Labs Inc. Investment Type Warrants Common Stock Initial Acquisition Date 5/31/2019 Maturity Date 5/31/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | May 31, 2029 | |||||
Fair Value, Ending Balance | $ 268 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software Linxup, LLC Investment Type Warrants Success Fee Initial Acquisition Date 11/3/2023 Maturity Date 11/3/2033 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Nov. 03, 2033 | |||||
Fair Value, Ending Balance | $ 294 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software Scale Computing, Inc. Common Stock Initial Acquisition Date 3/29/2019 Maturity Date 3/29/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 29, 2029 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software Scale Computing, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 3/29/2019 Maturity Date 3/29/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Mar. 29, 2029 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Beginning Balance | $ 567 | |||||
Fair Value, Ending Balance | $ 410 | $ 567 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Investment Type Warrants Series A Preferred Stock Initial Acquisition Date 10/5/2018 Maturity Date 10/5/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Oct. 05, 2028 | |||||
Fair Value, Ending Balance | $ 178 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Investment Type Warrants Series A Preferred Stock Initial Acquisition Date 12/28/2018 Maturity Date 10/5/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Oct. 05, 2028 | |||||
Fair Value, Ending Balance | $ 36 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Investment Type Warrants Series A Preferred Stock Initial Acquisition Date 6/27/2019 Maturity Date 6/27/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 27, 2029 | |||||
Fair Value, Ending Balance | $ 196 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Series A Preferred Stock Initial Acquisition Date 10/5/2018 Maturity Date 10/5/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Oct. 05, 2028 | |||||
Fair Value, Beginning Balance | 246 | |||||
Fair Value, Ending Balance | $ 246 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Series A Preferred Stock Initial Acquisition Date 12/28/2018 Maturity Date 12/28/2028 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Dec. 28, 2028 | |||||
Fair Value, Beginning Balance | 49 | |||||
Fair Value, Ending Balance | $ 49 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Series A Preferred Stock Initial Acquisition Date 6/27/2019 Maturity Date 6/27/2029 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jun. 27, 2029 | |||||
Fair Value, Beginning Balance | 272 | |||||
Fair Value, Ending Balance | $ 272 | |||||
Investment, Identifier [Axis]: Total Investments, Excluding U.S. Treasury Bills | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | 1,025,010 | |||||
Investment, Identifier [Axis]: Total U.S. Treasury | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Fair Value, Ending Balance | $ 41,999 | |||||
Investment, Identifier [Axis]: U.S. Treasury U.S. Treasury Bill, 4.324% Initial Acquisition Date 12/29/2023 Maturity Date 1/4/2024 | ||||||
Investments in and Advances to Affiliates [Line Items] | ||||||
Maturity Date | Jan. 04, 2024 | |||||
Fair Value, Ending Balance | $ 41,999 | |||||
[1] All investments in the portfolio company, which as of December 31, 2022 represented 1.97 % of the Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors. Gross additions includes increases in the basis of investments resulting from new portfolio investments, PIK interest, accretion of original issue discount (“OID”), the exchange of one or more existing investments for one or more new investments and the movement of an existing portfolio company into this category from a different category. Gross additions includes increases in the basis of investments resulting from new portfolio investments, PIK interest, accretion of original issue discount (“OID”), the exchange of one or more existing investments for one or more new investments and the movement of an existing portfolio company into this category from a different category. Gross reductions include decreases in the basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing Investments for one or more new investments and the movement of an existing portfolio company out of this category into a different category. All investments in the portfolio companies, which as of December 31, 2023 represented 9.58 % of the Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors. Gross reductions include decreases in the basis of investments resulting from principal collections related to investment repayments or sales, the exchange of one or more existing investments for one or more new investments and the movement of an existing portfolio company out of this category into a different category. |
Investments - Transactions Re_2
Investments - Transactions Related to Company's Affiliate and Control Investments (Parenthetical) (Details) | Dec. 31, 2023 | Dec. 31, 2022 |
Investments, All Other Investments [Abstract] | ||
Percentage of net assets at fair, restricted to resale | 9.58% | 1.97% |
Investments - Fair Value of Por
Investments - Fair Value of Portfolio of Investment, excluding U.S. Treasury Bills by Geographic Region and Industry (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 1,067,009 | $ 1,126,309 | ||||
Percentage of Net Assets | 195.04% | 195.52% | ||||
Investment, Identifier [Axis]: Affiliate Investments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 51,456 | [1] | $ 2,084 | [2] | ||
Percentage of Net Assets | 9.41% | 0.36% | ||||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | [1] | $ 23,586 | ||||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments Health Care Technology | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 23,586 | |||||
Percentage of Net Assets | 4.31% | |||||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments Health Care Technology Gynesonics, Inc. Investment Type Senior Secured SOFR+8.75%, 8.00% ceiling, 5.00% ETP Initial Acquisition Date 3/1/2023 Maturity Date 11/30/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 23,586 | |||||
Investment, Identifier [Axis]: Affiliate Investments Debt Investments Senior Secured Gynesonics, Inc. | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | [1] | 23,586 | ||||
Investment, Identifier [Axis]: Affiliate Investments Debt investments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 23,586 | |||||
Percentage of Net Assets | 4.31% | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 26,894 | [1] | $ 1,174 | [2] | ||
Percentage of Net Assets | 0.20% | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Application Software | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 856 | $ 1,174 | ||||
Percentage of Net Assets | 0.16% | 0.20% | ||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Application Software Coginiti Corp Common Stock Initial Acquisition Date 3/9/2020 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 1,174 | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Coginiti Corp | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | [2] | 1,174 | ||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Coginiti Corp Common Stock | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 856 | [1] | 1,174 | |||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Gynesonics, Inc. Series A-1 Preferred Stock | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | [1] | 4,577 | ||||
Investment, Identifier [Axis]: Affiliate Investments Equity Investments Gynesonics, Inc. Series A-2 Preferred Stock | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | [1] | 21,461 | ||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 26,894 | |||||
Percentage of Net Assets | 4.92% | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments Application Software Coginiti Corp, Investment Type Equity Common Stock Initial Acquisition Date 3/9/2020 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 856 | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments Health Care Technology | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 26,038 | |||||
Percentage of Net Assets | 4.76% | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments Health Care Technology Gynesonics, Inc. Investment Type Equity Series A-1 Preferred Stock Initial Acquisition Date 10/24/2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 4,577 | |||||
Investment, Identifier [Axis]: Affiliate Investments Equity investments Health Care Technology Gynesonics, Inc. Investment Type Equity Series A-2 Preferred Stock Initial Acquisition Date 3/1/2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 21,461 | |||||
Investment, Identifier [Axis]: Affiliate Investments Warrants | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 976 | [1] | $ 910 | [2] | ||
Percentage of Net Assets | 0.18% | 0.16% | ||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Application Software | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 663 | $ 910 | ||||
Percentage of Net Assets | 0.12% | 0.16% | ||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Application Software Coginiti Corp Common Stock Initial Acquisition Date 3/9/2020 Maturity Date 3/9/2030 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 910 | |||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Application Software Coginiti Corp Investment Type Warrants Common Stock Initial Acquisition Date 3/9/2020 Maturity Date 3/9/2030 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 663 | |||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Coginiti Corp | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 663 | [1] | 910 | [2] | ||
Investment, Identifier [Axis]: Affiliate Investments Warrants Gynesonics, Inc. | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | [1] | 313 | ||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Health Care Technology | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 313 | |||||
Percentage of Net Assets | 0.06% | |||||
Investment, Identifier [Axis]: Affiliate Investments Warrants Health Care Technology Gynesonics, Inc. Investment Type Warrants Success Fee Initial Acquisition Date 3/1/2023 Maturity Date 3/1/2030 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 313 | |||||
Investment, Identifier [Axis]: Control Investments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 950 | [1] | $ 9,290 | [2] | $ 29,131 | |
Percentage of Net Assets | 0.17% | 1.61% | ||||
Investment, Identifier [Axis]: Control Investments Debt Investments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 9,290 | [2] | 28,261 | |||
Percentage of Net Assets | 1.61% | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Data Processing & Outsourced Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 9,290 | |||||
Percentage of Net Assets | 1.61% | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Data Processing & Outsourced Services Pivot3, Inc. LIBOR+8.50% PIK, 11.00% floor, 4.00% ETP Initial Acquisition Date 5/13/2019 Maturity Date 1/15/2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 9,290 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Five | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 1,253 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Four | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 629 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc One | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 7,568 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Six | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 1,008 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Three | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 630 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Mojix, Inc Two | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 2,523 | |||||
Investment, Identifier [Axis]: Control Investments Debt Investments Pivot3, Inc | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 9,290 | [2] | 14,650 | |||
Investment, Identifier [Axis]: Control Investments Debt Investments Pivot3, Inc. | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 9,290 | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 950 | [1] | 870 | |||
Percentage of Net Assets | 0.17% | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments Data Processing & Outsourced Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 950 | |||||
Percentage of Net Assets | 0.17% | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments Data Processing & Outsourced Services Pivot3, Inc. Investment Type Equity Equity Interest Initial Acquisition Date 12/31/2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 950 | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments Mojix, Inc. Series A-1 Preferred Stock | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 870 | |||||
Investment, Identifier [Axis]: Control Investments Equity Investments Pivot3, Inc. | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | [1] | 950 | ||||
Investment, Identifier [Axis]: Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software Blueshift Labs, Inc. Investment Type Senior Secured Interest Rate SOFR+6.25%, 11.25% floor, 2.00% PIK, 1.50% ETP Initial Acquisition Date 12/19/2023 Maturity Date 12/15/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 25,083 | |||||
Investment, Identifier [Axis]: Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services Interactions Corporation Investment Type Senior Secured Interest Rate SOFR+9.26%, 9.76% floor, 3.4375% ETP Initial Acquisition Date 6/24/2022 Maturity Date 6/15/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 39,945 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 972,604 | $ 1,114,935 | ||||
Percentage of Net Assets | 177.78% | 193.55% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 1,084,485 | |||||
Percentage of Net Assets | 188.26% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 954,912 | |||||
Percentage of Net Assets | 174.54% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 196,540 | $ 176,582 | ||||
Percentage of Net Assets | 35.92% | 30.66% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software Circadence Corporation Investment Type Senior Secured Interest Rate SOFR+9.50% PIK, 12.26% floor, 7.50% ETP Initial Acquisition Date 12/20/2018 Maturity Date 12/15/2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 17,083 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software Circadence Corporation Investment Type Senior Secured Interest Rate SOFR+9.50%, 12.26% floor, 10.00% cash cap, 7.50% ETP Initial Acquisition Date 12/20/2018 Maturity Date 3/15/2024 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 19,028 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software Dtex Systems, Inc. Investment Type Senior Secured Interest Rate SOFR+9.25%, 9.75% floor, 1.75% ETP Initial Acquisition Date 6/1/2021 Maturity Date 6/1/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 10,033 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software FiscalNote, Inc. Investment Type Senior Secured Interest Rate PRIME+5.00%, 9.00% floor, 1.00% PIK, 4.25% ETP Initial Acquisition Date 10/19/2020 Maturity Date 7/15/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 64,466 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software FiscalNote, Inc. Investment Type Senior Secured Interest Rate PRIME+5.00%, 9.00% floor, 1.00% PIK, 5.75% ETP Initial Acquisition Date 10/19/2020 Maturity Date 7/15/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 64,615 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software VTX Intermediate Holdings, Inc. (dba VertexOne) Investment Type Senior Secured Interest Rate SOFR+9.00%, 9.50% floor, 10.00% cash cap, 4.50% ETP Initial Acquisition Date 12/28/2021 Maturity Date 12/28/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 87,814 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Application Software VTX Intermediate Holdings, Inc. (dba VertexOne) Investment Type Senior Secured Interest Rate SOFR+9.00%, 9.50% floor, 4.50% ETP Initial Acquisition Date 12/28/2021 Maturity Date 12/28/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 85,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Asset Management & Custody Banks | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 7,860 | |||||
Percentage of Net Assets | 1.44% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Asset Management & Custody Banks Betterment Holdings, Inc. Investment Type Senior Secured Interest Rate PRIME+4.50%, 8.50% floor Initial Acquisition Date 10/6/2023 Maturity Date 10/6/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 7,860 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Biotechnology | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 39,709 | |||||
Percentage of Net Assets | 6.89% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Biotechnology Mustang Bio, Inc. Investment Type Senior Secured Interest Rate SOFR+8.75%, 9.25% floor, 3.50% ETP Initial Acquisition Date 3/4/2022 Maturity Date 4/15/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 29,709 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Biotechnology TRACON Pharmaceuticals, Inc. Investment Type Senior Secured Interest Rate PRIME+5.00%, 8.50% floor, 4.25% ETP Initial Acquisition Date 9/2/2022 Maturity Date 9/1/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 10,000 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 104,581 | $ 86,182 | ||||
Percentage of Net Assets | 19.12% | 14.96% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services Elevate Services, Inc. Investment Type Senior Secured Interest Rate SOFR+7.50%, 12.78% floor Initial Acquisition Date 7/10/2023 Maturity Date 7/10/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 19,424 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services Interactions Corporation Investment Type Senior Secured Interest Rate SOFR+9.26%, 9.76% floor, 3.4375% ETP Initial Acquisition Date 6/24/2022 Maturity Date 6/15/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 39,504 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services ShareThis, Inc. Investment Type Senior Secured Interest Rate SOFR+8.25%, 10.86% floor, 3.00% ETP Initial Acquisition Date 8/18/2020 Maturity Date 7/15/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 1,007 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services ShareThis, Inc. Investment Type Senior Secured Interest Rate SOFR+8.25%, 10.86% floor, 3.00% ETP Initial Acquisition Date 8/18/2020 Maturity Date 9/30/2024 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 947 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services ShareThis, Inc. Investment Type Senior Secured Interest Rate SOFR+9.25%, 11.86% floor, 3.00% ETP Initial Acquisition Date 12/3/2018 Maturity Date 7/15/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 21,150 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services ShareThis, Inc. Investment Type Senior Secured Interest Rate SOFR+9.25%, 11.86% floor, 3.00% ETP Initial Acquisition Date 12/3/2018 Maturity Date 9/30/2024 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 19,895 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Data Processing & Outsourced Services Vesta Payment Solutions, Inc. Investment Type Senior Secured Interest Rate SOFR+7.00%, 9.00% floor, 3.00% ETP Initial Acquisition Date 11/29/2022 Maturity Date 11/15/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 24,370 | 24,521 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Education Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 25,796 | $ 25,305 | ||||
Percentage of Net Assets | 4.72% | 4.39% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Education Services Turning Tech Intermediate, Inc. (dba Echo 360, Inc.) Investment Type Senior Secured Interest Rate SOFR+8.50%, 9.00% floor, 13.00% cash cap, 3.00% ETP Initial Acquisition Date 6/22/2021 Maturity Date 12/14/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 25,796 | $ 25,305 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Electronic Equipment & Instruments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 26,790 | $ 77,551 | ||||
Percentage of Net Assets | 4.90% | 13.46% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Electronic Equipment & Instruments Brivo, Inc. Investment Type Senior Secured Interest Rate SOFR+6.85%, 10.89% floor, 3.00% ETP Initial Acquisition Date 10/20/2022 Maturity Date 10/20/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 26,790 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Electronic Equipment & Instruments Brivo,Inc. Investment Type Senior Secured Interest Rate SOFR+6.85%, 10.89% floor, 50% of interest PIK, 3.00% ETP Initial Acquisition Date 10/20/2022 Maturity Date 10/20/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 43,912 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Electronic Equipment & Instruments Intellisite Holdings, Inc. (dba Epic IO Technologies, Inc.) Investment Type Senior Secured Interest Rate SOFR+9.75%, 10.25% floor, 2.00% ETP Initial Acquisition Date 12/17/2021 Maturity Date 12/17/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 33,639 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Equipment | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 15,284 | $ 27,149 | ||||
Percentage of Net Assets | 2.79% | 4.71% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Equipment Moximed, Inc. Investment Type Senior Secured Interest Rate PRIME+5.25%, 8.75% floor, 3.50% ETP Initial Acquisition Date 6/24/2022 Maturity Date 7/1/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 15,284 | $ 14,772 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Equipment Revelle Aesthetics, Inc. Investment Type Senior Secured Interest Rate PRIME+5.50%, 8.75% floor, 4.00% ETP Initial Acquisition Date 3/30/2022 Maturity Date 4/1/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 12,377 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 126,204 | $ 225,915 | ||||
Percentage of Net Assets | 23.06% | 39.22% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Allurion Technologies, Inc. Investment Type Senior Secured Interest Rate PRIME+6.44%, 9.50% floor, 3.00% ETP Initial Acquisition Date 12/30/2021 Maturity Date 12/30/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 54,715 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology EBR Systems, Inc. Investment Type Senior Secured Interest Rate PRIME+4.90%, 8.90% floor, 4.50% ETP Initial Acquisition Date 6/30/2022 Maturity Date 6/15/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 40,337 | 19,648 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Gynesonics, Inc. Investment Type Senior Secured Interest Rate SOFR+8.75%, 9.25% floor, 3.50% ETP Initial Acquisition Date 12/1/2020 Maturity Date 12/1/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 50,022 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Mingle Healthcare Solutions, Inc. Investment Type Senior Secured Interest Rate SOFR+9.50%, 12.01% floor, .25% PIK, 10.50% ETP Initial Acquisition Date 8/15/2018 Maturity Date 12/15/2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 3,821 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Mingle Healthcare Solutions, Inc. Investment Type Senior Secured Interest Rate SOFR+9.75%, 12.26% floor, 10.50% ETP Initial Acquisition Date 8/15/2018 Maturity Date 12/15/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 3,791 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Nalu Medical, Inc. Investment Type Senior Secured Interest Rate PRIME+2.70%, 6.70% floor, 2.00% PIK, 4.50% ETP Initial Acquisition Date 10/12/2022 Maturity Date 10/12/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 21,191 | 19,756 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology Route 92 Medical, Inc. Investment Type Senior Secured Interest Rate SOFR+8.48%, 8.98% floor, 3.95% ETP Initial Acquisition Date 8/17/2021 Maturity Date 7/1/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 35,435 | 12,843 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology SetPoint Medical Corporation Investment Type Senior Secured Interest Rate SOFR+5.75%, 9.00% floor, 4.00% ETP Initial Acquisition Date 12/29/2022 Maturity Date 12/1/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 25,450 | 24,802 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Health Care Technology VERO Biotech LLC Investment Type Senior Secured Interest Rate SOFR+9.05%, 9.55% floor, 3.00% ETP Initial Acquisition Date 12/29/2020 Maturity Date 12/1/2024 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 40,308 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Human Resource & Employment Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 112,006 | $ 96,478 | ||||
Percentage of Net Assets | 20.47% | 16.75% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Human Resource & Employment Services CloudPay, Inc. Investment Type Senior Secured Interest Rate PRIME+6.25%, 10.25% floor, 2.00% ETP Initial Acquisition Date 9/26/2022 Maturity Date 8/17/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 75,465 | $ 59,693 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Human Resource & Employment Services Snagajob.com, Inc. Investment Type Senior Secured Interest Rate SOFR+8.50% PIK, 9.00% floor, 2.75% ETP Initial Acquisition Date 9/29/2021 Maturity Date 9/1/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 36,541 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Human Resource & Employment Services Snagajob.com, Inc. Investment Type Senior Secured Interest Rate SOFR+8.50%, 9.00% floor, 9.00% cash cap, 2.75% ETP Initial Acquisition Date 9/29/2021 Maturity Date 9/1/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 36,785 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 55,309 | $ 55,853 | ||||
Percentage of Net Assets | 10.11% | 9.70% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail Madison Reed, Inc. Investment Type Senior Secured Interest Rate PRIME+4.75%, 11.00% floor, 11.00% cash cap, 3.00% ETP Initial Acquisition Date 12/16/2022 Maturity Date 12/16/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 10,847 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail Madison Reed, Inc. Investment Type Senior Secured Interest Rate PRIME+4.75%, 11.00% floor, 3.00% ETP Initial Acquisition Date 12/16/2022 Maturity Date 12/16/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 9,353 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail Marley Spoon AG Investment Type Senior Secured Interest Rate SOFR+8.50%, 1.25% PIK, 9.26% floor Initial Acquisition Date 6/30/2021 Maturity Date 6/15/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 46,500 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet & Direct Marketing Retail Marley Spoon SE Investment Type Senior Secured Interest Rate SOFR+7.50%, 8.26% floor, 1.25% PIK Initial Acquisition Date 6/30/2021 Maturity Date 6/15/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 44,462 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 96,820 | $ 146,535 | ||||
Percentage of Net Assets | 17.70% | 25.44% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Bombora, Inc. Investment Type Senior Secured Interest Rate SOFR+4.75%, 6.75% floor, 3.25% PIK, 0.96% ETP Initial Acquisition Date 12/26/2023 Maturity Date 1/15/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 27,879 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Bombora, Inc. Investment Type Senior Secured Interest Rate SOFR+5.00%, 5.76% floor, 3.75% PIK, 2.00% ETP Initial Acquisition Date 3/31/2021 Maturity Date 3/31/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 21,337 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Fidelis Cybersecurity, Inc. Investment Type Senior Secured Interest Rate SOFR+11.00%, 12.00% floor, 2.39% ETP Initial Acquisition Date 3/25/2022 Maturity Date 5/13/2024 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 8,692 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Fidelis Cybersecurity, Inc. Investment Type Senior Secured Interest Rate SOFR+11.00%, 12.00% floor, 2.39% ETP Initial Acquisition Date 5/13/2021 Maturity Date 5/13/2024 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 11,857 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services INRIX, Inc. Investment Type Senior Secured Interest Rate SOFR+9.00%, 9.76% floor, 2.50% ETP Initial Acquisition Date 11/15/2021 Maturity Date 11/15/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 45,329 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Skillshare, Inc. Investment Type Senior Secured Interest Rate SOFR+6.50%, 10.72% floor, 3.00% ETP Initial Acquisition Date 11/8/2022 Maturity Date 11/8/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 29,183 | 24,414 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Synack, Inc. Investment Type Senior Secured Interest Rate PRIME+4.25%, 8.25% floor Initial Acquisition Date 6/30/2022 Maturity Date 6/30/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 34,906 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Internet Software and Services Synack, Inc. Investment Type Senior Secured Interest Rate SOFR+7.00%, 11.07% floor, 1.00% ETP Initial Acquisition Date 12/29/2023 Maturity Date 12/29/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 39,758 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Property & Casualty Insurance | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 74,767 | $ 49,143 | ||||
Percentage of Net Assets | 13.67% | 8.53% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments Property & Casualty Insurance Kin Insurance, Inc. Investment Type Senior Secured Interest Rate PRIME+6.25%, 12.50% floor, 3.00% ETP Initial Acquisition Date 9/26/2022 Maturity Date 9/15/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 74,767 | $ 49,143 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 112,955 | $ 78,083 | ||||
Percentage of Net Assets | 20.64% | 13.55% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software 3PL Central LLC Investment Type Senior Secured Interest Rate SOFR+4.50%, 6.50 floor, 2.50% PIK, 2.00% ETP Initial Acquisition Date 11/9/2022 Maturity Date 11/9/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 69,066 | $ 64,429 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software Dejero Labs Inc. Investment Type Second Lien Interest Rate SOFR+8.00%, 8.50% floor, 2.00% PIK, 3.00% ETP Initial Acquisition Date 12/22/2021 Maturity Date 12/22/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 14,399 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software Dejero Labs Inc. Investment Type Senior Lien Interest Rate SOFR+5.00%, 5.50 floor, 5.00% PIK, 3.00% ETP Initial Acquisition Date 12/22/2021 Maturity Date 12/22/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 13,654 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Debt Investments System Software Linxup, LLC Investment Type Senior Secured Interest Rate PRIME+3.25%, 11.75% floor, 2.25% ETP Initial Acquisition Date 11/03/2023 Maturity Date 11/15/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 29,490 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 5,721 | $ 14,605 | ||||
Percentage of Net Assets | 1.05% | 2.54% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Advertising | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 136 | |||||
Percentage of Net Assets | 0.03% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Advertising Minute Media Inc. Investment Type Equity Common Stock Initial Acquisition Date 12/13/2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 16 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Advertising Minute Media Inc. Investment Type Equity Preferred Stock Initial Acquisition Date 12/13/2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 120 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Application Software | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 390 | $ 1,769 | ||||
Percentage of Net Assets | 0.07% | 0.31% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Application Software Aria Systems, Inc. Investment Type Equity Series G Preferred Stock Initial Acquisition Date 7/10/2018 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 127 | $ 347 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Application Software FiscalNote, Inc. Investment Type Equity Common Stock Initial Acquisition Date 10/19/2020 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 263 | 1,422 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Health Care Technology | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 3,553 | $ 12,335 | ||||
Percentage of Net Assets | 0.65% | 2.14% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Health Care Technology CareCloud, Inc. Investment Type Equity 11% Series A Cumulative Redeemable Perpetual Initial Acquisition Date 1/8/2020 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 12,335 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Health Care Technology CareCloud, Inc. Investment Type Equity 11% Series A Cumulative Redeemable Perpetual Preferred Stock Initial Acquisition Date 1/8/2020 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 3,553 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Human Resource & Employment Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 1,357 | |||||
Percentage of Net Assets | 0.25% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Human Resource & Employment Services Snagajob.com, Inc. Investment Type Equity Convertible Note Initial Acquisition Date 10/26/2023 Maturity Date 12/31/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 1,357 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Internet & Direct Marketing Retail | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 125 | |||||
Percentage of Net Assets | 0.02% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Internet & Direct Marketing Retail Marley Spoon SE Investment Type Equity Common Stock Initial Acquisition Date 7/7/2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 125 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Technology Hardware, Storage & Peripherals | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 160 | $ 501 | ||||
Percentage of Net Assets | 0.03% | 0.09% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Equity Investments Technology Hardware, Storage & Peripherals Quantum Corporation Investment Type Equity Common Stock Initial Acquisition Date 8/13/2021 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 160 | $ 501 | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 11,971 | $ 15,845 | ||||
Percentage of Net Assets | 2.19% | 2.75% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Advertising | ||||||
Schedule of Investments [Line Items] | ||||||
Percentage of Net Assets | 0% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 2,196 | $ 3,649 | ||||
Percentage of Net Assets | 0.40% | 0.63% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Aria Systems, Inc. Investment Type Warrants Series G Preferred Stock Initial Acquisition Date 6/29/2018 Maturity Date 6/29/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 1,048 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Aria Systems, Inc. Series G Preferred Stock Initial Acquisition Date 6/29/2018 Maturity Date 6/29/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 2,865 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Blueshift Labs, Inc. Investment Type Warrants Success fee Initial Acquisition Date 12/19/2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 167 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Investment Type Warrants Series A-6 Preferred Stock Initial Acquisition Date 10/31/2019 Maturity Date 10/31/2029 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 12 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Investment Type Warrants Series A-6 Preferred Stock Initial Acquisition Date 12/20/2018 Maturity Date 12/20/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 48 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Investment Type Warrants Success fee Initial Acquisition Date 12/21/2023 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 283 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Series A-6 Preferred Stock Initial Acquisition Date 10/31/2019 Maturity Date 10/31/2029 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 22 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Circadence Corporation Series A-6 Preferred Stock Initial Acquisition Date 12/20/2018 Maturity Date 12/20/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 87 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Dtex Systems, Inc. Investment Type Warrants Series C-Prime Preferred Stock Initial Acquisition Date 6/1/2018 Maturity Date 6/1/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 233 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Dtex Systems, Inc. Series C-Prime Preferred Stock Initial Acquisition Date 6/1/2018 Maturity Date 6/1/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 214 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Dtex Systems, Inc. Series C-Prime Preferred Stock Initial Acquisition Date 7/11/2019 Maturity Date 7/11/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 356 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software Dtex Systems, Inc.Investment Type Warrants Series C-Prime Preferred Stock Initial Acquisition Date 7/11/2019 Maturity Date 7/11/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 389 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software FiscalNote, Inc. Earnout Initial Acquisition Date 7/29/2022 Maturity Date 7/29/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 105 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Application Software FiscalNote, Inc. Investment Type Warrants Earnout Initial Acquisition Date 7/29/2022 Maturity Date 7/29/2027 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 16 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Asset Management & Custody Banks | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 161 | |||||
Percentage of Net Assets | 0.03% | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Asset Management & Custody Banks Betterment Holdings, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 10/6/2023 Maturity Date 10/6/2033 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 146 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Asset Management & Custody Banks Betterment Holdings, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 10/6/2023 Maturity Date 10/6/2033 one | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 15 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 51 | $ 216 | ||||
Percentage of Net Assets | 0.01% | 0.04% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology Mustang Bio, Inc. Common Stock Initial Acquisition Date 3/4/2022 Maturity Date 3/4/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 59 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology Mustang Bio, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 3/4/2022 Maturity Date 3/4/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 39 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology TRACON Pharmaceuticals, Inc. Common Stock Initial Acquisition Date 9/2/2022 Maturity Date 9/2/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 157 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Biotechnology TRACON Pharmaceuticals, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 9/2/2022 Maturity Date 9/2/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 12 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Computer & Electronics Retail | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 68 | |||||
Percentage of Net Assets | 0% | 0.01% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Computer & Electronics Retail Massdrop, Inc. Series B Preferred Stock Initial Acquisition Date 7/22/2019 Maturity Date 7/22/2029 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 68 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 1,254 | $ 1,932 | ||||
Percentage of Net Assets | 0.23% | 0.34% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services Elevate Services, Inc. Investment Type Warrants Series C Preferred Stock Initial Acquisition Date 7/10/2023 Maturity Date 7/10/2033 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 384 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services Interactions Corporation Common Stock Initial Acquisition Date 6/24/2022 Maturity Date 6/24/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 204 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services Interactions Corporation Investment Type Warrants Common Stock Initial Acquisition Date 6/24/2022 Maturity Date 6/24/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 67 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services ShareThis, Inc. Investment Type Warrants Series D-3 Preferred Stock Initial Acquisition Date 12/3/2018 Maturity Date 12/3/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 803 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Data Processing & Outsourced Services ShareThis, Inc. Series D-3 Preferred Stock Initial Acquisition Date 12/3/2018 Maturity Date 12/3/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 1,728 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 745 | $ 563 | ||||
Percentage of Net Assets | 0.14% | 0.10% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments Brivo, Inc. Investment Type Warrants Series A-2 Preferred Stock Initial Acquisition Date 10/20/2022 Maturity Date 10/20/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 322 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments Brivo, Inc. Series A-2 Preferred Stock Initial Acquisition Date 10/20/2022 Maturity Date 10/20/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 107 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments Epic IO Technologies, Inc. Investment Type Warrants Success fee Initial Acquisition Date 12/17/2021 Maturity Date 12/17/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 423 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Electronic Equipment & Instruments Epic IO Technologies, Inc. Success fee Initial Acquisition Date 12/17/2021 Maturity Date 12/17/2024 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 456 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 240 | $ 284 | ||||
Percentage of Net Assets | 0.04% | 0.05% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment Moximed, Inc. Investment Type Warrants Series C Preferred Stock Initial Acquisition Date 6/24/2022 Maturity Date 6/24/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 138 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment Moximed, Inc. Series C Preferred Stock Initial Acquisition Date 6/24/2022 Maturity Date 6/24/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 163 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment Revelle Aesthetics, Inc. Investment Type Warrants Series A-2 Preferred Stock Initial Acquisition Date 3/30/2022 Maturity Date 3/30/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 102 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Equipment Revelle Aesthetics, Inc. Series A-2 Preferred Stock Initial Acquisition Date 3/30/2022 Maturity Date 3/30/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 121 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 2,506 | $ 2,594 | ||||
Percentage of Net Assets | 0.46% | 0.45% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 3/30/2021 Maturity Date 1/22/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 15 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Investment Type Warrants Earnout Initial Acquisition Date 8/2/2023 Maturity Date 8/1/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 77 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Series C Preferred Stock Initial Acquisition Date 3/30/2021 Maturity Date 3/30/2031 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 632 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Allurion Technologies, Inc. Series D-1 Preferred Stock Initial Acquisition Date 6/14/2022 Maturity Date 3/30/2031 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 259 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology EBR Systems, Inc. Investment Type Warrants Success fee Initial Acquisition Date 6/30/2022 Maturity Date 6/30/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 690 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology EBR Systems, Inc. Success fee Initial Acquisition Date 6/30/2022 Maturity Date 6/30/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 305 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Gynesonics, Inc. Series G Convertible Preferred Stock Initial Acquisition Date 11/19/2021 Maturity Date 11/19/2031 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 446 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Nalu Medical, Inc. Investment Type Warrants Series D-2 Preferred Stock Initial Acquisition Date 10/12/2022 Maturity Date 10/12/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 99 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Nalu Medical, Inc. Series D-2 Preferred Stock Initial Acquisition Date 10/12/2022 Maturity Date 10/12/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 137 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Route 92 Medical, Inc. Investment Type Warrants Success Fee Initial Acquisition Date 8/17/2021 Maturity Date 8/17/2031 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 897 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology Route 92 Medical, Inc. Success fee Initial Acquisition Date 8/17/2021 Maturity Date 8/17/2031 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 297 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology SetPoint Medical Corporation Investment Type Warrants Series B Preferred Stock Initial Acquisition Date 12/29/2022 Maturity Date 12/29/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 199 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology SetPoint Medical Corporation Investment Type Warrants Series B Preferred Stock Initial Acquisition Date 6/29/2021 Maturity Date 6/29/2031 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 133 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology SetPoint Medical Corporation Series B Preferred Stock Initial Acquisition Date 12/29/2022 Maturity Date 12/29/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 74 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology SetPoint Medical Corporation Series B Preferred Stock Initial Acquisition Date 6/29/2021 Maturity Date 6/29/2031 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 50 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology VERO Biotech LLC Investment Type Warrants Success Fee Initial Acquisition Date 12/29/2020 Maturity Date 12/29/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 396 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Health Care Technology VERO Biotech LLC Success fee Initial Acquisition Date 12/29/2020 Maturity Date 12/29/2025 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 394 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 1,239 | $ 1,310 | ||||
Percentage of Net Assets | 0.23% | 0.23% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Investment Type Warrants Series B Preferred Stock Initial Acquisition Date 6/30/2020 Maturity Date 6/30/2030 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 1,001 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Investment Type Warrants Series D Preferred Stock Initial Acquisition Date 8/17/2021 Maturity Date 8/17/2031 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 95 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Investment Type Warrants Series D Preferred Stock Initial Acquisition Date 9/26/2022 Maturity Date 9/26/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 143 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Series B Preferred Stock Initial Acquisition Date 6/30/2020 Maturity Date 6/30/2030 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 920 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services CloudPay, Inc. Series D Preferred Stock Initial Acquisition Date 8/17/2021 Maturity Date 8/17/2031 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 170 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Human Resource & Employment Services Snagajob.com, Inc. Series B-1 Preferred Stock Initial Acquisition Date 9/29/2021 Maturity Date 9/29/2031 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 220 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet & Direct Marketing Retail | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 154 | $ 133 | ||||
Percentage of Net Assets | 0.03% | 0.02% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet & Direct Marketing Retail Madison Reed, Inc. Investment Type Warrants Success fee Initial Acquisition Date 12/16/2022 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 154 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet & Direct Marketing Retail Madison Reed, Inc. Success fee Initial Acquisition Date 12/16/2022 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 133 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 1,642 | $ 3,245 | ||||
Percentage of Net Assets | 0.30% | 0.56% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Bombora, Inc. Common Stock Initial Acquisition Date 3/31/2021 Maturity Date 3/31/2031 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 248 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Bombora, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 12/26/2023 Maturity Date 12/26/2033 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 41 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Bombora, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 3/31/2021 Maturity Date 3/31/2031 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 104 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Fidelis Cybersecurity, Inc. Common Stock Initial Acquisition Date 3/25/2022 Maturity Date 3/25/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 100 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services INRIX, Inc. Common Stock Initial Acquisition Date 7/26/2019 Maturity Date 7/26/2029 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 2,198 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services INRIX, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 7/26/2019 Maturity Date 7/26/2029 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 735 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Longtail Ad Solutions, Inc. (dba JW Player) Common Stock Initial Acquisition Date 12/12/2019 Maturity Date 12/12/2029 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 345 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Longtail Ad Solutions, Inc. (dba JW Player) Investment Type Warrants Common Stock Initial Acquisition Date 12/12/2019 Maturity Date 12/12/2029 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 321 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Skillshare, Inc. Investment Type Warrants Success Fee Initial Acquisition Date 11/8/2022 Maturity Date 11/8/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 294 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Skillshare, Inc. Success fee Initial Acquisition Date 11/8/2022 Maturity Date 11/8/2026 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 225 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Synack, Inc. Common Stock Initial Acquisition Date 6/30/2022 Maturity Date 6/30/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 129 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Internet Software and Services Synack, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 12/29/2023 Maturity Date 6/30/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 147 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 438 | $ 297 | ||||
Percentage of Net Assets | 0.08% | 0.05% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance Kin Insurance, Inc. Investment Type Warrants Series D-3 Preferred Stock Initial Acquisition Date 5/5/2023 Maturity Date 9/26/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 81 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance Kin Insurance, Inc. Investment Type Warrants Series D-3 Preferred Stock Initial Acquisition Date 8/25/2023 Maturity Date 9/26/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 65 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance Kin Insurance, Inc. Investment Type Warrants Series D-3 Preferred Stock Initial Acquisition Date 9/26/2022 Maturity Date 9/26/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 292 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Property & Casualty Insurance Kin Insurance, Inc. Series D-3 Preferred Stock Initial Acquisition Date 9/26/2022 Maturity Date 9/26/2032 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 297 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 373 | $ 796 | ||||
Percentage of Net Assets | 0.07% | 0.14% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services Credit Sesame, Inc. Common Stock Initial Acquisition Date 1/7/2020 Maturity Date 1/7/2030 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 796 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Specialized Consumer Services Credit Sesame, Inc. Investment Type Warrants Common Stock Initial Acquisition Date 1/7/2020 Maturity Date 1/7/2030 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 373 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 562 | $ 191 | ||||
Percentage of Net Assets | 0.10% | 0.03% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software Dejero Labs Inc. Common Stock Initial Acquisition Date 5/31/2019 Maturity Date 5/31/2029 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 191 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software Dejero Labs Inc. Investment Type Warrants Common Stock Initial Acquisition Date 5/31/2019 Maturity Date 5/31/2029 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 268 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants System Software Linxup, LLC Investment Type Warrants Success Fee Initial Acquisition Date 11/3/2023 Maturity Date 11/3/2033 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 294 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 410 | $ 567 | ||||
Percentage of Net Assets | 0.07% | 0.10% | ||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Investment Type Warrants Series A Preferred Stock Initial Acquisition Date 10/5/2018 Maturity Date 10/5/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 178 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Investment Type Warrants Series A Preferred Stock Initial Acquisition Date 12/28/2018 Maturity Date 10/5/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 36 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Investment Type Warrants Series A Preferred Stock Initial Acquisition Date 6/27/2019 Maturity Date 6/27/2029 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 196 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Series A Preferred Stock Initial Acquisition Date 10/5/2018 Maturity Date 10/5/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 246 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Series A Preferred Stock Initial Acquisition Date 12/28/2018 Maturity Date 12/28/2028 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 49 | |||||
Investment, Identifier [Axis]: Non-Control/Non-Affiliate Investments Warrants Technology Hardware, Storage & Peripherals RealWear, Inc. Series A Preferred Stock Initial Acquisition Date 6/27/2019 Maturity Date 6/27/2029 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | 272 | |||||
Investment, Identifier [Axis]: Total Investments, Excluding U.S. Treasury Bills | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 1,025,010 | |||||
Percentage of Net Assets | 187.36% | |||||
Investment, Identifier [Axis]: Total U.S. Treasury | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 41,999 | |||||
Percentage of Net Assets | 7.68% | |||||
Investment, Identifier [Axis]: U.S. Treasury U.S. Treasury Bill, 4.324% Initial Acquisition Date 12/29/2023 Maturity Date 1/4/2024 | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 41,999 | |||||
Application Software | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 200,645 | $ 184,084 | ||||
Percentage of Net Assets | 36.67% | 31.96% | ||||
Health Care Technology | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 182,200 | $ 240,844 | ||||
Percentage of Net Assets | 33.30% | 41.81% | ||||
Human Resource & Employment Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 114,602 | $ 97,788 | ||||
Percentage of Net Assets | 20.95% | 16.98% | ||||
System Software | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 113,517 | $ 78,274 | ||||
Percentage of Net Assets | 20.74% | 13.58% | ||||
Data Processing & Outsourced Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 106,785 | $ 97,404 | ||||
Percentage of Net Assets | 19.52% | 16.91% | ||||
Internet Software and Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 98,462 | $ 149,780 | ||||
Percentage of Net Assets | 18% | 26% | ||||
Property and Casualty Insurance | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 75,205 | $ 49,440 | ||||
Percentage of Net Assets | 13.75% | 8.58% | ||||
Internet & Direct Marketing Retail | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 55,588 | $ 55,986 | ||||
Percentage of Net Assets | 10.16% | 9.72% | ||||
Electronic Equipment & Instruments | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 27,535 | $ 78,114 | ||||
Percentage of Net Assets | 5.04% | 13.56% | ||||
Education Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 25,796 | $ 25,305 | ||||
Percentage of Net Assets | 4.72% | 4.39% | ||||
Health Care Equipment | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 15,524 | $ 27,433 | ||||
Percentage of Net Assets | 2.83% | 4.76% | ||||
Asset Management & Custody Banks | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 8,021 | |||||
Percentage of Net Assets | 1.47% | |||||
Technology Hardware Storage and Peripherals | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 570 | $ 1,068 | ||||
Percentage of Net Assets | 0.10% | 0.19% | ||||
Specialized Consumer Services | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 373 | $ 796 | ||||
Percentage of Net Assets | 0.07% | 0.14% | ||||
Advertising | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 136 | |||||
Percentage of Net Assets | 0.03% | |||||
Biotechnology | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 51 | $ 39,925 | ||||
Percentage of Net Assets | 0.01% | 6.93% | ||||
Computer and Electronics Retail | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 68 | |||||
Percentage of Net Assets | 0.01% | |||||
Western United States | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 404,541 | $ 346,372 | ||||
Percentage of Net Assets | 73.94% | 60.13% | ||||
Northeastern United States | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 239,444 | $ 351,654 | ||||
Percentage of Net Assets | 43.77% | 61.04% | ||||
Midwestern United States | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 130,784 | $ 74,745 | ||||
Percentage of Net Assets | 23.91% | 12.98% | ||||
South Central United States | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 87,814 | $ 85,000 | ||||
Percentage of Net Assets | 16.05% | 14.76% | ||||
Northwestern United States | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 25,514 | $ 72,615 | ||||
Percentage of Net Assets | 4.66% | 12.61% | ||||
Southeastern United States | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 820 | $ 74,797 | ||||
Percentage of Net Assets | 0.15% | 12.98% | ||||
Total United States | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 888,917 | $ 1,005,183 | ||||
Percentage of Net Assets | 162.48% | 174.50% | ||||
United Kingdom | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 76,839 | $ 60,783 | ||||
Percentage of Net Assets | 14.05% | 10.55% | ||||
Germany | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 44,587 | $ 46,499 | ||||
Percentage of Net Assets | 8.15% | 8.07% | ||||
Canada | ||||||
Schedule of Investments [Line Items] | ||||||
Total investments at fair value | $ 14,667 | $ 13,844 | ||||
Percentage of Net Assets | 2.68% | 2.40% | ||||
[1] All investments in the portfolio companies, which as of December 31, 2023 represented 9.58 % of the Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors. All investments in the portfolio company, which as of December 31, 2022 represented 1.97 % of the Company’s net assets, may be deemed to be restricted securities under the Securities Act, and were valued at fair value as determined in good faith by the Company’s Board of Directors. |
Fair Value Measurements - Sched
Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Cash and cash equivalents | $ 2,970 | $ 5,761 |
Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 1,067,009 | 1,131,899 |
Cash and cash equivalents | 5,590 | |
Portfolio Investments | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 1,025,010 | 1,126,309 |
Portfolio Investments | Senior Secured Term Loans | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 964,099 | 1,080,121 |
Portfolio Investments | Second Lien Term Loans | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 14,399 | 13,654 |
Portfolio Investments | Convertible Note | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 1,357 | |
Portfolio Investments | Preferred Stock | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 29,838 | 12,682 |
Portfolio Investments | Common Stock | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 1,420 | 3,097 |
Portfolio Investments | Equity Interest | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 950 | |
Portfolio Investments | Warrants | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 12,947 | 16,755 |
U.S. Treasury Bill | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 41,999 | |
Level 1 | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 4,101 | 18,426 |
Cash and cash equivalents | 5,590 | |
Level 1 | Portfolio Investments | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 4,101 | 12,836 |
Level 1 | Portfolio Investments | Senior Secured Term Loans | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 0 | 0 |
Level 1 | Portfolio Investments | Second Lien Term Loans | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 0 | 0 |
Level 1 | Portfolio Investments | Convertible Note | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 0 | |
Level 1 | Portfolio Investments | Preferred Stock | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 3,553 | 12,335 |
Level 1 | Portfolio Investments | Common Stock | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 548 | 501 |
Level 1 | Portfolio Investments | Equity Interest | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 0 | |
Level 1 | Portfolio Investments | Warrants | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 0 | 0 |
Level 1 | U.S. Treasury Bill | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 0 | |
Level 2 | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 42,108 | 1,527 |
Cash and cash equivalents | 0 | |
Level 2 | Portfolio Investments | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 109 | 1,527 |
Level 2 | Portfolio Investments | Senior Secured Term Loans | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 0 | 0 |
Level 2 | Portfolio Investments | Second Lien Term Loans | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 0 | 0 |
Level 2 | Portfolio Investments | Convertible Note | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 0 | |
Level 2 | Portfolio Investments | Preferred Stock | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 0 | 0 |
Level 2 | Portfolio Investments | Common Stock | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 0 | 1,422 |
Level 2 | Portfolio Investments | Equity Interest | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 0 | |
Level 2 | Portfolio Investments | Warrants | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 109 | 105 |
Level 2 | U.S. Treasury Bill | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 41,999 | |
Level 3 | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 1,020,800 | 1,111,946 |
Level 3 | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 1,020,800 | 1,111,946 |
Cash and cash equivalents | 0 | |
Level 3 | Preferred Stock | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 120 | 347 |
Level 3 | Common Stock | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 16 | 1,174 |
Level 3 | Portfolio Investments | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 1,020,800 | 1,111,946 |
Level 3 | Portfolio Investments | Senior Secured Term Loans | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 964,099 | 1,080,121 |
Level 3 | Portfolio Investments | Second Lien Term Loans | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 14,399 | 13,654 |
Level 3 | Portfolio Investments | Convertible Note | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 1,357 | |
Level 3 | Portfolio Investments | Preferred Stock | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 26,285 | 347 |
Level 3 | Portfolio Investments | Common Stock | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 872 | 1,174 |
Level 3 | Portfolio Investments | Equity Interest | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 950 | |
Level 3 | Portfolio Investments | Warrants | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | 12,838 | $ 16,650 |
Level 3 | U.S. Treasury Bill | Fair Value, Recurring [Member] | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Investments | $ 0 |
Fair Value Measurements - Addit
Fair Value Measurements - Additional Information (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Carrying Value | $ 510,078 | $ 548,957 |
Long-Term Debt | 2026 Notes | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Debt instrument, fair value | 63,800 | 57,000 |
Borrowings | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Carrying Value | 510,078 | 548,957 |
Unamortized deferred debt costs | 9,172 | 10,293 |
Borrowings | 2026 Notes | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Unamortized deferred debt costs | 600 | 800 |
Borrowings | December 2026 Notes | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Carrying Value | 69,427 | 69,182 |
Unamortized deferred debt costs | 573 | 818 |
Common Stock | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | ||
Asset transfer out of level 2 into level 1 fair value | 1,400 | 5,400 |
Asset transfer out of level 3 into level 2 fair value | $ 900 | $ 2,200 |
Fair Value Measurements - Sch_2
Fair Value Measurements - Schedule of Level 3 Assets measured at Fair Value (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Beginning Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | $ 1,111,946 | $ 657,346 |
Transfers out of Level 3 | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (891) | (2,239) |
Purchases of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 200,054 | 622,591 |
PIK Interest | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 19,924 | 8,655 |
Sales or Prepayments of investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (289,078) | (154,213) |
Scheduled Principal Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (7,331) | |
Scheduled Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (9,754) | |
Amortization of Fixed Income Premiums or Accretion of Discounts | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 8,641 | 6,863 |
Net Realized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (18,387) | (2,851) |
Net Change in Unrealized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (4,078) | (14,452) |
Ending Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 1,020,800 | 1,111,946 |
Change in Unrealized Gain (loss) on Level 3 Investments Still Held | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (16,117) | (18,133) |
Senior Secured Term Loans | Beginning Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 1,080,121 | 623,054 |
Senior Secured Term Loans | Transfers out of Level 3 | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Senior Secured Term Loans | Purchases of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 166,660 | 614,636 |
Senior Secured Term Loans | PIK Interest | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 19,413 | 7,994 |
Senior Secured Term Loans | Sales or Prepayments of investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (289,034) | (151,905) |
Senior Secured Term Loans | Scheduled Principal Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (7,331) | |
Senior Secured Term Loans | Scheduled Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (9,754) | |
Senior Secured Term Loans | Amortization of Fixed Income Premiums or Accretion of Discounts | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 8,527 | 6,743 |
Senior Secured Term Loans | Net Realized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (17,013) | 0 |
Senior Secured Term Loans | Net Change in Unrealized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 2,756 | (10,647) |
Senior Secured Term Loans | Ending Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 964,099 | 1,080,121 |
Senior Secured Term Loans | Change in Unrealized Gain (loss) on Level 3 Investments Still Held | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (7,746) | (9,752) |
Second Lien Term Loans | Beginning Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 13,654 | 12,873 |
Second Lien Term Loans | Transfers out of Level 3 | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Second Lien Term Loans | Purchases of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Second Lien Term Loans | PIK Interest | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 511 | 661 |
Second Lien Term Loans | Sales or Prepayments of investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Second Lien Term Loans | Scheduled Principal Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Second Lien Term Loans | Scheduled Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Second Lien Term Loans | Amortization of Fixed Income Premiums or Accretion of Discounts | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 114 | 120 |
Second Lien Term Loans | Net Realized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Second Lien Term Loans | Net Change in Unrealized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 120 | 0 |
Second Lien Term Loans | Ending Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 14,399 | 13,654 |
Second Lien Term Loans | Change in Unrealized Gain (loss) on Level 3 Investments Still Held | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 121 | 0 |
Convertible Note | Beginning Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Convertible Note | Transfers out of Level 3 | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Convertible Note | Purchases of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 1,357 | |
Convertible Note | PIK Interest | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Convertible Note | Sales or Prepayments of investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Convertible Note | Scheduled Principal Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Convertible Note | Amortization of Fixed Income Premiums or Accretion of Discounts | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Convertible Note | Net Realized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Convertible Note | Net Change in Unrealized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Convertible Note | Ending Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 1,357 | |
Convertible Note | Change in Unrealized Gain (loss) on Level 3 Investments Still Held | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Preferred Stock | Beginning Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 347 | 1,332 |
Preferred Stock | Transfers out of Level 3 | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Preferred Stock | Purchases of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 28,220 | 0 |
Preferred Stock | PIK Interest | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Preferred Stock | Sales or Prepayments of investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | (800) |
Preferred Stock | Scheduled Principal Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Preferred Stock | Scheduled Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Preferred Stock | Amortization of Fixed Income Premiums or Accretion of Discounts | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Preferred Stock | Net Realized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | (2,000) |
Preferred Stock | Net Change in Unrealized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (2,282) | 1,815 |
Preferred Stock | Ending Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 26,285 | 347 |
Preferred Stock | Change in Unrealized Gain (loss) on Level 3 Investments Still Held | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (2,282) | (115) |
Common Stock | Beginning Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 1,174 | 0 |
Common Stock | Transfers out of Level 3 | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Common Stock | Purchases of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 16 | 4,551 |
Common Stock | PIK Interest | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Common Stock | Sales or Prepayments of investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Common Stock | Scheduled Principal Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Common Stock | Scheduled Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Common Stock | Amortization of Fixed Income Premiums or Accretion of Discounts | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Common Stock | Net Realized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Common Stock | Net Change in Unrealized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (318) | (3,377) |
Common Stock | Ending Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 872 | 1,174 |
Common Stock | Change in Unrealized Gain (loss) on Level 3 Investments Still Held | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (317) | (3,377) |
Equity Interest | Beginning Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Equity Interest | Transfers out of Level 3 | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Equity Interest | Purchases of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 950 | |
Equity Interest | PIK Interest | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Equity Interest | Sales or Prepayments of investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Equity Interest | Scheduled Principal Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Equity Interest | Amortization of Fixed Income Premiums or Accretion of Discounts | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Equity Interest | Net Realized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Equity Interest | Net Change in Unrealized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Equity Interest | Ending Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 950 | |
Equity Interest | Change in Unrealized Gain (loss) on Level 3 Investments Still Held | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Warrants | Beginning Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 16,650 | 20,087 |
Warrants | Transfers out of Level 3 | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (891) | (2,239) |
Warrants | Purchases of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 2,851 | 3,404 |
Warrants | PIK Interest | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Warrants | Sales or Prepayments of investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (44) | (1,508) |
Warrants | Scheduled Principal Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Warrants | Scheduled Repayments of Investments | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | |
Warrants | Amortization of Fixed Income Premiums or Accretion of Discounts | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 0 | 0 |
Warrants | Net Realized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (1,374) | (851) |
Warrants | Net Change in Unrealized Gain (Loss) | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | (4,354) | (2,243) |
Warrants | Ending Fair Value | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | 12,838 | 16,650 |
Warrants | Change in Unrealized Gain (loss) on Level 3 Investments Still Held | ||
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items] | ||
Level 3 assets measured at fair value | $ (5,893) | $ (4,889) |
Fair Value Measurements - Sch_3
Fair Value Measurements - Schedule of Quantitative Information Regarding Level 3 Fair Value Measurements (Details) - Level 3 $ in Thousands | Dec. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 1,020,800 | $ 1,111,946 |
Senior Secured Term Loans | Discounted Cash Flow Analysis | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 904,739 | $ 1,053,748 |
Senior Secured Term Loans | Discounted Cash Flow Analysis | Minimum | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.108 | 0.111 |
Senior Secured Term Loans | Discounted Cash Flow Analysis | Minimum | Origination Yield | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.108 | 0.105 |
Senior Secured Term Loans | Discounted Cash Flow Analysis | Minimum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.0029 | |
Senior Secured Term Loans | Discounted Cash Flow Analysis | Maximum | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.222 | 0.28 |
Senior Secured Term Loans | Discounted Cash Flow Analysis | Maximum | Origination Yield | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.199 | 0.193 |
Senior Secured Term Loans | Discounted Cash Flow Analysis | Maximum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.0749 | |
Senior Secured Term Loans | Discounted Cash Flow Analysis | Weighted Average | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.15 | 0.152 |
Senior Secured Term Loans | Discounted Cash Flow Analysis | Weighted Average | Origination Yield | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.136 | 0.129 |
Senior Secured Term Loans | Discounted Cash Flow Analysis | Weighted Average | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.0366 | |
Senior Secured Term Loans | PWERM | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 59,360 | $ 26,373 |
Senior Secured Term Loans | PWERM | Minimum | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.203 | 0.274 |
Senior Secured Term Loans | PWERM | Minimum | Origination Yield | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.108 | |
Senior Secured Term Loans | PWERM | Minimum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.0095 | |
Senior Secured Term Loans | PWERM | Maximum | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.465 | 0.374 |
Senior Secured Term Loans | PWERM | Maximum | Origination Yield | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.297 | |
Senior Secured Term Loans | PWERM | Maximum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.0316 | |
Senior Secured Term Loans | PWERM | Weighted Average | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.288 | 0.309 |
Senior Secured Term Loans | PWERM | Weighted Average | Origination Yield | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.173 | |
Senior Secured Term Loans | PWERM | Weighted Average | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.0189 | |
Second Lien Term Loans | Discounted Cash Flow Analysis | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 14,399 | $ 13,654 |
Second Lien Term Loans | Discounted Cash Flow Analysis | Minimum | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.161 | 0.161 |
Second Lien Term Loans | Discounted Cash Flow Analysis | Minimum | Origination Yield | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.131 | 0.122 |
Second Lien Term Loans | Discounted Cash Flow Analysis | Maximum | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.161 | 0.161 |
Second Lien Term Loans | Discounted Cash Flow Analysis | Maximum | Origination Yield | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.131 | 0.122 |
Second Lien Term Loans | Discounted Cash Flow Analysis | Weighted Average | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.161 | 0.161 |
Second Lien Term Loans | Discounted Cash Flow Analysis | Weighted Average | Origination Yield | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.131 | 0.122 |
Convertible Note | PWERM | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 1,357 | |
Convertible Note | PWERM | Minimum | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.45 | |
Convertible Note | PWERM | Minimum | Origination Yield | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.108 | |
Convertible Note | PWERM | Maximum | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.45 | |
Convertible Note | PWERM | Maximum | Origination Yield | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.108 | |
Convertible Note | PWERM | Weighted Average | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.45 | |
Convertible Note | PWERM | Weighted Average | Origination Yield | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Debt securities, measurement input | 0.108 | |
Preferred Stock | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 120 | $ 347 |
Preferred Stock | PWERM | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 26,038 | |
Preferred Stock | PWERM | Minimum | Risk-Free Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.047 | |
Preferred Stock | PWERM | Minimum | Average Industry Volatility | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.40 | |
Preferred Stock | PWERM | Minimum | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, outstanding term | 2 years | |
Preferred Stock | PWERM | Minimum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.0446 | |
Preferred Stock | PWERM | Maximum | Risk-Free Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.047 | |
Preferred Stock | PWERM | Maximum | Average Industry Volatility | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.40 | |
Preferred Stock | PWERM | Maximum | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, outstanding term | 2 years | |
Preferred Stock | PWERM | Maximum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.0446 | |
Preferred Stock | PWERM | Weighted Average | Risk-Free Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.047 | |
Preferred Stock | PWERM | Weighted Average | Average Industry Volatility | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.40 | |
Preferred Stock | PWERM | Weighted Average | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, outstanding term | 2 years | |
Preferred Stock | PWERM | Weighted Average | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.0446 | |
Preferred Stock | Waterfall Approach | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 127 | |
Preferred Stock | Waterfall Approach | Minimum | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, outstanding term | 3 years | |
Preferred Stock | Waterfall Approach | Minimum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.04 | |
Preferred Stock | Waterfall Approach | Maximum | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, outstanding term | 3 years | |
Preferred Stock | Waterfall Approach | Maximum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.04 | |
Preferred Stock | Waterfall Approach | Weighted Average | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, outstanding term | 3 years | |
Preferred Stock | Waterfall Approach | Weighted Average | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.04 | |
Common Stock | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 16 | 1,174 |
Common Stock | Option Pricing Model | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 856 | |
Common Stock | Option Pricing Model | Minimum | Risk-free Interest Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.043 | |
Common Stock | Option Pricing Model | Minimum | Average Industry Volatility | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.35 | |
Common Stock | Option Pricing Model | Minimum | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, outstanding term | 5 years | |
Common Stock | Option Pricing Model | Minimum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.0328 | |
Common Stock | Option Pricing Model | Maximum | Risk-free Interest Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.043 | |
Common Stock | Option Pricing Model | Maximum | Average Industry Volatility | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.35 | |
Common Stock | Option Pricing Model | Maximum | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, outstanding term | 5 years | |
Common Stock | Option Pricing Model | Maximum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.0328 | |
Common Stock | Option Pricing Model | Weighted Average | Risk-free Interest Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.043 | |
Common Stock | Option Pricing Model | Weighted Average | Average Industry Volatility | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.35 | |
Common Stock | Option Pricing Model | Weighted Average | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, outstanding term | 5 years | |
Common Stock | Option Pricing Model | Weighted Average | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.0328 | |
Equity Interest | PWERM | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 950 | |
Equity Interest | PWERM | Minimum | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.20 | |
Equity Interest | PWERM | Maximum | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.20 | |
Equity Interest | PWERM | Weighted Average | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Equity securities, measurement input | 0.20 | |
Warrants | Option Pricing Model | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 7,075 | $ 10,246 |
Warrants | Option Pricing Model | Minimum | Risk-free Interest Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.038 | 0.027 |
Warrants | Option Pricing Model | Minimum | Average Industry Volatility | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.25 | 0.25 |
Warrants | Option Pricing Model | Minimum | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, term | 9 months 18 days | 6 months |
Warrants | Option Pricing Model | Minimum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.0095 | 0.0116 |
Warrants | Option Pricing Model | Maximum | Risk-free Interest Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.053 | 0.049 |
Warrants | Option Pricing Model | Maximum | Average Industry Volatility | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 1.088 | 0.984 |
Warrants | Option Pricing Model | Maximum | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, term | 8 years 2 months 12 days | 5 years |
Warrants | Option Pricing Model | Maximum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.0749 | 0.8863 |
Warrants | Option Pricing Model | Weighted Average | Risk-free Interest Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.045 | 0.043 |
Warrants | Option Pricing Model | Weighted Average | Average Industry Volatility | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.454 | 0.49 |
Warrants | Option Pricing Model | Weighted Average | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, term | 3 years 1 month 6 days | 2 years 2 months 12 days |
Warrants | Option Pricing Model | Weighted Average | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.0395 | 0.0547 |
Warrants | PWERM | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 3,912 | $ 6,404 |
Warrants | PWERM | Minimum | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.20 | |
Warrants | PWERM | Minimum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.0235 | |
Warrants | PWERM | Maximum | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.40 | |
Warrants | PWERM | Maximum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 1.9938 | |
Warrants | PWERM | Weighted Average | Discount Rate | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.346 | |
Warrants | PWERM | Weighted Average | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.131 | |
Warrants | Waterfall Approach | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Investments | $ 1,851 | |
Warrants | Waterfall Approach | Minimum | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, term | 3 years | |
Warrants | Waterfall Approach | Minimum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.0258 | |
Warrants | Waterfall Approach | Maximum | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, term | 3 years | |
Warrants | Waterfall Approach | Maximum | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.04 | |
Warrants | Waterfall Approach | Weighted Average | Estimated Time to Exit | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, term | 3 years | |
Warrants | Waterfall Approach | Weighted Average | Revenue Multiples | ||
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] | ||
Warrants outstanding, measurement input | 0.0339 |
Concentration of Credit Risk -
Concentration of Credit Risk - Additional Information (Details) - Credit Concentration Risk - PortfolioCompanies | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Total Fair value of Investments | ||
Concentration Risk [Line Items] | ||
Number of largest portfolio investment companies | 5 | 5 |
Total Fair value of Investments | Investment in Portfolio Companies | ||
Concentration Risk [Line Items] | ||
Concentration of credit risk, percentage | 38% | 30% |
Net Assets | ||
Concentration Risk [Line Items] | ||
Number of largest portfolio investment companies | 14 | 16 |
Net Assets | Minimum | ||
Concentration Risk [Line Items] | ||
Concentration of credit risk, percentage | 5% | 5% |
Commitments and Contingencies -
Commitments and Contingencies - Summary of Payments Due by Period (Details) - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 |
Commitments And Contingencies [LineItems] | |||||||
Borrowings | $ 519,250,000 | $ 559,250,000 | $ 81,000,000 | $ 99,000,000 | $ 61,000,000 | $ 59,500,000 | $ 0 |
Borrowings, 1-3 years | 367,000,000 | ||||||
Borrowings, 3-5 years | 152,250,000 | 559,250,000 | |||||
Deferred Incentive Fees | 12,500,000 | 8,808,000 | |||||
Deferred Incentive Fees, Less than 1 Year | 2,567,000 | 674,000 | |||||
Deferred Incentive Fees, 1-3 years | 3,919,000 | 1,760,000 | |||||
Deferred Incentive Fees, 3-5 years | 2,548,000 | 1,023,000 | |||||
Deferred Incentive Fees, More than 5 Years | 131,000 | 1,552,000 | |||||
Commitments | 528,415,000 | 564,259,000 | |||||
Commitments, Less than 1 Year | 2,567,000 | 674,000 | |||||
Commitments, 1-3 years | 370,919,000 | 1,760,000 | |||||
Commitments, 3-5 years | 154,798,000 | 560,273,000 | |||||
Commitments, More than 5 Years | 131,000 | 1,552,000 | |||||
Unsecured Debt | 2026 Notes | |||||||
Commitments And Contingencies [LineItems] | |||||||
Borrowings | 95,000,000 | 70,000,000 | |||||
Borrowings, 1-3 years | 95,000,000 | ||||||
Borrowings, 3-5 years | 70,000,000 | ||||||
Unsecured Debt | 2027 Notes | |||||||
Commitments And Contingencies [LineItems] | |||||||
Borrowings | 152,250,000 | 152,250,000 | |||||
Borrowings, 3-5 years | 152,250,000 | 152,250,000 | |||||
Credit Facility | |||||||
Commitments And Contingencies [LineItems] | |||||||
Borrowings | 272,000,000 | 337,000,000 | $ 61,000,000 | $ 99,000,000 | $ 61,000,000 | ||
Borrowings, 1-3 years | 272,000,000 | ||||||
Borrowings, 3-5 years | 337,000,000 | ||||||
Deferred Payments | Advisory Agreement | |||||||
Commitments And Contingencies [LineItems] | |||||||
Deferred Incentive Fees | 9,165,000 | 5,009,000 | |||||
Borrowings | |||||||
Commitments And Contingencies [LineItems] | |||||||
Borrowings | 519,250,000 | 559,250,000 | |||||
Borrowings | Credit Facility | |||||||
Commitments And Contingencies [LineItems] | |||||||
Borrowings | $ 272,000,000 | $ 337,000,000 |
Commitments and Contingencies_2
Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Commitments and Contingencies Disclosure [Abstract] | ||
Unfunded loan commitments | $ 201,520 | $ 315,685 |
Commitments and Contingencies_3
Commitments and Contingencies - Schedule of Unfunded Commitments to Extend Financing (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | $ 201,520 | $ 315,685 |
3PL Central LLC (dba Extensiv) | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 11,500 | 15,000 |
Betterment Holdings, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 5,000 | |
Blueshift Labs, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 14,500 | |
Bombora, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 2,000 | |
Brivo, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 6,000 | 16,000 |
CloudPay, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 15,000 | |
Dtex Systems, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 15,000 | |
EBR Systems, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 10,000 | 30,000 |
Intellisite Holdings, Inc. (dba Epic IO Technologies, Inc.) | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 6,000 | |
Interactions Corporation | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 10,000 | 10,000 |
Kin Insurance, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 25,000 | |
Linxup, LLC | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 7,500 | |
Madison Reed, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 1,200 | 2,400 |
Moximed, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 15,000 | 15,000 |
Nalu Medical, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 15,000 | 25,000 |
Revelle Aesthetics, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 12,500 | |
Route 92 Medical, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 20,000 | 42,000 |
SetPoint Medical Corporation | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 40,000 | 40,000 |
Skillshare, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 10,000 | 15,000 |
Snagajob.com, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 6,785 | 6,785 |
Snagajob.com, Inc. | Convertible Note | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | 2,035 | |
Synack, Inc. | Senior Secured Term Loan | ||
Schedule Of Investments [Line Items] | ||
Total unused commitments to extend financing | $ 25,000 | $ 25,000 |
Net Increase in Net Assets Resu
Net Increase in Net Assets Resulting from Operations per Common Share - Computation of Basic Income Per Common Share (Detail) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |||||||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Earnings Per Share [Abstract] | ||||||||
Net Income (Loss) | $ 44,341 | $ 32,250 | $ 45,619 | |||||
Weighted-average shares outstanding for the period | ||||||||
Basic | 40,509,269 | 40,971,242 | 34,183,358 | 27,617,425 | 18,701,021 | 9,300,960 | 2,795,274 | 10,774 |
Diluted | 40,509,269 | 40,971,242 | 34,183,358 | |||||
Basic and diluted income per common share | ||||||||
Basic | $ 1.09 | $ 0.79 | $ 1.33 | |||||
Diluted | $ 1.09 | $ 0.79 | $ 1.33 |
Net Assets - Additional Informa
Net Assets - Additional Information (Details) - USD ($) | 1 Months Ended | 12 Months Ended | 22 Months Ended | 24 Months Ended | ||||||||
Nov. 02, 2023 | Oct. 25, 2021 | Dec. 01, 2017 | Oct. 31, 2015 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Mar. 24, 2021 | Dec. 31, 2023 | Sep. 29, 2021 | Feb. 24, 2022 | Mar. 31, 2020 | |
Class Of Stock [Line Items] | ||||||||||||
Common stock, shares authorized | 100,000,000 | 100,000,000 | 100,000,000 | |||||||||
Common stock, par value | $ 0.01 | $ 0.01 | $ 0.01 | |||||||||
Proceeds from common stock issued | $ 119,294,000 | |||||||||||
Issuance of common stock, value | 119,294,000 | |||||||||||
Stock repurchased during period, shares | 0 | 871,345 | 0 | |||||||||
Stock repurchased during period, value | $ 10,800,000 | |||||||||||
Dividends common stock | $ 73,322,000 | $ 51,593,000 | $ 44,943,000 | |||||||||
Stock issued during period, shares, dividend reinvestment plan | 204,658 | 781,498 | 1,830,974 | |||||||||
Stock issued during period, value, dividend reinvestment plan | $ 2,500,000 | $ 10,900,000 | $ 26,995,000 | |||||||||
Maximum cost of shares that may be repurchased | $ 25,000,000 | $ 25,000,000 | $ 25,000,000 | $ 25,000,000 | ||||||||
Stock repurchase program, expiration date | Nov. 02, 2024 | Feb. 24, 2023 | ||||||||||
Dividend Paid | ||||||||||||
Class Of Stock [Line Items] | ||||||||||||
Dividends common stock | $ 73,300,000 | |||||||||||
Dividends Paid In Cash | ||||||||||||
Class Of Stock [Line Items] | ||||||||||||
Dividends common stock | 70,800,000 | 40,700,000 | 17,900,000 | |||||||||
Dividend Declared | ||||||||||||
Class Of Stock [Line Items] | ||||||||||||
Dividends common stock | $ 73,300,000 | $ 51,600,000 | $ 44,900,000 | |||||||||
R. David Spreng | ||||||||||||
Class Of Stock [Line Items] | ||||||||||||
Issuance of common stock, Shares | 1,667 | |||||||||||
Issuance of common stock, value | $ 25,000 | |||||||||||
Runway Growth Holdings LLC | ||||||||||||
Class Of Stock [Line Items] | ||||||||||||
Issuance of common stock, Shares | 22,564 | |||||||||||
Issuance of common stock, value | $ 300,000 | |||||||||||
Offering price | $ 15 | $ 15 | ||||||||||
IPO | ||||||||||||
Class Of Stock [Line Items] | ||||||||||||
Issuance of common stock, Shares | 6,850,000 | |||||||||||
Offering price | $ 14.6 | |||||||||||
Proceeds from common stock issued | $ 93,000,000 | |||||||||||
Initial Private Offering | ||||||||||||
Class Of Stock [Line Items] | ||||||||||||
Issuance of common stock, Shares | 18,241,157 | |||||||||||
Issuance of common stock, value | $ 275,000,000 | |||||||||||
Second Private Offering | ||||||||||||
Class Of Stock [Line Items] | ||||||||||||
Issuance of common stock, Shares | 9,617,379 | |||||||||||
Issuance of common stock, value | $ 144,300,000 | |||||||||||
Capital commitments | $ 181,700,000 |
Net Assets - Summary of Distrib
Net Assets - Summary of Distributions Declared and Paid (Details) - $ / shares | 12 Months Ended | ||||||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | ||
Dividends Payable [Line Items] | |||||||
Amount per Share | [1] | $ 1.81 | $ 1.26 | $ 1.33 | $ 1.49 | $ 2.2 | $ 0.75 |
May 3, 2018 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | May 03, 2018 | ||||||
Type | Quarterly | ||||||
Record Date | May 15, 2018 | ||||||
Payment Date | May 31, 2018 | ||||||
Amount per Share | $ 0.15 | ||||||
July 26, 2018 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Jul. 26, 2018 | ||||||
Type | Quarterly | ||||||
Record Date | Aug. 15, 2018 | ||||||
Payment Date | Aug. 31, 2018 | ||||||
Amount per Share | $ 0.25 | ||||||
November 1, 2018 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Nov. 01, 2018 | ||||||
Type | Quarterly | ||||||
Record Date | Oct. 31, 2018 | ||||||
Payment Date | Nov. 15, 2018 | ||||||
Amount per Share | $ 0.35 | ||||||
March 22, 2019 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Mar. 22, 2019 | ||||||
Type | Quarterly | ||||||
Record Date | Mar. 22, 2019 | ||||||
Payment Date | Mar. 26, 2019 | ||||||
Amount per Share | $ 0.4 | ||||||
May 2, 2019 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | May 02, 2019 | ||||||
Type | Quarterly | ||||||
Record Date | May 07, 2019 | ||||||
Payment Date | May 21, 2019 | ||||||
Amount per Share | $ 0.45 | ||||||
May 2, 2019 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | May 02, 2019 | ||||||
Type | Quarterly | ||||||
Record Date | May 31, 2019 | ||||||
Payment Date | Jul. 16, 2019 | ||||||
Amount per Share | $ 0.46 | ||||||
July 30, 2019 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Jul. 30, 2019 | ||||||
Type | Quarterly | ||||||
Record Date | Aug. 05, 2019 | ||||||
Payment Date | Aug. 26, 2019 | ||||||
Amount per Share | $ 0.45 | ||||||
September 27, 2019 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Sep. 27, 2019 | ||||||
Type | Quarterly | ||||||
Record Date | Sep. 30, 2019 | ||||||
Payment Date | Nov. 12, 2019 | ||||||
Amount per Share | $ 0.04 | ||||||
December 9, 2019 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Dec. 09, 2019 | ||||||
Type | Quarterly | ||||||
Record Date | Dec. 10, 2019 | ||||||
Payment Date | Dec. 23, 2019 | ||||||
Amount per Share | $ 0.4 | ||||||
March 5, 2020 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Mar. 05, 2020 | ||||||
Type | Quarterly | ||||||
Record Date | Mar. 06, 2020 | ||||||
Payment Date | Mar. 20, 2020 | ||||||
Amount per Share | $ 0.4 | ||||||
May 7, 2020 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | May 07, 2020 | ||||||
Type | Quarterly | ||||||
Record Date | May 08, 2020 | ||||||
Payment Date | May 21, 2020 | ||||||
Amount per Share | $ 0.35 | ||||||
August 5, 2020 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Aug. 05, 2020 | ||||||
Type | Quarterly | ||||||
Record Date | Aug. 06, 2020 | ||||||
Payment Date | Aug. 20, 2020 | ||||||
Amount per Share | $ 0.36 | ||||||
October 1, 2020 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Oct. 01, 2020 | ||||||
Type | Quarterly | ||||||
Record Date | Oct. 01, 2020 | ||||||
Payment Date | Nov. 12, 2020 | ||||||
Amount per Share | $ 0.38 | ||||||
March 4, 2021 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Mar. 04, 2021 | ||||||
Type | Quarterly | ||||||
Record Date | Mar. 05, 2021 | ||||||
Payment Date | Mar. 19, 2021 | ||||||
Amount per Share | $ 0.37 | ||||||
April 29, 2021 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Apr. 29, 2021 | ||||||
Type | Quarterly | ||||||
Record Date | Apr. 30, 2021 | ||||||
Payment Date | May 13, 2021 | ||||||
Amount per Share | $ 0.37 | ||||||
July 19, 2021 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Jul. 19, 2021 | ||||||
Type | Quarterly | ||||||
Record Date | Jul. 20, 2021 | ||||||
Payment Date | Aug. 12, 2021 | ||||||
Amount per Share | $ 0.34 | ||||||
October 28, 2021 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Oct. 28, 2021 | ||||||
Type | Quarterly | ||||||
Record Date | Nov. 08, 2021 | ||||||
Payment Date | Nov. 22, 2021 | ||||||
Amount per Share | $ 0.25 | ||||||
February 24, 2022 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Feb. 24, 2022 | ||||||
Type | Quarterly | ||||||
Record Date | Mar. 08, 2022 | ||||||
Payment Date | Mar. 22, 2022 | ||||||
Amount per Share | $ 0.27 | ||||||
April 28, 2022 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Apr. 28, 2022 | ||||||
Type | Quarterly | ||||||
Record Date | May 10, 2022 | ||||||
Payment Date | May 24, 2022 | ||||||
Amount per Share | $ 0.3 | ||||||
July 28, 2022 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Jul. 28, 2022 | ||||||
Type | Quarterly | ||||||
Record Date | Aug. 09, 2022 | ||||||
Payment Date | Aug. 23, 2022 | ||||||
Amount per Share | $ 0.33 | ||||||
October 27, 2022 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Oct. 27, 2022 | ||||||
Type | Quarterly | ||||||
Record Date | Nov. 08, 2022 | ||||||
Payment Date | Nov. 22, 2022 | ||||||
Amount per Share | $ 0.36 | ||||||
February 23, 2023 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Feb. 23, 2023 | ||||||
Type | Quarterly | ||||||
Record Date | Mar. 07, 2023 | ||||||
Payment Date | Mar. 21, 2023 | ||||||
Amount per Share | $ 0.4 | ||||||
February 23, 2023 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Feb. 23, 2023 | ||||||
Type | Supplemental | ||||||
Record Date | Mar. 07, 2023 | ||||||
Payment Date | Mar. 21, 2023 | ||||||
Amount per Share | $ 0.05 | ||||||
May 2, 2023 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | May 02, 2023 | ||||||
Type | Quarterly | ||||||
Record Date | May 15, 2023 | ||||||
Payment Date | May 31, 2023 | ||||||
Amount per Share | $ 0.4 | ||||||
May 2, 2023 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | May 02, 2023 | ||||||
Type | Supplemental | ||||||
Record Date | May 15, 2023 | ||||||
Payment Date | May 31, 2023 | ||||||
Amount per Share | $ 0.05 | ||||||
August 1, 2023 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Aug. 01, 2023 | ||||||
Type | Quarterly | ||||||
Record Date | Aug. 15, 2023 | ||||||
Payment Date | Aug. 31, 2023 | ||||||
Amount per Share | $ 0.4 | ||||||
August 1, 2023 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Aug. 01, 2023 | ||||||
Type | Supplemental | ||||||
Record Date | Aug. 15, 2023 | ||||||
Payment Date | Aug. 31, 2023 | ||||||
Amount per Share | $ 0.05 | ||||||
November 1, 2023 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Nov. 01, 2023 | ||||||
Type | Quarterly | ||||||
Record Date | Nov. 13, 2023 | ||||||
Payment Date | Nov. 28, 2023 | ||||||
Amount per Share | $ 0.4 | ||||||
November 1, 2023 | |||||||
Dividends Payable [Line Items] | |||||||
Declaration Date | Nov. 01, 2023 | ||||||
Type | Supplemental | ||||||
Record Date | Nov. 13, 2023 | ||||||
Payment Date | Nov. 28, 2023 | ||||||
Amount per Share | $ 0.06 | ||||||
[1] All per share activity, excluding dividends, is calculated based on the weighted-average shares outstanding for the relevant period. |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Taxes Disclosure [Line Items] | |||
Percentage of minimum net ordinary income and net short-term capital gains in excess of net long-term capital losses for distribution | 90% | ||
Percentage of minimum distribution amount exceeds distributions for year | 4% | ||
Percentage of minimum capital gains exceed capital losses for distribution for one year period | 98.20% | ||
Percentage of minimum net ordinary income for each calendar for distribution | 98% | ||
Expense for U.S federal excise tax | $ 0.7 | $ 0.3 | $ 0 |
Payment of excise tax percentage | 4% | ||
Capital Loss Carryforward | |||
Income Taxes Disclosure [Line Items] | |||
Capital loss carryforward amount utilized to offset realized capital gains | $ 0 | $ 0 | $ 1.4 |
Income Taxes - Schedule of Tax
Income Taxes - Schedule of Tax Differences Primarily Related to Non-Deductible Excise Taxes Paid (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Taxes Disclosure [Line Items] | |||
Additional paid-in capital | $ 605,110 | $ 605,774 | |
Additional paid-in capital | $ 0 | ||
Accumulated undistributed earnings | $ 0 | ||
Accumulated undistributed earnings | (47,637) | (19,320) | |
Revision of Prior Period, Adjustment | |||
Income Taxes Disclosure [Line Items] | |||
Additional paid-in capital | (664) | (290) | |
Accumulated undistributed earnings | $ 664 | $ 290 |
Income Taxes - Summary of Tax C
Income Taxes - Summary of Tax Character of Distributions Paid (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||
Ordinary income | $ 73,322 | $ 51,593 | $ 44,943 |
Income Taxes - Summary of Tax_2
Income Taxes - Summary of Tax cost of Investments, Net and Gross Changes in Unrealized Appreciation (Depreciation) on Investments Owned (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Income Taxes Disclosure [Line Items] | |||
Net unrealized gain (loss) on a tax basis | $ (38,472) | $ (23,593) | $ 2,548 |
U.S. Federal Income Tax | |||
Income Taxes Disclosure [Line Items] | |||
Tax Cost of Investments | 1,105,481 | 1,149,902 | 726,969 |
Unrealized gain on a tax basis | 11,239 | 9,207 | 23,598 |
Unrealized loss on a tax basis | (49,711) | (32,800) | (21,050) |
Net unrealized gain (loss) on a tax basis | $ (38,472) | $ (23,593) | $ 2,548 |
Income Taxes - Summary of Compo
Income Taxes - Summary of Components of Distributable Earnings on a Tax Basis (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 |
Income Tax Disclosure [Abstract] | |||
Undistributed ordinary Income | $ 17,726 | $ 10,473 | $ 329 |
Capital loss carry forwards | (26,726) | (6,011) | (2,931) |
Other accumulated losses | (165) | (189) | (213) |
Net unrealized gain (loss) on a tax basis | (38,472) | (23,593) | 2,548 |
Accumulated earnings/(deficit) on a tax basis | $ (47,637) | $ (19,320) | $ (267) |
Derivative Financial Instrument
Derivative Financial Instruments - Additional Information (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Derivative Instruments, Gain (Loss) [Line Items] | |||
Net realized gain/(loss) | $ (1.4) | $ (0.9) | $ 0.8 |
Net change in unrealized investment | $ (5.2) | $ (2.3) | $ 2.8 |
Borrowings - Schedule of Borrow
Borrowings - Schedule of Borrowings (Details) - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 |
Debt Instrument [Line Items] | |||||||
Principal | $ 519,250,000 | $ 559,250,000 | $ 81,000,000 | $ 99,000,000 | $ 61,000,000 | $ 59,500,000 | $ 0 |
Carrying Value | 510,078,000 | 548,957,000 | |||||
Credit Facility | |||||||
Debt Instrument [Line Items] | |||||||
Principal | 272,000,000 | 337,000,000 | $ 61,000,000 | $ 99,000,000 | $ 61,000,000 | ||
Borrowings | |||||||
Debt Instrument [Line Items] | |||||||
Total Commitment | 797,250,000 | 647,250,000 | |||||
Principal | 519,250,000 | 559,250,000 | |||||
Deferred Debt Cost | (9,172,000) | (10,293,000) | |||||
Carrying Value | 510,078,000 | 548,957,000 | |||||
Borrowings | Credit Facility | |||||||
Debt Instrument [Line Items] | |||||||
Total Commitment | 550,000,000 | 425,000,000 | |||||
Principal | 272,000,000 | 337,000,000 | |||||
Deferred Debt Cost | (4,434,000) | (4,640,000) | |||||
Carrying Value | 267,566,000 | 332,360,000 | |||||
Borrowings | April 2026 Notes | |||||||
Debt Instrument [Line Items] | |||||||
Total Commitment | 25,000,000 | ||||||
Principal | 25,000,000 | ||||||
Deferred Debt Cost | (277,000) | ||||||
Carrying Value | 24,723,000 | ||||||
Borrowings | December 2026 Notes | |||||||
Debt Instrument [Line Items] | |||||||
Total Commitment | 70,000,000 | 70,000,000 | |||||
Principal | 70,000,000 | 70,000,000 | |||||
Deferred Debt Cost | (573,000) | (818,000) | |||||
Carrying Value | 69,427,000 | 69,182,000 | |||||
Borrowings | July 2027 Notes | |||||||
Debt Instrument [Line Items] | |||||||
Total Commitment | 80,500,000 | 80,500,000 | |||||
Principal | 80,500,000 | 80,500,000 | |||||
Deferred Debt Cost | (1,924,000) | (2,380,000) | |||||
Carrying Value | 78,576,000 | 78,120,000 | |||||
Borrowings | August 2027 Notes | |||||||
Debt Instrument [Line Items] | |||||||
Total Commitment | 20,000,000 | 20,000,000 | |||||
Principal | 20,000,000 | 20,000,000 | |||||
Deferred Debt Cost | (511,000) | (653,000) | |||||
Carrying Value | 19,489,000 | 19,347,000 | |||||
Borrowings | December 2027 Notes | |||||||
Debt Instrument [Line Items] | |||||||
Total Commitment | 51,750,000 | 51,750,000 | |||||
Principal | 51,750,000 | 51,750,000 | |||||
Deferred Debt Cost | (1,453,000) | (1,802,000) | |||||
Carrying Value | $ 50,297,000 | $ 49,948,000 |
Borrowings - Schedule of Compon
Borrowings - Schedule of Components of Interest Expense Amortization of Deferred Debt Costs, Unused Fees on Credit Facility and Other Costs (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Debt Instrument [Line Items] | |||
Interest Expense | $ 38,642 | $ 13,756 | $ 2,544 |
Amortization of Deferred Debt Costs | 3,027 | 1,390 | 472 |
Unused Facility and Other Fees | 1,474 | 1,615 | 1,126 |
Total Interest and Other Debt Financing Expenses | $ 43,143 | $ 16,761 | $ 4,142 |
Weighted Average Cost of Debt | 8.32% | 6.86% | 5.80% |
Credit Facility | |||
Debt Instrument [Line Items] | |||
Interest Expense | $ 22,559 | $ 7,713 | $ 2,492 |
Amortization of Deferred Debt Costs | 1,664 | 921 | 467 |
Unused Facility and Other Fees | 1,474 | 1,615 | 1,126 |
Total Interest and Other Debt Financing Expenses | $ 25,697 | $ 10,249 | $ 4,085 |
Weighted Average Cost of Debt | 9.24% | 7.60% | 5.82% |
April 2026 Notes | |||
Debt Instrument [Line Items] | |||
Interest Expense | $ 1,530 | ||
Amortization of Deferred Debt Costs | 87 | ||
Total Interest and Other Debt Financing Expenses | $ 1,617 | ||
Weighted Average Cost of Debt | 8.98% | ||
December 2026 Notes | |||
Debt Instrument [Line Items] | |||
Interest Expense | $ 2,975 | $ 2,734 | $ 52 |
Amortization of Deferred Debt Costs | 210 | 182 | 5 |
Total Interest and Other Debt Financing Expenses | $ 3,185 | $ 2,916 | $ 57 |
Weighted Average Cost of Debt | 4.55% | 4.52% | 4.69% |
July 2027 Notes | |||
Debt Instrument [Line Items] | |||
Interest Expense | $ 6,038 | $ 2,566 | |
Amortization of Deferred Debt Costs | 557 | 219 | |
Total Interest and Other Debt Financing Expenses | $ 6,595 | $ 2,785 | |
Weighted Average Cost of Debt | 8.19% | 8.04% | |
August 2027 Notes | |||
Debt Instrument [Line Items] | |||
Interest Expense | $ 1,400 | $ 467 | |
Amortization of Deferred Debt Costs | 142 | 44 | |
Total Interest and Other Debt Financing Expenses | $ 1,542 | $ 511 | |
Weighted Average Cost of Debt | 7.71% | 7.64% | |
December 2027 Notes | |||
Debt Instrument [Line Items] | |||
Interest Expense | $ 4,140 | $ 276 | |
Amortization of Deferred Debt Costs | 367 | 24 | |
Total Interest and Other Debt Financing Expenses | $ 4,507 | $ 300 | |
Weighted Average Cost of Debt | 8.71% | 8.44% |
Borrowings - Schedule of Comp_2
Borrowings - Schedule of Components of Interest Expense Amortization of Deferred Debt Costs, Unused Fees on Credit Facility and Other Costs (Parenthetical) (Details) $ in Millions | 12 Months Ended |
Dec. 31, 2022 USD ($) | |
Debt Disclosure [Abstract] | |
Supplemental fees | $ 0.2 |
Borrowings - Additional Informa
Borrowings - Additional Information (Details) - USD ($) | 12 Months Ended | |||||||||||||
Apr. 13, 2023 | Dec. 07, 2022 | Aug. 31, 2022 | Jul. 28, 2022 | Dec. 10, 2021 | May 31, 2019 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Feb. 10, 2022 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | |
Debt Instrument [Line Items] | ||||||||||||||
Unamortized deferred debt costs | $ 9,172,000 | $ 10,293,000 | ||||||||||||
Aggregate amount paid | 275,000,000 | 208,000,000 | $ 199,000,000 | |||||||||||
Net proceeds of sales of equity interests | 210,000,000 | 484,000,000 | 161,000,000 | |||||||||||
Debt instrument, outstanding balance | $ 519,250,000 | $ 559,250,000 | $ 81,000,000 | $ 99,000,000 | $ 61,000,000 | $ 59,500,000 | $ 0 | |||||||
Weighted Average | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Weighted average effective interest rate | 8.15% | 5.89% | ||||||||||||
Weighted average outstanding principal Credit Facility balance | $ 278,200,000 | $ 134,900,000 | ||||||||||||
Credit Facility | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Debt instrument principal amount | $ 100,000,000 | $ 550,000,000 | ||||||||||||
Line of credit facility stated maturity date | Apr. 20, 2025 | |||||||||||||
Expiration date | Apr. 20, 2026 | |||||||||||||
Line of credit facility, amortization period | 1 year | |||||||||||||
Credit Facility | Maximum | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Line of credit facility, maximum borrowing capacity | $ 600,000,000 | |||||||||||||
Variable advance rate | 65% | |||||||||||||
Unused commitment fees percentage | 1% | |||||||||||||
Credit Facility | Maximum | SOFR | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Applicable margin rate | 3.35% | |||||||||||||
Credit Facility | Minimum | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Unused commitment fees percentage | 0.25% | |||||||||||||
Credit Facility | Minimum | SOFR | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Applicable margin rate | 2.95% | |||||||||||||
2026 Notes | Long-Term Debt | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Debt instrument principal amount | $ 25,000,000 | $ 70,000,000 | ||||||||||||
Debt instrument, interest rate stated percentage | 8.54% | 4.25% | ||||||||||||
Debt instrument, interest rate increase percentage | 1% | |||||||||||||
2026 Notes | Long-Term Debt | Debt Instrument Initial Issuance Closed on December 10, 2021 | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Debt instrument principal amount | $ 20,000,000 | |||||||||||||
Debt instrument, description | The December 2026 Notes were issued in two closings; the initial issuance of $20.0 million closed on December 10, 2021 and the second issuance of $50.0 million closed on February 10, 2022. | |||||||||||||
2026 Notes | Long-Term Debt | Debt Instrument Second and Final Issuance Closed on February 10, 2022 | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Debt instrument principal amount | $ 50,000,000 | |||||||||||||
December 2026 Notes | Long-Term Debt | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Debt instrument, interest rate stated percentage | 4.25% | |||||||||||||
Debt instrument due date | Dec. 10, 2026 | |||||||||||||
Aggregate offering costs including underwriter's discounts and commissions | $ 1,000,000 | |||||||||||||
Unamortized deferred debt costs | $ 600,000 | 800,000 | ||||||||||||
Line of credit facility, interest rate description | Interest on the December 2026 Notes will be due semiannually in arrears on June 10 and December 10 of each year, commencing on June 10, 2022. | |||||||||||||
Debt instrument, frequency of periodic payment | semiannually | |||||||||||||
April 2026 Notes | Long-Term Debt | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Debt instrument, interest rate stated percentage | 8.54% | |||||||||||||
Debt instrument due date | Apr. 13, 2026 | |||||||||||||
Aggregate offering costs including underwriter's discounts and commissions | $ 400,000 | |||||||||||||
Unamortized deferred debt costs | $ 300,000 | 0 | ||||||||||||
Line of credit facility, interest rate description | Interest on the April 2026 Notes will be due semiannually in arrears on April 13 and October 13 of each year, commencing on October 13, 2023. | |||||||||||||
Debt instrument, frequency of periodic payment | semiannually | |||||||||||||
July 2027 Notes | Long-Term Debt | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Debt instrument principal amount | $ 80,500,000 | |||||||||||||
Debt instrument, interest rate stated percentage | 7.50% | |||||||||||||
Debt instrument due date | Jul. 28, 2027 | |||||||||||||
Aggregate offering costs including underwriter's discounts and commissions | $ 2,700,000 | |||||||||||||
Unamortized deferred debt costs | $ 1,900,000 | 2,400,000 | ||||||||||||
Line of credit facility, interest rate description | Interest on the 2027 Notes will be due quarterly in arrears on March 1, June 1, September 1 and December 1 of each year, commencing September 1, 2022. | |||||||||||||
Debt instrument, frequency of periodic payment | quarterly | |||||||||||||
Debt instrument redemption description | The July 2027 Notes may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after July 28, 2024, at a redemption price of $25 per July 2027 Note plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to the date fixed for redemption. | |||||||||||||
Debt instrument, redemption price per share | $ 25 | |||||||||||||
August 2027 Notes | Long-Term Debt | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Debt instrument principal amount | $ 20,000,000 | |||||||||||||
Debt instrument, interest rate stated percentage | 7% | |||||||||||||
Debt instrument due date | Aug. 31, 2027 | |||||||||||||
Aggregate offering costs including underwriter's discounts and commissions | $ 700,000 | |||||||||||||
Unamortized deferred debt costs | $ 500,000 | 700,000 | ||||||||||||
Line of credit facility, interest rate description | Interest on the August 2027 Notes will be due semiannually in arrears on February 15 and August 15 of each year, commencing on February 15, 2023. | |||||||||||||
Debt instrument, frequency of periodic payment | semiannually | |||||||||||||
December 2027 Notes | Long-Term Debt | ||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||
Debt instrument principal amount | $ 51,750,000 | |||||||||||||
Debt instrument, interest rate stated percentage | 8% | |||||||||||||
Debt instrument due date | Dec. 28, 2027 | |||||||||||||
Aggregate offering costs including underwriter's discounts and commissions | $ 1,800,000 | |||||||||||||
Unamortized deferred debt costs | $ 1,500,000 | $ 1,800,000 | ||||||||||||
Line of credit facility, interest rate description | Interest on the 2027 Notes will be due quarterly in arrears on March 1, June 1, September 1, and December 1 of each year, commencing March 1, 2023. | |||||||||||||
Debt instrument, frequency of periodic payment | quarterly | |||||||||||||
Debt instrument redemption description | The December 2027 Notes may be redeemed in whole or in part at any time or from time to time at the Company's option on or after December 31, 2024, at a redemption price of $25 per December 2027 Note plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to the date fixed for redemption. | |||||||||||||
Debt instrument, redemption price per share | $ 25 |
Borrowings - Schedule of Senior
Borrowings - Schedule of Senior Securities Outstanding (Details) - USD ($) | 12 Months Ended | ||||||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | |
Debt Instrument [Line Items] | |||||||
Amount outstanding | $ 519,250,000 | $ 559,250,000 | $ 81,000,000 | $ 99,000,000 | $ 61,000,000 | $ 59,500,000 | $ 0 |
Asset Coverage per Unit | 2,054,000 | 2,030,000 | 8,484,000 | 5,710,000 | 7,169,000 | 3,813,000 | |
2027 Senior Notes | |||||||
Debt Instrument [Line Items] | |||||||
Amount outstanding | 152,250,000 | 152,250,000 | |||||
Asset Coverage per Unit | 4,593,000 | 4,784,000 | |||||
2026 Senior Notes | |||||||
Debt Instrument [Line Items] | |||||||
Amount outstanding | 95,000,000 | 70,000,000 | 20,000,000 | ||||
Asset Coverage per Unit | 6,759,000 | 9,229,000 | 31,310,000 | ||||
Credit Facility | |||||||
Debt Instrument [Line Items] | |||||||
Amount outstanding | 272,000,000 | 337,000,000 | 61,000,000 | 99,000,000 | 61,000,000 | ||
Asset Coverage per Unit | $ 3,011,000 | $ 2,709,000 | $ 10,938,000 | $ 5,710,000 | $ 7,169,000 | ||
Credit Facility - CIBC | |||||||
Debt Instrument [Line Items] | |||||||
Amount outstanding | 59,500,000 | ||||||
Asset Coverage per Unit | $ 3,813,000 |
Financial Highlights - Schedule
Financial Highlights - Schedule of Financial Highlights (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | ||||||||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | ||
Investment Company, Financial Highlights [Line Items] | |||||||||
Net Asset Value Per Share, Beginning Balance | [1] | $ 14.22 | $ 14.65 | $ 14.84 | $ 14.58 | $ 15.14 | $ 14.66 | $ 10.38 | $ 15 |
Net investment income | [1] | 1.93 | 1.46 | 1.3 | 1.38 | 1.95 | 1.26 | (0.66) | (83.81) |
Total from investment operations | [1] | 1.09 | 0.79 | 1.33 | 1.71 | 1.48 | 1.26 | (0.52) | (83.82) |
Distributions | [1] | (1.81) | (1.26) | (1.33) | (1.49) | (2.2) | (0.75) | ||
Offering costs | [1] | (0.21) | (0.03) | ||||||
Accretion (dilution) | [1],[2] | 0.04 | 0.02 | 0.04 | 0.19 | (0.03) | 4.8 | 79.2 | |
Net Asset Value Per Share, Ending Balance | [1] | $ 13.5 | $ 14.22 | $ 14.65 | $ 14.84 | $ 14.58 | $ 15.14 | $ 14.66 | $ 10.38 |
Net assets at beginning of period | $ 576,052 | $ 606,195 | $ 466,244 | $ 376,313 | $ 167,369 | $ 127,040 | $ 3,477 | $ 25 | |
Net assets at end of period | 547,071 | 576,052 | 606,195 | 466,244 | 376,313 | 167,369 | 127,040 | 3,477 | |
Weighted average net assets | $ 574,594 | $ 589,669 | $ 508,836 | $ 403,188 | $ 283,774 | $ 141,046 | $ 40,389 | $ 152 | |
Weighted average shares outstanding, Basic | 40,509,269 | 40,971,242 | 34,183,358 | 27,617,425 | 18,701,021 | 9,300,960 | 2,795,274 | 10,774 | |
Ratio/Supplemental Data: | |||||||||
Total return based on net asset value | [3] | 7.67% | 5.67% | 7.68% | 12% | 10.83% | 8.39% | 41.23% | (30.80%) |
Total return based on market value | [4] | 0.245 | 0.0023 | ||||||
Ratio of net investment income to average net assets | [5],[6] | 13.62% | 10.14% | 8.74% | 9.44% | 12.85% | 8.30% | (4.56%) | (595.90%) |
Ratio of total operating expenses to average net assets | [5],[6] | 14.96% | 8.13% | 5.23% | 4.85% | 6.58% | 6.42% | 12.46% | 595.90% |
Ratio of total operating expenses excluding incentive fees to average net assets | [6] | 11.64% | 5.90% | 3.41% | 3.05% | 3.64% | 5.42% | 12.46% | 595.90% |
Ratio of net increase (decrease) in net assets resulting from operations to average net assets | [6] | 7.72% | 5.47% | 8.97% | 11.65% | 9.74% | 8.34% | (3.56%) | (595.90%) |
Portfolio turnover rate | [7] | 18.61% | 19.17% | 52.05% | 26.31% | 35.72% | 14.08% | 206.80% | |
Net Realized Gain (Loss) | |||||||||
Investment Company, Financial Highlights [Line Items] | |||||||||
Net realized gain (loss) and Change in unrealized (loss) | [1] | $ (0.45) | $ (0.03) | $ 0.12 | $ (0.19) | $ 0.03 | |||
Net Change in Unrealized Gain (Loss) | |||||||||
Investment Company, Financial Highlights [Line Items] | |||||||||
Net realized gain (loss) and Change in unrealized (loss) | [1] | $ (0.39) | $ (0.64) | $ (0.09) | $ 0.52 | $ (0.5) | $ 0.14 | $ (0.01) | |
[1] All per share activity, excluding dividends, is calculated based on the weighted-average shares outstanding for the relevant period. Accretion (dilution) represents the effect of issuance of common stock and repurchase of treasury stock. Total return based on net asset value is calculated as the change in net asset value per share during the period plus dividends per share, divided by the beginning net asset values per share. Total return based on market value is calculated as the change in market value per share during the period plus dividends per share, divided by the beginning market value per share. For the periods 2021 and prior, total return based on market value is not applicable as the Company was not yet public for the entirety of the period. The ratio includes incentive fees and as incentive fees are performance driven, the amount expensed in future periods may vary significantly and is dependent on overall investment performance, early terminations, scheduled prepayments and other liquidity events. The ratios are calculated based on weighted average net assets for the relevant period. The portfolio turnover rate for the period is calculated by taking the lesser of investment portfolio purchases or sales during the period, divided by the average investment portfolio value during the period. |
Subsequent Events - Additional
Subsequent Events - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |||||
Feb. 14, 2024 | Feb. 01, 2024 | Jan. 01, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Subsequent Event [Line Items] | ||||||
Investment Owned, at Fair Value | $ 1,067,009 | $ 1,126,309 | ||||
Percentage of Net Assets | 195.04% | 195.52% | ||||
Repayment of senior secured loan | $ 296,409 | $ 168,898 | $ 303,602 | |||
Investment fund | 1,106,849 | $ 1,150,602 | ||||
Subsequent Event | ||||||
Subsequent Event [Line Items] | ||||||
Subsequent event description | Effective January 1, 2024, the Company placed one loan to Mingle Healthcare Solutions, Inc. on non-accrual status | |||||
Dividend declared date | Feb. 01, 2024 | |||||
Ordinary distribution | $ 0.4 | |||||
Supplemental distribution | $ 0.07 | |||||
Record date | Feb. 12, 2024 | |||||
Dividends payable date | Feb. 28, 2024 | |||||
MarleySpoon SE | Subsequent Event | ||||||
Subsequent Event [Line Items] | ||||||
Principle repayments received | $ 7,100 | |||||
Mingle Healthcare Solutions Inc | ||||||
Subsequent Event [Line Items] | ||||||
Outstanding principal of loan | 4,300 | |||||
Investment Owned, at Fair Value | $ 3,800 | |||||
Percentage of Net Assets | 0.37% |